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ABSTRACT 
A comparison of host-parasite interactions between T. gondii and N. caninum 
Mariwan Musa Mohammed 
Toxoplasma gondii and Neospora caninum are closely related obligatory 
intracellular apicomplexan parasites that invade and multiply in almost all 
mammalian host cells. They cause disease in immunocompromised animals, abortion 
in the intermediates host and great economic losses to the farming industry. 
However, there are several biological differences between these parasites, including 
host range, zoonotic capacity, transmission, virulence and definitive host. What 
causes these biological differences is not well understood. To fully understand these 
biological differences, the host-parasite interactions of these parasites have been 
investigated in this study using several different approaches at the molecular level. 
Due to the importance of protein-protein interactions (PPIs) and multiple 
protein complexes (MPCs) in host-parasite interactions, blue native polyacrylamide 
gel electrophoresis (BN-PAGE) combined with liquid chromatography tandem mass 
spectrometry (LC MS/MS) was used to study T. gondii and N. caninum tachyzoites. 
Several interesting complexes were identified in N. caninum tachyzoites and include 
mitochondrial complexes, proteasome, glideosome and moving junction molecules 
that play an important role in the physiology and invasion of host cells. In addition, 
in T. gondii the microneme MIC1/6 complex was found migrated and/or co-
associated with the important surface antigen glycoprotein SAG1, which is critical in 
the initial interaction with host surface peptidoglycan. 
In order to understand the direct interactions between parasite secretory 
proteins such as dense granule proteins (GRA2 and GRA7) and host cell proteins; a 
pull-down assay has been used to elucidate the binding partners of expressed 
recombinant GRA2 and GRA7 in both parasites within the host cell lysate. Several 
methods were applied to purify the recombinant GRA proteins such as affinity 
chromatography using nickel or cobalt, salting-out, denaturing buffer using urea and 
reverse phase HPLC. TgGRA2 was successfully purified by HPLC and attempts 
have been made to study its role in host-parasite interactions using a pull-down 
assay. 
Since these parasites secrete an array of secretory proteins, including kinases, 
to manipulate host cell responses; phosphopeptide enrichment, combined with LC 
MS/MS has been used to study the global response in the host signalling pathway 
through protein phosphorylation and signal transduction in response to infection with 
T. gondii and N. caninum. Three important differences were identified; about one-
third of the phosphoproteomes of the host cell in response to infection by T. gondii 
and N. caninum was different. Approximately 21 % of the phospho-motifs were 
found differentially enriched between host cells infected with T. gondii compared to 
N. caninum infection and finally the pathway analysis showed that a few pathways 
were differentially enriched between infections with these parasites, such as 
glycolysis/gluconeogenesis and mTOR signalling pathway in infection with T. gondii 
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but not with N. caninum. The differences in the host cell phosphoproteome indicated 
that these parasites interact with the host cell differently.  
As a means of understanding the broader host response to infection with these 
parasites at the systems biology level, integrated data analyses were performed on 
quantitative data from the transcriptome, proteome and phosphoproteome of host 
cells infected with the two parasites. Data analyses showed that host cells produce 
more proteins in response to infection with T. gondii than with N. caninum after 36 
hours post infection (p.i.). In addition, data analysis showed that T. gondii inhibits 
apoptosis and acute inflammatory responses more when compared to N. caninum. 
Overall, the results presented in this thesis have provided new insights into 
the biological differences between T. gondii and N. caninum. Several interesting 
differences in host-parasite interactions at both the qualitative and quantitative levels 
were identified. These interactions are related to the virulence and transmission 
strategy of the parasites and so are potentially associated with the biological 
differences between these parasites. 
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1.1. Toxoplasma gondii and Neospora caninum 
Toxoplasma gondii and Neospora caninum are obligatory intracellular 
protozoan parasites belonging to the Apicomplexa that invade and multiply in almost 
all mammalian cells. The similarity in morphology between T. gondii and N. 
caninum has led to the misidentification of the latter as T. gondii until 1984 (Dubey 
et al., 2002). The Apicomplexa also include pathogens responsible for causing 
veterinary and medical illnesses: Eimeria (coccidiosis) (Lee et al., 2010), Theileria 
(theileriosis) (Perera et al., 2014), Babesia (babesiosis) (Homer et al., 2000), 
Plasmodium (the causative agent of malaria) (Gutman and Guarner, 2010) and 
Cryptosporidium (cryptosporidiosis) (Cama et al., 2007; Fayer et al., 1998). The 
members of this phylum are characterised by the presence of an apical complex 
(Speer et al., 1999). 
1.2. Economic impact of toxoplasmosis and neosporosis 
Toxoplasma gondii causes toxoplasmosis, a disease of veterinary and medical 
importance in almost all parts of the world (Tenter et al., 2000), while N. caninum is 
the causative pathogen of the veterinary disease neosporosis. T. gondii is considered 
a primary disease of humans and sheep (and goat and pigs) (Buxton and Innes, 1995; 
Dubey, 2003). In sheep, T. gondii has been documented as one of the primary causes 
of infective ovine abortion globally (Dubey and Beattie, 1988). The economic impact 
of toxoplasmosis in sheep is mainly associated with foetal resorption, abortion, 
stillbirth and neonatal mortality when infection occurs for the first time during 
pregnancy. In Uruguay, it has been reported to cause annual loses about 15-32 % of 
lambs per year which account for wastage of US$1.4-4.7 million (Freyre et al., 
1999). Seroprevalence studies of T. gondii from sheep all over the world between 
1988 and 2009 showed that positive sheep varied from 3-95.7 %, reviewed in Dubey 
(2009). 
In humans, acquired toxoplasmosis in most immunocompetent individuals is 
self-limiting without showing clinical symptoms (Luft and Remington, 1992). In 
pregnant women, congenital toxoplasmosis occurs as a result of primary acute 
infection with T. gondii leading to abortion (Montoya and Remington, 2008). In 
immunocompromised patients, such as those with AIDs, reactivation of chronic 
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infection in the brain and other tissues can result in necrotising encephalitis or even 
death with or without clinical symptoms (Dubey et al., 2012; Halonen and Weiss, 
2013). 
Neospora caninum causes neosporosis mainly in cattle and dogs and is 
consider as the major causes of abortion in cattle and great economic losses in farm 
animals worldwide (Dubey, 2003). In the UK, neosporosis has been found as the 
most frequently diagnosed cause of abortion in dairy cattle; estimated at 
approximately 12.5 % or 6000 abortions per year (Davison et al., 1999a). A recent 
UK study of the prevalence in cattle herds showed that > 90 % of herds was 
seropositive for N. caninum (Woodbine et al., 2008). Neosporosis in dogs can affect 
all ages and causes neuromuscular diseases most frequently in puppy and dogs less 
than six months old (Barber and Trees, 1996; Weissenböck et al., 1997). 
1.3. Life cycles of T. gondii and N. caninum 
The life cycles of T. gondii (Figure 1.1) and N. caninum (Figure 1.2) are 
heteroxenous and polyxenous and comprised of three infective stages: the 
tachyzoites, bradyzoites and sporozoites (Dubey, 2003; Dubey et al., 1998). The 
morphology and ultrastructure of infective stages are very similar between T. gondii 
and N. caninum (Lindsay et al., 1999a; McAllister et al., 1998; Speer et al., 1998; 
Speer et al., 1999). The definitive hosts are felids and canids for T. gondii and N. 
caninum, respectively; they shed environmentally resistant oocysts, which sporulate 
within 3-5 days of excretion (Dubey et al., 1998; McAllister et al., 1998). After 
ingestion of oocysts by intermediate hosts, sporozoites differentiate to tachyzoites 
and invade different cells and tissues. The tachyzoite is the actively moving, 
invading and multiplying stage, causing disease in almost all kind of host cells 
except the enteroepithelial cells of the definitive host (Frenkel, 1973). Following the 
invasion, tachyzoites reside within a non-fusogenic parasitophorous vacuole (PV) 
(Mordue et al., 1999a) and multiply asexually by repeated endodyogeny (Speer et 
al., 1999). In response to an increase in the host immunity, tachyzoite convert to 
slowly proliferating cyst-forming bradyzoites which can survive for many years in a 
quiescent state in immunocompetent hosts. Once the immunity is compromised, the 
bradyzoites reactivate and differentiate to tachyzoites which results in the 
reactivation of infection (Hemphill et al., 2006).  
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Figure 1.1: Life cycle of T. gondii, adapted from Dubey et al. (1998). 
 
 
 
Figure 1.2: Life cycle of N. caninum, adapted from Dubey (2003). 
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1.4. Hosts and transmission routes  
With toxoplasmosis, infected cats excrete oocysts in their faeces and 
contaminate soil, pasture and sources of water  (Dubey, 1998); consumption of food 
and water contaminated with oocysts results in infection of intermediate hosts. 
Almost all vertebrates including humans, are intermediate hosts (Elmore et al., 2010) 
and horizontal transmission is the main route of infection which leads to tissue cysts 
development primarily in the brain and other neural tissues. T. gondii is also 
transmitted vertically in pregnant intermediate hosts following oocyst infection as 
well as in human through ingestion of undercooked meat containing tissue cysts 
(Dubey, 2013; Torrey et al., 2013). Naïve cats may acquire the infection orally 
through the ingestion of animal tissues (intermediate hosts) infected with tachyzoites 
and tissue cysts as well as food and water contaminated with oocysts (Dubey et al., 
1998). 
In N. caninum, the range of intermediate hosts is narrow compared to T. 
gondii. Canids excrete oocysts which contaminate pasture and transmit horizontally 
to intermediate hosts such as cattle and other animals like sheep, goats, horses; dogs 
can also be intermediate hosts (Dubey, 2003; Dubey and Lindsay, 1996). Pigeons 
were also found infected with N. caninum and assumed to play role as natural 
reservoir host (Mineo et al., 2009). N. caninum so far has not been reported to cause 
infection and diseases in humans (Dubey et al., 2007; McCann et al., 2008). Dogs 
get infections orally through ingestion of infected animal tissues containing cysts 
(Cavalcante et al., 2011; Lindsay et al., 1999b; McAllister et al., 1998) by ingesting 
sporulated oocysts (Bandini et al., 2011) or may become infected by foetal fluids or 
placental material of infected cattle (Dijkstra et al., 2002a).  
N. caninum is mainly transmitted by vertical transmission from the infected 
pregnant dam to the foetus by crossing the placenta; it can be from acquiring an 
exogenous infection during pregnancy or reactivation of an endogenous infection 
(Trees and Williams, 2005). Transplacental transmission has been induced 
experimentally in dogs (Cole et al., 1995; Dubey and Lindsay, 1989) and reported in 
naturally infected dogs (Dubey et al., 1988; Dubey et al., 2005). To maintain 
continuous parasite life cycle in farm cattle; it is believed that both horizontal and 
vertical transmission routes are necessary in maintaining infection level (Dijkstra et 
al., 2002b; Williams et al., 2009). However, endogenous infection efficiencies in 
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dairy herds have been reported to be as high as 78-95 % (Davison et al., 1999b; Paré 
et al., 1997) and it is considered to be the main transmission route of N. caninum 
(Dubey et al., 2007; Williams et al., 2009).  
In general, there are several major biological differences between these 
parasites as shown in Table 1.1. 
 
Table 1.1. Main biological differences between T. gondii and N. caninum   
Biological difference T. gondii N. caninum References 
Host range Wide Narrow   
(Dubey, 2004; Dubey et 
al., 2007; Trees et al., 
1999) 
Zoonotic potential Yes  No  
(Dubey et al., 2007; 
McCann et al., 2008; 
Tenter et al., 2000) 
Transmission 
Mostly 
horizontally  
Mostly 
vertically  
(Davison et al., 1999b; 
Jones and Dubey, 2010; 
Williams et al., 2009). 
Virulence to host 
Strain 
specific 
virulence 
Reduced 
virulence 
(Lei et al., 2014; Reid et 
al., 2012; Saeij et al., 
2005) 
Definitive hosts Felids  Canids  
(Frenkel et al., 1970; 
McAllister et al., 1998) 
 
1.5. Host cell invasion by T. gondii and N. caninum and host-parasite 
interactions 
T. gondii and N. caninum are obligate intracellular organisms that have to 
invade host cells successfully in order to survive, grow, multiply and evade the 
immune system of the host (Besteiro et al., 2011; Hemphill et al., 1996; Ojo et al., 
2014). Invasive stages use the apical complex and secretary organelles proteins 
which sequentially released during host cell invasion resulting in host-parasite 
interactions, facilitate host cell invasion processes (Carruthers and Sibley, 1997) and 
recruitment of nutritional resources from the host cell (Coppens et al., 2006). Host-
parasite interaction happens during attachment and adhesion of invasive stages to the 
host cells membrane (Naguleswaran et al., 2002), invasion and PV formation 
(Besteiro et al., 2011; Besteiro et al., 2009), nutritional resource acquisition, 
Chapter One 
7 
 
maintenance of infection, multiplication within PV (Mercier et al., 2005) and 
manipulation of the host genome (Bougdour et al., 2013). 
1.5.1. The apical complex and secretory organelles of the infective stages 
Apical complex is the anterior part of the invasive stages consisting of apical 
rings, polar rings, a conoid, subpellicular microtubules and three invasion-related 
organelles called rhoptries, micronemes and dense granules (Naguleswaran et al., 
2002; Speer et al., 1999). The sequential protein secretions from these organelles 
(Figure 1.3) help the invasive stages to attach, invade, adapt and establish infection  
within the host cell (Besteiro et al., 2011; Carruthers and Sibley, 1997; Mercier et al., 
2005). 
 
 
Figure 1.3: Role of secretory organelles in invasion and establishment of infection by T. gondii. 
ROMs: Rhomboid protease(s). Adapted from (Carruthers and Boothroyd, 2007), more information 
added based on (Bougdour et al., 2014; Carruthers and Sibley, 1997; Mercier et al., 2005).  
 
1.5.1.1. Micronemes 
Micronemes are rod-like shape organelle mostly present in the anterior part of 
the zoites (Dubey et al., 1998). The proteins produce by micronemes are called MIC 
or MAP (MIC-associated proteins) (Buxton et al., 2002) are expressed by 33 and 38 
microneme genes of T. gondii and N. caninum, respectively (Reid et al., 2012). The 
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gliding activity of Apicomplexan parasites has been related to the abundance of the 
micronemes (Tomley and Soldati, 2001). In T. gondii, TgMIC2 (Carruthers and 
Sibley, 1997) and in N. caninum, NcMIC3 (Naguleswaran et al., 2002) initiates 
motility, attachment and invasion of the host cells. In both parasites, apical 
microneme antigen 1 (AMA1) is one of the main constituents of the moving junction 
(MJ) complex and plays an important role in host cell invasion (Alexander et al., 
2005; Besteiro et al., 2009; Zhang et al., 2007). 
In T. gondii, microneme proteins have different affinity within the parasite; 
some of the microneme proteins have transmembrane domains (e.g. MIC2, MIC6 
and MIC8) (Di Cristina et al., 2000; Reiss et al., 2001) and others are soluble 
proteins such as MIC1, MIC3, MIC4 and M2AP. The soluble microneme proteins 
are targeted to and associate with transmembrane microneme proteins which function 
as escalator and form complexes, therefore any destruction in any one protein may 
affect complex formation and affects its partner targeting (Huynh et al., 2003; Reiss 
et al., 2001). Microneme proteins are characterised by having several different copies 
of the limited number of adhesive domains which implicated in activities related to 
host cell interaction and invasion, reviewed in Carruthers and Tomley (2008).  
1.5.1.2. Rhoptries 
Rhoptries are club-shaped apical complex organelles that consist of a narrow 
neck portion which extends into the interior of the conoid and connected posteriorly 
with bulb portion (Dubey et al., 1998). Rhoptry proteins are expressed by 68 rhoptry 
genes in both Neospora and Toxoplasma (Reid et al., 2012). The protein 
secretion/excretion of rhoptries called RON (when the proteins confined to the neck 
portion), while proteins of the rhoptry bulb compartment refers to as ROP (Besteiro 
et al., 2011). Rhoptry proteins play important roles in the initial invasion process and 
in the later stage of invasion, localisation and establishment of intracellular PV 
(Bradley et al., 2005). RON proteins are released and excreted on to the surface of 
the target host cell plasma membrane and participate in the formation of the MJ 
through association with AMA1 (Besteiro et al., 2009).  
Structurally ROP proteins are homologues to protein kinases of the 
mammalian cells (Bradley et al., 2005; El Hajj et al., 2006) and several of these 
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proteins are active protein kinases whilst others lack the known kinase-like catalytic 
domain and are expected to be pseudokinases (El Hajj et al., 2006; Lei et al., 2014). 
In T. gondii, ROP18 overexpression was found related to increase in multiplication 
rate and virulence (El Hajj et al., 2007). Also ROP18 is related to virulence through 
phosphorylation of the host cell GTPases (IRGs) and prevent destruction of PVM by 
IF-γ, whereas in N. caninum does not seem to play the same role due to 
pseudogenisation of ROP18 (Lei et al., 2014; Reid et al., 2012). In T. gondii ROP18 
is protected from IFN-γ mediated clearance processes by ROP5 in activated 
macrophages (Behnke et al., 2012). ROP16 is also involved in virulence through 
phosphorylation of the host signalling pathway (STAT3/6) to modify the early 
inflammatory response of the host mediated by cytokine, interleukin-12 (IL-12) 
(Butcher et al., 2011; Ong et al., 2010; Saeij et al., 2007).  
1.5.1.3. Dense granules 
In T. gondii and N. caninum, the proteins located in dense granules (DG) and 
without known homologues and function in other organisms are designated as GRA 
proteins (Sibley et al., 1991). GRA proteins from T. gondii and N. caninum are 
produced by 17 and 15 genes, respectively (Reid et al., 2012). However, the number 
of identifying GRA proteins is increasing and so far 21 GRA proteins have been 
identified in T. gondii ME49, as reviewed in Mercier and Cesbron-Delauw (2015). 
DGs are small homogenous vesicle-like structure located at both the apical end and 
behind the nucleus (Hemphill et al., 1998). DG proteins are secreted at the sub-apical 
location of the parasite and targeted to the PV by means of typical signal peptides in 
the N-terminal part of most of the DG proteins (Karsten et al., 1998). The time of 
secretion of most of the contents of DG proteins occurs within one hour of the 
invasion and formation of PV (Carruthers and Sibley, 1997; Dubremetz et al., 1993). 
DG proteins of T. gondii are the most intensively studied secretory proteins among 
members of the Apicomplexa and several orthologues were also identified in N. 
caninum such as NcGRA1 (Atkinson et al., 2001), NcGRA2 (Ellis et al., 2000), 
NcGRA6 (Liddell et al., 1998), NcGRA7 (Hemphill et al., 1998) and NcGRA14 (Liu 
et al., 2013). DG proteins have been found to be involved in several important vital 
processes for the invaded parasites. These processes include nutritional acquisition, 
providing an environment for the proliferation of parasites, regulating parasite egress 
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and modulating early immune response to infection (Braun et al., 2013; Cesbron-
Delauw, 1994; Coppens et al., 2006; Galinski and Barnwell, 1996; Okada et al., 
2013; Travier et al., 2008; Treeck et al., 2011). 
1.5.2. Attachment and invasion of host cell 
At the early stage of the invasion, intracellular Ca
2+
 levels of the parasite 
regulates activation of calcium-dependent protein kinases (CDPK1) which is 
necessary for regulation of the microneme secretions of adhesin such as MIC2, MIC4 
and AMA1 (Carruthers and Sibley, 1999; Donahue et al., 2000); they trigger gliding 
motility, adhesion and invasion of the host cells (Lourido et al., 2010; Nagamune et 
al., 2008). The first point of host-parasite interaction comes from adhesion following 
the parasites contact with the host cell surface (Hemphill et al., 1996). T. gondii and 
N. caninum interact differently with the artificially produced and naturally occurring 
host cell surface antigen sulphated proteoglycans (Jacquet et al., 2001; Naguleswaran 
et al., 2002). T. gondii interacts mostly through heparin sulphate, whereas N. 
caninum interacts mostly through chondroitin sulphate (Naguleswaran et al., 2002). 
In T. gondii, adhesion was found to be mediated through binding parasite surface 
antigens TgSAG3 with the host surface sulphated proteoglycan (Jacquet et al., 2001), 
while N. caninum interact through NcSAG1 and NcMIC3 (Jacquet et al., 2001; 
Nishikawa et al., 2000). In addition, NcSRS2 was found to interact with host cell 
surface antigen but not through proteoglycan (Nishikawa et al., 2000). The adhesion 
process is critical for protein secretion from the invasion organelles (microneme and 
rhoptries). In T. gondii, first contact of tachyzoites with host cell plasma membrane 
results in secretion of microneme proteins, such as MIC2, onto the surface of the 
tachyzoites. This allows the parasite to make tight adhesion through anterior part 
resulting in the protrusion of the conoid which enables rhoptry proteins to pass onto 
the host cell plasma membrane and consequently moving junction (MJ) formation 
(Carruthers and Sibley, 1997).  
The MJ is an electron-dense, circular tight intersection between the plasma 
membrane of the apical tip of the invasive zoites and the target host cells (Aikawa et 
al., 1978; Besteiro et al., 2011). The MJ aids in propelling the parasite into the 
nascent PV during entry into the host cells (Besteiro et al., 2011; Suss-Toby et al., 
1996). Nascent PV formation is a fast process which forms from both the host cell 
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plasma membrane (excluded from most host surface proteins) and parasite secretory 
products except microneme; it is critical for protecting the parasites from host cell 
lysosome (Gendrin et al., 2008; Joiner et al., 1990; Mordue et al., 1999; Sinai et al., 
1997). In T. gondii apical membrane antigen 1 (AMA1) a type 1 integral membrane 
protein (Donahue et al., 2000; Hehl et al., 2000) works as a ligand interacting with 
C-terminal of RON2; RON2/4/5/8 complex, which is secreted from rhoptry neck 
serves as receptor in the membrane of the host cells during invasion and moving 
junction formation (Alexander et al., 2005; Besteiro et al., 2009; Collins et al., 2009; 
Straub et al., 2009; Straub et al., 2011; Tyler and Boothroyd, 2011; Zhang et al., 
2007). However, the detail of how MJ plays role in selective sieving of the host 
membrane protein is not known. 
Once the MJ has established, in T. gondii ROP1 has been found discharged 
into the area (Carruthers and Sibley, 1997) and despite the early release of ROPs 
directly after MICs, ROPs are related to the later stage of invasion and early 
establishment of the PV formation and infection (Besteiro et al., 2011; Saffer et al., 
1992). ROP2/4/18 were found in strands extended from the parasitophorus vacuole 
membrane (PVM) into the cytoplasm of the host cells were associated with DG 
protein GRA7 (Alaganan et al., 2014; Dunn et al., 2008).  
1.5.3. Maintenance of infection 
Following the formation of the nascent PV shortly after invasion, dense 
granule proteins are secreted into the PV at approximately 20 minutes post invasion 
(Carruthers and Sibley, 1997). The intravacuolar release of most of the DG proteins 
is likely responsible for the maturation of the nascent PV and PVM (Mercier et al., 
2005; Sibley et al., 1995). Following the invasion, a nano-tubulovesicular network 
(NTN) forms at the posterior end of the parasite, which later on distribute throughout 
the PV and connects with the PVM (Sibley et al., 1995). The exact role of this 
network is not clear, suggesting that it may be important to increase the surface area 
necessary for transmission of nutrient and waste between the parasite and the host 
cell (Mercier et al., 2002). However, the exact role of most of the GRA proteins 
located at the interplay between the host cytosol and the parasite plasma membrane 
are not known especially in the exchange of nutritional resources and excretion of 
parasite waste. 
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Following invasion and establishment of an infection, PV and PVM are 
modified and decorated by many proteins secreted from the rhoptries and dense 
granules (Hajj et al., 2006; Mercier et al., 2005; Saffer et al., 1992; Travier et al., 
2008). In T. gondii, TgGRA15 in type II strain is localised to PVM where involved 
in positive activation of NF-κB (p65/RelA subunit) and IL-12 production (Melo et 
al., 2011; Rosowski et al., 2011). However, T. gondii plays role in blocking the host 
apoptotic pathway through inhibition of caspase initiation which is required for NF-
κB activation (Payne et al., 2003). TgGRA7 and ROP2/4 were also found to interact 
in strand-like structure extending from PVM into the host cytosol (Dunn et al., 
2008). Furthermore, ROP2 has been shown to be more likely to interact with the 
mitochondrial import machinery and to associate tight relationship with the host 
mitochondria (Sinai and Joiner, 2001). In both parasites, several host cell organelles 
such as mitochondria and endoplasmic reticulum were found surrounding and 
forming intimate interactions with the PVM in close proximity to the host cell 
nucleus (Hemphill et al., 2004; Magno et al., 2005; Sinai and Joiner, 2001) and 
believed that the high affinity could be due to protein-protein interactions (PPIs) 
between PVM and host organelles (Sinai et al., 1997). Co-fractionation study of 
infected cell with T. gondii showed that GRA3 and ROP2/3/4 were enriched with 
endoplasmic reticulum (ER) marker calnexin suggested a stable interaction between 
these membranes (Sinai et al., 1997). In T. gondii, DG proteins such as GRA16 and 
GRA24 were recently discovered to export beyond the PVM into the host cell 
nucleus to regulate host gene expression (Bougdour et al., 2013; Braun et al., 2013). 
In T. gondii, previous studies showed that some rhoptry proteins are similar 
to and behave like host kinases (Saeij et al., 2006; Saeij et al., 2007) such as ROP16 
and ROP18 and implemented in phosphorylation of host proteins which is critical in 
virulence and protection against host immune system (Lei et al., 2014; Ong et al., 
2010). While N. caninum ROP18 was failed to phosphorylate host cell protein due to 
its pseudogenisation (Lei et al., 2014; Reid et al., 2012). 
Invaded parasites start to egress from infected cell when they occupy almost 
all the cytoplasmic spaces. Egress is as important as the invasion processes, since the 
invasion is accompanied by multiplication whilst egress is very critical for 
propagation in the host from infected cells to non-infected cells leaving the infected 
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cell to die (Arrizabalaga and Boothroyd, 2004). The intraparasitic Ca
2+
 is critical for 
invasion and egress (Moudy et al., 2001). Based on the similarity of both processes, 
it is suggested that they might use the same signalling pathway (Black et al., 2000; 
Hoff and Carruthers, 2002). However, what is necessary to trigger natural egress is 
not known. 
Though host-parasite interactions have been extensively studied with T. 
gondii infection, less is known about N. caninum infection and the differences 
between these two parasites. The question arises here how N. caninum interact with 
host cell? It is not clear whether N. caninum follow the same strategies used by T. 
gondii or uses different ways of manipulating the host cell and host responses. 
However, there is some evidence showing that protein-protein interactions (PPIs) 
play an important role in some of the differences between these two species. For 
example, T. gondii and N. caninum interact differently with the host cell surface 
antigen sulphated proteoglycans (Naguleswaran et al., 2002; Naguleswaran et al., 
2003) and immunity-related glycoprotein (IRG) of the host cell (Lei et al., 2014; 
Reid et al., 2012). 
1.6. Protein-protein interactions  
PPIs are organized direct physical contact between at least two proteins that 
are regulated in response to stimuli. This physical contact may consequently lead to 
conformational changes or post-translational modifications (PTMs) which alter the 
activity, affinity and co-operativity of the binding proteins (Berggard et al., 2007; 
Ngounou Wetie et al., 2014). PPIs play fundamental roles in controlling all cellular 
processes such as controlling physical activity, maintaining cellular organization, 
mediating signal transduction and regulation of metabolic enzymes (Braun and 
Gingras, 2012; Jones and Thornton, 1995). Thus, to know the function of a particular 
protein in a cellular environment, it is critical to identify the binding partner of the 
proteins which requires thorough exploration of total PPIs (interactome) (Braun and 
Gingras, 2012; Ngounou Wetie et al., 2014). PPIs can be divided based on the 
lifetime of interactions in to stable and transient or a combination of both (Nooren 
and Thornton, 2003). Stable PPIs consequently leads to formation of multiple protein 
complexes (MPCs) under certain conditions, both temporally and spatially (Alberts, 
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1998); MPCs are important to govern almost all cellular processes (Lasserre et al., 
2010).  
1.6.1. Protein-protein interactions play an important role in the biology of T. 
gondii and N. caninum 
In T. gondii and N. caninum, PPIs play an important role in the invasion and 
maintenance of infection in host cells; these proteins are derived from both the 
surface antigens and secretory organelles. While PPIs have been extensively studied 
with T. gondii; less is known about in N. caninum.  
In T. gondii, indirect-immunofluorescence assays (IFA) study of microneme 
proteins showed that MIC6/1/4 and MIC8/3 are secreted as functional complexes and 
associate with the parasite plasma membrane (Meissner et al., 2002a), TgMIC6/1/4 
complex has been found to play critical roles in host cell attachment and invasion 
(Zheng et al., 2009). Using pull-down assays, immunoprecipitation and IFA showed 
that an aldolase forms a bridge between actino-myosin cytoskeleton and the surface 
adhesin, TgMIC6 (Zheng et al., 2009) and TgMIC2 (Jewett and Sibley, 2003) which 
play an important role in parasite motility. In T. gondii, an immunoprecipitation and 
blue native (BN)-PAGE study found that MIC2 is associated with M2AP on the 
parasite plasma membrane necessary for host cell attachment and invasion (Jewett 
and Sibley, 2004). The T. gondii surface antigen TgSAG3 interacts with host cell 
surface heparin sulphate which is important in mediating adhesion of tachyzoites 
with host cell surface; this interaction was isolated using pull-down assay and 
antigen-host cell surface adhesion/coprecipitation assay (Jacquet et al., 2001; 
Naguleswaran et al., 2002). Moreover, based on immunoprecipitation and/or 
coimmunoprecipitation and IFA, found that TgAMA1 interact and form complexes 
with TgRON2/4/5/8 which is critical for MJ formation (Alexander et al., 2005; 
Besteiro et al., 2009); while TgRON9 and RON10 found to form complexes but do 
not associate with the MJ formation (Lamarque et al., 2012). In N. caninum, surface 
antigen NcSAG1 and microneme proteins NcMIC1, NcMIC3 and NcMIC4 on the 
surface of the tachyzoites interact with host cell surface chondroitin sulphate; these 
interactions were found using a pull-down assay, IFA, antigen-host cell surface 
coprecipitation assay and solid phase binding assay (Keller et al., 2002; Keller et al., 
2004; Naguleswaran et al., 2002; Nishikawa et al., 2000). In addition, NcSRS2 
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interacts with host cell surface antigen but not through proteoglycan (Nishikawa et 
al., 2000).  
In T. gondii, ROP18 is directly involved in phosphorylation of parasite 
substrate on the PVM (El Hajj et al., 2007). Using IFA and kinase assay, ROP16 and 
ROP18 were also found involved in phosphorylation of host cell proteins and 
regulation of parasite virulence (Lei et al., 2014; Ong et al., 2010). ROP4 has also 
been observed to be phosphorylated on the PVM using [γ-32P]ATP labelling of 
cellular extracts, but whether the host or parasite kinases are involved in the 
phosphorylation is not known (Carey et al., 2004). In T. gondii infection, ROP2/4 
interacts with GRA7 in a strand-like structure extending from the PVM to the 
cytoplasm of the host cells; GRA7 found phosphorylated only in the presence of 
infected cells and confirmed using alkaline phosphatase (Dunn et al., 2008). GRA4/6 
specifically interact with GRA2 leading to formation of multimeric complex that is 
stably linked with the NTN (Labruyere et al., 1999). Also, using 
coimmunoprecipitation TgGRA16 was found form complexes with the host enzymes 
HAUSP and PP2A necessary for regulation of p53 tumour suppressor pathway and 
the cell cycle arrest (Bougdour et al., 2013). In addition, these parasites move by a 
glideosome a multisubunit protein complex forms of interaction of at least five 
proteins including TgMyoA, MLC1, TgGAP40, GAP45 and TgGAP50 and isolated 
using immunoprecipitation method (Frenal et al., 2010; Gaskins et al., 2004). These 
PPIs and complex formation show that T. gondii and perhaps N. caninum extensively 
recruit PPIs to invade, establish infection and adaption within the infected host cells.  
Despite the success in the identification of protein complexes, these studies 
were performed to understand individual interactions that happen at a time. However, 
they cannot be applied for global identification of PPIs compared to some other 
procedures such as blue native (BN)-PAGE. In addition, stage wide PPIs studies 
using the native condition of separation of MPCs are necessary to understand the 
core MPCs happening ubiquitously at a given time that are crucial to maintain 
cellular organisation. 
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1.6.2. Methods used to study protein-protein interactions  
To study the functions of proteins and understand the biomolecular 
interaction with other proteins, a method with high efficiency in separation and 
isolation of different protein complexes is required. Therefore, there are several 
different methods that can be used to study PPIs including genetics methods such as 
yeast two-hybrid, biochemical methods such co-immunoprecipitation (Co-IP) and 
affinity purification (AP), proteomics methods such protein microarrays and gel-
based methods such as blue native-polyacrylamide gel electrophoresis (BN-PAGE), 
bioinformatics methods (Ngounou Wetie et al., 2014) and enrichment methods for 
PTMs of proteins (Treeck et al., 2011). 
1.6.2.1. Blue native-polyacrylamide gel electrophoresis for native isolation of 
multiprotein complexes 
BN-PAGE is a native gradient PAGE technique used for one-step isolation 
and high resolution separation of enzymatically active protein complexes. Originally, 
this method was developed for the isolation of mitochondrial membrane protein 
complexes of the respiratory chain in the enzymatically active form (Fandino et al., 
2005; Schagger and Jagow, 1991). BN-PAGE is considered as one of the current 
most effective technique for the investigation of native protein complexes (Dejgaard 
et al., 2010). The advantages of BN-PAGE include: firstly, isolation of high 
molecular MPCs weight between 10 kDa and 10 mDa. Secondly, it can be used for 
the isolation of whole protein complexes from biological samples such as cells and 
organelle membrane (Lasserre et al., 2010; Pfeiffer et al., 2003; Schagger, 2001; 
Wittig et al., 2006) and total cell and tissue homogenates (Schagger et al., 1996; 
Wittig et al., 2006). Thirdly, BN-PAGE can be performed in most laboratories and is 
cost effective (Wittig et al., 2006). However, it has to be optimised empirically for 
each set of different samples. 
In this method, non-ionic detergents (digitonin, dodecylmaltoside, triton X-
100) are used for the solubilisation of membrane protein complexes and 
aminocaproic acid is used in the buffers to support the solubilisation (Schagger and 
Jagow, 1991; Wittig et al., 2006). Unlike SDS-PAGE which separate proteins based 
on mass/charge ratio, BN-PAGE relies on the size of protein complexes and the 
negative charge shift which is given by the Coomassie blue G-250 (CBG-250) to the 
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external of the proteins. Negative charge enables proteins to move from the cathode 
to the anode in the gradient polyacrylamide gel. In addition, it causes the membrane 
protein complexes to lose the hydrophobic character upon interacting with the dye 
which in turn becomes hydrophilic (water-soluble) proteins. The migration of protein 
complexes slows down with running distances as well as with increasing the gradient 
of the gel due to the pore size and ultimately the migration of protein complexes stop 
completely (Wittig et al., 2006). The complexes separated on one dimensional (1D) 
BN-PAGE are dissociated into the subunit proteins using denaturing Tricine-SDS-
PAGE or it can be used directly for functional studies without using SDS-PAGE 
(Schagger and von Jagow, 1991).  
Until recently little research has been done on the complexome of 
apicomplexan parasites using BN-PAGE. In T. gondii, BN-PAGE has been used to 
characterise the stable protein complexes of MIC2 and M2AP on the plasma 
membrane of the tachyzoite stage (Jewett and Sibley, 2004). In addition, BN-PAGE 
has been used successfully to study protein complexes in detergent-resistant 
membranes of Plasmodium falciparum schizonts. Proteins from seven known 
complexes were identified including MSP-1/7, the low (RAP1/2 and RAP1/3) and 
high molecular weight rhoptry complexes (RhopH1/H2/H3), and the invasion motor 
complex (GAP45/GAP50/myosinA) (Sanders et al., 2007). In addition, the whole 
20S subunit of proteasome of P. falciparum has been isolated using BN-PAGE 
(Sessler et al., 2012).  
1.6.2.2. Pull-down assays for affinity purification of protein complexes 
The pull-down assay is a robust way of purifying and identifying individual 
protein complexes in vitro when specific antibody against the bait is not available. 
The recombinant bait protein is usually expressed fused to different tags such as 
glutathione S-transferase (GST-fused protein), poly-histidine tail, maltose-binding 
protein (MBP), calmodulin-binding peptide (CBP) or small peptide epitopes such as 
FLAG, HA, c-myc. These tags have high affinity to different anti-tag (chemical) 
ligand such as glutathione, nickel ions immobilized-metal affinity chromatography 
(IMAC), streptavidin. The anti-tag ligand can be immobilised on solid support such 
as agarose e.g. sepharose beads. The tag-fused bait is first expressed, purified and 
either (1) incubated with the lysate containing prey proteins and applied to the 
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column containing solid support or (2) immobilised on solid support and then 
incubated with cell lysate containing prey proteins. In either case the bait-prey 
complex is then eluted with appropriate buffer and analysed using SDS-PAGE and 
mass spectrometry (MS) (Forler et al., 2003; Miernyk and Thelen, 2008; Orru et al., 
2003). 
The effect of the tag on the recombinant bait protein is reviewed in (Arnau et 
al., 2006); the positive effects include improving protein yield, protection of the 
protein against enzymatic digestion, aids protein refolding and maintain antigenicity 
and increasing solubility. While, the negative effects include changes to protein 
conformation, inhibition of enzyme activity, change the biological activity and 
increases toxicity. The benefits of pull-down assay also include purification not only 
the pray protein, but also proteins that bind to the prey in a physiological setting (von 
Mering et al., 2002). It is considered a robust method to isolate and identify protein 
complexes (Berggard et al., 2007). The weakness of these techniques is unable to 
detect a less-stable complexes and complexes that dissociate under this setting 
(Ngounou Wetie et al., 2014). Some of in vitro interactions could be non-
physiological and only occur as a result of contact with other target during cells lyses 
preparation which is not happening in vivo (Berggard et al., 2007).  
Most of the studies performed for studying PPIs in T. gondii are based on 
immunoprecipitation and/or co-immunoprecipitation and IFA using specific antibody 
produced against the binding partners of the protein complexes. These methods have 
led to the identification of many protein complexes, such as the 
TgAMA1/RON2/4/5/8 complex, which is critical for moving junction formation 
during invasion (Alexander et al., 2005; Besteiro et al., 2009). However, pull-down 
assays have been used to study in vitro PPIs in T. gondii and led to the isolation and 
identification of PPIs between TgMIC2 C-terminal and aldolase critical for parasite 
motility (Jewett and Sibley, 2003). In addition, it has been also used to identify the 
interaction of aldolase with C-terminal of TgMIC6 and actin-cytoskeleton of the 
parasite (Zheng et al., 2009). Also pull-down assays have been used to characterise 
the binding affinity of recombinant TgSAG3 with heparin sulphate which associates 
with the surfaces of host cells (Jacquet et al., 2001). Furthermore, affinity 
chromatography using α-lactose-agarose column has resulted in pull-down and 
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purification of NcMIC4 from the whole tachyzoite lysate of N. caninum; NcMIC4 
was found to bind to host cell surface through chondroitin sulphate  (Keller et al., 
2004). 
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1.6.2.3. Protein phosphorylation  
Precursor proteins are often covalently processed and modified post-
translationally through enzymatic cleavage or addition of one or more modifying 
group to at least one of the amino acids. These modifications determine functional 
states of the proteins, targeting to its location, fate and interaction with other proteins 
(Mann and Jensen, 2003). Hundreds of modifications of proteins have been reported 
(Garavelli, 2004). The most common types of PTMs include cleavage of N-terminal 
signal peptides, which is necessary for regulation of proteins that enter into the 
secretory pathway (Jensen et al., 2002), phosphorylation which is implicated in 
signal transduction and is crucial for regulation of almost all cellular processes 
(Villen and Gygi, 2008), N- and O-glycosylation, plays diverse roles within cell such 
as protein folding (Jensen et al., 2002) and acetylation, which plays a critical role in 
regulation of eukaryotic transcription (Sterner and Berger, 2000).  
Protein phosphorylation is characterised by the addition of at least one 
phosphoryl group to three hydroxyl-containing amino acids such as tyrosine, serine 
and threonine (Shi, 2009). It is a reversible process regulated by kinases and 
phosphatases (Jacot and Soldati-Favre, 2012; Shi, 2009). These enzymes are 
extensively regulated in response to many stimuli such as metabolites, hormones and 
growth factors (Zolnierowicz and Bollen, 2000). In response to stimuli, cellular 
receptors activate specific intracellular protein kinases (PKs) resulting in signal 
transduction through binding to certain phospho-motif containing protein and 
subsequent involvement in the corresponding kinase signalling pathway (Pawson, 
1995). Subsequently activation of signalling pathway results in multiple PPIs, 
activation of different enzymes, and regulation of cellular processes such as cell 
growth, differentiation, development, functions and death (Kondapalli et al., 2005; 
Pawson, 1995; Shchemelinin et al., 2006; Villen and Gygi, 2008). Thus, genome-
based protein phosphorylation (phosphoproteome) studies are critical to understand 
the overall phosphorylation events happening ubiquitously within cells or organisms 
(Villen and Gygi, 2008). In addition, it could be also important to make a 
comparative study of host cell in response to infection with different organisms.  
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Phosphoproteome is a term applied to the whole set of protein 
phosphorylations in a given cell (Stern, 2001) and was used for the first time by 
Alms et al. (1999). Phosphoproteomics is a division of proteomics that study the 
scope and the roles of protein phosphorylation in cells for identification and 
annotation of proteins that phosphorylates as a result of PTMs (Gomase and Akella, 
2009). Thus to study the consequence of a protein phosphorylation in regulation of 
cellular processes, it is important to understand the following (Zolnierowicz and 
Bollen, 2000): (1) the identity of the phosphorylated proteins and the amino acid 
involved in phosphorylation, (2) the responses produced to its phosphorylation, (3) 
the enzymes involved in the phosphorylation and  (4) the mechanisms that determine 
the activation of these enzymes both spatially and temporally.  
Development of enrichment methods for purification of phosphopeptides in 
combination with MS has opened the way to study phosphoproteome. MS have been 
exploited for studying protein phosphorylation because of high accuracy, resolution 
and sensitivity (Le Blanc et al., 2003; Olsen and Mann, 2004). While 
phosphopeptide enrichment strategy is critical for three reasons: first, low expression 
level of the phosphoproteins that regulate the cellular activity at a given time (Villen 
and Gygi, 2008) and second, due to the stoichiometry of a phosphoprotein is less 
than one percent of the total of that protein (Hunter and Cooper, 1985) and third, due 
to poor ionisation of phosphopeptides in the mixture containing a non-
phosphorylated peptides (Cho et al., 2012). Phosphopeptides enrichment methods, in 
combination with mass spectrometry, are extensively used as a high throughput 
method for large scale analysis of phosphoproteome (Pinkse et al., 2004). It has been 
used successfully in profiling of thousands of phosphoproteins from different 
organisms such as human (Cho et al., 2012), yeast (Wilson-Grady et al., 2008), 
Apicomplexan parasites (Treeck et al., 2011) and host cell in response to pathogens 
(Luo et al., 2014; Wojcechowskyj et al., 2013). 
MS-based investigation of global phosphoproteome of Plasmodium 
falciparum schizont stage, intracellular and purified tachyzoites of T. gondii has led 
to the identification of 7835, 11822 and 21498 phosphopeptides, respectively 
(Treeck et al., 2011). They suggested that protein phosphorylation is a regulatory 
process that is extensively used in the normal physiology of these parasites and in 
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host-parasite interactions. The phosphorylated proteins were found belonging to 
different fractions of the tachyzoites such as nucleus, mitochondrion, apicoplast, cell 
surface, inner membrane complex and invasion related organelles. Parasite proteins 
and kinases such as ROP21 and FIKK family secreted into host cell were found 
phosphorylated suggested that protein phosphorylation is adopted as a strategy to 
regulate parasite proteins secreted into the host cell and/or host-parasite interactions. 
However, Treeck et al. (2011) did not discuss the phosphoproteome of the infected 
host cells (at 28 hr p.i) because of data were not generated. A large scale 
phosphorylation study of blood form of Trypanosoma brucei has led to the 
identification of 852 phosphopeptides; the identified phosphoproteins found involved 
in crucial biological processes such as signal transduction, DNA and RNA 
processing, protein production and degradation (Nett et al., 2009). Thus, there is an 
apparent lack of studies of phosphoproteome of host cell in response to infection 
with T. gondii and N. caninum. Therefore, the present study is considered as the first 
pioneering study investigated phosphoproteome of host cell in response to infection 
with these parasites. 
However, conventional methods such as biochemical (kinase assay and 
radiolabelling) and genetic (mutation) studies used for analysing phosphoproteins 
and related enzymes are very important to study individual proteins at a time; they 
provided important information about the dynamics of proteins and signalling 
pathway (Gomase and Akella, 2009; Hastie et al., 2006). In T. gondii, using 
conventional methods has led to the identification of several important 
phosphorylation events; ROP16 and ROP18 have been found involved in 
phosphorylation of host cell proteins and regulation of parasite virulence (Lei et al., 
2014; Ong et al., 2010). Using [γ-32P]ATP labelling of cellular extracts has identified 
phosphorylated form of ROP4 on the PVM (Carey et al., 2004). In addition, alkaline 
phosphatase treatment of TgGRA7 which form complexes with TgROP2/4 found 
that GRA7 phosphorylated only in the presence of infected host cells (Dunn et al., 
2008). However, these methods are not effective to study the whole protein 
phosphorylation and the function of each phosphoprotein within the background of 
signalling systems (Gomase and Akella, 2009; Villen and Gygi, 2008).  
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1.6.2.3.1. Immobilised metal affinity chromatography for enrichment of 
phosphopeptides 
IMAC takes the advantage of affinity of a phosphate group to different metals 
such as iron (III) or (Fe
3+
) (Andersson and Porath, 1986) gallium (III) or (Ga
3+
)
 
(Posewitz and Tempst, 1999) or  titanium (IV) or Ti4+ (de Graaf et al., 2014). IMAC 
is used for enrichment of phosphopeptides/phosphoproteins from cell lysate 
containing proteins or a mixture of peptides. In this method, a metal ions such as Fe
3+
 
is immobilised to beads such as agarose through ligand such as nitriloacetic acid 
(NTA) (Neville et al., 1997) and incubated with the phosphopeptides or proteins 
containing lysate. Bound phosphopeptides or proteins are eluted by washing with 
phosphate buffer, or by increasing the pH. Phosphopeptide IMAC enrichment can be 
combined with other enrichment methods such as strong cation exchange 
chromatography (SCX) (Trinidad et al., 2006; Villen and Gygi, 2008) and strong 
anion exchange chromatography (SAX) (Nuhse et al., 2003). The combination of 
SCX and IMAC has been applied successfully to various biological samples such as 
mouse liver and fly embryos and led to the identification of 5,500 and 13,000 
phosphopeptides, respectively (Villen et al., 2007; Zhai et al., 2008) and also to the 
enrichment of thousands of phosphopeptides from P. falciparum schizonts and 
tachyzoites of T. gondii (Treeck et al., 2011). However, the combined use of SCX or 
SAX with IMAC or TiO2 is more cost prohibitive than using IMAC or TiO2 alone. 
1.6.2.3.2. Metal oxide affinity chromatography (MOAC) for enrichment of 
phosphopeptides 
MOAC is a form of IMAC and used for the same purpose of IMAC. The 
metals mostly used are titanium dioxide (TiO2) (Pinkse et al., 2004) or zirconium 
dioxide (ZrO2) (Kweon and Hakansson, 2006), aluminium hydroxide (Al(OH)3) 
(Wolschin et al., 2005), niobium pentoxide (Nb2O5) (Ficarro et al., 2008) in the form 
of solid bead or coated beads. However MOAC like IMAC does not only enrich 
phosphopeptide but also frequently found to enrich nonphosphorylated peptides 
containing multiple acidic amino acid residues (Collins et al., 2007). Studies have 
found that introducing low pH environment with tryptic peptides during purification 
decreases nonspecific binding of acidic amino acids through protonation of the 
carboxylate group (Larsen et al., 2005). O-methyl esterification results in blocking of 
the acidic residues which consequently improved the specificity of the binding of 
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phosphopeptides (Ficarro et al., 2002). However, O-methyl esterification results in 
partial deamination and methylation of acidic amino acids asparagine and glutamine 
and the resulted products further complicate MS analysis and interpretation of data 
(Seward et al., 2004). Selectivity of phosphopeptides binding to TiO2 is improved by 
loading 2,5-dihydroxybenzoic acid (DHB) (Larsen et al., 2005). Purification of 
phosphorylated amino acids using TiO2 have been further improved by using 
reducing agents such as phthalic acid which resulted in the very efficient enrichment 
of phosphoamino acids (Bodenmiller et al., 2007).  
TiO2 alone has been used to enrich phosphorylated proteins of schizont stage 
of Theileria annulata and identified 65 phosphoproteins (Wiens et al., 2014). In 
addition, using TiO2 combined with SCX has led to the identification of 10096 
phosphorylation sites on 2551 protein groups and quantification of 8275 
phosphorylation sites between the bloodstream and procyclic form of Trypanosoma 
brucei (Urbaniak et al., 2013). Furthermore, a combination of in-gel digestion and 
SAX with TiO2 identified 2541 phosphorylation sites from phosphoproteome of 
Plasmodium falciparum schizonts (Lasonder et al., 2012). Phosphoprotein analyses 
of fission yeast using IMAC and TiO2 found that both of the techniques were 
resulted in similar profile and in total 2887 distinct phosphorylation sites was 
identified which assigned to 1194 peptides (Wilson-Grady et al., 2008). 
1.7. Mass spectrometric analyses of peptides 
Mass spectrometry is a very sensitive and powerful tool for analysing and 
identifying proteins and peptides from mixtures of different biological samples using 
variety of MS machines. Examples of these machines are ion trap (IT), triple 
quadruple, hybrid quadruple/ time of flight (TOF),  Fourier transform ion cyclotron 
resonance (FT-ICR) and hybrid linear IT/FT (ICR or orbitrap) (Collins et al., 2007). 
The techniques mentioned earlier for isolation and purification of protein complexes 
and phosphoproteomes can be combined with MS to identify their compositions. 
Generally, proteins are identified in a mixture using MS for two strategies including 
protein mapping (peptide mass fingerprinting PMF) and protein sequencing and post-
translational modification analysis. Apicomplexan parasites proteome are extensively 
studied using pre-fractionation and in-gel digestion or gel-free in-solation digestion 
coupled with MS. Using MS, the proteomes of T. gondii and N. caninum tachyzoites 
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has been analysed and hundreds to thousands of proteins have been identified and 
characterised  (Bradley et al., 2005; Sohn et al., 2011; Xia et al., 2008). Proteomics 
data provide valuable information to interpret transcriptomics data as well as 
annotation of genome of these parasites (Sohn et al., 2011; Xia et al., 2008). Also 
thousands of identified proteins by MS from different organisms including 
apicomplexan parasites are hosted in EupathDB (Aurrecoechea et al., 2013). These 
databases provide great support for genome-wide proteomics studies in many 
parasitic organisms such as T. gondii and N. caninum and ease access by parasitology 
communities to predict and annotated genes from all over the world.   
With tandem MS (MS/MS), proteins are first digested proteolytically into 
peptides using an enzyme such as trypsin. The resulting peptides are loaded into the 
HPLC system to separate the peptides; the eluted peptides from HPLC are then 
ionised by an ionisation source such as electrospray ionisation (ESI) as found on 
linear trap quadrupole (LTQ) MS (Thermo Finnigan). Using data dependent 
acquisition (DDA), the mass to charge ratio (m/z) of the ionised peptides is 
measured, and the most abundant peptides usually 3-10 are selected for 
fragmentation using collision induced dissociation (CID) and m/z of the resulting ion 
fragments is measured. The resulting information from mass spectra from each 
sample are matched to the known peptides called peptide spectrum match (PSM) 
which then analysed, visualised and interpreted; these analyses are performed using 
different Bioinformatics tools. 
1.8. Bioinformatics and data processing  
Bioinformatics tools are used to identify ionised spectral peptides detected by 
MS. These peptides are identified from an in silico database of an organism 
containing all theoretical peptides. The theoretical peptides are produced from 
enzymatic digestion (e.g. by trypsin) of the proteome predicted from the genome of 
the organism of interest. The in silico peptides of Toxoplasma and Neospora as well 
as several other parasite species are available at the online EupathDB database - 
http://www.toxodb.org/toxo/(Aurrecoechea et al., 2013). Human in silico peptides 
can be found at http://www.uniprot.org/uniprot/. Following identification of spectral 
peptides, a cut-off filter is applied to the identified peptides based on the false - 
discovery rate (FDR) scoring system. The FDR scoring is based on searching the 
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identified peptides in a real database of the organism against a decoy database which 
separate nonsense peptides from actual identification. Thus the high the number of 
the significant peptides per protein the identification of that protein is more 
confident. There are many different algorithms that are used for identification of 
mass spectral data from in silico peptides such as Mascot (Matrix Science), OMSSA 
(Geer et al. 2004), PEAKS
®
 (BSI, Waterloo, ON, Canada), and X!Tandem (Craig 
and Beavis, 2004; Fenyö and Beavis, 2003). The combination of these algorithms 
can be used to apply more confidence identification.  
For quantification of peptides and proteins, spectral data are analysed with 
quantification software such as Progenesis LC–MS (Newcastle upon Tyne, UK). 
This software aligns sample spectra replicates and measures the intensities of 
different peptides and proteins compared to control sample spectra, analysed and 
processed at the same time with tested sample. The quantified peptides and proteins 
are then exported into any search engine mentioned earlier containing a database of 
interested organism for identification of peptides and proteins. 
1.9. Systems biology for understanding host cell response to infection with 
pathogens 
Gene expression and protein production are complex processes that 
controlled by transcriptional, posttranscriptional and epigenetic regulators, which in 
part regulated by systems that integrate whole biological processes in a given cell or 
an organism (Braun, 2014). These regulatory interactions may associate with low 
correlation reported between transcripts and protein abundance (Ghazalpour et al., 
2011; Vogel and Marcotte, 2012). Thus, it is important to analyse the gene or protein 
of interest within the complexes biological system. Conventionally study of cellular 
components is carried out individually to highlight their biology, which consequently 
results in generation of very detailed data about a gene to answer a single hypothesis 
(Wastling and Xia, 2013). However, the advances in technology and generation of 
genome-wide biological data are progressing toward investigating a system biology 
as a whole (Wastling et al., 2012). Systems biology integrates different biological 
data such as genomics, transcriptomics and proteomics generated from the high 
throughput analytical tool to highlight the functional relationship between 
differentially expressed genes and protein abundance (Braun, 2014; Wastling et al., 
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2012). Systems biology is important to understand the biological processes and 
events happen ubiquitously at a given time or in response to infections (Jovanovic et 
al., 2015). A systematic approach of host cell response to infection is important to 
elucidate how pathogens control transcriptome and proteome before and after 
infection. Understanding systems biology of host cell in response to infection with T. 
gondii and N. caninum could help dissect differential host-parasite interactions and 
the biological differences between the two parasites. 
1.10. Aims and objectives of the study 
Despite all the available information about the morphology, life cycle, hosts 
and transmission routes of T. gondii and N. caninum; the factors responsible for these 
differences are not known. The question is what causes these differences despite the 
remarkable similarity in their genome and transcriptome (Ramaprasad et al., 2015; 
Reid et al., 2012). Thus comparative analysis of these parasites at the molecular level 
may be crucial to understand these biological differences that could be responsible 
for host-parasite interaction.  
The secretory organelles of T. gondii are more extensively studied than those 
in N. caninum leading to understanding some of the important critical processes 
necessary for movement, invasion, establishment of infection and host cell 
regulation. However, because the majority of these proteins especially those of DG 
do not possess homologue in other organisms, the molecular function of these 
proteins is not understood very well. Based on the homology, N. Cannon should have 
a similar set of proteins to that of T. gondii (Reid et al., 2012); but whether and how 
they participate in the biological differences between these parasites is under 
investigation. Studying the molecular function of these proteins in in vitro and in 
vivo may reveal further differences between these parasites. In addition, investigation 
of the binding partners of these proteins could help understand their functions.  
Toxoplasma gondii and N. caninum have been found to use PPIs as a mean to 
interact, invade, establish infection and modulate host cell responses. The aim of this 
study was to understand the biological differences between T. gondii and N. caninum 
through scrutinising host-parasite interactions. Identifying the PPIs and MPCs of 
these parasites and genome-wide host cell responses at phosphoproteome level to 
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infection with these parasites would dissect the biological differences between these 
parasites.  
In chapter two, a native method of separation of MPCs, BN-PAGE combined 
with LC MS/MS has been used to screen for MPCs in T. gondii in order to 
understand the differences in their complexomes. This is because of the importance 
of PPIs and MPCs in the normal physiology, invasion and maintenance of T. gondii, 
though less is known about N. caninum. Thus, the hypothesis is that host-parasite 
interactions differ between T. gondii and N. caninum due to differences in their 
MPCs. 
In chapter three, in order to understand the direct interactions between 
parasite secretory protein and host cell proteins, a pull-down assay has been used to 
study the binding partners of recombinant dense granule proteins GRA2 and GRA7 
from both parasites within the host cell lysate under physiological settings. There is 
strong evidence that in T. gondii, the dense granule proteins GRA2 and GRA7 play 
vital roles in the maturation and maintenance of the PV and PVM. This implies that 
they may play an intermediate role through direct or indirect host-parasite 
interaction. However, their functions are yet to be fully understood. The hypothesis 
of this project is that GRA2 and GRA7 may play a different role in host-parasite 
interaction in infection with both parasites; thus GRA2 and GRA7 can be exploited 
to study their roles in biological differences between these parasites. 
Toxoplasma gondii secretes an array of secretory proteins, including kinases 
into the host cell during invasion to manipulate host cell responses, but less is known 
about in N. caninum. Therefore, in chapter four a global response in the host cell 
signalling pathway through protein phosphorylation and signal transduction in 
response to infection with T. gondii and N. caninum at 20 hr p.i. was analysed using 
phosphopeptides enrichment methods combined with LC MS/MS. The hypothesis is 
that T. gondii and N. caninum induce different host responses through protein 
phosphorylation and activation of different signalling pathways. 
In order to understand the broader host response to infection with the two 
parasites at a systems biology level, chapter five looked at the integrative data 
analyses performed for quantitative data from transcriptome, proteome and 
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phosphoproteome of host cell infected with T. gondii and N. caninum. The 
hypothesis is that studying the comparative system response of host cells to these 
parasites using quantitative data may uncover the biological differences between 
these parasites. 
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CHAPTER TWO: Using blue native polyacrylamide gel 
electrophoresis to characterize T. gondii and N. caninum 
membrane-bound proteins and protein complexes 
 
Chapter Two 
31 
 
2.1. INTRODUCTION 
Proteomics is an effective method to study and collect biomolecular data 
about proteins (Lasserre et al., 2010). Proteins extracted from any cell, tissue, organ 
or whole organism can be analysed directly using liquid chromatography (LC) 
coupled to mass spectrometry (MS). In addition, mixtures of extracted proteins can 
be separated based on two dimensional sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (2D SDS-PAGE) before analysis with LC MS to obtain information 
about two-dimensional maps. Despite the fact that these approaches are important in 
identifying the proteins in a sample, little information is obtained about the molecular 
function of proteins except that inferred by homology (Lasserre et al., 2010). 
Therefore, studying protein-protein interactions (PPIs) which play significant roles in 
almost all of the cellular processes is one way to understand the functional state and 
molecular mechanisms of proteins. In order to function in a regulatory manner most 
proteins have to interact with others; these interactions result in the formation of 
MPCs (Swamy et al., 2006). MPCs can be divided into three types including 
constitutive (stable) and signal-induced (transient) or combination of both. The stable 
MPCs are the high abundance and constant, such as multisubunit receptor, 
proteasome and ribosome. The transient MPCs are of low copy number and 
temporary, such as binding of activated relay proteins to the activated receptor 
tyrosin-phosphorylated protein. While protein complexes that characterise by both 
states include transcription factors. Thus MPCs can be changed in space and time 
based on the cellular status. The entire complement of MPCs of a cell, tissue or 
organism is known as the complexome. Understanding complexome is important for 
mapping of PPIs and better perception of protein function and cellular organisation 
(Camacho-Carvajal et al., 2004). The complexome is studied by the implementation 
of different approaches that dissect MPCs directly called  complexomics (Camacho-
Carvajal et al., 2004). 
2.1.1. The role of multiprotein complexes in T. gondii and N. caninum  
Every cell and organism use PPIs and MPCs to maintain cellular processes 
that are necessary for normal cellular physiology. PPIs in T. gondii  and N. caninum   
play an important role in the invasion of host cells and the subsequent establishment 
of the infection, for example, in T. gondii it has been found that DG proteins are 
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stored as both soluble and complex forms (Braun et al., 2008; Labruyere et al., 1999) 
and are secreted as a soluble form into PV space where they form complexes (more 
detail is given in Chapter 3) (Mercier et al., 2005). The micronemes and rhoptries 
also play a storage role for several proteins (Bradley et al., 2005; Soldati et al., 2001; 
Zhang et al., 2007) and form protein complexes (Lamarque et al., 2012; Saouros et 
al., 2005). Furthermore, proteins from micronemes have been shown to be excreted 
and form MPCs on the surface of the parasite and forms tight adhesion through 
interaction with the host cells surface proteins (Huynh et al., 2003; Keller et al., 
2002; Naguleswaran et al., 2002; Rabenau et al., 2001). Also in T. gondii, MPCs 
play important role in the invasion process; microneme protein TgAMA1 is secreted 
on the surface of the parasite interacts and form complexes with RON2/4/5/8 on the 
surface of the invading cell which facilitate formation of MJ and internalisation of 
the parasite (Alexander et al., 2005; Besteiro et al., 2011; Straub et al., 2009; Straub 
et al., 2011).  
Also apicomplexan parasites use a unique way of movement called gliding 
motility to move within the host, during cell invasion and when they egress from the 
infected host cells (Gilk et al., 2009). Gliding motility is powered by the glideosome, 
a macromolecular complex comprising of five protein subunits (Frenal et al., 2010). 
The myosin heavy chain is one of the subunits of the glideosome which forms the 
actin-myosin motor; this motor is supported by other proteins such as glycolytic 
aldolase that links F-actin to the cell surface adhesin complex, MIC2/M2AP (Jewett 
and Sibley, 2003). 
2.1.2. Methods used to study protein-protein interactions in T. gondii and N. 
caninum 
The sophisticated nature of apicomplexan parasites and technological 
limitations have hampered complete understanding of the biology of invasion and 
interaction with host cells despite decades of research. In addition, studies conducted 
in the last two decades showed that identification of proteins, PPIs and MPCs of 
different secretory proteins are partly associated with mystery of understanding of 
these organisms (Alexander et al., 2005; Besteiro et al., 2009; Bradley et al., 2005; 
Carruthers and Sibley, 1997; Frenal et al., 2010). Several different methods to study 
PPIs have been used to investigate the functional status of interacting proteins in 
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apicomplexan parasites. The approaches most frequently used include biochemical 
methods such as Co-IP and AP. In the former an antibody is raised against a protein 
to be tested; in the latter either an endogenous protein produced in a normal cell or 
expressed as a fusion tag in a transgenic cell which is then incubated with antibody to 
isolate and purify the target protein and its binding partner. In T. gondii, Co-IP was 
used to identify proteins involved in PPIs and MPCs critical for parasite motility 
such as the glideosome (Frenal et al., 2010), adhesion with the host cell 
plasmalemma such as the TgMIC4/1/6 complex (Saouros et al., 2005) and for 
protein involved in MJ and invasion of the host cell such as TgAMA1/RON2/4/5/8 
(Alexander et al., 2005; Besteiro et al., 2009). While AP has been used in T. gondii 
to identify the interaction between TgMIC2, TgMIC6 and aldolase critical for 
parasite motility (Jewett and Sibley, 2003; Zheng et al., 2009). 
Other methods include yeast two-hybrid assays (Y2H), in which two proteins 
to be tested for PPIs are expressed as fusion proteins in yeast. In T. gondii, this 
approach has been used to identify the interacting protein partners of TgROP18 from 
the host cell, eight novel host cell proteins were obtained (Du et al., 2013). However, 
co-IP, AP and Y2H are expensive, laborious and can be used only to study one MPC 
or PPI at a time. 
To study the biomolecular interactions of multiprotein complexes, an 
extraction method that keeps it in its native form is necessary. Thus, blue 
native/SDS-PAGE (BN/SDS-PAGE) is the most reliable method (Lasserre et al., 
2010). BN/SDS-PAGE (Figure 2.1) is a gradient polyacrylamide gel electrophoretic 
technique that is used for high resolution isolation and separation of enzymatically 
active MPCs between 10 kDa and 10 mDa especially from biological cells and 
organelle membranes (Pfeiffer et al., 2003; Schagger, 2001; Wittig et al., 2006). It 
can be used for the extraction of protein complexes from total cell and tissue 
homogenates (Schagger et al., 1996; Wittig et al., 2006). Until recently, little 
research has been done on the complexome of apicomplexan parasites. In spite of 
that BN-PAGE has been used successfully to study protein complexes in detergent-
resistant membranes of Plasmodium falciparum schizonts. Proteins from seven 
known complexes were identified, including MSP-1/7, the low (RAP1/2 and 
RAP1/3) and high molecular weight rhoptry complexes (RhopH1/H2/H3) and the 
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invasion motor complex (GAP45/GAP50/myosinA) (Sanders et al., 2007). However, 
BN-PAGE has not been applied to study the whole membrane-bound proteins and 
the complexome of apicomplexans. 
 
 
Figure 2.1: Principle of BN-PAGE. A: proteins and MPCs are separated under native conditions in a 
first-dimension BN-PAGE and b: a gel strip containing proteins and MPCs is prepared under reducing 
state using SDS and is applied to a two-dimensional BN/SDS-PAGE. The protein subunits of MPCs 
are separated in the two-dimensional BN/SDS-PAGE gel. MPCs: multiprotein complexes Adapted 
from (Camacho-Carvajal et al., 2004).  
 
2.1.3. Aims and objectives of the study 
The hypothesis is that host-parasite interactions differ between T. gondii and 
N. caninum due to differences in their MPCs that comprise the complexomes 
necessary for parasite physiology, invasion processes and maintenance of infection.  
A comparative analysis of the complexomes was performed based on the 
composition of MPCs identified from the tachyzoite stage of T. gondii and N. 
caninum using BN-PAGE combined with LC MS/MS. 
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2.2. MATERIALS AND METHODS 
2.2.1. Host cell and parasite maintenance 
T. gondii RH strain and N. caninum Liverpool strain were maintained twice 
weekly in culture in monolayers of Vero cells (African Green Monkey Kidney 
Fibroblast).  
2.2.1.1. Vero cell maintenance 
Vero cells were maintained in growth medium consisting of IMDM (Iscove's 
Modified Dulbecco's Media, Lonza) supplemented with 10 % bovine foetal serum 
(BFS) (Biosera) and 1 % penicillin 10,000 units/streptomycin 10 mg/ml (Sigma). 
Cells and parasites were incubated at 37 °C in 5 % CO2 in a humidified incubator. 
2.2.1.2. Vero cell passage 
Vero cells were passaged once a week. Confluent monolayers of Vero cells 
were washed with 5 ml PBS-EDTA (Lonza) before detaching the cells with 5 ml of 
Trypsin-Versene (EDTA) solution (Lonza) for 3-5 min at 37 °C in 5 % CO2. The cell 
suspension was collected and transferred to a 50 ml centrifuge tube and centrifuged 
at 1,000 × g for 5 min. The cell pellet was resuspended in 5 ml growth medium 
where 10 µl were used for cell counting using Neubauer (haemocytometer) cell 
counting chamber (Marienfeld-Superior). Cells were seeded again at 1 × 10
5
 in 5 ml 
of growth medium in a tissue culture flask of 25 cm
3
 (T25) and infected with the 
parasites after overnight incubation at 37 °C in the presence of 5 % CO2.  
2.2.1.3. Maintenance of T. gondii and N. caninum tachyzoites  
Parasites were passaged when most of the infected host cells were lysed at 
about three to four days post infection (p.i.). Infected host cells were detached from 
the flasks using a 18 mm blade cell scrapper (Falcon
®
) and collected in a 50 ml 
centrifuge tube. Parasites were counted before passaging by adding 10 µl of infected 
cell suspension to haemocytometer chamber. A ratio of 4:1 of parasites to cells was 
used for maintaining both parasites throughout the experiment.  
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2.2.1.4. Harvesting of T. gondii and N. caninum tachyzoites 
Infected cells were incubated at the same environment described in section 
2.2.1.1. The parasites were harvested four days p.i. when almost all the cells were 
damaged by the egressed parasites. Parasites purification and harvesting were carried 
out using 3 μm pore-sizes Nuclepore™ track-etched membranes (Whatman®). Nine 
T25 flasks of infected cells were scraped with 18 mm blade cell scraper. The scraped 
host cells infected with T. gondii or N. caninum were collected in 50 ml centrifuge 
tubes. Flasks were washed with 5 ml PBS, which was added to the previous 
collection before centrifuged at 1,500 × g for 10 min. The pellets were resuspended 
in 5 ml growth medium and passage through a 27 gauge needle (Terumo) five times. 
An additional 25 ml growth medium were added then injected into the filter unit. 
Another 10 ml of cold PBS was pushed through the filter. The number of the 
parasites tachyzoites was counted using haemocytometer. Parasites were then 
centrifuged at 1,500 × g for 10 min at 4 °C. The pellet was washed twice with 10 ml 
cold PBS. Finally the pellet was resuspended in 1 ml cold PBS and centrifuged using 
bench-top centrifuge (Heraeus) at 16,000 × g for 3 min at 4 °C and the pellet was 
either used directly or kept at -20 °C for future use.  
2.2.2. Protein extraction from T. gondii and N. caninum tachyzoites 
Protein extraction was performed in two successive stages; homogenisation to 
open and break the tachyzoites and solubilisation to extract the membrane-bound 
protein and multiple protein complexes.  
2.2.2.1. Homogenisation of tachyzoites pellet 
The homogenization of the tachyzoites pellet was carried out according to a 
modified protocol of Schagger and von Jagow (1991). All the steps were carried out 
on ice. A pellet of 2 × 10
8
- 5 × 10
8
 tachyzoites was suspended in 0.5 ml of cold 
homogenization buffer (440 mM sucrose, 20 mM sodium phosphate, 2 mM EDTA, 
and 0.1 mM phenylmethylsulfonyl fluoride (PMSF) (Amresco), pH 7.2). 
Homogenised cells were transferred into pre-cooled 2 ml glass Dounce homogenizer 
and left on ice for 10 min. The cells were ground three times manually by moving up 
and down for 30 second each. Homogenized cells suspension were transferred into 
1.5 ml eppendorf tube, the homogeniser was washed with 0.5 ml homogenisation 
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buffer and added to the previous collection followed by centrifugation at 16,000 × g 
for 30 min at 4 °C. The supernatant was discarded and the pellet was washed again 
with the same homogenization buffer and centrifuged. Finally the pellet was 
collected.  
2.2.2.2. Solubilisation of tachyzoites pellets 
The solubilisation of the pellet containing tachyzoites was carried out as 
previously described (Schagger and von Jagow, 1991). The resulting pellet was 
resuspended in 92.5 µl of solubilisation buffer containing a non-ionic detergent (750 
mM aminocaproic acid (Applichem Lifescience), 50 mM Bis-Tris/HCl (Amresco), 1 
mM EDTA (pH 7.0), 10 µg/ml of aprotinin (Amresco), 10 µg/ml of leopeptin 
(Amresco), 1 mM PMSF and 1 % dodecyl-D-maltoside (Invitrogen)) and incubated 
on ice for one hour. The supernatant was collected after centrifugation at 16,000 × g 
for 30 min at 4 °C and was used either directly or kept at -80 °C. The protein 
concentration was determined using Coomassie (Bradford) Protein Assay Kit 
(Thermo Scientific) as described in section 2.2.3. 
2.2.2.3. Optimisation of the solubilisation and homogenisation 
2.2.2.3.1. Optimisation of the homogenisation 
Three methods of homogenisation were used in order to optimise this step. 
The first method involved using a Micropestle (Eppendorf) for resuspending pellets, 
pellet was homogenised for 30 min on ice and shearing forces applied for 30 × 5 min 
interval. Secondly, sonication was done on ice water for 6 × 5 min cycles using a 
water bath sonicator (Fisherbrand
®
) with or without saponin detergent at 0.05%. 
Samples were cooled for 2 min on ice between each cycle. In the third method, a 
probe sonicator (Sonics
®
) was used for 3 min with 30 sec on and 2 min off pulse on 
ice at 40 % output. 
2.2.2.3.2. Optimisation of the solubilisation 
The solubilisation of membrane bound proteins and protein complexes were 
performed by increasing the time and speed of centrifugation. First, the 
centrifugation time was increased to one hour at 16,000 × g at 4 °C.  Second, the 
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centrifugation speed was increased to 100,000 × g at 4 °C for 30 min using Optima 
MAX-XP Ultracentrifuge (Beckman).  
 2.2.3. Protein assay 
Protein concentration was determined using a Coomassie (Bradford) Protein 
Assay Kit (Thermo scientific). A serial concentration of bovine serum albumin 
standard proteins at 25 µg/ml, 20 µg/ml, 15 µg/ml, 10 µg/ml, 5 µg/ml and 2.5 µg/ml 
were used in duplicate along with two duplicate blanks; one of the blanks was set as 
zero µg/ml. The samples were prepared in serial dilution and in duplicates using 
doubled distilled H2O (ddH2O). Duplicates of 150 µl of each standards and samples 
were pipetted into a 96-well plate (Fisherbrand
®) and 150 μl dye reagent added to 
each well and mixed thoroughly. The plate was incubated at room temperature for 5 
min and the absorbance was measured at 595 nm using Tecan-Infinite
® 
F50 (Tecan 
Group Ltd.). Sample concentrations were calculated according to the standard curve 
produced from concentrations of protein standards. 
2.2.4. One-dimensional blue native polyacrylamide gel electrophoresis (1D 
BN-PAGE) 
Discontinuous blue native gradient polyacrylamide gel electrophoresis was 
used for separation of protein complexes and membrane bound proteins of the whole 
parasite tachyzoite lysate. Bis-Tris gel 3-12 % (BN1001box) or 4-16 % 
(BN1002box) (Life Technologies) were used for the 1D BN-PAGE. The amount of 
reagents for casting one Bis-Tris gel (0.16 × 14 × 14 cm) of 4–16 % is shown in 
Table 2.1. 
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Table 2.1: 1D BN-PAGE composition and polymerisation conditions. Adapted 
from (Schagger et al., 1994; Wittig et al., 2006)  
Reagent Stacking gel 3.5 % Gradient Separation gel 
4 % 16 % 
AB-3 mix (49.5 %)* 0.44 ml 1.5 ml 4.9 ml 
Gel buffer (3 ×)** 2 ml 6 ml 5 ml 
Glycerol - - 3 g 
H2O 3.5 ml 10.4 ml 2.045 ml 
APS (10 %) 50 µl 100 µl 50 µl*** 
TEMED 5 µl 10 µl 5 µl*** 
*AB-mix (acrylamide-bisacrylamide mixture): The 49.5 % T, 3 % C mixture contains 48 g 
acrylamide/100 ml and 1.5 g bisacrylamide/100 ml. ‘T %’ is the total concentration of  acrylamide-
bisacrylamide mixture, ‘C %’ is referred to the percentage of cross linker form by bisacrylamide to the 
total amount of monomer (Hjerten, 1962). 
**Gel buffer (3 ×): 1.5 M 6-aminocaproic acid, 150 mM Bistris adjusted with HCl to pH 7.0 (4 °C). 
***Add fresh. APS: Ammonium persulphate, TEMED: Tetramethylethylenediamine 
Depending on the protein concentration of the extracted protein samples, 
protein loading was varied between experiments, 50-100 µg of protein was loaded 
per lane. Coomassie blue G-250 (5 %) in 500 mM aminocaproic acid (Invitrogen) 
was added to the extracted proteins to be run in a ratio so that the concentration of 
the dye was 1:4 of Dodecyl-D-maltoside. 5 % glycerol was added to the protein 
samples prior to loading on the gel. 
The Cathode running buffer (50 mM Tricine, 50 mM Bistris-HCl pH 7.0, 
0.02 % Coomassie blue G-250 and stored at 4 °C) was used only in the upper 
chamber. The anode buffer (50 mM Tricine, 50 mM Bistris-HCl pH 7.0 at 4 °C) was 
stored at 4 °C and used in the lower chamber.  
Electrophoresis was done using Xcell surelock™ Mini-cell (Invitrogen™). 
Prepared sample proteins were added to the wells of casted BN-PAGE (each sample 
added to two wells, one for staining and visualization of the bands and the other one 
for performing 1D SDS-PAGE. The cathode buffer was added to the upper chamber 
and the anode buffer to the lower chamber. Electrophoresis was started at 150 volts 
for 60 min at 4 °C cold room until the protein samples run down to about one third of 
the gel. Voltage was then increased to 250 V with the current limited to 8-10 mA for 
90-120 min. 
The gel was removed from the cassette after electrophoresis had finished. The 
gel cuts into two slices, one for staining with Coomassie blue and the other one for 
SDS-PAGE. Gel slices for SDS-PAGE was transferred into a small glass Petri-dish 
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containing 5 ml SDS-sample buffer (12.5 mM Tris, 4 % SDS, 20 % glycerol, 5 mM 
Dithiothritol (DTT) and 0.02 % bromophenol blue) and incubated for 10 min at room 
temperature (RT) on a rocking platform. The gel slice was boiled in a microwave for 
15 sec at highest temperature set and incubated for 20 min at room temperature (RT) 
on a gel rocker. The gel slice was then loaded on the stacking gel for the second 
dimension separation on SDS-PAGE. 
2.2.5. Two-dimensional blue native/sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (2D BN/SDS-PAGE) 
Two-dimensional BN/SDS-PAGE was used to analyse the protein subunits 
separated in the 1D BN/PAGE. Sliced 1D gel of BN-PAGE was laid on a 7 × 8 cm 
SDS-PAGE gel using plastic cassettes (Invitrogen™). Gels were cast following the 
recipes listed in Table 2.2 for stacking gel and Table 2.3 for resolving gel. Liquefied 
Agarose (Bioline) 2 % was used to fix the sliced 1D gel between the plates and 
covered with SDS sample buffer. Gels were run in running buffer (25 mM Tris, 192 
mM glycine, 0.1 % SDS, pH 8.3) at 200 V for 45 min. 
 
Table 2.2: Recipe of stacking gel (4 %) 
Reagent Volume 
ddH2O 3.025 ml  
30 % (w/v) Acrylamide-bisacrylamide (Sigma-Aldrich) 0.65 ml  
0.5 M Tris/HCl (pH 6.8)  1.25 ml  
10 % (w/v) SDS  50 μl  
10 % (w/v) ammonium persulfate (Sigma) 25 μl* 
TEMED (VWR) 5 μl* 
*Add fresh 
 
Table 2.3: Recipe of resolving gel (12 %) 
Gel Reagent  Volume  
ddH2O  3.4 ml  
30 % (w/v) Acrylamide-bisacrylamide 4 ml  
1.5 M Tris/HCl (pH 8.8)  2.5 ml  
10 % (w/v) SDS  50 µl  
10 % (w/v) ammonium persulfate  75 μl* 
TEMED  7.5 μl* 
*Add fresh 
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2.2.6. Staining of 1D SDS-PAGE 
 After electrophoresis, gel was fixed in 40 % (v/v) ethanol, 10 % (v/v) acetic 
acid followed by 25 sec boiling in microwave oven. Gel was then incubated at RT 
using a gel rocker for 20 min. After fixation, the gel was washed twice in dH2O for 5 
min. The gel was stained overnight using colloidal Coomassie blue G-250 (20 % 
(v/v) methanol, 0.08 % (w/v) Coomassie Brilliant Blue G-250, 0.8 % (v/v) 
phosphoric acid, 8 % (w/v) ammonium sulphate).  
2.2.7. In-gel trypsin digestion 
Slices of gel from 1D BN-PAGE and 2D BN/SDS-PAGE were excised using 
clean glass Pasteur pipettes. Slices were placed in 0.5 ml microcentrifuge tubes and 
each gel plug was estimated at 10 µl. The plugs were destained twice in 10 µl 
destaining solution (50 mM ammonium bicarbonate/50 mM of acetonitrile) and 
incubated at 37 °C for 10 min. Proteins were reduced using 50 µl of 9.85 mM of 
dithiothreitol (VWR) in 25 mM ammonium bicarbonate and incubated at 37 °C for 
30 min. DTT was removed and discarded. Alkylation step was carried out in 50 µl of 
55 mM of iodoacetamide (Sigma) in 25 mM ammonium bicarbonate in the dark for 
30 min at RT. After iodoacetamide had removed and discarded, 10 µl of 100 % 
acetonitrile was added and incubated at 37 °C for 15 min. The solvent was removed 
and discarded, while the plugs were incubated to evaporate at 37 °C for 10 min. 10 µl 
of diluted sequencing grade trypsin (Sigma) containing 100 ng trypsin in 25 mM 
ammonium bicarbonate was added to the gel plug and incubate at 37 °C for one hour. 
Further 10 µl of 25 mM ammonium bicarbonate was added and incubated at 37 °C 
overnight. The reaction of trypsin digestion was stopped by adding 2 µl of 2.6 M 
formic acid. Finally, digested samples were centrifuged at 13,000 × g for 1 min and 
the supernatant was transferred to a new tube and kept at -20 °C. 
2.2.8. Liquid chromatography (LC)-MS/MS and data analysis 
The LC-MS/MS work for 1D BN-PAGE and 2D BN/SDS-PAGE in-gel 
digestion was carried out by Dr. S. Armstrong, University of Liverpool. Peptide 
mixtures were analysed by on-line nanoflow LC using the nanoACQUITY-nLC 
system (Waters) coupled to an Amazon ion trap mass spectrometer (Bruker 
Daltonics) equipped with the manufacturer’s CaptiveSpray ion source. The analytical 
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column (nanoACQUITY UPLCTM BEH130 C18, 15 cm 75 μm, 1.7 μm capillary 
column) was maintained at 35 °C and a flow-rate of 500 nl/min. The gradient 
consisted of 3-40 % acetonitrile in 0.1 % formic acid for 30 min, followed by a ramp 
of 40-85 % acetonitrile in 0.1 % formic acid for 3 min. Full scan MS spectra (m/z 
range, 300-2,000) were acquired by the Amazon in enhanced resolution mode at a 
resolution of 20,000. Analysis was performed in data-dependant mode. The top 5 
most intense ions from MS1 scan (full MS) were selected for tandem MS by 
collision induced dissociation (CID). The ICC target was set at 200,000. Raw 
Amazon files were converted to mzML using the CompassXport 3.0.5 tool (Bruker). 
Peptide identifications were established using the Mascot (version 2.3.02, Matrix 
Science) (http://www.matrixscience.com) search engine against a custom database 
separately that contained predicted proteomes from T. gondii ME49 strain and N. 
caninum Liverpool strain (ToxoDB, Toxoplasma Genomics Resource, Version 11). 
Mascot search parameters were set with precursor mass tolerance 0.5 Da and 
fragment mass tolerance of 0.5 Da. Carbamidomethylation of cysteine (C) was set as 
a fixed modification and oxidation of methionine (M) was included as a variable 
modification. One missed tryptic cleavage was permitted. Cleavage was done by 
trypsin, which cuts C-term side of K and R (Lysine and Arginine, respectively) 
unless next residue is P (Proline). A significance threshold of p < 0.05 was applied to 
the Mascot search results and ion scores < 31 were omitted. Proteins were considered 
as valid with protein score ≥ 50 with at least two unique peptides. The NCBI basic 
local alignment search tool (BLAST) (Altschul et al., 1997) in the Gene bank 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) and in the ToxoDB databases (ToxoDB, 
Toxoplasma Genomics Resource, Version 11) were used to investigate for 
orthologous proteins. 
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2.3. RESULTS 
2.3.1. Homogenisation and solubilisation optimisation and one-dimensional 
blue native polyacrylamide gel (1D BN-PAGE) 
Different methods of optimisation were used to obtain the best protein 
extraction and gel resolution for MPCs from whole tachyzoite lysates. These 
included different homogenisation tools (Dounce homogeniser, micropestle, water 
bath sonication and probe sonicator) and spin time/speed. 
Initially a glass Dounce homogeniser was used for homogenisation, the 10 
cm 4-16 % gradient 1D BN-PAGE gel loaded with 100 µg of protein extract 
resulting from solubilisation (section 2.2.2.1) of N. caninum tachyzoites and Vero 
cells is shown in Figure 2.2a. Results showed that streaking and background staining 
of the BN-PAGE were the main problems that hampered visualisation of the bands 
resulted from the migration of proteins and MPCs.   
Modifications to the previous run were applied to the homogenisation, 
centrifugation time and gradient gel concentration. Tachyzoites were incubated on 
ice for 30 min and a micropestle was used to apply shearing force to the tachyzoites 
manually every 5 min. Centrifugation was performed at 16,000 × g for 30 min at 4 
°C for the homogenised fraction and one hour for the solubilised membrane bound 
proteins. The result of 3-12 % 1D BN-PAGE gel was loaded with 100 µg of 
extracted protein from T. gondii and N. caninum is shown in Figure 2.2b, which has 
exhibited apparent improvement in resolution despite a milder background staining 
issue. 
To further optimise the visualisation of the 1D BN-PAGE gel, water bath 
sonication was used in the homogenisation step. Ultracentrifugation at 100,000 × g at 
4 °C for 30 min was also applied to differentially solubilise the membrane bound 
proteins and protein complexes. The resulting 1D BN-PAGE gel which was loaded 
with 50 µg of extracted protein from T. gondii and N. caninum is shown in Figure 
2.2c, which exhibited better visualisation of the bands with less background staining. 
Less background staining could be related to the amount of protein loaded (50 µg) 
(Figure 2.2c) which is half the amount used compared to previous gels (100 µg) per 
each well (Figure 2.2b). However, better efficiency of homogenisation measured by 
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number and intensity of bands on gel is still to be achieved. In addition, detergent 
was used at a low concentration in the homogenisation buffer (Figure 2.2d), which 
could help break the cells and release more soluble proteins for further enrichment of 
membrane bound proteins. Saponin (0.5 % v/v) was added to the homogenisation 
buffer and 6 × 5 min water bath sonication was used. The resulting 1D BN-PAGE 
gel loaded with 18 µg of extracted protein from T. gondii and N. caninum (because 
of low amount of protein yield that recovered from this method) is shown in Figure 
2.2d, which showed very weak protein bands suggesting that detergent treatment 
might resulted in the loss of proteins during protein extraction. 
A probe sonicator was used in conjunction with ultracentrifugation to 
increase the recovery of more membrane bound protein and reduce background 
staining. The probe sonicator was used for 2 × 30 sec (74 Hz) at 40 % amplitude 
output. The 1D BN-PAGE gel, which was loaded with 50 µg of extracted protein 
from T. gondii and N. caninum, is shown in Figure 2.2e. However, it seems that 
sonication by probe sonicator has made no obvious improvement than water bath 
sonication concerning the gel resolution. 
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Figure 2.2: Optimisation of 1D BN-PAGE gel from tachyzoites lysate of T. gondii and N. caninum. Different methods were used to extract and optimise the 1D BN-PAGE 
from tachyzoites lsate of T. gondii and N. caninum as described in section 2.3.1. L: protein standard labelled with the molecular weight of each protein. V: Vero cells, Nc: N. 
caninum tachyzoites and Tg: T. gondii tachyzoites.  Protein loading varied between experiments: Lane a (V and Nc) and lane b (Nc and Tg) contain 100 µg of the extracted 
proteins; lane c (Nc and Tg) contains 50 µg; lane d (Nc and Tg) contains 18 µg and lane e (Nc and Tg) contains 50 µg. 
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2.3.2. 1D BN-PAGE of whole tachyzoite multiprotein complexes of N. 
caninum and T. gondii 
Gel slices from 1D BN-PAGE of N. caninum (Figures 2.3a, slice 1-5) and T. 
gondii (Figure 2.4a, slice 1-11) were analysed with mass spectrometry.  Protein was 
considered to be significant identifications with at least two or more unique peptides 
and with Mascot protein score of ≥ 50. Two or more proteins when co-existed in the 
same gel spot were considered as potential PPIs (because PPIs is more likely to be 
exist in the presence or co-existing of two or more protein in 1D BN-PAGE). The 
results from N. caninum and for T. gondii gels are shown in Table 2.4 and 2.6, 
respectively. 
2.3.3. 2D BN/SDS-PAGE of whole tachyzoite multiprotein complexes of N. 
caninum and T. gondii 
Gel strips from 1D BN-PAGE of N. caninum and T. gondii samples (Figures 
2.3a and 2.4a, respectively) were applied to the 2D SDS-PAGE (Figure 2.3b and 
2.4b, respectively). 2D BN/SDS-PAGE showed that protein subunits were separated 
and 32 and 13 gel slices of the separated protein on the gels from N. caninum (Figure 
2.3b) and T. gondii (Figure 2.4b), respectively, were analysed by mass spectrometry. 
The results from N. caninum gel and T. gondii results are shown in Table 2.5 and 2.7.  
 
 
Figure 2.3: 2D BN/SDS-PAGE of differentially purified membrane proteins and complexes of N. 
caninum. a) 1D BN/PAGE: M) protein standard, Nc) 100 µg of N. caninum tachyzoite lysate, b) 2D 
BN/SDS-PAGE. 1-37 with arrows indicate locations of the gel cut for in gel digestion and mass 
spectrometry analysis. 
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Figure 2.4: 2D BN/SDS-PAGE of differentially purified membrane proteins and complexes of T. 
gondii. a) 1D BN/PAGE: M) protein standard, Tg) 100 µg of T. gondii tachyzoite lysate, 2) 2D 
BN/SDS-PAGE. 1-24 with arrows indicate locations of gel cut for in gel digestion and mass 
spectrometry analysis. 
 
2.3.4. In-gel digestion and mass spectrometry of 1D BN-PAGE and 2D 
BN/SDS-PAGE from N. caninum and T. gondii  
The detail of the results from mass spectrometry of 1D BN-PAGE and 2D 
BN/SDS-PAGE (Figure 2.3 and 2.4) from N. caninum and T. gondii are shown in 
Appendix in Tables I and II, respectively. These tables show the total number of 
proteins identified from each spot analysed by MS, including all the proteins that 
were considered significant based on the threshold applied by the Mascot software. 
Mascot scoring is based on the ions score of individual peptide which is -10log(P), 
where P is the probability that the observed match of a peptide is a random event. 
Ions scores > 31 of an individual peptide indicate the identity or extensive homology 
(p<0.05). 
Neospora mass spectrometry results from 1D BN-PAGE (Figure 2.3a) and 
2D BN/SDS-PAGE (Figure 2.3b) based on the custom filters applied in section 2.3.2 
are shown in Tables 2.4 and 2.5, respectively. Results showed that several protein 
subunits were identified in each slice suggesting that they could be associating with 
each other. Several of these proteins were identified as “hypothetical protein”, 
“conserved hypothetical protein”, or “unspecified product”. The sequences of these 
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proteins were searched for protein orthologue using BLAST
®
 and ToxoDB (Version 
11) and one of the orthologue proteins name from T. gondii ME49 strain (the most 
completed genome sequence annotation) was chosen (Tables 2.4 and 2.5).  
Results from 1D BN-PAGE (Table 2.4) showed that isolated protein bands 
contained multiple proteins. N. caninum gel slice 1 (Figure 2.3a) consisted of nine 
significantly identified proteins; three of them were members of the glideosome 
(NCLIV_048570, NCLIV_049900 and NCLIV_029420), two of the proteins were 
from the proteasome (NCLIV_065750 and NCLIV_048880), from mitochondria 
(NCLIV_022220), rhoptry (NCLIV_001970), and from other compartments 
(NCLIV_034460 and NCLIV_019110). 
On the other hand, proteins identified from gel slice 2 (Figure 2.3a) were 
from different subcellular locations such as rhoptry (NCLIV_001970), plasmalemma 
(NCLIV_033230 and NCLIV_032770) and HSP90-like protein, related protein 
(NCLIV_019110). While gel slice 3 (Figure 2.3a) was composed of five protein 
subunits including actin (NCLIV_003440), subtilase enzyme (NCLIV_021050), 
protein disulfide isomerase (NCLIV_011410), 14-3-3 protein homolog 
(NCLIV_024820) and putative 40S ribosomal protein S18 (NCLIV_047630). Five 
protein subunits from gel slice 4 (Figure 2.3a) were identified which include 
phosphoglycerate kinase 1 (NCLIV_011270), protein disulfide isomerase 
(NCLIV_011410), 14-3-3 protein homolog (NCLIV_024820), ribosomal protein 
RPL8 (NCLIV_021080) and putative cAMP-dependent protein kinase 
(NCLIV_017370). 
Results from 2D BN/SDS-PAGE of N. caninum from spot 6-21 separated on 
straight line down on the gel; these spots could contain protein subunits of MPCs 
and/or co-migrated proteins to the same band (Figure 2.3b and Table 2.5), identified 
six proteins RON1, RON2, RON3, RON5, RON8, and a ROP2 family member 
(NCLIV_054120, NCLIV_054120, NCLIV_048590, NCLIV_064620, 
NCLIV_055360, NCLIV_070010 and NCLIV_001970, respectively) that belong to 
the rhoptries. In addition three protein subunits were identified from gel slice 14 
(Figure 2.3b): putative myosin heavy chain (NCLIV_003050), subtilisin 
(NCLIV_021050) and TgRON5 (NCLIV_055360). While in analysed gel spots 22-
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33 (Figure 2.3b and Table 2.5), RON2, RON3, RON5, ROP2 family member and 
ROP40 (NCLIV_012920) also were identified and they all belong to rhoptries.  Also 
gel slice 34 (Figure 2.3b) showed three proteins (NCLIV_050470, NCLIV_022220, 
NCLIV_061940) from the mitochondria were associated with each other and with 
rhoptry ROP2 family member (NCLIV_001970), glideosome GAP45 
(NCLIV_048570) and putative cAMP-dependent protein kinase (NCLIV_017370). 
While spot 35 only contained one significant protein, Putative microneme protein 
MIC3 (NCLIV_010600). 
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Table 2.4: Protein complexes and/or co-existed proteins identified from 1D BN-
PAGE protein bands (Figure 2.3a) from N. caninum tachyzoite lysates. Proteins 
listed are from individual gel spot that contains two or more proteins (PPIs is 
more likely to be exist in the presence or co-existing of two or more protein in 
1D BN-PAGE). Protein was considered to be significant identifications with at 
least two or more unique peptides and with Mascot protein score of ≥ 50.  
Gel 
slice 
no. 
Protein ID 
accession 
Protein description Protein 
score 
T. gondii orthologue 
(Protein ID accession)* 
1 
NCLIV_034460  Hypothetical protein 341 
Cell division cycle 48 protein 
(TGME49_273090) 
NCLIV_001970  Unspecified product  171 TgROP2 family member** 
NCLIV_048570  
Conserved hypothetical 
protein 
151 
Gliding-associated protein 45 
(GAP45) (TGME49_223940) 
NCLIV_049900  Hypothetical protein 106 
Myosin A 
(TGME49_235470) 
NCLIV_065750  
Alpha 2 subunit of 20S 
proteasome (ISS), related 
99 - 
NCLIV_029420  
Putative myosin light chain 
MLC1 
98 - 
NCLIV_019110  HSP90-like protein, related 73 - 
NCLIV_048880  
Proteasome subunit beta 
type-7, related 
73 - 
NCLIV_022220  Hypothetical protein 51 
Mitochondrial-processing 
peptidase beta subunit, 
putative (TGME49_202680) 
2 
NCLIV_032770  Hypothetical protein 112 
Vacuolar proton-translocating 
ATPase subunit, putative 
(TGME49_232830) 
NCLIV_019110 HSP90-like protein, related 105 - 
NCLIV_033230  
SRS domain-containing 
protein 
91 - 
NCLIV_001970  Unspecified product 67 TgROP2 family member 
3 
NCLIV_011410  Protein disulfide isomerase 227 - 
NCLIV_024820 14-3-3 protein homolog 97 - 
NCLIV_021050 Unspecified product 77 
Subtilase family serine 
protease, putative 
(TGME49_204050) 
NCLIV_047630 
Putative 40S ribosomal 
protein S18 
62 
- 
 
NCLIV_003440 Actin, related 53 - 
4 
NCLIV_011410  Protein disulfide isomerase  274 - 
NCLIV_017370  
Putative cAMP-dependent 
protein kinase regulatory 
subunit  
92 - 
NCLIV_021080  Hypothetical protein 72 
ribosomal protein RPL8 
(RPL8) (TGME49_204020) 
NCLIV_011270  Hypothetical protein 69 
Phosphoglycerate kinase 1 
(TGME49_318230) 
NCLIV_024820  14-3-3 protein homolog  52 - 
* Orthologue name of T. gondii protein for uncharacterised N. caninum proteins (hypothetical protein, 
unspecified product and conserved hypothetical protein). Dash sign (-) indicates that the protein is 
characterised in the database of N. caninum. **Accession number for ROP2 family member is not 
given as ROP2 family comprises several members with similar protein sequences. 
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Table 2.5: Protein identified from 2D SDS-PAGE (Figure 2.3b) differentially 
purified from N. caninum tachyzoite lysates. Proteins listed are from individual 
gel spot that contains significantly identified protein. Protein was considered to 
be significant identifications with at least two or more unique peptides and with 
Mascot protein score of ≥ 50. 
Gel 
slice 
no. 
Protein ID 
accession 
Protein description Protein 
score 
T. gondii orthologue 
(Protein ID accession)* 
8 
NCLIV_070010 
Hypothetical protein, 
conserved 
209 TgRON8 (TGME49_306060) 
NCLIV_042820 
DNA FLJ58099, highly 
similar to Homo sapiens 
clathrin, heavy polypeptide-
like 1 (CLTCL1) 
99 - 
NCLIV_031970  Hypothetical protein 59 
Pre-mRNA splicing factor 
PRP8, putative 
(TGME49_231970) 
9 
NCLIV_007800 Unspecified product 86 
Hypothetical protein 
(TGME49_253370) 
NCLIV_042820 
cDNA FLJ58099, highly 
similar to Homo sapiens 
clathrin, heavy polypeptide-
like 1 (CLTCL1), 
53 - 
10 
NCLIV_042820  
cDNA FLJ58099, highly 
similar to Homo sapiens 
clathrin, heavy polypeptide-
like 1 (CLTCL1) 
243 - 
NCLIV_070010 
Hypothetical protein, 
conserved 
177 TgRON8 (TGME49_306060) 
NCLIV_048590 Unspecified product 135 TgRON3 (TGME49_223920) 
12 NCLIV_064620  Unspecified product 215 TgRON2 (TGME49_300100) 
13 NCLIV_064620  Unspecified product 200 TgRON2 (TGME49_300100) 
14 
NCLIV_003050 
Putative myosin heavy 
chain 
158 - 
NCLIV_021050  Unspecified product 100 
Subtilisin SUB1 
(TGME49_204050) 
NCLIV_055360  Unspecified product 65 TgRON5 (TGME49_311470) 
15 
NCLIV_055360 Unspecified product 112 TgRON5 (TGME49_311470) 
NCLIV_019110 HSP90-like protein, related 53 - 
16 NCLIV_055360 hypothetical protein 90 TgRON5 (TGME49_311470) 
18 NCLIV_001970 Unspecified product 134 TgROP2 family member 
19 NCLIV_054120 Unspecified product 98 TgRON1 (TGME49_310010) 
20 NCLIV_001970  Unspecified product 165 TgROP2 family member 
23 
NCLIV_042820 
cDNA FLJ58099, highly 
similar to Homo sapiens 
clathrin, heavy polypeptide-
like 1 (CLTCL1) 
328 - 
NCLIV_048590 Unspecified product 84 RON3 (TGME49_223920) 
24 NCLIV_064620 Unspecified product 270 TgRON2 (TGME49_300100) 
26 NCLIV_055360 Unspecified product 134 TgRON5 (TGME49_311470) 
29 NCLIV_055490 
Heat shock protein 70 
(Precursor), related 
67 - 
30 NCLIV_001970 Unspecified product 235 TgROP2 family member 
Chapter Two 
52 
 
31 
NCLIV_001970 Unspecified product 220 TgROP2 family member 
NCLIV_012920 Unspecified product 63 TgROP40 (TGME49_291960) 
33 
NCLIV_053580 
50S ribosomal protein L4P, 
related 
170 - 
NCLIV_001970 Unspecified product 130 TgROP2 family member 
NCLIV_047530 
Conserved hypothetical 
protein 
85 
Hypothetical protein 
(TGME49_225150) 
NCLIV_006180 
Putative duplicated carbonic 
anhydrase 
61 - 
34 
NCLIV_050470 Hypothetical protein 159 
Peptidase M16 family 
protein  beta subunit, putative 
(TGME49_236210) 
NCLIV_022220  Hypothetical protein 124 
Peptidase M16, alpha subunit, 
putative (TGME49_202680) 
NCLIV_048570 
Conserved hypothetical 
protein 
96 
Gliding-associated protein 45 
(GAP45) (TGME49_223940) 
NCLIV_017370 
Putative cAMP-dependent 
protein kinase regulatory 
subunit 
93 - 
NCLIV_061940 Hypothetical protein 88 
Eukaryotic porin, putative 
(TGME49_218280) 
NCLIV_001970  Unspecified product 72 TgROP2 family member 
35 NCLIV_010600 
Putative microneme protein 
MIC3 
105 - 
37 NCLIV_019110 HSP90-like protein, related 436 - 
* Orthologue name of T. gondii protein for uncharacterised N. caninum proteins (hypothetical protein, 
unspecified product and conserved hypothetical protein). Dash sign (-) indicates that the protein is 
characterised in the database of N. caninum. 
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Toxoplasma mass spectrometry results from 1D BN-PAGE of (Figure 2.4a) 
and 2D BN/SDS-PAGE (Figure 2.4b) based on the custom filters applied in section 
2.3.2 are shown in Tables 2.6 and 2.7, respectively. Results from the T. gondii 
analysis showed that only gel slices 7 and 9 from 1D BN-PAGE contained more than 
one protein with potentially interacting proteins. Gel slice 7 contained SAG-related 
sequence SRS29B (TGME49_233460) and microneme protein MIC6 
(TGME49_218520). Gel slice 9 consisted of three proteins including protein 
disulfide isomerase (TGME49_211680), 14-3-3 protein (TGME49_263090) and 
ribosomal protein RPSA (TGME49_266060). On the other hand analysis from 2D 
SDS-PAGE showed only gel slices 12, 19 and 21 contained significantly identified 
proteins.  
 
Table 2.6: Protein complexes and/or co-existed proteins identified from 1D BN-
PAGE protein bands (Figure 2.4a) differentially purified from T. gondii 
tachyzoite lysates. Proteins listed are from individual gel spot that contains two 
or more proteins (PPIs is more likely to be exist in the presence or co-existing of 
two or more protein in 1D BN-PAGE). Protein was considered to be significant 
identifications with at least two or more unique peptides and with Mascot protein 
score of ≥ 50.  
Gel slice 
no. 
Protein ID 
accession 
Protein description Protein 
score 
7 
TGME49_233460 
SAG-related sequence SRS29B (SRS29B) 
or (SAG1) 
157 
TGME49_218520 Microneme protein MIC6 66 
9 
TGME49_211680 Protein disulfide isomerase 304 
TGME49_263090 14-3-3 protein 215 
TGME49_266060 Ribosomal protein RPSA (RPSA) 54 
 
 
Table 2.7: Proteins identified from 2D SDS-PAGE (Figure 2.4b) of differentially 
purified from T. gondii tachyzoite lysates. Proteins listed are from individual gel spot 
that contains significantly identified protein. Protein was considered to be significant 
identifications with at least two or more unique peptides and with Mascot protein 
score of ≥ 50.  
Gel slice 
no. 
Protein ID 
accession 
Protein description Protein 
score 
12 TGME49_290950 Clathrin heavy chain, putative 406 
19 TGME49_244560 Heat shock protein 90, putative 219 
21 TGME49_247550 Heat shock protein HSP60 (HSP60) 70 
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2.4. DISCUSSION 
Blue native electrophoresis was used to study the complexome of T. gondii 
and N. caninum at the fast growing and multiplying tachyzoite stages. A comparative 
study of the complexomes of both parasites could help in dissecting the biological 
differences between these two related organisms. 
To date BN-PAGE has not been used to study the complexomes of T. gondii 
or N. caninum or in the comparison between them. In this project efforts have been 
made to optimise the technique so that can be used efficiently to study these parasites 
and understand their complexomes based on the protein interactions and complexes 
from total cell lysates, including membrane bound protein complexes. Despite some 
progress towards optimisation of the technique, technical problems have hampered 
further improvement in the optimisation.  
Proteins of the gel slices from 1D BN-PAGE and 2D BN/SDS-PAGE from N. 
caninum (Figure 2.3) and T. gondii (Figure 2.4) were digested with trypsin and 
analysed using LC MS/MS. The data analysis from this study showed that many 
proteins were potentially associated together, while some of these associations could 
be due to non-specific interactions, protein subunits from complexes such as the 
proteasome and glideosome were found together following 1D BN-PAGE. The 
identification of proteins from known complexes indicates that some of these 
interactions were not a consequence of non-specific interactions. In this study, three 
subunits of the glideosome protein complex TgMyoA-MLC1-GAP45 
(NCLIV_049900, NCLIV_029420 and NCLIV_048570, respectively, Table 2.4) 
were found together which is in agreement with the study of Gaskins et al. (2004) on 
T. gondii. The present study is also comparable with the study of Sanders et al. 
(2007), identified the invasion motor complex comprised of 
(GAP45/GAP50/myosinA) from detergent-resistant membranes of Plasmodium 
falciparum schizonts using BN-PAGE. The glideosome is a macromolecular 
complex that powers substrate-dependent gliding motility of apicomplexan parasites 
and is required for migration through the host biological barrier, invasion of host 
cells, and egress (Keeley and Soldati, 2004). In T. gondii, the glideosome is 
comprised of MyoA (TgMyoA) which is a class XIV member of a family of 
apicomplexan-specific myosin (Heintzelman and Schwartzman, 1997) and is 
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associated with myosin light chain (TgMLC1) (Herm-Götz et al., 2002). MyoA is 
critical for parasite motility within the host, invasion of host cells and egress from 
infected cells (Meissner et al., 2002b). Previous studied in T. gondii found that other 
subunit were associated with the glideosome such as the gliding associated proteins 
TgGAP40 (Frenal et al., 2010), TgGAP45 and TgGAP50 (Gaskins et al., 2004). In 
this study, GAP40 and GAP50 were not identified which might be due to an 
insufficient centrifugation force (16,000 × g) to extract these proteins from inner 
membrane complexes (IMCs); a high centrifugation force (100,000 × g) is required 
to extract membrane bound proteins solubilised by non-ionic detergent (Wittig et al., 
2006). GAP50 is an integral transmembrane glycoprotein and plays an important role 
as a receptor in the IMCs for TgMyoA-TgMLC1-GAP45 (Gaskins et al., 2004). In 
addition, TgGAP40 was identified as a polytopic protein of the IMC. The findings of 
the present study of co-existing TgMyoA-TgMLC1-TgGAP45 subunits of the 
glideosome together are in agreement with those of Gaskins et al. (2004) who found 
that the glideosome forms in two stages. Initially the TgMyoA-TgMLC1-TgGAP45 
complex forms and assembles in the cytosol of an immature daughter parasite, it 
eventually translocates to the mature IMC were it associates with the membrane 
anchor TgGAP50 forming the functional glideosome. The final assembly of the 
functional glideosome is mediated by phosphorylation of the TgGAP45 (Gilk et al., 
2009). While the exact role of the recently identified subunit GAP40 in the complex 
is not known (Frenal et al., 2010).  
In the present study, proteasome complex subunits were also found together 
such as alpha 2 subunit of 20S proteasome (ISS) related protein and proteasome 
subunit beta type-7 related protein (NCLIV_065750 and NCLIV_048880, 
respectively) (Table 2.4). In addition, two other proteasome proteins 
(NCLIV_028230 and NCLIV_017470) were found in the same spot but only 
contained one peptide per each (Appendix, Table I). The proteasome is a non-
lysosomal macromolecular protease of multisubunit proteins present in eukaryotic 
cells (Bochtler et al., 1999). The proteasome plays an important role in the regulation 
of various vital cellular processes (DeMartino and Slaughter, 1999). In eukaryotic 
cells, 26S proteasome comprises of two sub complexes of 20S proteasome the 
proteolytic core and a 19S regulator which makes the enzyme ATP dependent and 
specific for proteolysis of ubiqitinated substrates (Ferrell et al., 2000). In T. gondii, it 
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has been shown that the proteasome is located mainly in the cytosol (Paugam et al., 
2001). The proteasome plays a critical role in the virulence and regulation of 
differentiation of parasitic protozoan such as life cycle progression in Trypanosoma 
cruzi (González et al., 1996) and T. gondii (Shaw et al., 2000). These studies are in 
agreement with results from the current work where, in addition to proteasome 
subunits in N. caninum, cell division cycle 48 protein (NCLIV_034460) was also 
found co-existed together  or associated with the complex. This suggests that cell 
division cycle 48 protein potentially recruited by the proteasome during cell 
progression of tachyzoite stage. However, presence of proteins of different MPCs 
together in one gel slice could be due to physical interactions occurring between 
different complexes resulted from whole tachyzoite solubilisation or just co-
migration of proteins to the same molecular size on the BN-PAGE. 
In this study the N. caninum protein disulfide isomerase NcDPI 
(NCLIV_011410) (Table 2.4) was found associating/co-localising with different 
proteins such as ribosomal proteins (NCLIV_021080), 14-3-3 protein 
(NCLIV_024820) and kinases such as phosphoglycerate kinase 1 (NCLIV_011270) 
and putative cAMP-dependent protein kinase regulatory subunit (NCLIV_017370). 
Also in T. gondii (Table 2.6), disulfide isomerase (TGME49_211680) was found 
associating/co-localising with ribosomal proteins (TGME49_266060) and 14-3-3 
protein (TGME49_263090). This enzyme functions to introduce disulfide bonds into 
newly synthesised proteins inside the endoplasmic reticulum mainly on two cysteines 
situated in close proximity (Oka and Bulleid, 2013). It is a critical step in the folding 
and maturation of secretory proteins containing disulfide bonds (Matagne and 
Dobson, 1998) which promote structural stability and enable the assembly of multi-
protein complexes (Hogg, 2003). Immunogold-electron microscopy study showed 
that NcDPI was localised to tachyzoite cytoplasm, microneme and plasma membrane 
surface (Naguleswaran et al., 2005). They also found that NcDPI was associated with 
adhesion of tachyzoites with host cell surface membrane and its inhibition reduced 
host cell surface adhesion; suggested that plays important role in processing of 
molecules involved in adhesion and invasion of host cell (Naguleswaran et al., 
2005). The association of this enzyme could be related to PTMs of these proteins and 
transform them to the functional state before targeting to a destined location. 
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In the present study, 2D BN/SDS-PAGE from N. caninum based on the 
orthologue proteins from T. gondii, several related rhoptry proteins were identified 
including RON1, RON2, RON3, RON5, RON8, a ROP2 family member and ROP40 
(Figure 2.3b, Table 2.5). These results are in agreement with the proteomic analysis 
of a rhoptry organelle fractions that have identified several proteins from the rhoptry 
bulb and neck, as well as many other proteins and enzymes in T. gondii (Bradley et 
al., 2005) and N. caninum (Marugán-Hernández et al., 2011). The former found 
TgRON1, 2, 3, and 4 while the later found NcRON2, 3, 4, and 8 from the analysis. 
This suggests that these proteins could be associating together inside the rhoptry 
organelles. In addition RON2, 3, 4, 5 and 8 were found to play important roles in the 
moving junction formation following attachment of T. gondii and N. caninum 
tachyzoites (Alexander et al., 2005; Sohn et al., 2011; Straub et al., 2009). The tight 
association between these proteins inside the parasite rhoptry and beyond the parasite 
plasma membrane during invasion processes and its critical role in the moving 
junction formation suggest that these proteins may form complexes. Complex 
formation inside rhoptries and secretion as one macromolecule may help the parasite 
to invade the host cells very quickly and establishment of infection. 
In the present study, ROP2 family member from spot 1 of 1D BN-PAGE 
(Table 3.4) and spot 34 of BN/SDS-PAGE (Table 4.5) was found associating/co-
migrating with mitochondrial proteins from N. caninum. A recent studied found that 
ROP18 is associated with a complex containing a ROP2 family member, 
pseudokinases ROP8/2 and GRA7 on the cytosolic surface of PVM and ROP18 was 
found to play critical role in the virulence of the parasite following infection of host 
cell (Alaganan et al., 2014; El Hajj et al., 2007; Lei et al., 2014). Furthermore, a 
previous study using co-IPs found that TgROP2 family member, pseudokinases 
ROP2/4 and GRA7 were associating together on strand-like structure extending from 
PVM and demonstrated that TgGRA7 was phosphorylated only within infected host 
cell (Dunn et al., 2008). In addition, previous studies showed that in both parasites, 
several host cell organelles were found in intimate association with PVM near the 
host cell nucleus such as mitochondria and endoplasmic reticulum (Hemphill et al., 
2004; Magno et al., 2005; Sinai and Joiner, 2001) and thought might result from 
protein-protein interaction between PVM and host organelles (Sinai et al., 1997). 
TgROP2 has been shown to have more likely to play key role as an interacting 
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molecules of the parasite with the mitochondrial import machinery of the host cell 
(Sinai and Joiner, 2001). Finding of the present study suggests that ROP2 family 
member from N. caninum might also interact with mitochondrial protein of the host. 
In the present study, spot 7 from 1D BN-PAGE (Table 2.6, Appendix Table 
II) from T. gondii showed that the microneme protein MIC6 (TGME49_218520) and 
MIC1 interacted/co-localised with SRS29B (TGME49_233460). MIC6 is an escorter 
transmembrane protein found in oligomeric complex in T. gondii comprised of 
MIC6-1-4 (Saouros et al., 2005). In T. gondii, the transmembrane domains of 
escorter MICs were found playing critical roles in complex formation and directing 
other soluble microneme proteins to the micronemes (Meissner et al., 2002a; Reiss et 
al., 2001). On the other hand SRS29B (SAG1) is a surface antigen adhesin that binds 
through its N-terminal to the surface of the tachyzoites by a 
glycosylphosphatidylinositol (GPI)-anchor (Jung et al., 2004). It plays an important 
role in mediating attachment and invasion of host cell through interaction with host 
surface proteins (He et al., 2002) and in attracting host immunity and maintenance of 
balance between parasite and host through reducing the virulence of the acute 
infection caused by T. gondii tachyzoites (Boothroyd et al., 1998; Lekutis et al., 
2001). Oligomerisation increases the opportunity of proteins from different 
organelles to makes distinct complexes that facilitate invasion collaboratively 
(Alexander et al., 2005; Carruthers and Tomley, 2008). Interaction/co-localisation of 
MIC6, MIC1 and SRS29B in this study may indicate that these proteins together play 
role in facilitating attachment and invasion of host cell by tachyzoites. 
In this study, BN/SDS-PAGE was used to investigate the differences between 
host-parasite interactions based on the complexome of tachyzoites stage of both 
parasites. Several different complexes were identified that play important part in 
gliding motility, attachment and invasion of host cell. However, limitation of access 
to laboratory instrument for BN/SDS-PAGE has laden further development to 
understand the complexomes of both T. gondii and N. caninum and host-parasite 
interaction. Native MPCs within the parasites both during and after invasion, could 
help understand the biological differences between these parasites. Therefore, the 
next step was to fractionate different compartment of tachyzoites using sucrose 
gradient fractionations before applying to BN-PAGE would be useful to decrease the 
complexity of the tachyzoites lysate. With a less complex sample the probability of 
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non-specific interactions occurring between MPCs of different compartment would 
be lower resulting in better separation of MPCs on the BN-PAGE. It would be 
important to study the host-parasite interactions based on the PPIs and MPCs of the 
same compartments or fractions of the tachyzoites from both parasites.  
BN-PAGE is a valuable analysis tool to perform screening to identify 
potential protein binding partners. Potential PPIs can be later analysed further using 
biochemical analysis and pull-down assay to confirm the presence of interaction. 
Therefore next project is to study comparative host-parasite interaction based on 
using the same recombinant proteins from both T. gondii and N. caninum; and 
because of the importance and availability of recombinant genes of dense granule 
proteins GRA7 and GRA2 of both parasites. In addition a potential binding partner 
of GRA7 which is a ROP2 family member was found associated with mitochondrial 
proteins of N. caninum. However it was not possible to determine which member of 
the T. gondii ROP2 family was the orthologue of NCLIV_001970) as they are very 
similar in protein sequences. Thus GRA7 was used in pull-down because it is a well-
known binding partner of ROP2 family members at the interface between the 
cytoplasmic face of PVM and host cell organelles (Alaganan et al., 2014; Dunn et 
al., 2008). While TgGRA2 has been found in gel slice 9 (Figure 2.4a and Table 2.6, 
Appendix Table I) based on the significant threshold applied by Mascot but no any 
binding partner was identified. Thus TgGRA2 and TgGRA7 from both parasites will 
be used to pull-down interacting partner from the host cell. 
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CHAPTER THREE: Pull-down assay for characterisation of T. 
gondii and N. caninum dense granule proteins in host-parasite 
interactions 
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3.1. INTRODUCTION 
Toxoplasma gondii and N. caninum exploit intracellular strategies within 
infected host cells that help successful establishment of infection and replication. 
Successful invasion results in formation of PV surrounded by a PVM (Sinai, 2014). 
PV provides the necessary environment required for replication of the highly 
multiplying tachyzoite stage and to evade detection and destruction by the host 
immune system (Besteiro et al., 2011; Mercier et al., 2005; Sinai and Joiner, 1997). 
The nascent PVM is excluded from most of the host cell membrane proteins at the 
time of invasion, preventing it being involved in host vesicular traffic and it is non-
fusogenic with lysosomes (Gendrin et al., 2008; Mordue et al., 1999). Infective 
stages employ an array of proteins from secretory organelles that play significant 
roles in the attachment, invasion, establishment of infection (Carruthers and Sibley, 
1997) and the alteration of host cell physiology (Bougdour et al., 2014). Several 
proteins from each organelle have been characterised and identified with certain 
critical functions having been assigned for some of them. However, the exact 
function of most of these proteins is not yet known, particularly most of the secretory 
proteins of the dense granules (Carey et al., 2000; Mercier et al., 2005). In 
Toxoplasma and Neospora, these proteins have been found to be involved in 
remodelling the PVM and formation of NTN in the PV (Carruthers and Sibley, 1997; 
Hemphill et al., 1998; Lebrun et al., 2007; Mercier et al., 2002; Michelin et al., 
2009; Travier et al., 2008). 
3.1.1. Dense granule proteins and their association with parasitophorus 
vacuoles and the parasitophorus vacuole membrane 
The intravacuolar release of the DG proteins is likely responsible for the 
maturation of the nascent PV (Mercier et al., 2005; Sibley et al., 1995). Following 
invasion, a NTN forms within 10-20 min at the posterior end of the parasite, which 
later distributes throughout the PV forming elongated tubules of 60-90 nm in 
diameter that connect with the PVM (Sibley et al., 1995). DG proteins divided into 
two groups: firstly, a group with no significant homology to any other known protein 
(Carey et al., 2000; Fischer et al., 1998) and were named as GRA (Sibley et al., 
1991); secondly, a group comprising proteins with homologies to already 
characterised proteins from other organisms, as reviewed in Mercier et al. (2005). 
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GRA proteins are a group of proteins with small to large molecular weight ranging 
between 12.8 kDa (e.g. TgGRA5) to 94.2 kDa (e.g. TgGRA10) (Mercier and 
Cesbron-Delauw, 2015). The number of GRA proteins identified and characterised is 
increasing, especially in T. gondii and N. caninum. In T. gondii zoites, currently 25 
proteins have been known to be stored and localised to the DG organelles including 
GRA1-GRA10, GRA11-12, GRA14-GRA16, GRA19-25, cyclophilin (CyP18), 
protease inhibitors (TgPI-1, TgPI-2), Tg14-3-3, T. gondii patatin-like protein 
(TgPL1) and isoforms of nucleotide triphosphate hydrolase (TgNTPasa-I, 
TgNTPasa-II) reviewed in Mercier et al. (2005) (Bougdour et al., 2013; Braun et al., 
2013; Masatani et al., 2013; Okada et al., 2013). These proteins are secreted in a 
soluble form, targeted to either vacuolar matrix (Cy-18, TgPI-1, TgPI-2, TgPL1, 
GRA1 and GRA2), the NTN (GRA2, GRA3, GRA4, GRA6, GRA7, GRA9, GRA12, 
GRA14, GRA23, TgNTPasa), the PVM (GRA3, GRA5, GRA7, GRA8, GRA10, 
GRA14, GRA23) or beyond the PVM into the cytosol of the infected host cells 
(GRA15, GRA16, GRA24). 
In N. caninum, several orthologues to T. gondii have also been identified and 
characterised. These include NcGRA1 (Atkinson et al., 2001), NcGRA2 (Ellis et al., 
2000), NcGRA14 (Liu et al., 2013), NcGRA6 (Liddell et al., 1998), NcGRA7 
(Hemphill et al., 1998). As in T. gondii, DGs contain other secretory/ excretory 
molecules such as nucleotide triphosphate hydrolase-type I (NTPasa I) (Asai et al., 
1998) and protease inhibitors (NcPI) (Morris et al., 2004). 
3.1.2. Structure and molecular function of dense granules proteins 
GRA proteins are characterised by having a short N-terminal hydrophobic 
signal peptide. GRA1 is a soluble protein that lacks central hydrophobic membrane 
domain, while most of the GRA proteins contain a central hydrophobic membrane 
domain, either at least a single hydrophobic alpha-helix transmembrane domain e.g. 
GRA3, GRA4, GRA5, GRA6, GRA7, GRA8) or multiple amphipathic alpha-helices, 
such as GRA2 and GRA9,  as reviewed from Mercier et al. (2005). Recently 
TgGRA16 and 24 were found to contain internal repeats sequence that contains 
putative nuclear localisation signals (Bougdour et al., 2013; Braun et al., 2013). 
GRA proteins are found in both soluble and complex forms within the dense granule 
matrix (Labruyere et al., 1999; Michelin et al., 2009; Sibley et al., 1995). Following 
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infection of the host cell by T. gondii, DG proteins are secreted as soluble proteins 
into the PV. These either stay in soluble form e.g. GRA1, GRA16 and GRA24 or 
subsequently become associated with the NTN and PVM (Bougdour et al., 2013; 
Braun et al., 2013; Sibley et al., 1995; Travier et al., 2008). GRA2 is secreted within 
multi-lamellar vesicles and assembles at a posterior invagination of the parasite. In 
the posterior invagination, NTN first form then distribute in the PV matrix. The NTN 
forms connections with intravacuolar membranes and GRA2 associates with the 
NTN as an integral membrane protein (Sibley et al., 1995). Experiments using gene 
knockout mutants of GRA2 found that the NTN formation is induced by GRA2 
(Mercier et al., 2002). The integrity of both amphipathic alpha-helices of GRA2 is 
essential for precise formation of the network and is further stabilized by GRA6 
(Mercier et al., 2002). GRA6 binds to the network via hydrophobic interactions, 
while GRA4 associates with the NTN established by GRA2 through strong protein–
protein interactions (PPIs). Thus, GRA4 and GRA6 specifically interact with GRA2 
leading to the formation of a multimeric complex that is stably linked with the NTN 
(Labruyere et al., 1999). GRA12 cannot be translocated to the parasite posterior 
invagination in the absence of GRA2 (Michelin et al., 2009). However, GRA9 
remains in both the soluble form and the NTN membranes associated form following 
secretion from anterior end of the parasite without trafficking through the posterior 
invagination (Adjogble et al., 2004). Other GRA proteins localise at and associate 
with the NTN to a lesser extent, such as GRA3, GRA5 and GRA7, as reviewed in 
Mercier et al. (2005). 
The PVM is similar to the NTN as it is also decorated by several proteins 
secreted from DG shortly after invasion. These proteins possess at least one 
transmembrane domain that provides possible membrane anchors. GRA3, GRA5, 
GRA7, GRA8 were detected as PVM associated proteins (Achbarou et al., 1991; 
Bonhomme et al., 1998; Carey et al., 2000; Dubremetz et al., 1993; Gendrin et al., 
2008; Lecordier et al., 1993). In addition, GRA proteins have been found beyond the 
boundary of the PVM in fine strands extending from the PVM membrane into the 
cell cytoplasm that can be detected as early as 15 min p.i. (Coppens et al., 2006; 
Dubremetz et al., 1993; Dunn et al., 2008; Jacobs et al., 1998). The function and 
composition of the GRA7-containing strands are unknown (Dunn et al., 2008). 
GRA1, GRA3 and GRA7 were found associating with these strand-like structures, 
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however GRA1 was only found associating for only 30 min p.i. (Dubremetz et al., 
1993; Dunn et al., 2008). TgGRA7 was also found in a complex consisted of 
ROP18/8/2; GRA7 was found playing critical role in acute virulence in mice through 
binding with IRG a6 protein which subsequently leading to IRG inactivation and 
clearance from PVM (Alaganan et al., 2014). In addition, in the type-II strain of T. 
gondii, GRA15 is secreted into the host cell upon invasion and mediate translocation 
of NF-κB and induction of IL-12, possibly signifying that GRA proteins also play a 
role not only as structural components of the NTN and PVM but also as effectors that 
can modulate host signalling pathways (Rosowski et al., 2011). Furthermore, GRA24 
travel to nucleus of the infected host cell leading to nuclear translocation and 
activation of p38α mitogen activated protein (MAP) kinase through sustained 
autophosphorylation (Braun et al., 2013). Consequently, activation of the host cell 
kinase leading to up-regulation of the transcription factors Egr-1 and c-Fos and the 
associated synthesis of key proinflammatory cytokines (interleukin-12 and the 
chemokine MCP-1), resulting in control of early parasite replication in vivo (Braun 
et al., 2013). 
3.1.3. Structure of GRA2 and GRA7 in T. gondii and N. caninum 
The primary translation of mature messenger of TgGRA2, TgGRA7, 
NcGRA2 and NcGRA7 products consist of polypeptides comprising of 185 amino 
acids (AA) (molecular weight (MW) of 19.8 kDa), 236 AA (25.9 kDa), 211 AA 
(22.42 kDa) and 217 AA (22.49 kDa), respectively. The secondary structures 
predicted for these GRAs are shown in Figure 3.1, were based on the protein 
sequences from T. gondii ME49 strain used in the construction of recombinant 
proteins for TgGRA2 (TGME49_227620), TgGRA7 (TGME49_203310), and from 
N. caninum Liverpool strain for NcGRA2 (NCLIV_045650) and NcGRA7 
(NCLIV_021640). Secondary structure predictions of proteins can differ based on 
the software used. TgGRA2 consists of a signal peptide at AA 1-23, the N-terminal 
sequence at AA 24-68, amphipathic α-helical regions at AA 69-144 (AA 70–92, 95–
110 and 119–139 (Travier et al. 2008)) and C-terminal peptide between AA 145-185  
(Mercier et al., 1993). The primary structure of TgGRA7 has a putative signal 
peptide at the N-terminus starting from AA 1–26 (Fischer et al., 1998) as almost all 
GRA proteins (Braun et al., 2008; Travier et al., 2008). The two hydrophobic regions 
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spanning AA 5–24 and 181–202, the second one is identified as to be a putative 
transmembrane region (Fischer et al., 1998). 
NcGRA2 (Ellis et al., 2000) has about 50 % protein sequence homology with 
TgGRA2, the predicted NcGRA2 secondary structure contains three amphipathic α-
helical regions spanned residues 70-110, 110-150 and 170-190, unique C-terminal 
sequence, conserved N-terminus with a signal peptide (WILVVAVGALVGA) 
identical to TgGRA2 (Ellis et al., 2000). While, NcGRA7 is 36 % identical to the 
TgGRA7 protein sequence; NcGRA7 contains a signal peptide at 1-25 and a putative 
transmembrane domain between AA 135-160 (NCLIV_021640) as shown in Figure 
3.1. 
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Figure 3.1: Secondary structure prediction of dense granule proteins GRA2 and GRA7 from T. gondii (Tg) and N. caninum (Nc). Secondary structure prediction was based on 
the protein sequences used in the construction of recombinant proteins of TgGRA2 (TGME49_227620), TgGRA7 (TGME49_203310), NcGRA2 (NCLIV_045650) and 
NcGRA7 (NCLIV_021640). The prediction analysis was performed using the Jpred 3 secondary structure prediction server (Cole et al., 2008). 
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3.1.4. Aims and objectives of the study 
There is strong evidence that in T. gondii, DG proteins GRA2 and GRA7 play 
vital roles in the maturation and maintenance of the PV and PVM; implying that they 
may play intermediate role through direct or indirect host-parasite interaction. 
However, their functions are not yet known. Therefore, based on the findings from 
Chapter 2, GRA2 and GRA7 were selected to study comparative host-parasite 
interactions between T. gondii and N. caninum because (1) we were interested to 
study the biology of these GRA proteins using pull-down assay to understand their 
role in host-parasite interaction and (2) based on the data found in the chapter 2, the 
presence of binding partner (TgROP2 family members) of GRA7 in N. caninum in 
BN-PAGE analysis (by orthologue) which was found co-existed with mitochondrial 
proteins. In addition TgGRA2 was co-existed with other proteins but none of the co-
existed protein was known to interact with TgGRA2. 
The hypothesis of the present study was GRA2 and GRA7 play different role 
in host-parasite interaction in T. gondii and N. caninum infection. This study aimed 
to study a comparative host-parasite interactions using purified recombinant GRA2 
and GRA7 proteins from T. gondii and N. caninum as bait to study their binding 
partners from host cell lysates using pull-down assay and identified using MS/MS.  
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3.2. MATERIALS AND METHODS 
3.2.1. Cloning of GRA2 and GRA7 from T. gondii and N. caninum 
The miniprep of pE-SUMOpro Kan expression vector containing the cloned 
genes GRA2 and GRA7 from both T. gondii and N. caninum were received from Dr 
Marie Phelan from the NMR Centre for Structural Biology, University of Liverpool. 
pE-SUMOpro Kan vector used to enhance gene expression, high recombinant protein 
yield, increase solubility and folding of hydrophobic protein such as membrane 
bound proteins. Cloned plasmid DNA with GRA2 and GRA7 were produced by 
GeneArt® Gene Synthesis (Life Technologies) using the following sequences: T. 
gondii GRA2 (TGME49_227620) and GRA7 (TGME49_203310) and N. caninum 
GRA2 (NCLIV_045650) and GRA7 (NCLIV_021640) consisted of 492, 639, 567 
and 576 bp, respectively (Table 3.1). In the pE-sumoPro Kan vector, these GRA 
genes are ligated to 6 × histidine-SUMO tag sequence consisting of 320 bp which 
also expresses with the GRA genes upon induction. The full sequence of GRA genes 
is shown in Appendix Table III. The signal peptide (SP) sequences were removed 
from each of the cloned recombinant genes in expression vector.  
 
Table 3.1: Cloned genes from T. gondii and N. caninum  
Gene 
name 
Accession number
1
 Gene length  Cloned sequence 
length after 
removal of SP 
Sequence length of 
removed SP (location in 
the sequence) 
TgGRA2 TGME49_227620 555 bp  492 bp 63 bp (bp 1-63) 
TgGRA7 TGME49_203310 708 bp 639 bp  69 bp (bp 1-69) 
NcGRA2 NCLIV_045650 633 bp 567 bp  66 bp (bp 1-66) 
NcGRA7 NCLIV_021640 651 bp 576 bp  75 bp (bp 1-75) 
1
 Information about Gene sequences were obtained from ToxoDB, Toxoplasma Genomics Resource, 
Version 11 (Gajria et al., 2008) 
 
3.2.1.1. Transformation of BL21 (DE3) Competent cells with expression 
vector containing recombinant genes of GRA proteins 
Competent BL21 (Novagen
®
) cells were transformed with one of the 
miniprep containing the insert gene of GRA2 and GRA7 from T. gondii and N. 
caninum. Competent cells (20 µl) were transformed with 1 µl of the plasmid 
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containing the recombinant gene in a 1.5 ml tube and incubated on ice for 5 min. The 
cells were heat shocked for 30 sec in a water bath at 42 ºC, then incubated on ice for 
another 2 min. 80 µl of SOC media (Novagen
®
) was added to the transfected cells 
and incubated in shaking incubator at 220 RPM at 37 °C for 1 hr. After incubation, 
25 µl of the cells were added onto the surface of LB agar containing 35 µg/ml 
kanamycin and spread evenly using sterile bent steel rod and incubated overnight at 
37 ºC. Several colonies were picked up and cultured in 5 ml LB medium containing 
175 µg of kanamycin and incubated overnight at 37 ºC. Transformed colonies were 
screened by PCR to confirm that they contained the correctly sized inserts. 
3.2.1.2. PCR screening of colonies from transformed BL21 (DE3) competent 
cells 
 PCRs were performed individually for each cloned gene from transformed 
competent BL21 in 25 µl reactions containing 1 × PCR buffers containing 15 mM 
MgCl2, 0.2 mM of dNTP mix (QIAGEN), 0.1 mM from each T7 forward primer 
(Eurofins Scientific) (5’ TAATACGACTCACTATAGG 3’) and T7 terminator 
primer (Eurofins Scientific) (5’ GCTAGTTATTGCTCAGCGG 3’), 2.5 U of Taq 
DNA polymerase (Qiagen). A colony on the growing plate was picked up using 
sterilised pipette tip and was mixed with the PCR reaction mix. T7 primers add 550 
bp to the cloned genes upon amplification. The expected size for the recombinant 
TgGRA2, TgGRA7, NcGRA2, and NcGRA7 is 1041, 1188, 1116 and 1125 bp, 
respectively. The PCR reaction conditions were 94 C for 1 min; 30 × 94 C for 1 
min, 50 C for 1 min, 72 C for 2 min; 72 C for 10 min. 
PCR products were run at 110 V for 30 min on a 1.5 % agarose gel in 1 × 
TBE (87.5 mM Tris base, 89 mM boric acid, 3 mM EDTA) and stained with SYBR
®
 
Safe DNA Gel Stain (Invitrogen).  
3.2.1.3. Glycerol stock of transformed competent BL21 (DE3) 
The PCR positive colony from transformed competent BL21 with GRA genes 
was grown in LB media overnight in the presence of 35 µg/ml of kanamycin. The 
grown cells were harvested at 1,500 RPM for 5 min and resuspended in the LB 
media in the absence of the kanamycin, mixed 1:1 of 50 % autoclaved glycerol 
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solution homogenised by slow vortexing and were shock frozen using liquid nitrogen 
and stored at -80 °C for future use. 
3.2.2. Recombinant fusion-tagged protein expression 
Transformed competent BL21 cells from glycerol stock were grown in LB 
media or minimal media. Initially, LB media was used to grow transformed cells and 
express the recombinant GRA proteins. LB media was used in IMAC protein 
purification and with BugBuster
®
 reagent. Minimal media was used as an alternative 
to LB media to minimise the expected enzymatic activity from the transformed cells 
for the rest of the project including IMAC (HisTrap HP column), salting out, HPLC 
and with urea at pH 8. 
Starter cultures of 5 ml of LB media (1 % (w/v) of tryptone, 0.5 % (w/v) 
yeast extract, 85.5 mM of NaCl in dH2O, pH 7.5 adjusted with NaOH and sterilised 
by autoclaving for 15 min at 121 °C) containing 175 µg of kanamycin were 
inoculated with transformants for each GRA gene. The culture was grown in 15 ml 
loose cap tubes and incubated overnight at 37 °C with shaking at 220 rpm. The 
starter culture was used to inoculate 250 ml of LB media containing kanamycin (8.75 
mg) in a ratio of 1/100 ml.  
Minimal media was prepared from the following: M9 salt (42.3 mM 
disodium phosphate, anhydrous, 22 mM potassium dihydrogen phosphate, 8.5 mM 
sodium chloride and 18.7 mM ammonium chloride, pH 7.4 adjusted with HCl and 
autoclaved), 0.4 % (v/v) D-glucose (sterilised by 0.2 µm cellulose acetate filter 
(Minisart
®
), 1 mM magnesium sulphate, 10 mM calcium chloride, 166 µM thiamine 
(sterile filtered) and 100 µl (v/v) PTM-1 salt (consisting of 400 mM boric acid, 30 
mM cobalt (II) chloride hexahydrate, 10 mM copper sulphate pentahydrate, 80 mM 
manganese (II) chloride tetrahydrate, 10 mM zinc sulphate heptahydrate and 5 mM 
iron (II) suphate heptahydrate (steriled filtered)). The same procedure was used for 
growing transformants with GRA genes in minimal media as performed in LB media. 
 Transformed competent cells were grown until they reached on optical 
density (OD) of 0.6-0.7 which took 3 hr in LB medium or 6 hr for minimal medium. 
The cells were induced to express recombinant proteins using 1 µM of isopropyl β-
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D-1-thiogalactopyranoside (IPTG) (Fermentas). After induction, cells were incubated 
in LB media at 37 °C for 3 hr, or overnight at room temperature in minimal media. 
After incubation, induced transformants were harvested by centrifugation at 5,000 × 
g for 30 min at 4 °C and supernatant was discarded. Depending on the methods used, 
the pellet was either used directly or resuspended in 10 ml of lysis buffer (50 mM di-
sodium hydrogen phosphate, 150 mM sodium chloride and 20 mM imidazole 
(Sigma-Aldrich)) for approximately 2 g wet-cell-mass and either used directly or 
kept at -20 °C for future use.  
The expected molecular weight of the recombinant protein (GRA protein plus 
SUMO-tag (12.41 kDa)) from T. gondii TgGRA2 and TgGRA7 are 30.07 kDa and 
35.89 kDa respectively. While in N. caninum, the expected molecular weight of 
NcGRA2 and NcGRA7 are 32.55 kDa and 32.37 kDa, respectively (Table 3.2). 
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Table 3.2: Protein sequences of cloned GRA2 and GRA7 genes from T. gondii (Tg) and N. caninum (Nc) 
Protein name Accession number No. of amino 
acids +/- SP 
MW of protein 
kDa +/- SP  
Protein sequence
1 
TgGRA2 TGME49_227620 185/164 19.81/17.66 
MFAVKHCLLVVAVGALVNVSVRAAEFSGVVNQGPVDVPFSGKPLDERAVG
GKGEHTPPLPDERQQEPEEPVSQRASRVAEQLFRKFLKFAENVGQHSEKAFKK
AKVVAEKGFTAAKTHTVRGFKVAKEAAGRGMVTVGKKLANVESDRSTTTTQ
APDSPNGLAETQAPVEPQQRAAHVPVPDFSQ 
TgGRA7 TGME49_203310 236/213 25.92/23.48 
MARHAIFFALCVLGLVAAALPQFATAATASDDELMSRIRNSDFFDGQAPVDS
LRPTNAGVDSKGTDDHLTTSMDKASVESQLPRREPLETEPDEQEEVHFRKRGV
RSDAEVTDDNIYEEHTDRKVVPRKSEGKRSFKDLLKKLALPAVGMGASYFAA
DRILPELTEQQQTGEEPLTTGQNVSTVLGFAALAAAAAFLGMGLTRTYRHFSP
RKNRSRQPALEQEVPESGKDGEDARQ 
 
NcGRA2 
 
NCLIV_045650 211/189 22.42/20.14 
MFTGKRWILVVAVGALVGASVKAADFSGRGTVNGQPVGSGYSGYPRGDDV
RESMAAPEDLPGERQPETPTAEAVKQAAAKAYRLLKQFTAKVGQETENAYYH
VKKATMKGFDVAKDQSYKGYLAVRKATAKGLQSAGKSLELKESAPTGTTTA
APTEKVPPSGPRSGEVQRTRKEQNDVQQTAEMLAEEILEAGLKKDDGEGRGTP
EAEVN 
 
NcGRA7 
 
NCLIV_021640 217/192 22.49/19.96 
MARQATFIVALCVCGLAIAGLPRLASAGDLATEQHEGDIGYGVRAYAGVSN
YDGDDDAAGNPVDSDVTDDAITDGEWPRVVSGQKPHTTQKGSLIKKLAVPVV
GALTSYLVADRVLPELTSAEEEGTESIPGKKRVKTAVGIAALVAAAAFAGLGL
ARTFRHFVPKKSKTVASEDSALGNSEEQYVEGTVNGSSDPEQERAGGPLIPEG
DEQEVDTE 
1
The underlined and highlight in red amino acid sequences are signal peptides that their DNA coding sequences are not included in the recombinant genes. 
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3.2.3. Recombinant protein purification 
Harvested pellets of induced transformants containing recombinants GRA 
proteins (from section 3.2.2) were homogenised completely using a clean spatula and 
vortexing before using in downstream processing for purification of expressed 
proteins (Figure 3.2).  
 
 
Figure 3.2: Schematic illustration of the optimisation of the recombinant protein purification. The 
purification procedures were performed in three steps including lysis and two purification steps before 
data analysis. All steps were performed using TgGRA2. The keys denote the protein/media used at 
each stage, 2 (TgGRA2), 7 (TgGRA7), 2 (NcGRA2) and 7 (NcGRA7). L: LB media and M: minimal 
media. *: Mechanical lysis was used with lysis buffer of Nickel-HisTrap HP column. 
 
3.2.3.1. Lysis of recombinant GRA proteins 
To optimise conditions for the purification of the recombinant GRA proteins 
for use as bait in the pull-down experiments, three different lysis methods were used: 
IMAC, BugBuster and urea (Figure 3.2). 
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3.2.3.1.1. IMAC lysis for Nickel-Nitrilotriacetic acid HisTrap purification 
Cell pellets from induced transformants grown in LB or minimal were 
homogenised on ice with one tablet of protease inhibitor cocktail, EDTA-free 
(Thermo Scientific) per 20 ml of lysis buffer (50 mM of di-sodium phosphate, 150 
mM of sodium chloride, 10 mM of imidazole, pH 7.5 adjusted by HCl) and lysed on 
ice using a probe sonicator (SONICS
®
) for 3 min at 50 % amplitude with 10 sec 
pulse and off for 30 sec. The lysate was clarified by 20 min centrifugation at 4 °C at 
18,000 × g and filtered through 0.45 µm syringe filter. The filtrate was kept at 4 °C.  
3.2.3.1.2. IMAC lysis for HisPur Cobalt Resin purification 
5 ml of IPTG-induced competent BL21 in LB media was transferred to a 
sterile centrifuge tube, centrifuged at 5,000 × g for 5 min and supernatant was 
discard. The pellet was resuspended in 1 ml of TBS (25 mM Tris-HCl, 150 mM 
NaCl, pH 7.2) (Thermo Scientific) and transferred to a 1.5 ml microcentrifuge tube 
and centrifuged at 5,000 × g for 5 min and supernatant was discard. The pellet was 
resuspended in 196 μl of ice-cold TBS per 5 ml of original culture volume. 1 × 
protease inhibitors cocktail (Sigma) were added per the original culture volume. 200 
μl of Pierce Lysis Buffer (Thermo Scientific) (Tris buffered solution of 75 mM NaCl 
with 1 % of propriety of nonionic detergent) was added per 5 ml of original culture 
volume. Inverted immediately until thoroughly mixed and incubate on ice for about 
30 min with inversion at 10 min interval for 3 ×. After incubation has finished, 
centrifuged at 12,000 × g for 5 min to clarify crude competent BL21 lysate and the 
supernatant was collected in another microcentrifuge tube and stored on ice at 4 °C. 
3.2.3.1.3. BugBuster
®
 lysis for Nickel-Nitrilotriacetic acid HisTrap 
purification 
3.2.3.1.3.1. Preparation of soluble proteins fraction   
This fraction consists of soluble protein present in both the periplasm and 
cytoplasm. Harvested pellets of IPTG-induced competent BL21 in LB media were 
resuspended in BugBuster lysis buffer at RT. BugBuster lysis buffer consisting of 
BugBuster  reagent, protease inhibitor cocktail EDTA-free (1 tablet per 10 ml) and 
Benzonase
®
 Nuclease (Novagen
®
) (25 units Benzonase
®
 Nuclease per 1 ml 
BugBuster reagent was added and mixed by gentle vortexing) was prepared 
Chapter Three 
75 
 
immediately before use. 5 ml lysis buffer was used per gram of wet cell pellet (this 
approximately corresponds to about 2.5 ml per 50 ml culture). The cell suspension 
was incubated on a shaking platform or rotating mixer at a slow setting for 10–20 
min at RT. After incubation, insoluble cell debris removed by centrifugation at 
16,000 × g for 20 min at 4 °C. The supernatant transferred to a fresh tube and kept at 
4 °C and the pellet was processed for inclusion body purification. 
3.2.3.1.3.2. Preparation of inclusion body fraction 
The pellet from the soluble fraction preparation was resuspended in 2.5 ml of  
BugBuster reagent containing 1 kU/ml Lysozyme (Novagen
®
) and incubated at RT 
for 5 min. 15 ml (6 volumes) of 1:10 diluted BugBuster reagent in ddH2O were 
added to the suspension and vortexes gently for 1 min. The suspension was 
centrifuged at 5,000 × g for 15 min at 4 °C. The supernatant was collected and kept 
on ice at 4 °C. 
3.2.3.1.4. Urea lysis for Nickel-Nitrilotriacetic acid HisTrap purification 
Protein pellets were lysed under denaturing conditions and resuspended with 
10 ml of lysis and equilibration buffer consisting of 100 mM NaH2PO4, 10 mM 
Tris/HCl (pH 8.0) and 8 M urea. The suspended cells were stirred slowly for 30 min 
to lyse completely at RT. The lysate were centrifuged at 16,000 × g for 30 min at RT 
and the supernatant was collected. 
3.2.3.2. Purification of recombinant proteins I 
3.2.3.2.1. Purification using a Nickel-Nitrilotriacetic acid HisTrap HP 
column 
HisTrap high purification (HP) column (GE Healthcare Life Sciences) 5 ml 
capacity was used for purification of the recombinant GRA proteins. HisTrap HP 
columns are prepacked with nickel sepharose high performance for high-resolution 
purification of histidine-tagged proteins by IMAC. The HisTrap column was washed 
and equilibrated with 25 ml of washing buffer 1 (50 mM of di-sodium phosphate, 
150 mM of sodium chloride, 10 mM of imidazole, pH 7.5 adjusted by HCl). Ice-cold 
lysate from section 3.2.3.1.1 and 3.2.3.1.3 was loaded onto the Nickel column using 
syringe and collected in 15 ml tube and named flow-through. The column washed 
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using 15 ml of washing buffer 1 and the throughput named as wash 1. The column 
re-washed again with 15 ml washing buffer 2 (50 mM of disodium phosphate, 150 
mM of sodium chloride, 40 mM of imidazole, pH 7.5) and named as Wash 2. The 
protein was eluted from the column using 15 ml of elution buffer (50 mM of di-
sodium phosphate, 150 mM of sodium chloride, 500 mM of imidazole, pH 7.5) and 
saved on ice and named as elution 1. Finally, the column loaded with another 15 ml 
of elution buffer and saved as before and named elution 2; 10 µl from each fraction 
was run on an SDS-PAGE as shown in section 3.2.4.1. 
For lysate from section 3.2.3.1.4, the histrap HP column was washed and 
equilibrated with 20 ml of lysis and equilibration buffer (100 mM NaH2PO4, 10 mM 
Tris/HCl (pH 8.0) and 8 M urea), 10 ml of the cleared lysate were passed through the 
column very slowly and the flow through was collected and labelled as flow through. 
The column then washed with 20 ml of washing buffer (100 mM NaH2PO4, 10 mM 
Tris/HCl (pH 6.3) and 8 M urea) and the eluates were collected in 8 fractions of 2.5 
ml each. Finally, 20 ml of elution buffer (100 mM NaH2PO4, 10 mM Tris/HCl (pH 
4.5) and 8 M urea) was used to elute the recombinant proteins and the eluates were 
collected in 4 fractions of 5 ml each; 10 µl from each fraction was run on an SDS-
PAGE as shown in section 3.2.4.1. 
3.2.3.2.2. Purification using HisPur Cobalt Resin 
A wash buffer consisting of 1:1 of TBS to Pierce lysis buffer containing 10 
mM imidazole was prepared. The HisPur Cobalt Resin was thoroughly resuspended 
using a vortex mixer and 50 μl were pipetted into each labelled spin column. The 
binding capacity of 25 μl of settled HisPur Cobalt Resin (Thermo scientific) is > 250 
μg of polyhistidine-tagged protein. 400 μl of the wash solution was added to each 
spin column and inverted several times to equilibrate the immobilized Cobalt-chelate 
Resin. Spin column placed in a collection tube and spun at 1,250 × g for 30 sec, and 
the flow-through washing solution was discarded. The latter steps of washing were 
repeated 5 ×. 
 Following washing and equilibration, 350 µl of polyhistidine-tagged fusion 
protein lysate was added to the column and incubated at 4 °C for at least 1 min with 
gentle rocking motion on a rotating platform. After the incubation, the column placed 
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into a collection tube and spun at 1,250 × g for 1 min and the fraction was labelled as 
bait flow-through and place on ice at 4 °C. Then the spin column washed with 400 µl 
of wash solution, inverted several times and spun at 1,250 × g for 1 min. The 
washing step was repeated 5 ×. The fraction was labelled as wash. 
The bounded recombinant protein was eluted using elution buffer consisting 
of washing buffer with 300-500 mM imidazole. 250 μl of the elution buffer was 
added to the column and incubated for 5 min at RT with gentle rocking on a rotating 
platform. The column was spun at 1,250 × g for 1 min and labelled as Elution 1 and 
placed on ice. At the end of recombinant protein purification, an SDS-PAGE was 
performed for each fraction as shown in section 3.2.4.1. 
3.2.3.3. Purification of recombinant proteins II 
3.2.3.3.1. Purification of recombinant protein by salting out  
A second step of purification was applied to eluent prepared by Ni-NTA 
HisTrap HP column under native condition from section 3.2.3.1.1 using ammonium 
sulphate salt (VWR) to separate different proteins and reduce complexity based on 
their solubility. GRA proteins used in this experiment contain multiple hydrophobic 
membrane domains, so expecting elution of GRA proteins in low concentration of 
ammonium sulphate salt allowing fractionation and enrichment of GRA protein. 
Different concentrations of ammonium sulphate were used starting from 10 % to 100 
% to purify the recombinant TgGRA2 or NcGRA2 among other proteins that are 
from competent BL21 expression system. 1 ml was added per each eppendorf tube, 
10 eppendorf tubes were label and to each one a concentration was added consisted 
of 10 %, 20 %, 30 %, 40 %, 50 %, 60 %, 70 %, 80 %, 90 % and 100 % as initial 
screening to identify the start concentration at which the recombinant protein begins 
to precipitate. After the ammonium sulphate was added then allowed to mix 
thoroughly using rotating plate for 1 hr and then centrifuged at 10,000 × g for 30 
min, the precipitate was collected and 1 ml of TBS buffer pH 7.4 was added to the 
pellet; then 10 µl from each concentration was loaded on SDS-PAGE. The lowest 
concentration of ammonium sulphate that caused the recombinant protein to 
precipitate was then used for further salting out by increasing the concentration by 3 
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% and again as mentioned earlier centrifuged and resuspended; 10 µl from each 
concentration was loaded on an SDS-PAGE as shown in section 3.2.4.1. 
3.2.3.3.2. High-performance liquid chromatography (HPLC) purification of 
the recombinant proteins 
An HPLC (Varian Prostar 210 Solvent Delivery Module) connected to an 
analytical column with C18 phase, 5 µm particle sizes, 300 Å pore size, 30 × 4.6 mm 
(Phenomenex) was used for purification of the eluted recombinant proteins from Ni-
NTA HisTrap as second step of purification. Eluted protein samples were desalted 
prior to loading on the HPLC using PD-10 desalting column (GE Healthcare) 
according to the manufacturer’s instructions. The HPLC column was cleaned each 
time before use with 30 % acetonitrile in HPLC grade water (VWR), then 
equilibrated with 95 % of water (solution A) and 5 % of acetonitrile (solution B) for 
20 min, sample (2 ml) was loaded onto the column. Proteins were separated using a 
linear gradient to 75 % solution B for 60 min and finally to 100 % solution B for 20 
min. The protein fractions of interest were collected manually at the beginning of the 
chromatographic peak showed on the screen connected to the HPLC using 1.5 ml 
eppendorf tube then kept on ice. The recombinant protein was identified using SDS-
PAGE, LC MS/MS and western blotting. The protein concentration was determined 
using Coomassie Plus (Bradford) Assay Kit (Thermo Fisher) and stored at -80 °C 
after snap freezing with liquid nitrogen. 
3.2.4. Analysis of purified recombinant protein and data analysis 
3.2.4.1. 1D SDS-PAGE 
Proteins fractions from purification steps were run on a 12 % 1D SDS-PAGE 
for quality control. Gels were run, fixed and stained as described in Chapter 2, 
sections 2.2.5 and 2.2.6. 
3.2.4.2. Western blot analysis for HPLC purified recombinant protein 
Purified fractions from HPLC were run on 1D SDS-PAGE in duplicates, one 
for staining with Coomassie blue and the other to be analysed using western blot. 
Western blotting was performed to identify the recombinant GRA proteins based on 
the presence of SUMO-tag; because of anti GRA proteins were not available 
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commercially. Anti SUMO-tag antibodies (Abcam) were used to identify 
recombinant proteins via Semi-dry transfer western blot using Semiphor Transphor 
Unit (Amersham Bioscience). Poly-vinylidine fluoride (PVDF) transfer membrane 
(EMD Millipore Corporation) were used for immunoblotting the transferred proteins. 
PVDF were activated using 100 % methanol for 1 min and equilibrated in SDS-
PAGE transfer buffer (25 mM Tris/HCl (pH 8.3), 192 mM glycine and 20 % 
methanol. Four pieces of 0.83 mm thick filter paper (Thermo Scientific) were 
saturated for 5 min in the transfer buffer. The SDS-PAGE gel was placed on PVDF 
and sandwiched between the filter papers and placed on the surface of positive 
electrode. The negative electrode was placed on the top of the sandwiched layers and 
run according to the manufacturer’s instruction for 1 hr at 20 V and 45 mA. After the 
run has finished, the PVDF membrane was blocked for 1 hr at RT using blocking 
buffer consisted of 5 % (w/v) of skimmed milk powder (Tesco) in TBST (50 mM 
Tris-HCl (pH8.3), 150 mM NaCl, 0.5% (v/v) Tween-20 (Sigma). The membrane was 
washed 5 × for 5 min each with TBST buffer. A specific rabbit polyclonal anti-
SUMO3 antibody (Abcam) was used to detect the expressed recombinant proteins. 
The primary antibody was diluted 1:10,000 in 5 % (w/v) of skimmed milk in TBST. 
The PVDF membrane was incubated for overnight at 4 °C. The membrane was 
washed 5 × for 5 min each with TBST buffer. Anti-Rabbit IgG conjugated to horse 
radish peroxidase (HRP) produced in goat (Sigma-Aldrich, Inc.) was used to detect 
anti-SUMO3 antibody, diluted 1:10,000 in 5 % (w/v) of skimmed milk in TBST.  
PVDF membrane was incubated with later dilution for 1 hr at RT. Finally the 
membrane was washed 5 × 5 min with TBST buffer. The secondary antibody were 
detected through the activity of horseradish peroxidase (HRP)-conjugated using 
Clarity™ Western ECL Substrate kit (Bio-Rad Laboratories, Inc.), diluted 1:1 ratio 
and added to the blot, and incubate for 5 min. The membrane was imaged with a 
ChemiDoc
™
 MP Imaging System (Bio-Rad Laboratories, Inc.). 
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3.2.4.3. In-gel trypsin digestion, LC-MS/MS and data analysis  
In-gel trypsin digestion, LC-MS/MS (using the Bruker Amazon ion trap mass 
spectrometer) and data analysis were performed for purified recombinant proteins 
from section 3.2.3.1.1 (TgGRA2 and TgGRA7) and 3.2.3.3.2 (TgGRA2) according 
to protocols described in Chapter 2, sections 2.2.7 and 2.2.8. In addition to the 
Toxoplasma database and Uniprot E.coli (UniP_EcoliK12_Feb 2015) databases were 
also used in the Mascot search. DNA coding sequence of SUMO tag was added to 
the database using SUMO fusion protein sequence used in the pE-SUMOpro Kan. 
Proteins with more than two unique peptides matched the criteria applied by Mascot 
(individual ion score of peptides > 32 indicate identity or extensive homology (p < 
0.05)) and protein score of ≥ 50 were considered as significant identification. 
3.2.5. Pull-down assay using purified recombinant TgGRA2 
 Pull-down assay was carried out using HisPur Cobalt Resin kit (used also for 
purification of recombinant GRA protein) for recombinant TgGRA2 protein purified 
by HPLC. Vero host lysate was used as prey protein(s) to identify host binding 
partner(s) of the TgGRA2 protein.  
3.2.5.1. Immobilisation of purified TgGRA2 
A total of 100 µg of TgGRA2 that was previously purified by reverse phase 
HPLC was added to the column for use as a bait protein. A 10 µg aliquot of the 
recombinant protein was run on an SDS-PAGE as control. The remaining steps of 
bait immobilisation were carried out as for purification of recombinant bait protein in 
section 3.2.3.2.2.  
3.2.5.2. Preparation of prey proteins from Vero cell lysate 
Vero cells were grown as described in Chapter 2, section 2.2.1.1. A total of 2 
× 10
7
 Vero cells were transfer to a sterile 1.5 ml tube and homogenised with 1,200 µl 
of washing buffer 1 without imidazole (section 3.2.3.2.2) containing protease 
inhibitor cocktail EDTA-free (Sigma) (the protease inhibitor cocktail consists of 4.16 
mM of 4-(2-Aminoethyl) benzenesulfonyl fluoride hydrochloride (AEBSF), 3.2 μM 
of aprotinin, 200 μM of bestatin, 56 μM of E-64, 8 μM of leupeptin and 6 μM of 
pepstatin A). The homogenised suspension was pipetted up and down and incubated 
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on ice at 4 °C for 40 min. After incubation, the suspension spun at 12,000 × g at 4 °C 
for 10 min. The supernatant was collected and imidazole was added to a final 
concentration of 10 mM and thoroughly mixed by inverting the tube and kept at 4 °C 
on ice.  
3.2.5.3. Prey protein capture from host cell lysate 
A total of 700 µl (200 µg proteins) of the cell lysate was added to the column 
from section 3.2.5.1 containing immobilised recombinant TgGRA2 and incubated at 
4 °C with rocking motion on a rotating platform for 1.30 hr. The sample was 
centrifuge at 1,250 × g for 1 min and the flow through labelled as prey flow-through 
and place on ice. 400 μl of wash solution added and inverted several times to mix 
thoroughly and centrifuge at 1,250 × g for 1 min. The washing step was repeated five 
times. 
3.2.5.4. Bait-prey elution  
The elution of TgGRA2-prey complex was performed following the elution 
stage of the protocol described in section 3.2.3.2.2 for purification of recombinant 
protein. The bound recombinant protein was eluted using elution buffer consisting of 
washing buffer 1 (section 3.2.3.2.2) with 300-500 mM imidazole. A total of 250 μl of 
the elution buffer was added to the column and incubated for 5 min at RT with gentle 
rocking on a rotating platform. The column was spun at 1,250 × g for 1 min and 
eluent was placed on ice. The elution fraction was concentrated (10 ×) beside the 
non-concentrated elution due to low protein binding in the elution fraction. 
StrataClean resin (Agilent Technologies) was used for concentration of the eluent 
and 2 µl was added to 100 µl of the protein solution in 1 ml tube and diluted by 500 
µl of dH2O, vortexed for 1 min and centrifuged for 2 min at 5,000 rpm. The 
supernatant was discarded and 10 µl of SDS-PAGE sample buffer was added and 
heated at 95 °C for 5 min then loaded on SDS-PAGE as described in 3.2.4.1. 
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3.3. RESULTS 
3.3.1. PCR screening of colonies from transformed BL21 (DE3) competent 
cells containing recombinant GRA2 and GRA7 from T. gondii and N. 
caninum 
PCRs were performed individually for cloned GRA2 and GRA7 of T. gondii 
and N. caninum from transformed competent BL21 to identify correctly cloned 
genes. A 1.5 % agarose gel was performed to identify the amplified PCR product 
from the transformants colonies (Figure 3.3). The expected size for the recombinant 
TgGRA2 is 1041 bp and TgGRA7 is 1188 bp. On the other hand, the expected size of 
recombinant genes for NcGRA2 and NcGRA7 are 1116 bp and 1125 bp, respectively. 
The results of the PCR showed that both the GRA2 and GRA7 from T. gondii and N. 
caninum are at the expected sizes. 
 
 
Figure 3.3: PCR products of the T. gondii and N. caninum colonies run on 1.5 % agarose gel. 1: 
TgGRA2 and 2: TgGRA7. 3: NcGRA2 and 4: NcGRA7. L: 100 bp DNA ladder and C: negative control. 
 
3.3.2. Expression of the recombinant GRA proteins from T. gondii and N. 
caninum  
Transformed competent BL21with TgGRA2, TgGRA7, NcGRA2 and NcGRA7 
before and after induction by IPTG for 3 hr in LB media (Figure 3.4A) and for 
overnight in minimal media (Figure 3.4B and C) were analysed using SDS-PAGE 
(Figure 3.4). Figure 3.4B and C shows that the induced competent BL21 lysate 
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contains additional protein bands indicating that the cloned recombinant TgGRA2 
and TgGRA7, NcGRA2 and NcGRA7 genes were expressed.  
 
 
Figure 3.4: Expression and purification of recombinant proteins of T. gondii and N. caninum. A1: 
BL21 cell lysate before induction, B: TgGRA2 and TgGRA7 elution fraction after expression and C: 
NcGRA2 and NcGRA7 elution fraction after expression. Tg2 (TgGRA2), Tg7 (TgGRA7), Nc2 
(NcGRA2) and Nc7 (NcGRA7). L: protein standard labelled with protein molecular weight. Red 
arrows in B and C indicate location of expressed TgGRA2, TgGRA7, NcGRA2 and NcGRA7, 
respectively. The gels were stained using colloidal Coomassie stain. BL21 cell was grown and 
induced in LB media (A) and minimal media (B and C). Ni-NTA HisTrap HP column was used for 
purification of the recombinant protein. 
 
3.3.3. Purification of recombinant proteins 
Several different approaches were taken to obtain the cleanest/purest 
recombinant GRA proteins from T. gondii and N. caninum. Recombinant GRA2 and 
GRA7 proteins from both parasites were expressed but TgGRA2 was used most 
frequently as candidate through all the procedures used for protein purification in this 
project from transformants grown in either LB or minimal media as explained in 
section 3.2.2 and Figure 3.2.  
3.3.3.1. Purification of recombinant proteins using immobilized metal ion 
affinity chromatography  
Figure 3.5 shows 1D SDS-PAGE of eluted recombinant protein fractions 
from TgGRA2 and TgGRA7 purified by Ni-NTA HisTrap HP. Several bands of 
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proteins migrated along the eluted protein fraction indicating that proteins of 
different molecular sizes were co-eluted. The bands indicated in Figure 3.5 were 
analysed by MS and the results confirmed to be TgGRA2 and TgGRA7 (Table 3.3). 
The expected molecular weights of the recombinant proteins (GRA protein with 
SUMO-tag) were 30.7 kDa and 35.89 kDa for TgGRA2 and TgGRA7, respectively.  
 
 
Figure 3.5: Purification of recombinant proteins of T. gondii. Tg2: TgGRA2 elution, TG7: TgGRA7 
and L: protein standard labelled with protein molecular weight.  Proteins were expressed in BL21 cells 
in LB media and gels stained with colloidal Coomassie blue. Protein spots Tg2.1-5 and Tg7.1-6 were 
excised from TgGRA2 and TgGRA7, respectively. Each spot was tryptically digested and analysed by 
LC-MS/MS.  
 
Mass spectrometry analysis of recombinant TgGRA2 and TgGRA7 (Table 
3.3) showed that the bands analysed from the SDS-PAGE (Figure 3.5) contained 
peptides from TgGRA2 or TgGRA7 as well as peptides from a variety of E. coli 
proteins and SUMO-tag. The expressed TgGRA2 and TgGRA7 were identified in 
numerous bands as shown in Table 3.3. Migration of recombinant proteins to 
different molecular size on the 1D SDS-PAGE may indicate that these proteins were 
broken down at some point after expression. Protein degradation may occur either 
following expression by enzymatic activity of the transformed BL21 or during 
preparation and purification of the recombinant proteins.  
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Table 3.3: Mass spectrometry analysis of recombinant GRA2 and GRA7 from T. 
gondii. Mass spectrometry and data analysis using Mascot of different fraction of 
IMAC purification of poly-histidine SUMO-tagged protein of T. gondii GRA2 
and GRA7 from in-gel digestion of protein bands by trypsin from Figure 3.5 
Gel 
spot 
no.   
Protein accession Protein description Protein 
score 
No. of 
peptide 
sequence 
Protein 
mass 
(kDa) 
Protein 
coverage 
% 
Tg2.1 
SUMOTag SUMO tag 216 2 12402 16 
P0ACJ8|CRP_ECOLI* 
cAMP-activated 
global transcriptional 
regulator CRP 
188 3 23907 16 
TGME49_227620 
Dense granule 
protein GRA2 
(GRA2)  
142 4 19960 19 
Tg2.2 
P02931|OMPF_ECOLI 
Outer membrane 
protein F 
525 9 39420 26 
P0ACJ8|CRP_ECOLI* 
cAMP-activated 
global transcriptional 
regulator CRP 
329 6 23907 29 
SUMOTag SUMO tag 80 2 12402 30 
TGME49_227620 
Dense granule 
protein GRA2 
(GRA2)  
66 2 19960 8 
Tg2.3 
SUMOTag SUMO tag 168 2 12402 16 
P0A7V8|RS4_ECOLI* 
30S ribosomal 
protein S4 
143 4 23623 20 
P60438|RL3_ECOLI* 
50S ribosomal 
protein L3 
139 3 22341 18 
P02931|OMPF_ECOLI 
Outer membrane 
protein F 
121 3 39420 9 
Tg2.4 
P0ACJ8|CRP_ECOLI* 
cAMP-activated 
global transcriptional 
regulator CRP 
331 7 23907 35 
SUMOTag SUMO tag 234 2 12402 30 
P0A7V3|RS3_ECOLI* 
30S ribosomal 
protein S3 
143 3 26078 17 
TGME49_227620 
Dense granule 
protein GRA2 
(GRA2)  
76 3 19960 25 
P0A7V8|RS4_ECOLI* 
30S ribosomal 
protein S4 
68 3 23623 12 
Tg2.5 
P0ACJ8|CRP_ECOLI* 
cAMP-activated 
global transcriptional 
regulator CRP 
407 6 23907 32 
SUMOTag SUMO tag 205  12402 37 
Tg7.1 
TGME49_203310 
Dense granule 
protein GRA7 
(GRA7)  
540 5 26071 23 
P0A853|TNAA_ECOLI
* 
Tryptophanase 406 10 53250 22 
SUMOTag SUMO tag 315 2 12402 30 
P0AG30|RHO_ECOLI* 
Transcription 
termination factor 
Rho 
249 5 47143 12 
P02943|LAMB_ECOLI Maltoporin 135 3 50106 8 
P0A7V3|RS3_ECOLI 30S ribosomal 104 2 26078 8 
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protein S3 
Tg7.2 
P61889|MDH_ECOLI* 
Malate 
dehydrogenase 
295 5 32599 22 
P0CE47|EFTU1_ECOL
I* 
Tryptophanase 226 5 53250 13 
P0AFH8|OSMY_ECOL
I 
Osmotically-
inducible protein Y 
119 3 21172 26 
TGME49_203310 
Dense granule 
protein GRA7 
(GRA7)  
182 2 26071 8 
P0ABK5|CYSK_ECOL
I* 
Cysteine synthase A 116 2 34636 7 
P0A6F5|CH60_ECOLI
* 
60 kDa chaperonin 115 4 57575 11 
P0A7K2|RL7_ECOLI 
50S ribosomal 
protein L7/L12 
104 2 12399 27 
P0A850|TIG_ECOLI Trigger factor 59 2 48274 7 
P0A6F9|CH10_ECOLI 10 kDa chaperonin 54 2 10492 28 
Tg7.3 
P0A7V3|RS3_ECOLI* 
30S ribosomal 
protein S3 
919 7 26078 35 
P0A9K9|SLYD_ECOLI
* 
FKBP-type peptidyl-
prolyl cis-trans 
isomerase SlyD 
239 3 21293 17 
P62707|GPMA_ECOLI
* 
2,3-
bisphosphoglycerate-
dependent 
phosphoglycerate 
mutase 
131 3 28650 15 
P69441|KAD_ECOLI* Adenylate kinase 125 4 23739 21 
P0A853|TNAA_ECOLI
* 
Tryptophanase 119 5 53250 14 
P0A8P6|XERC_ECOLI
* 
Tyrosine 
recombinase XerC 
114 3 34015 11 
P32664|NUDC_ECOLI
* 
NADH 
pyrophosphatase 
113 2 30123 7 
P0A7V0|RS2_ECOLI* 
30S ribosomal 
protein 
113 3 26895 14 
TGME49_203310 
Dense granule 
protein GRA7 
(GRA7)  
74 2 26071 8 
P0ACK8|FUCR_ECOL
I* 
L-fucose operon 
activator 
74 2 27684 9 
P0A7L0|RL1_ECOLI 
50S ribosomal 
protein L1 
69 2 24825 12 
P0AGJ2|TRMH_ECOL
I* 
tRNA 
(guanosine(18)-2'-
O)-methyltransferase 
69 2 25609 12 
Tg7.4 
P0A7V8|RS4_ECOLI* 
30S ribosomal 
protein S4 
364 9 23623 45 
P60438|RL3_ECOLI* 
50S ribosomal 
protein L3 
360 5 22341 25 
P0A7V3|RS3_ECOLI* 
30S ribosomal 
protein S3 
231 4 26078 20 
P0A9K9|SLYD_ECOLI
* 
FKBP-type peptidyl-
prolyl cis-trans 
isomerase SlyD 
127 3 21293 17 
P0AFZ3|SSPB_ECOLI
* 
Stringent starvation 
protein B 
115 3 18362 19 
P0AFM6|PSPA_ECOLI Phage shock protein 98 3 25588 15 
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* A 
TGME49_203310 
Dense granule 
protein GRA7 
(GRA7)  
96 2 26071 8 
P0ACA3|SSPA_ECOLI
* 
Stringent starvation 
protein A 
90 2 24457 12 
P0A908|MIPA_ECOLI
* 
MltA-interacting 
protein 
85 2 27924 10 
SUMOTag SUMO tag 84 3 12402 37 
P0A917|OMPX_ECOL
I 
Outer membrane 
protein X 
75 2 18759 15 
Tg7.5 
P0ACJ8|CRP_ECOLI* 
cAMP-activated 
global transcriptional 
regulator CRP 
1724 13 23907 50 
P60723|RL4_ECOLI* 
50S ribosomal 
protein L4 
180 3 22184 18 
P0A7V3|RS3_ECOLI* 
30S ribosomal 
protein S3 
120 2 26078 8 
P0A9K9|SLYD_ECOLI
* 
FKBP-type peptidyl-
prolyl cis-trans 
isomerase SlyD 
120 2 21293 12 
TGME49_203310 
Dense granule 
protein GRA7 
(GRA7)  
114 2 26071 10 
P64588|YQJI_ECOLI* 
Transcriptional 
regulator YqjI 
98 2 23954 10 
P0A6N4|EFP_ECOLI Elongation factor P 67 2 20746 10 
P0ADK0|YIAF_ECOLI
* 
Uncharacterized 
protein YiaF 
61 2 25872 10 
Tg7.6 
P0A7V3|RS3_ECOLI* 
30S ribosomal 
protein S3 
207 4 26078 22 
P0A9K9|SLYD_ECOLI
* 
FKBP-type peptidyl-
prolyl cis-trans 
isomerase SlyD 
167 3 21293 17 
SUMOTag SUMO tag 127 3 12402 37 
P0AG55|RL6_ECOLI* 
50S ribosomal 
protein L6 
103 2 19060 12 
P0CE47|EFTU1_ECOL
I* 
Elongation factor Tu 
1 
101 3 43538 9 
P0A853|TNAA_ECOLI
* 
Tryptophanase 90 3 53250 11 
*Indicates that these proteins contain at least three histidine or cysteine or both in their amino acid 
sequences  
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As an alternative and more robust way of purifying recombinant protein, 
cobalt is recommended for more specific interaction with histidine tagged 
recombinant protein, so HisPur™ cobalt resin was used  for recombinant TgGRA2 
(Cobalt resin showed slightly better purification compared to Nickel based IMAC 
based on 1D SDS-PAGE (Figure 3.6A). However, the recombinant TgGRA2 was not 
pure due to degradation and/or co–elution of several proteins of the BL21 cells 
during purification as confirmed by LC-MS/MS (Table 3.3).  
In order to understand whether time of induction play roles in decreasing the 
production of degraded recombinant protein and/or co-eluent and obtaining the pure 
recombinant protein, the induction time was reduced from 3 hr to 90 min. The 
TgGRA2 gene was expressed and results show that fewer proteins were eluted and to 
some extent better purification was achieved (Figure 3.6B). However at this point the 
eluent containing recombinant TgGRA2 cannot be used in pull-down assay because 
of other degraded/co-eluent proteins present and thus further purification is required 
to get pure recombinant protein. 
 
 
Figure 3.6: Purification of the recombinant protein of T. gondii GRA2 using HisPur cobalt resin kit. 
Recombinant TgGRA2 induced for 3 hours (A1) or 90 min (B1), L: protein standard. 10 µl of the 
elution was used and stained with colloidal Coomassie stain. Arrows show the expressed recombinant 
TgGRA2 protein. LB media used to grow the competent BL21. 
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Despite the fact that a complete protease inhibitor was added before lysis, 
proteolytic break down of the recombinant protein cannot be excluded as TgGRA7 
and the SUMO-tag were found on multiple bands on SDS-PAGE gel. LB media was 
used for growing the transformed cells; enriched growth media may enhance more 
enzymatic activity and therefore protein cleavage. In order to optimise the 
purification method used, especially to decrease the possibility of enzymatic lysis 
and break down of recombinant protein during expression, minimal media (Figure 
3.2) was used as described in section 3.2.2 and the 1D SDS-PAGE from recombinant 
GRA2 and GRA7 of T. gondii and N. caninum are shown in Figure 3.4B and C. 
However based on 1D SDS-PAGE (Figure 3.6B and C), there is little or no 
improvement concerning the number of protein bands that eluted from purification 
steps as seen with LB media (Figure 3.5). Results indicate that breaking down and/or 
co-elution of protein with the recombinant protein may be not related to the type of 
the media used. 
It was also noticed from the migration of the major protein bands on 1D SDS-
PAGE (Figure 3.4B, C and Figure 3.5), T. gondii and N. caninum recombinant 
GRA2 and GRA7 proteins with Sumo-tag migrated to higher molecular mass in 
SDS-PAGE than predicted from the primary translation product of GRA proteins 
containing Sumo-tag (Table 3.2). Based on the protein standard, recombinant 
TgGRA2, TgGRA7, NcGRA2 and NcGRA7 were migrated to 40 and 47, 40 and 50 
kDa, respectively. However, the expected molecular weight of the recombinant 
protein with SUMO-tag (12.41 kDa) from T. gondii TgGRA2 and TgGRA7 are 30.7 
kDa and 35.89 kDa respectively. While in N. caninum, the expected molecular 
weight of NcGRA2 and NcGRA7 with Sumo-tag are 32.55 kDa and 32.37 kDa, 
respectively. 
3.3.3.2. Protein purification using BugBuster reagents 
BugBuster protein extraction reagents were used to purify and separate the 
soluble proteins from the inclusion bodies as an approach to separate soluble from 
non-soluble (membrane-bound) proteins after expression. This method allows using 
only fraction that contains mainly the expressed recombinant protein before further 
purification and elution using Ni-NTA-HisTrap HP (Figure 3.7). Recombinant 
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TgGRA2, NcGRA2 and NcGRA7 were expresses in LB media and the results show 
that still there are more proteins bands co-eluted with the recombinant proteins and 
great difference was not observed compared to purification with Nickel-Histrap HP 
only (Figure 3.4B and C and Figure 3.5) without recombinant protein separation by 
BugBuster reagents. 
 
 
Figure 3.7: Purification of recombinant GRA proteins of T. gondii and N. caninum using BugBuster 
protein extraction reagents and Ni-NTA HisTrap HP column. A1: elution of inclusion body fraction of 
recombinant TgGRA2, B2 and B3: elution of inclusion body fraction of recombinant NcGRA2 and 
NcGRA7, respectively. L: Protein standard. 10 µl of elution fraction were used. BL21 cells were 
grown and induced in LB media. 
 
3.3.3.3. Recombinant protein purification under denaturing conditions 
Purification of the recombinant TgGRA2 was performed under denaturing 
conditions using 8 M urea. To stop expected catalytic activity of all the enzymes that 
might cause degradation of the expressed recombinant proteins. Also urea helps 
unfolding and separation of interacting proteins from each other including 
recombinant GRA proteins.  
Urea was used as a lysis buffer directly after harvesting cells and the same 
buffer was applied through the whole processes of the purification with changes in 
pH during different steps to purify and elute the recombinant proteins (Figure 3.8). 
Results of 1D SDS-PAGE from different fractions of the purification under 
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denaturing approach reveal that many proteins co-eluted under denaturing condition 
as well.  
 
 
Figure 3.8: Purification of recombinant T. gondii GRA2 under denaturing conditions. 10 ml of 8 M 
Urea buffer was used as lysis buffer and equilibration buffer at pH 8 and passed through the histrap 
HP column. 1: the flow through was collected in about 1 drop/sec using syringe. 20 ml of the same 
buffer was used with pH 6.3 as washing buffer and each 2.5 ml collected continuously (2-9). 20 ml of 
the same buffer used with pH 4.5 as elution buffer and collected as 5 ml per each fraction (10-13). 10 
µl was used to run on 1D SDS-PAGE and stained with colloidal coomassie stain. L: protein standard 
and C: the lysate of induced transformants. BL21 cells were grown and induced in LB media. 
 
3.3.3.4. Purification of recombinant GRA proteins using salting out 
Recombinant proteins from bacterial expression systems bind to IMAC and 
elute under native and denaturing conditions. However several protein bands were 
co-eluted with the eluent containing the recombinant GRA proteins. An additional 
step is needed to separate the recombinant GRA proteins from others co-eluted 
proteins. The solubility of the expressed recombinant GRA proteins (hydrophobic) 
was exploited to purify it. Ammonium sulphate salt was used to separate different 
protein based on their solubility in different salt concentrations. After the 
recombinant proteins had been eluted from IMAC (Ni-NTA HisTrap HP column) 
they were subjected to the second step of purification (Figure 3.2) using different salt 
concentration of 10 -100 % (w/v) ammonium sulphate. Based on the hydrophobicity 
of the protein, soluble protein requires higher concentration of ammonium sulphate 
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to precipitate than hydrophobic protein. Figures 3.9A and 3.10A show 1D SDS-
PAGE of TgGRA2 and NcGRA2 that started to precipitate at 25 % and 20 % of 
ammonium sulphate, respectively. Further precipitation with more ammonium 
sulphate was applied to 25 % (Figure 3.9A) and increased to 30 % and 33 % (Figure 
3.9B), and also more ammonium sulphate was added to 20 % (Figure 3.10A) and 
increased to 25 % and 35 % (Figure 3.10B). Results showed better resolution and 
purification, however, still there are other proteins that co-purified with the 
recombinant proteins (Figures 3.9B and 3.10B). 
 
 
Figure 3.9: Precipitation of recombinant T. gondii GRA2 using a successive concentration of solid 
ammonium sulphate after native purification using imidazole. %: (w/v) concentration of solid 
ammonium sulphate. B: further fractionation to the 25 % fraction was applied using more solid 
ammonium sulphate to 30 % and to 33 %. S33 %: supernatant of 33 % fraction. L: protein standard 
and C: the eluted sample by Ni-NTA HisTrap HP used in the experiment. BL21 cells were grown and 
induced in LB media. 
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Figure 3.10: Fractionation of recombinant N. caninum GRA2 using a successive concentration of solid 
ammonium sulphate after native purification using imidazole. %: (w/v) concentration of solid 
ammonium sulphate. B: further fractionation of 20% was applied using more solid ammonium 
sulphate to 25 % and to 35 %. S35%: supernatant of 35%. L: protein standard with molecular mass. C: 
the eluted sample by Ni-NTA HisTrap HP used in the experiment. BL21 cells were grown and 
induced in LB media. 
 
3.3.3.5. Purification of recombinant protein using reverse phase HPLC 
Pull down assays require pure protein to be used as bait to understand the 
physical interaction and function of that particular protein with the prey protein(s).  
HPLC was used as a second step for purification (Figure 3.2) of recombinant 
TgGRA2 after elution under native condition using Ni-NTA HisTrap HP column. 
Figure 3.11a shows a complete graph of an HPLC run during purification of 
recombinant TgGRA2. One peak was separated (as indicated by the red arrow) and 
analysed using 1D SDS-PAGE (Figure 3.11b, lane 2) and MS/MS (Table 3.4) and 
confirmed to be TgGRA2. The Mascot search matched to both SUMO-tag and 
TgGRA2 with total coverage of 50 % and 47.8 %, respectively. Results indicate that 
the purified fraction contains recombinant protein that can be used as pure bait to 
study its interacting partners from both T. gondii and host cells.   
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Figure 3.11: Purification of recombinant TgGRA2. a: Graphical representation of the reverse phase 
HPLC fractionations of the recombinant T. gondii GRA2 protein. Eluted fraction of transformants 
containing recombinant TgGRA2 gene without induction prepared by Ni-NTA HisTrap HP (Blue 
graph line) and with induction using IPTG (red graph line). The eluted fractions were desalted using 
PD-10 and run on HPLC. The arrow shows the peak of recombinantTgGRA2 protein fraction. b: 1D 
SDS-PAGE of reverse phase HPLC fraction. 1: Elution of recombinant protein T. gondii GRA2 under 
native condition before run on HPLC and 2: after HPLC fractionation using the main peak showed on 
the graph of the HPLC run fractions (100 µl (10 µg) of the peak fraction was concentrated using 2 µl 
strata clean beads). BL21 cell was grown and induced in LB media. 
 
Table 3.4: Mass spectrometry analysis of the in-solution digestion of the HPLC 
fraction of recombinant TgGRA2 protein.  
Protein accession Protein description Protein 
score 
Protein mass 
(kDa) 
Protein coverage 
(%) 
SUMO Tag SUMO tag 1007 12402 50 
TGME49_227620 
Dense granule protein 
GRA2 (GRA2) 
970 19960 47.8 
 
3.3.3.6. Western blot analysis of the HPLC purified recombinant TgGRA2  
HPLC purified recombinant TgGRA2 were analysed using western blot to 
identify the recombinant TgGRA2 protein containing SUMO-tagged-TgGRA2. 
Results showed that the band purified by the HPLC interacted with the anti-SUMO 
antibody as shown in Figure 3.12.  
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Figure 3.12: Identification of the expressed purified recombinant T. gondii GRA2 by western blot. 1: 
HPLC purified recombinant T. gondii GRA2 stained with colloidal Coomassie stain and 2: T. gondii 
GRA2 developed by western blot using anti-SUMO antibody. L: protein standard with molecular 
weight. BL21 cells were grown and induced in minimal media. 
 
3.3.4. Pull-down assay from Vero cell lysate using HPLC purified 
recombinant TgGRA2 
A pilot pull-down assay was performed to test the ability of the purified 
HPLC fraction containing recombinant TgGRA2 protein to bind to prey protein from 
host (Vero) cell lysate. Controls from both HPLC purified recombinant protein 
TgGRA2 protein and from Vero cells were run beside the experiment using Cobal 
Resin Kit. Figure 3.13 is 1D SDS-PAGE of Vero cell lysate pulled-down by 
recombinant TgGRA2 protein, shows that the recombinat TgGRA2 protein is not 
detected in the elution fraction (Figure 3.13, lane 7 and lane 8). This result was not 
expected due to the fact that protease inhibitor was added, however SUMO-tag may 
be cleaved-off from the recombinant TgGRA2 by SUMO enzymes that normally 
present in euharyotic cell. The experiment could not be repeated because of a lack of 
recombinant TgGRA2 protein purified by HPLC.   
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Figure 3.13: Pull-down using recombinant TgGRA2 protein purified by HPLC using cobalt resin kit. 
1: Vero lysate (200 µg), 2: Flowthrough, 3:elution of Vero bound protein to IMAC (control), 4:elution 
from 3 concentrated 10 × by 2 µl of strat clean beads, 5: purified recombinant HPLC fraction of 
TgGRA2 (10 µl), 6: flowthrough after incubation of recombiant TgGRA2 with Vero lysate, 7: elution 
of interacting recombant TgGRA2 with binding partners from Vero lysate, 8: elution from 7 
concentrated 10 × by 2 µl of strat clean beads.  
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3.4. DISCUSSION  
The present study aimed to dissect the comparative host-parasite interaction 
using recombinant GRA2 and GRA7 proteins from T. gondii ME49 and N. caninum 
Liverpool strain. The expressed proteins are fused to SUMO-tag which enhance gene 
expression and high protein yield, increases solubility especially membrane bound 
protein and proper folding of insoluble protein (Butt et al., 2005; Marblestone et al., 
2006; Zuo et al., 2005). Due to the location and significance of these proteins in the 
maturation of PV and PVM, their interactions with the host molecules were 
investigated to identify differences in host-parasite interactions between T. gondii 
and N. caninum.  
3.4.1. Recombinant GRA protein purification 
Pull-down experiments require using pure recombinant bait proteins to pull-
down prey partners. Pure recombinant bait is critical to investigate for high quality 
interaction and reduces the possibility of nonspecific interaction and false positive 
results. Thus polyhistidine attached to the SUMO-tag was exploited to purify these 
proteins using IMAC column (Ni-NTA HisTrap HP and Cobalt HisPur Resin kit). 
The recombinant GRA proteins were co-eluted with other protein from the 
endogenous protein of the competent BL21 expression system as shown by MS 
analysis (Table 3.3). Thus the recombinant GRA proteins require further purification 
before performing pull-down assay. In addition, the recombinant GRA proteins 
migrated to different molecular sizes on the SDS-PAGE; which could be due to 
enzymatic degradation by the expression system and/or (2) degraded during 
preparation and purification.  
The result of this study is comparable to the recent study performed on 
recombinant T. gondii GRA2 and GRA6 (Bittame et al., 2015), they found 
expression of these membrane related protein very difficult and attempted several 
vectors before they could get relatively pure recombinant proteins. They used pUET1 
expression vector to express the recombinant proteins, which expressed bound to N-
terminal S tag of pancreatic ribonuclease and 6 × histidine tag was attached to both 
terminals. However, they used similar purification method (IMAC) to that used in 
the present study to purify the recombinant proteins; based on the SDS-PAGE 
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presented in their study, the recombinant bait proteins were not purified as single 
band but rather other protein bands with the recombinant protein were migrated to 
different molecular size, suggested to be due to protein degradation.  
In the present study, two problems were required to be solved to purify the 
bait protein. The first was co-elution of proteins from the bacterial system and the 
second was migration of the bait protein to different molecular mass location on 1D 
SDS-PAGE. So to tackle these problems, five different methods were carried out to 
get pure recombinant GRA proteins.  
Firstly, a cobalt Resin kit was used as an alternative to Ni-NTA HisTrap HP 
column. Cobalt Resin is more specific for binding proteins containing polyhistidine, 
resulting in high pure recombinant protein elution (Yang et al., 1997). However in 
the present study, Cobalt IMAC (Figure 3.6) resulted in a nearly similar purification 
profile to that of the Ni-NTA HisTrap HP purification based on the 1D SDS-PAGE 
comparison (Figure 3.4B and Figure 3.5). Co-purification of these proteins with 
recombinant proteins could be due to several reasons; (1) presence of similar 
sequences within the protein of the bacterial system with rich regions of 
histidine/cysteine that have high affinity to IMAC (Westra et al., 2001) and/or (2) 
they interact with sepharose beads on which these IMAC metals (nickel and cobalt) 
were supported. Based on MS analysis of the sequences of the co-eluted proteins, 
there is no rich region of histidine/cysteine but rather most of them contain multiple 
(more than three) histidine and/or cysteines distributed within the protein sequences. 
Also (3) co-elution of these proteins could be due to non-specific interaction with the 
recombinant protein either with the SUMO-tag or with the GRA proteins. 
Secondly, minimal media was used for growing transformants as an 
alternative to LB media to decrease the possibility of breaking down of recombinant 
protein by the enzymatic activity of the expression system. LB media is an enriched 
media that allows transformants to grow faster than minimal media (Marley et al., 
2001), thus it will result in production of basic molecules necessary for maintaining 
growth. Expression of recombinant GRA proteins in minimal media (Figure 3.4B 
and) did not result in better purification of recombinant protein than in LB media 
(Figure 3.5). The reason could be due to (1) the enzymatic activity of the expression 
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system responsible for lytic activity against the recombinant protein is activated in 
both media or (2) it might happen during lysis of transformants, preparation and 
purification of recombinant proteins. 
Thirdly, the preparation and purification of recombinant TgGRA2 and 
NcGRA2 were performed under denaturing condition using 8 M urea. This was to 
investigate whether migration and degradation of the proteins were related to the 
lytic activity of the expression system and/or preparation of the recombinant GRA 
proteins. High concentrations of urea unfold proteins and inactivate enzymes 
(Bennion and Daggett, 2003; Kumar et al., 2006) which consequently reduces the 
possibility of enzymatic degradation of the expression system and protein-protein 
interaction. However the results (Figure 3.8) showed that these proteins are co-eluted 
with recombinant TgGRA2 and NcGRA2 under denaturing condition as well. The 
present results suggest that the multiple amino acids such as histidine and/or cysteine 
within protein sequences of the bacterial system could interact non-specifically with 
the sepharose bead and allows them to co-elute with recombinant GRA proteins. 
Fourthly, as an attempt to separate these co-eluted proteins from recombinant 
GRA proteins: a second step of purification was applied to the elution fraction of Ni-
NTA HisTrap exploiting the solubility of these proteins. Ammonium sulphate salt is 
used to reduce complexity of a mixture of protein prior to further purification using 
affinity chromatography (Jain et al., 2004; Kusnadi et al., 1998; Schagen et al., 
2000). In the present study, precipitation by ammonium sulphate salt was used to 
separate the co-eluted (recombinant GRAs from co-eluted E. coli protein) proteins 
from each other. Different concentrations of ammonium sulphate from 10-100 % 
were used and the results showed that the co-eluent was co-precipitated through most 
of the concentration applied (Figure 3.9, 3.10). The results indicate that the co-eluted 
protein may have very close solubility rate in ammonium sulphate to that of the 
recombinant GRA proteins. As E. coli proteins were co-purified with the expressed 
recombinant protein, the recombinant protein could not be used directly in the 
experiment without further purification. 
Fifthly, in the present study, a second purification step was performed for 
fraction containing TgGRA2 eluted from Ni-NTA HisTrap HP using reverse phase 
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(RP) HPLC. This allows separation of the proteins based on their hydrophobicity; the 
more the hydrophobic protein is the higher the concentration of organic solvent is 
required to remove it from the solid support. Thus co-eluted protein and the 
recombinant GRA protein are separated based on their hydrophobicity within organic 
solvent. The recombinant TgGRA2 was tried and successfully purified. Purified 
recombinant protein was analysed and identified using different methods (Figure 3.2) 
such as SDS-PAGE (Figure 3.11b), western blotting (Figure 3.12) and LC MS/MS 
(Table 3.4). However, technical problem with the HPLC machine hampered the 
processes of further protein purification. 
Another plan which was not attempted due to time constraints was to exploit 
the SUMO tag as an affinity tag and purifying the bait by co-immunoprecipitation 
(Co-IP) method. Co-IP is a technique used to identify PPIs through directing a 
specific antibody against a target protein to indirectly capture the binding partner of 
the target protein. In this case anti-SUMO antibody is either directly incubated with 
the lysate of expression system contains unpurified expressed bait or following a 
purification steps using IMAC. The antibody-bait complex is then purified using 
protein A or protein G immobilised to solid support. The complex is incubated with 
host cells lysate containing prey(s). The bait-complex partners can be purified by 
either protein A or protein G or using IMAC. The antibody-bait complex also can be 
used directly in far-western blotting. One advantage of this technique is the binding 
of anti-SUMO with SUMO tag could help protect the SUMO tag from proteolytic 
degradation by the SUMO enzyme. Another benefit of using anti-SUMO antibody is 
specifically bind to the SUMO tag that is only present in recombinant bait and in 
case of any contamination second step purification can be applied exploiting 
presence of polyhistidine by using IMAC. 
3.4.2. Pull-down assay for host cell lysate using T. gondii GRA2 
Recombinant TgGRA2 purified by reverse phase HPLC was used as bait to 
pull down prey protein from host cell lysate (Vero cell). However, results showed 
that the bait protein was not eluted from the elution fraction that should be present 
alone or with binding partner(s). There are two possibilities for the absence of 
recombinant TgGRA2: firstly, the bound SUMO-tag to the IMAC was removed by 
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SUMO-cleaving enzymes that are normally present in host cell of all eukaryotes 
(Hay, 2007; Johnson, 2004) and washed off from the IMAC during wash steps. 
Secondly it may interact with other proteins from the cell lysate and led to loss its 
configuration and binding activity with the IMAC column and swept away by the 
wash solutions. The pull-down was tried once because of the amount of recombinant 
protein acquired was very small and that the accessibility of HPLC was not possible. 
However, these explanations are not explicit unless at least triplicates of the pull-
down assay are performed. 
3.4.3. T. gondii and N. caninum GRA2 and GRA7 showed higher molecular 
weight in 1D SDS-PAGE 
In the present study, GRA2 and GRA7 displayed a higher molecular mass in 
SDS-PAGE analysis (Figure 3.4B and C and Figure 3.5) than predicted from primary 
translation product produced in native state within the parasites. According to the 
primary structure of the recombinant TgGRA2, molecular weight should be around 
30 kDa (TgGRA2 is 17.66 kDa plus 12.41 SUMO-tag); expressed recombinant 
TgGRA2 and purified HPLC fraction showed a protein band migrated to about 40 
kDa based on 1D SDS-PAGE. In addition, TgGRA7 was found migrated to about 47 
kDa. The reason for the higher molecular weight of the recombinant TgGRA2 and 
TgGRA7 proteins of the present study is not known. It could be due to the structure 
of these proteins that contain transmembrane domain (GRA7) and multiple 
amphipathic α-helices (GRA2) from both parasites. These could increase SDS 
binding amount and slow down its migration in SDS-PAGE (Rath et al., 2009). Also 
mass shift might be resulted from the addition of SUMO-tag bound to the GRA 
proteins.  
Previous studies showed that the native mature TgGRA2 polypeptide was 
modified post-translationally through glycosylation (Achbarou et al., 1991; Charif et 
al., 1990; Darcy et al., 1988; Zinecker et al., 1998). Glycosylation might be due to 
presence of many serine and threonine residues in the sequence of the GRA2 which 
provide sites for O-glycosylation (Mercier et al., 1993; Zinecker et al., 1998). While 
in native TgGRA7 the higher molecular mass in SDS-PAGE analysis may be caused 
by glycosylation of the asparagine residue at amino acid position 213 which may 
represents a potential N-glycosylation site (Fischer et al., 1998). Here we cannot 
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expect the role of glycosylation as a main cause of mass shift of recombinant GRA 
proteins; this is due to the fact that there is no evidence of glycosylation of 
recombinant protein to occur in E. coli (Demain and Vaishnav, 2009).  
Host-parsite interaction during infection with these parasites could result in 
different host response to different effector produced from invasion organelles and 
surface antigenes during infection by T. gondii and N. caninum. Different responses 
of host cells to infection can be exploited to study the comparative host-parasites 
interaction particularly PTMs of protein. PTMs such as protein phosphorylation and 
analysis of pathways of host cells that respond differntly to infection with these 
parasites could help understanding the differences in host-parasite interaction. 
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of the host cell response to infection with T. gondii and N. 
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4.1. INTRODUCTION 
Several biological differences have been found between T. gondii and N. 
caninum including host range, zoonotic capacity, transmission, virulence and 
definitive host (Davison et al., 1999b; Dubey, 2004; Dubey et al., 2007; Lei et al., 
2014; McAllister et al., 1998; McCann et al., 2008; Tenter et al., 2000; Williams et 
al., 2009). Despite these differences the genome and transcriptome of these parasites 
are remarkably conserved (Reid et al., 2012). Many efforts have been made to study 
the expression level of transcriptome and proteome of these parasites and host in 
response to infection (Blader et al., 2001; Nelson et al., 2008; Reid et al., 2012; Xia 
et al., 2008). A microarray study showed that many host cell genes were modulated 
in response to infection with T. gondii; genes modulated in early infection (1-2 hr 
p.i.) were found encode proteins involved in immune response to pathogens, while 
later in infection (> 6-24 hr p.i.) modulated genes were found encode proteins 
associate with glucose and mevalonate metabolism (Blader et al., 2001). Quantitative 
gel-based proteomics using two dimensional electrophoresis (2D SDS-PAGE) and 
difference gel electrophoresis (DIGE) on host cell in response to infection at 
different time point (6-24 hr p.i.), found that protein expressions and its modification 
increased with time (with maximum changes at 24 hr p.i.), in response to infection 
with T. gondii (Nelson et al., 2008). Comparative transcriptional analysis of non-
infected mice forebrain and T. gondii infected samples (acute at 10 days p.i. and 
chronic stage at 28 days p.i.) revealed high expression of genes associated with 
innate immune response in infected mice, whereas more than two fold increases in 
innate immunity-related transcripts was observed in chronic infection than acute 
stage (Pittman et al., 2014). Nelson et al. (2008) suggested that most of the changes 
in response to infection cannot be revealed by transcriptional studies, but considered 
protein studies are more robust in interpretation of host response to infection as 
proteins are ‘the true effectors’. The effect of protein can be measured by both the 
absolute quantities and their functional forms. The functional form of proteins are 
often due to PTMs that are not analysed directly using transcriptional studies (Nelson 
et al., 2008). Expression status of genes may not be enough to understand how they 
fit in different pathways or events involved because of inability to tell actual 
information about functional status of PTMs of proteins.  
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4.1.1. Role of post-translational modification of proteins 
Analysis of PTMs of protein is one way to understand the functional status of 
proteins in response to infection and the cellular function they involved. Hundreds of 
modifications types of proteins have been reported (Garavelli, 2004). Protein 
phosphorylation is one of the most common types of PTMs which is implicated in 
signal transduction and is crucial for regulation of almost all cellular processes 
(Villen and Gygi, 2008). In apicomplexan parasites, protein phosphorylation plays an 
important role in the regulatory mechanisms within and outside the parasites after 
invasion of the host cells (Treeck et al., 2011). Thus, the differences between T. 
gondii and N. caninum could be beyond the level of protein expression. Using 2D 
SDS-PAGE, Xia et al. (2008) showed that in T. gondii tachyzoites, the same protein 
identification possesses different isoforms and different form of PTMs. Furthermore, 
DIGE analysis of host cell protein in response to infection with T. gondii 
demonstrated that many of protein changes were resulted from PTMs and protein 
phosphorylation was found as one of the most important modifications (Nelson et al., 
2008). In addition, protein phosphorylation is considered more critical than just 
transcript and protein expressions for understanding the broader theme of the 
signalling processes happening ubiquitously in cells at a given time (Gomase and 
Akella, 2009; Villen and Gygi, 2008). However, PTMs and particularly protein 
phosphorylation has not been extensively studied in the differences between T. 
gondii and N. caninum infected host cells. Dissecting the protein phosphorylations of 
host cells in response to infection with these parasites could be critical for 
understanding the comparative host-parasite interactions. 
4.1.2. Regulation of host protein through phosphorylation during infection 
with pathogens  
In other pathogens, protein phosphorylation of infected host cells was also 
found playing important roles in host-pathogen interactions. Immunoblot analysis of 
Helicobacter pylori showed that binding to AGS cells induced tyrosine 
phosphorylation of two host cell proteins of 145 and 105 kDa and suggested that 
adhesion consequently leading to signal transduction within the affected cells (Segal 
et al., 1996). Enteropathogenic Escherichia coli (EPEC) induces tyrosine 
phosphorylation of host cell proteins Hsp90 to initiate cytoskeletal rearrangement 
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and bacterial internalisation (Rosenshine et al., 1992). Many pathogens were also 
found using beneficial strategy through interfering with the phosphorylation of the 
intracellular-signalling pathways of host cell (Bhavsar et al., 2007). Yersinia spp. 
produce kinase-like protein such as YpkA, autophosphorylates and activates in host 
cells resulting in modulation of host actin cytoskeleton (Prehna et al., 2006). In viral 
infection, viral effectors subvert the activation of protein kinases of the cell such as 
PKR, autophosphorylation of PKR is necessary for defences against viral infection 
and apoptosis (Hasnain et al., 2003). 
4.1.3. Phosphorylation of host protein during infection with T. gondii and N. 
caninum  
Apicomplexan parasites possess rhoptry proteins such as ROP5, 11 and 16 
and 18 that are structurally homologue to protein kinases of the mammalian cells 
(Bradley et al., 2005; El Hajj et al., 2006). Several of these proteins were found as 
active protein kinases contain kinase-like catalytic domain while others lack the 
known catalytic trial and are expected to be pseudokinases (El Hajj et al., 2006; Lei 
et al., 2014). In T. gondii, TgROP18 protein was found re-localised at the PVM 
following invasion and involved in phosphorylation of parasite substrate especially a 
70-kDa protein of tachyzoites (El Hajj et al., 2007). Several kinases-like proteins 
from T. gondii such as TgROP16 and TgROP18 were found involved in 
phosphorylation of host cell proteins directly following invasion and infection within 
the host environment (Lei et al., 2014; Ong et al., 2010).  
Phosphorylation of host cell proteins by T. gondii is found related to 
adaptation and protection from the immune system within the host environment. 
Regulation of host cell protein phosphorylations by protein kinases from these 
parasites have been found implicated in virulence of the parasites. In T. gondii 
infection, interferon-induced host cell immunity-related GTPases (IRGs) is loaded 
onto the formed PVM within the first hour of infection (Khaminets et al., 2010). 
There are strong evidences of differential host cell protein phosphorylation between 
T. gondii and N. caninum infections. For example, IRGs were found phosphorylated 
by TgROP18 in virulent strain and subsequent protection of PVM from destruction 
in IFNγ-induced cells, whereas N. caninum was found failed to phosphorylate IRGs 
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due to pseudogenisation of Neospora gene ROP18 (Lei et al., 2014; Reid et al., 
2012). 
In T. gondii, other ROP proteins such as TgROP16 has also been found 
involved in virulence through direct and strain-specific phosphorylation of the host 
cell signal transducer and activator of transcription (STAT3/6) signalling pathway 
(Butcher et al., 2011; Ong et al., 2010; Saeij et al., 2007; Yamamoto et al., 2009). It 
was found that STAT3 and 6 in HFF cells infected with type I or type III strains at 18 
hr p.i. were higher activated than the ones infected with type II strains (Saeij et al., 
2007). In IFNγ-induced murine macrophages infected with different strain of T. 
gondii, it was found that ROP16 in type I or type III resulted in high phosphorylation 
and activation of STAT3; but infection with type II resulted in activation of STAT3 
for short time followed by induction of high secretion of IL-12p40, which was 
thought to be related to different disease outcomes (Saeij et al., 2007). In T. gondii 
infection with type I or type III, direct phosphorylation and sustained activation of 
STAT6/3 result in modification of early inflammatory response of the host cells 
mediated by cytokine, IL-12 (Ong et al., 2010; Saeij et al., 2007; Yamamoto et al., 
2009). 
To understand the critical role of protein phosphorylation in the biological 
differences between T. gondii and N. caninum infections, large scale 
phosphoproteome analyses of the host cell during infection would be very important. 
Large scale phosphoproteome can be studied using MS/MS to analyse the entire set 
of the proteomics at any given time with high level of accuracy, specificity and 
sensitivity (Collins et al., 2007; Gruhler et al., 2005). MS-based investigation of 
global phosphoproteome of Plasmodium falciparum and T. gondii led to the 
identification of 5,000 and 10,000 of new phosphorylation sites, respectively (Treeck 
et al., 2011). Investigation of protein phosphorylation in host cell in response to 
infection with these related parasites could play an important role in directing and 
expanding our understanding toward identifying the factors responsible for the 
biological differences between T. gondii and N. caninum. 
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4.1.4. Aims and objectives of the study: 
Despite the significance of host cell phosphorylation events found during 
infection with both parasites, there is an apparent lack of systematic studies about 
proteome-wide phosphorylation events of host cell proteins in response to infection. 
This study aimed to analyse the comparative protein phosphorylation of host cells in 
response to infection with these parasites at 20 hr p.i using MS-based 
phosphoproteome approaches.  
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4.2. MATERIALS AND METHODS 
4.2.1. Host cells and parasites maintenance 
Human foreskin fibroblasts (HFF) cells were used as host cells for 
cultivating, maintaining and harvesting both T. gondii VEG strain and N. caninum 
Liverpool strain. The HFF cells were maintained and passaged similarly to that of 
Vero cells as mentioned in section 2.2.1.1 and 2.2.1.2, except that 2 × 10
5
 or 6 × 10
5
 
cells were seeded per 25 cm
3 
flask (T25) and 75 cm
3
 flasks (T75), respectively. 
Tachyzoites were maintained as described in section 2.2.1.3 and were 
harvested as described in section 2.2.1.4.   
4.2.2. Time point study 
Concurrently, both T. gondii and N. caninum were grown for 20 hr p.i. in a 
ratio of 20:1 parasites to initial number of HFF cells seeded. The time point of 20 hr 
p.i. was chosen because the multiplications of most of the T. gondii and N. caninum 
tachyzoites were found at 2
nd
 and 3
rd
 stage of endodyogeny and before egress. A total 
of 2 × 10
7
 parasites were used to infect the host cells that were maintained for three 
days following seeding with 1 × 10
6
 cells/T75 flask. At 20 hr p.i., growth medium 
was discarded and cells were washed with PBS prewarmed to 37 °C. Infected cells 
were detached using 3 mL of 1 × trypsin free EDTA (SAFC biosciences
™
) 
prewarmed to 37 °C and incubated for 2-3 min at 37 °C in 5 % CO2. Five mL of PBS 
were added to the detached HFF cells and collected in a 50 ml conical falcon 
centrifuge tube containing 5 ml of growth media prewarmed to RT. Cell suspension 
was centrifuged at 1,000 × g for 5 min at 4 °C, supernatant was discarded and the 
pellet was resuspended in 10 ml cold PBS and re-centrifuged at 4 °C. The last step 
was repeated and the pellet was collected in 1 ml cold PBS in an Eppendorf tube 
followed by a final centrifuge at 12,000 × g for 3 min at 4 °C. The pellets were 
collected and kept at -80 °C for future use. Uninfected HFF cell samples were 
collected along with each infected HFF cell sample. 
 Toxoplasma gondii and N. caninum were harvested as described in section 
2.2.1.3; the harvested tachyzoites were spiked into the non-infected HFF cells as 
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control in a ratio of 6:1 parasites per cells for the initial number of parasites used for 
infection of HFF cell. A total of 1.2 × 10
8 
purified parasites were spiked into non-
infected pellet of HFF cells per T75 flask to be used as mock infection samples. 
Mock infection was used to minimise bias that arise due to the amount of protein 
used from infected cell and non-infected cell for enrichment with TiO2. 
4.2.3. Protein preparation from harvested samples 
Harvested pellets from both infected samples and mocks from 1-2 T75 tissue 
culture flasks were prepared for phosphoprotein analysis. Each pellet was 
resuspended in 250 µl of a master mix lysis buffer, which comprised 22.5 mM 
ammonium bicarbonate, 200 µg of RapiGest™ SF surfactant (Waters), 1 × 
phosphatase inhibitor cocktail 2 (Sigma),  protease inhibitor cocktail-EDTA free 
(Sigma) (containing 4.16 mM of AEBSF, 3.2 μM of aprotinin, 200 μM of bestatin, 
56 μM of E-64, 8 μM of leupeptin and 6 μM of pepstatin A), 100 µM of 
benzimidine, 200 µM of phenylmethanesulfonyl fluoride, 400 µM of β-
glycerophosphate, 400 µM of sodium fluoride and 12 µM of sodium orthovanadate. 
Pellets were resuspended in master mix lysis buffer and incubated on ice for 30 min. 
Samples were further lysed and homogenised using probe sonicator (Sonics
®
) on ice 
for 5 times for 30 sec pulse (74 Hz) and 1 min off at 40 % amplitudes output. Cell 
lysates were spun down at 16,000 × g for 1 hr at 4 °C and the supernatant was 
collected and protein concentration was measured using Bradford assay (Thermo 
scientific). 
4.2.4. Protein assay 
Protein concentration was estimated by carrying out a Bradford assay from 
both infected HFF cells and the mock as described in section 2.2.3. An equivalent of 
100 µg were taken for global quantification on mass spectrometer separately 
alongside with 1 mg for enrichment of phosphopeptides using TiO2 SpinTips 
(Protea
®
). 
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4.2.5. Analysis of sample lysates on an Orbitrap Velos mass spectrometer  
4.2.5.1. In-solution digestion and analysis 
The required protein amount comprised an equivalent of 100 µg was taken 
for global quantification separately alongside with 1 mg for phosphopeptides 
enrichment. Each sample for global quantification was diluted in 25 mM ammonium 
bicarbonate to a volume of 170 μl before heated at 80 °C for 10 min with a brief 
vortex at 5 min. Samples were then reduced with 3 mM dithiothreitol and the sample 
incubated for 10 min at 60 °C. Samples were cooled down to room temperature before 
alkylation with 9 mM iodoacetamide and incubated for 30 min in the dark at RT. 
Proteins were then digested with proteomic grade porcine trypsin (Sigma-Aldrich
®
) 
at a ratio of 1 µg: 50 µg of trypsin to lysate proteins and incubated overnight at 37 
°C. Digestion was stopped by acidification with a final concentration of 0.5 % 
trifluoroacetic acid and incubated for 45 min at 37 °C. The solution was centrifuged 
at 13,000 × g for 15 min at room temperature. The supernatant was collected where 
the digest for global quantification was kept at -20 °C for subsequent mass 
spectrometric analysis and the digestion for phosphopeptides enrichment was further 
processed using TiO2 SpinTips kit.  
4.2.5.2. Enrichment of phosphopeptides from the digestion 
Enrichment of phosphopeptides was performed using TiO2 SpinTips kit as 
per the manufacturer’s instruction (Protea®). Briefly, SpinTip was washed twice to 
wet the packing material by adding 100 µl each time of reconstitution and wash 
solution and then centrifuged at 4,000 × g for 5 min. The digestion was reconstituted 
with equal amount of reconstitution and wash solution. Total volume of 400 µl was 
divided into two 200 µl aliquots which were loaded to the SpinTip and centrifuged at 
4,000 × g for 3 min. The flow through was reloaded once to enhance binding then 
discarded. Retained peptides on the SpinTip were washed four times (twice with 100 
µl of the reconstitution and wash solution, and twice with 100 µl of the wash 2 
solution) and each time spun at 4,000 × g for 3 min. The bounded phosphopeptides 
were eluted with 200 µl of elution solution, centrifuged at 4,000 × g for 3 min. The 
elution process was repeated once more and the elution solution was combined 
together before drying off by Concentrator plus (Eppendorf) for 6 hr at room 
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temperature. Dried off peptides were resuspended in 20 µl recombination buffer 
containing 3 % acetonitrile and 0.5 % TFA followed by bath sonication for 10 min at 
4 °C. 
4.2.5.3. Tandem mass spectrometry analysis (Velos –orbitrap) 
Mass spectrometry analysis was performed by Dr Stuart Armstrong 
(Department of Infection Biology, Institute of Infection and Global Health, 
University of Liverpool) as follows: peptide mixtures from both samples (mock 
infection and at 20 hr p.i. time point) were analysed by on-line nanoflow liquid 
chromatography using the nanoACQUITY-nLC system (Waters MS technologies, 
Manchester, UK) coupled to an LTQ-Orbitrap Velos mass spectrometer equipped 
with the manufacturer’s nanospray ion source. The analytical column 
(nanoACQUITY UPLCTM BEH130 C18 15 cm × 75 µm, 1.7 µm capillary column) 
was maintained at 35 °C and a flow-rate of 300 nl/min. The gradient consisted of 3-
40 % acetonitrile in 0.1 % formic acid for 90 min then a ramp of 40-85% acetonitrile 
in 0.1% formic acid for 5 min. Full scan MS spectra (m/z range 300-2000) were 
acquired by the Orbitrap at a resolution of 30,000. Analysis was performed in data 
dependant mode. The top 20 most intense ions from MS1 scan (full MS) were 
selected for tandem MS by collision induced dissociation (CID) and all product 
spectra were acquired in the LTQ ion trap.  
4.2.5.4. Protein identification using multiple search engines  
Raw data from mass spectrometric analysis were submitted to PEAKS
®
 
Studio (version 7.0, BSI, Waterloo, ON, Canada). The following settings were used 
for the searches: data refinement was performed with no merged scans, with 
precursor charge correction and no filtering. InChorus searching was performed 
including search engines comprised of Peaks, Mascot (Matrix Science), OMSSA 
(Geer et al., 2004) and X!Tandem (Craig and Beavis, 2004) with a mass tolerance of 
10 ppm for the precursor and 0.8 ppm for the fragment ion. Trypsin was used as 
enzyme specificity; carbamidomethyl cysteine was set as fixed modification, and 
oxidation of methionine (M), phosphorylation of serine, threonine and tyrosine 
(STY) were set as variable modifications. Peptides with a maximum of 3 variable 
modifications and one missed cleavage were allowed. The peptides were searched 
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for protein identification against locally-installed databases including the annotated 
protein sequences for N. caninum (ToxoDB-9.0_NcaninumLIV_AnnotatedProteins. 
fasta) and for T. gondii (ToxoDB-10.0_TgondiiME49_AnnotatedProteins.fasta) 
[downloaded from ToxoDB (Gajria et al., 2008)]. UniProt-human reference 
proteome databases release 2014_02 was used for identification of human proteins 
(http://www.uniprot.org/). A false discovery rate (FDR) of ≤ 1 % was used as a cut-
off for the peptide identifications. Total number of matched phosphopeptides 
between infection with T. gondii and N. caninum were presented using a Venn 
diagram (http://bioinforx.com/). 
4.2.6. Pathway analysis 
The identified phosphoproteins from HFF cells infected with T. gondii, N. 
caninum or mock infection were submitted to online functional annotation tool 
DAVID Bioinformatics Resources version 6.7 (Huang et al., 2008). The entries of 
protein accession number from proteins of interest were submitted as gene lists. In 
DAVID tool, the KEGG Pathway was chosen for pathway analysis. P-value cut-off ≤ 
0.05 was applied to pathways to be considered statistically significant enriched in the 
annotation categories. The phosphoproteins enriched in each pathway for one 
parasite were also mapped manually for the other parasite when the same pathway 
was not statistically enriched, to compare the discrepancies of phosphoprotein 
coverage.  
4.2.7. Phosphopeptide motif analysis 
Phosphopeptide motifs were analysed using web-based motif-x programme 
(Chou and Schwartz, 2011) using default settings. Briefly, the phosphopeptides were 
queried against background data in international protein index (IPI) human proteome. 
Each time one AA (S or T or Y) used to identify the motif with +7 and -7 up and 
down of the selected AA (total of 15 AA). The occurrence of the motif was set to at 
least 5 × with significant threshold of 0.000001 which correspond to actual alpha-
value of approximately 0.0003 by Bonferroni method. 
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4.2.8. Phosphoprotein quantification 
For quantitation of global protein and enriched phosphopeptides, Progenesis 
LC-MS software from Nonlinear Dynamics (Newcastle upon Tyne, U.K.) was used 
to carry out label-free quantification. Peptides and proteins quantification using 
Progenesis LC-MS consisted of several consequent steps. First of all, raw data from 
Orbitrap Velos mass spectrometer were imported. Once all the data have been 
imported, the most appropriate reference LC-MS was run to align all the other runs, 
which were performed by automatic reference run alignment. After the aligned runs 
have been reviewed, they were filtered in the filtering stage based on charge state and 
number of isotopes. Monoisotopic spectra with +2 to +7 charges were maintained for 
analysis while the remaining features that were not matching the filter were removed 
completely from the analysis. The next stage was study design for analysed runs 
which reflected biological groupings of the replicates in the original study followed 
by peptides quantified from both groups. Quantified features were identified at 
peptides and proteins level by exporting it into PEAKS
®
 software. The analysed data 
were exported into pep.xml which was later imported into Progenesis LC-MS to 
match the identified peptides and proteins to the quantified spectra. The quantified 
spectra were standardised using built in normalisation tool in Progenesis LC-MS. For 
comparison between host cell infections with T. gondii and N. caninum, label-free 
quantification was carried out based on cut-off filters including a p value < 0.05 for 
significant phosphopeptides quantification and a fold change of > 1.5 to determine 
the differentially expressed phosphopeptides. 
4.2.9. Subcellular localisation and Types of identified and quantified 
phosphoproteins 
Subcellular location and types (based on molecular function) of quantified 
phosphoproteins were determined using ingenuity pathway analysis (IPA) software 
(Ingenuity
®
 Systems, Redwood City, CA). In addition, an upstream regulator 
analysis for pathway or kinases involved in phosphorylation of the quantified 
phosphopeptides was performed using IPA.  
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4.3. RESULTS  
4.3.1. Comparative analysis of doubling process at 20 hr p.i. 
Figure 4.1 shows the growth comparison of tachyzoites based on the doubling 
processes of T. gondii and N. caninum in infected HFF cells at 20 hr p.i. Most of the 
tachyzoites from both parasites were found at 2
nd
 (4 tachyzoites) or 3
rd
 (8 
tachyzoites) doubling rounds.  
 
 
Figure 4.1: The doubling processes of T. gondii and N. caninum in infected HFF cells at 20 hr p.i. a): 
HFF cells infected with T. gondii VEG strain at a ratio of 5:1 parasites to cells, red arrows shows 
parasites at the 2
nd
 and 3
rd
 doubling stages at 400 × magnification. b): HFF cells infected with T. 
gondii VEG strain at a ratio of 20:1 parasites to cells at 400 ×. c): HFF cells infected with N. caninum 
Liverpool strain at a ratio of 5:1 parasites to cells, red arrows shows parasites at the 2
nd
 and 3
rd
 
doubling stages at 400 ×. d): HFF cells infected with N. caninum Liverpool strain at a ratio of 20:1 
parasites to cells at 20 hr p.i. at 400 ×. Pictures were taken by AxioCam ERCs % Rev. 2.0 (2 mega 
pixels) connected to an inverted microscope (Carl Zeiss Microscopy GmbH, Germany) with 400 × 
magnification. 
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4.3.2. Total identified peptides and phosphopeptides using TiO2 and data 
analysis using PEAKS
®
  
Total numbers of globally identified peptides from HFF cell infected with T. 
gondii and of mock infected with T. gondii (containing peptides from both host cell 
and the parasite) were 17,422 and 16,651, respectively. Total number of identified 
peptides from HFF cells infected with N. caninum and of mocks infected with N. 
caninum (containing peptides from both host cell and the parasite) were 16,415 and 
17,250, respectively (Table 4.1). 
The total numbers of identified peptides (phosphopeptides and non-
phosphopeptides) in the TiO2 enriched samples from HFF cell infected with T. gondii 
and mocks infection were 5,171 and 3,455, respectively. While total number of 
identified peptides in HFF cell infected with N. caninum and mock infection were 
4,556 and 3,043, respectively (Table 4.1). 
 
Table 4.1: Total number of peptides and phosphopeptides identified from global 
proteome and from TiO2 enrichment using PEAKS
®
 
Conditions Global quantification 
sample
1
  
TiO2 enrichment 
sample
1
 
HFF cells infected with T. gondii  17,422 5,171 
HFF cells spiked with  T. gondii 16,651 3,455 
HFF cells infected with  N. caninum  16,415 4,556 
HFF cells spiked with N. caninum  17,250 3,043 
1
 Including both peptides and phosphopeptides from both HFF cell and the parasites 
 
4.3.3. Enrichment performance of TiO2 SpinTips kit 
The enrichment fold of non-redundant phosphopeptides using TiO2 SpinTips 
kit is shown in Table 4.2. The lowest enrichment fold was reported from HFF cell 
spiked with N. caninum and T. gondii at 10.52 and 10.54 folds, respectively. A 
similar enrichment fold was reported from infected HFF cells as well; while the 
highest enrichment fold was observed from parasite peptides in N. caninum and T. 
gondii mock infections at 16.53 and 23.42 folds, respectively. 
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Table 4.2: The enrichment of non-redundant phosphopeptides identified using 
TiO2. 
Conditions Global quantification
1 
TiO
2
 Enrichment
2 
Fold 
enrichment 
Peptides  Phosphopeptides Peptides Phosphopeptides 
 Parasite peptides in 
Toxoplasma infection  
2025 12 285 176 14.67 
Host peptides in 
Toxoplasma infection  
15242 143 2914 1796 12.56 
 Parasite peptides in mock 
infection with  
Toxoplasma  
6335 31 632 726 23.42 
Host peptides in mock 
infection with  
Toxoplasma  
10203 82 1233 864 10.54 
Parasite peptides in 
Neospora infections 
1973 12 284 151 12.58 
Host peptides from  
Neospora  infection 
14277 153 2491 1630 10.65 
Parasite peptides in mock 
infection with  
Neospora  
5486 34 417 562 16.53 
Host peptides in mock 
infection with Neospora 
11638 92 1098 968 10.52 
1
 The whole cell lysate without TiO2 enrichment. 
2
 The enriched phosphopeptides from each sample using TiO2 SpinTip kit 
 
4.3.4. Phosphopeptides enrichment from HFF cells using Peaks
®
 
Redundancy in the identified phosphopeptides obtained from the biological 
replicates of the infected host cells and the mock infection was eliminated. The total 
number of phosphopeptides from host cells infected with T. gondii and N. caninum 
was 1,796 and 1,630, respectively. Total number of phosphopeptides from mock 
infected HFF cells was 864 and 968 for T. gondii and N. caninum, respectively 
(Figure 4.2). Phosphopeptides from HFF cells infected with T. gondii, N. caninum 
and mock infections were compared. There are 1101 phosphopeptides overlap 
between T. gondii and N. caninum infections (Figure 4.2 a) which accounted for 
61.30 % and 67.54 %, respectively. Host cells infected with T. gondii and N. 
caninum showed nearly two fold more of phosphopeptides identified than mock 
infections (Figure 4.2b and c). At the phosphoprotein level, there were 359 
phosphoproteins that overlapped between host cells infected with both parasites 
(Figure 4.3) and 151 phosphoproteins from HFF cells infected with T. gondii were 
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different from infection with N. caninum. A total of 101 phosphoproteins were found 
in infection with N. caninum but not in T. gondii (Figure 4.3). 
 
 
Figure 4.2: Comparison of non-redundant phosphopeptides enriched using TiO2 from HFF cells. a) 
HFF cell infected with T. gondii and N. caninum. b) HFF infected with tachyzoites from T. gondii and 
T. gondii (mock) and c) HFF cell infected with N. caninum and N. caninum (mock).  
 
 
Figure 4.3: Comparison of non-redundant phosphoproteins enriched using TiO2 from HFF cells 
infected with T. gondii and N. caninum. 
 
4.3.5. Subcellular location and types of phosphoproteins 
The subcellular locations and types (based on molecular function) of 
phosphoproteins were analysed using IPA to understand their distribution in response 
to infection with these parasites. Host cells infected with N. caninum and T. gondii 
showed very similar distribution in both subcellular location and types of enriched 
phosphoproteins as shown in Figure 4.4 and 4.5, respectively.  
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Figure 4.4: Subcellular location of enriched phosphoproteins from host cell infected with T. gondii 
and N. caninum. 
 
 
 
Figure 4.5: Types of enriched phosphoproteins from host cell infected with T. gondii and N. caninum. 
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4.3.6. Phosphorylation sites of phosphopeptides identified from infected 
HFF cells 
Investigating phosphorylation sites is important to understand the differences 
in signalling pathways and the kinases most frequently involved between both 
infections. Phosphorylated proteins were investigated for differences in 
phosphorylation sites between the non-infected host cell and host cell in response to 
infection with T. gondii and N. caninum. The phosphorylation sites (phosphoserine, 
phosphothreonine and phosphotyrosine) were found distributed similarly between 
non-infected and infected host cell with T. gondii and N. caninum (Table 4.3). 
However, similar to what was observed at the phosphopeptide level, the highest 
number of phosphorylation sites were found in infected HFF cells which were nearly 
two times higher than mock infections (Table 4.3). 
 
Table 4.3: The phosphorylation sites identified in HFF cells infected and mock 
infected with T. gondii and N. caninum at 20 hr p.i. 
Phosphorylation 
type 
No. of host 
phosphosites in 
T. gondii 
infection /% 
No. of host 
phosphosites in 
mock infection 
with T. gondii/% 
No. of host 
phosphosites 
in N. caninum  
infection /% 
No. of host 
phosphosites in 
mock infection with 
N. caninum/% 
Phosphoserine 1985/85.93 971/88.35 1795/85.6 1083/87.76 
Phosphothreonine 310/13.42 121/11 287/13.69 147/11.91 
Phosphotyrosine  15/0.65 7/0.64 15/0.72 4/0.32 
Total  2310 1099 2097 1234 
 
4.3.7. Motif analysis from enrich Phosphopeptides 
Motifs analysis was performed in order to investigate the involvement of 
different kinases with various phospho-motifs between the two infections. Motif 
analysis of phosphoserine containing peptides showed differences between host cell 
infected with T. gondii and N. caninum. A total of 19 motifs were enriched where 
four motifs were differentially enriched for each infection as shown in Table 4.4 
which is equivalent to 21.05 % differences. On the other hand, phosphothreonine 
containing peptides showed that only four motifs were enriched where two of them 
were differentially enriched in T. gondii as shown in Table 4.5. 
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Table 4.4: HFF cell motifs from enriched phosphopeptides of host cells infected 
with T. gondii and N. caninum based on the phosphorylated serine amino acid. 
s Motif Motif score from 
infection with 
T. gondii 
Fold 
increase 
Motif score from 
infection with 
N. caninum 
Fold 
increase 
1 ....R..sP.P.... 40.67 41.46 40.32 42.70 
2 .....P.sP...... 26.10 9.48 27.04 9.87 
3 .......sP...... 16.00 4.48 16.00 4.49 
4 .......sD.E.... 32.00 19.69 32.00 19.00 
5 ....RR.s....... 22.09 11.98 22.62 12.23 
6 ....R..s....... 16.00 4.35 16.00 4.40 
7 .......sE.E.... 30.26 12.94 27.56 12.33 
8 .......sSP..... 27.88 9.43 28.55 9.80 
9 .......s.E..... 13.39 2.79 9.84 2.55 
10 .......s.SP.... 20.29 8.42 23.52 10.54 
11 .......s....E.. 6.44 2.38 6.64 2.60 
12 .......sP...R.. 24.83 11.47 - - 
13 ....R..s.S..... 23.65 10.32 - - 
14 ......Rs...S... 13.19 10.97 - - 
15 .......s....D.. 8.57 2.93 - - 
16 .....S.sP...... - - 24.95 9.02 
17 ....RS.s....... - - 23.44 9.12 
18 .......s.DE.... - - 16.82 17.73 
19 .....R.s....... - - 8.10 2.79 
 
Table 4.5: HFF cell motifs from enriched phosphopeptides of host cells infected 
with T. gondii and N. caninum based on the phosphorylated threonine amino 
acid. 
s Motif Motif score from 
infection with 
T. gondii 
Fold 
increase 
Motif score from 
infection with 
N. caninum 
Fold 
increase 
1 .......tP...... 15.95 3.72 16.00 4.41 
2 .....SPt....... 15.56 14.51 20.93 18.11 
3 ....K..tP...... 22.11 20.72 - - 
4 .......tSP..... 14.10 14.74 - - 
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4.3.8. Pathway analysis for the enriched phosphopeptides from HFF cells 
infected with T. gondii and N. caninum 
The identified phosphoproteins enriched from infected HFF cells were 
submitted to DAVID functional annotation tool for pathway analysis. The results are 
shown in Table 4.6 and 4.7 for T. gondii and N. caninum, respectively. Comparing 
the pathways from both conditions showed that three pathways (mTOR signalling 
pathway, glycolysis/gluconeogenesis and endometrial cancer) from HFF cells 
infected with T. gondii were not enriched in N. caninum infection. Five pathways 
(erbB signalling pathway, renal cell carcinoma, gap junction, long-term potentiation, 
and vascular smooth muscle contraction) enriched in N. caninum infection were not 
enriched for T. gondii infection (Table 4.8). The detail information about individual 
proteins involved in the differentially enriched pathway is shown in Table 4.9.  
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Table 4.6: Pathways enriched in T. gondii infection  
s Name of the pathways P-Value Gene count %* Uniprot genes entry accession number 
1 Spliceosome 2.60E-09 21 4.13 
Q09161, Q86XP3, P52272, O75643, P49756, Q13573, Q7L014, Q13247, O75494, 
Q96I25, Q8IWX8, O43290, P08107, P07910, Q9UKV3, O15042, P08621, Q00839, 
P61978, P09651, Q01130 
2 Focal adhesion 1.71E-06 22 4.32 
P02751, P08648, P18206, Q9Y490, O96013, P51636, P02452, P21333, Q15942, 
P35222, O14974, P08123, Q03135, Q14315, P04049, P05412, P50552, Q15746, 
O15530, P49023, Q9NVD7, Q9NRY4 
3 Regulation of actin cytoskeleton 1.92E-04 19 3.73 
P02751, P08648, P18206, O96013, O15143, Q8WYL5, P19634, P10398, O14974, 
P35579, Q14155, P35580, Q8TE77, P04049, Q15746, Q15052, P49023, P25054, 
Q9NRY4 
4 Insulin signalling pathway 0.004335 12 2.36 
Q13131, P04049, Q13085, O15530, Q15642, P49815, Q13541, P62753, P10398, 
P17612, P13861, P10644 
5 
Pathogenic Escherichia coli 
infection 
0.010119 7 1.38 Q92974, O15143, Q9BQE3, P68363, P35222, P19338, Q14247 
6 Glycolysis / Gluconeogenesis 0.012888 7 1.38 Q9NR19, P04406, P60174, P06733, P14618, P08559, P17858 
7 mTOR signalling pathway 0.026345 6 1.18 Q13131, O15530, P49815, Q13541, P62753, P23588 
8 Endometrial cancer 0.026345 6 1.18 P04049, O15530, P25054, P35221, P10398, P35222 
9 
Arrhythmogenic right ventricular 
cardiomyopathy (ARVC) 
0.036842 7 1.38 P02545, P08648, P15924, P17302, P35221, P35222, P11532 
10 Adherens junction 0.038918 7 1.38 O43318, P18206, Q8WWI1, O60716, P35221, P35222, Q07157 
*Percentage of genes involved in the pathway from submitted data to the total number of the background genes in the pathway  
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Table 4.7: Pathways enriched in N. caninum infection  
s Name of the pathways P-Value Gene 
count 
%* Uniprot genes entry accession number 
1 Focal adhesion 1.51E-07 22 4.81 
P08648, P18206, Q9Y490, O96013, P51636, P02452, P21333, Q13177, Q15942, P35222, 
O14974, P08123, Q03135, Q14315, P04049, P05412, P50552, Q15746, P49023, Q9NVD7, 
O43707, P15056 
2 Spliceosome 3.69E-07 17 3.72 
P52272, P49756, Q13573, Q13247, Q9BUQ8, Q8IWX8, Q13435, P07910, O43290, Q9UKV3, 
O15042, O60508, P08621, Q00839, P61978, P09651, Q01130 
3 
Regulation of actin 
cytoskeleton 
1.02E-04 18 3.94 
P08648, P18206, O96013, Q8WYL5, P19634, P10398, Q13177, O14974, P35579, Q14155, 
Q8TE77, P04049, Q15746, Q15052, P49023, P62328, O43707, P15056 
4 ErbB signalling pathway 0.003008 9 1.97 P04049, P05412, O96013, Q13541, P10398, Q13177, P16333, Q13557, P15056 
5 Adherens junction 0.005798 8 1.75 O43318, P18206, Q8WWI1, O60716, P35221, O43707, P35222, Q07157 
6 Long-term potentiation 0.012024 7 1.53 P04049, Q14573, P10398, P17612, O14974, Q13557, P15056 
7 
Vascular smooth muscle 
contraction 
0.013554 9 1.97 P04049, Q14573, Q15746, Q05682, P10398, P17612, O14974, Q9Y6F6, P15056 
8 
Arrhythmogenic right 
ventricular cardiomyopathy 
(ARVC) 
0.019995 7 1.53 P02545, P08648, P15924, P17302, P35221, O43707, P35222 
9 
Pathogenic Escherichia coli 
infection 
0.021843 6 1.31 Q71U36, P68363, P16333, P35222, P19338, Q14247 
10 Insulin signalling pathway 0.036807 9 1.97 P04049, Q15642, Q13541, P62753, P10398, P17612, P13861, P10644, P15056 
11 Gap junction 0.039527 7 1.53 P04049, Q14573, Q71U36, P17302, P68363, P17612, Q07157 
12 Renal cell carcinoma 0.047286 6 1.31 P04049, P05412, O96013, P10398, Q13177, P15056 
*Percentage of genes involved in the pathway from submitted data to the total number of the background genes in the pathway  
Chapter Four 
125 
 
Table 4.8: The comparative differences of pathways analysed from 
phosphopeptides IDs enriched by TiO2 from HFF cells infected with T. gondii 
and N. caninum.  
Enriched pathway HFF cells infection 
with T. gondii 
HFF cells infection with 
N. caninum 
Adherent junction   
Arrhythmogenic right ventricular 
cardiomyopathy 
  
Focal adhesion   
Insulin signalling pathway   
Pathogenic Escherichia coli infection   
Regulation of actin cytoskeleton    
Spliceosome   
Glycolysis/gluconeogenesis   
MTOR signalling pathway   
Endometrial cancer   
ErbB signalling pathway   
Gap junction   
Long-term potentiation   
Renal cell carcinoma    
Vascular smooth muscle contraction   
 
Table 4.9: Pathways differentially enriched from HFF cells infected with T. 
gondii and N. caninum. 
Pathway Gene ID Protein name  EC* T. gondii  N. caninum 
mTOR 
Q13131 
5'-AMP-activated protein 
kinase catalytic subunit 
alpha-1, AMPK1 
2.7.11.1   
O15530 
3-phosphoinositide-
dependent protein kinase 
1, PDK1 
2.7.11.1   
P49815 Tuberin, TSC2 -   
Q13541 
Eukaryotic translation 
initiation factor 4E-
binding protein 
1, EIF4EBP1 
-   
P62753 
40S ribosomal protein 
S6, RPS6 
-   
P23588 
Eukaryotic translation 
initiation factor 
4B, EIF4B 
-   
Glycolysis/ 
gluconeogenesis 
P06733 Alpha-enolase, ENO1 4.2.1.11   
P14618 Pyruvate kinase, PKM 2.7.1.40   
P08559 
Pyruvate dehydrogenase 
E1 component subunit 
alpha, PDHA1 
1.2.4.1   
P17858 
ATP-dependent 6-
phosphofructokinase, 
liver type, PFKL 
2.7.1.11   
Q9NR19 
Acetyl-coenzyme A 
synthetase, ACAS2 
6.2.1.1   
P04406 Glyceraldehyde-3- 1.2.1.12   
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phosphate 
dehydrogenase, GAPDH 
P60174 
Triosephosphate 
isomerase, TPI1 
5.3.1.1   
Endometrial cancer 
P04049 
RAF proto-oncogene 
serine/threonine-protein 
kinase, RAF1 
2.7.11.1   
P35221 
Catenin alpha-1, 
CTNNA1 
-   
P10398 
Serine/threonine-protein 
kinase A-Raf, ARAF 
-   
P35222 Catenin beta-1, CTNNB1 -   
O15530 
3-phosphoinositide-
dependent protein kinase 
1, PDK1 
2.7.11.1   
P25054 
Adenomatous polyposis 
coli protein, APC 
-   
ErbB 
P04049 
RAF proto-oncogene 
serine/threonine-protein 
kinase, RAF1 
2.7.11.1   
P05412 
Transcription factor AP-
1,  JUN 
-   
O96013 
Serine/threonine-protein 
kinase PAK 4, PAK4 
2.7.11.1   
Q13541 
Eukaryotic translation 
initiation factor 4E-
binding protein 1, 
EIF4EBP1 
-   
P10398 
Serine/threonine-protein 
kinase A-Raf, ARAF 
2.7.11.1   
Q13557 
Calcium/calmodulin-
dependent protein kinase 
type II subunit delta, 
CAMK2D 
2.7.11.17   
Q13177 
Serine/threonine-protein 
kinase PAK 2, PAK2 
2.7.11.1   
P16333 
Cytoplasmic protein 
NCK1, NCK1 
-   
P15056 
Serine/threonine-protein 
kinase B-raf, BRAF 
2.7.11.1   
Gap junction 
P04049 
RAF proto-oncogene 
serine/threonine-protein 
kinase, RAF1 
2.7.11.1   
Q14573 
Inositol 1,4,5-
trisphosphate receptor 
type 3, ITPR3 
-   
P17302 
Gap junction alpha-1 
protein, GJA1 
-   
P68363 
Tubulin alpha-1B chain, 
TUBA1B 
-   
P17612 
cAMP-dependent protein 
kinase catalytic subunit 
alpha, PRKACA 
-   
Q07157 
Tight junction protein 
ZO-1, TJP1 
-   
Q71U36 
Tubulin alpha-1A chain, 
TUBA1A 
-   
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Long-term 
potentiation 
P04049 
RAF proto-oncogene 
serine/threonine-protein 
kinase, RAF1 
2.7.11.1   
Q14573 
Inositol 1,4,5-
trisphosphate receptor 
type 3, ITPR3 
-   
P10398 
Serine/threonine-protein 
kinase A-Raf  
-   
P17612 
cAMP-dependent protein 
kinase catalytic subunit 
alpha, PRKACA 
2.7.11.11   
O14974 
Protein phosphatase 1 
regulatory subunit 12A, 
PPP1R12A 
-   
Q13557 
Calcium/calmodulin-
dependent protein kinase 
type II subunit delta, 
CAMK2D 
-   
P15056 
Serine/threonine-protein 
kinase B-raf, BRAF 
-   
Renal cell carcinoma 
P04049 
RAF proto-oncogene 
serine/threonine-protein 
kinase, RAF1 
2.7.11.1   
P05412 
Transcription factor AP-
1, JUN 
-   
O96013 
Serine/threonine-protein 
kinase PAK 4, PAK4 
2.7.11.1   
P10398 
Serine/threonine-protein 
kinase A-Raf, ARAF 
2.7.11.1   
Q13177 
Serine/threonine-protein 
kinase PAK 2, PAK2 
2.7.11.1   
P15056 
Serine/threonine-protein 
kinase B-raf, BRAF 
2.7.11.1   
Vascular smooth 
muscle contraction 
P04049 
RAF proto-oncogene 
serine/threonine-protein 
kinase, RAF1 
2.7.11.1   
Q14573 
Inositol 1,4,5-
trisphosphate receptor 
type 3, ITPR3 
-   
Q15746 
Myosin light chain 
kinase, smooth muscle, 
MYLK 
2.7.11.18   
Q05682 Caldesmon, CALD1 -   
P10398 
Serine/threonine-protein 
kinase A-Raf, ARAF 
2.7.11.1   
P17612 
cAMP-dependent protein 
kinase catalytic subunit 
alpha, PRKACA 
2.7.11.11   
O14974 
Protein phosphatase 1 
regulatory subunit 12A, 
PPP1R12A 
-   
Q9Y6F6 Protein MRVI1, MRVI1 -   
P15056 
Serine/threonine-protein 
kinase B-raf, BRAF 
2.7.11.1   
*Enzyme Commission number 
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4.3.8.1. Mammalian target of rapamycin (mTOR) signalling pathway 
mTOR signalling pathway  is one of the pathways that only enriched in T. 
gondii infection. Among the phosphoproteins identified (shown in Table 4.6), three 
are playing roles in the regulation of the core pathway (AMPK1, PDK1, and TSC2) 
while the other three (EIF4EBP1, RPS6 and EIF4B) are substrates for the core 
pathway (Figure 4.6). However, only the last three molecules (EIF4EBP1, RPS6 and 
EIF4B) have been found phosphorylated in N. caninum infection as well.  
 
 
Figure 4.6: mTOR signalling pathway of host cell. Enriched phosphopeptides coverage from host cell 
infected at 20 hr p.i. with T. gondii and N. caninum. Red rectangle box: phosphopeptides 
phosphorylated only in T. gondii infection. Yellow rectangle box: phosphopeptides phosphorylated in 
T. gondii and N. caninum infection. Pathway is available online on the KEGG pathway site 
(http://www.genome.jp/kegg/pathway.html).  
 
4.3.8.2. Glycolysis/gluconeogenesis pathway 
Pathway analysis showed that more phosphopeptides from HFF cells infected 
with T. gondii were enriched (Table 4.6) in the Glycolysis/gluconeogenesis pathway 
than N. caninum infection at 20 hr p.i. (Figure 4.7). 
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Figure 4.7: Metabolic pathway coverage: Glycolysis and gluconeogenesis. The enriched 
phosphopeptides from HFF cells infected by both parasites at 20 hr p.i. Red rectangle box: 
phosphopeptides phosphorylated only in T. gondii infection. Pathway is available online on the KEGG 
pathway site (http://www.genome.jp/kegg/pathway.html). 
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4.3.9. Phosphopeptides quantification from host cell infected with T. gondii 
and N. caninum 
In total, 6565 peptides were quantified in TiO2 enrichment of T. gondii and N. 
caninum infections, where 2540 of them were phosphopeptides (Figure 4.8a). When 
comparing between the two infections, only 397 phosphopeptides were statistically 
significant (p < 0.05) (Figure 4.8b). A total of 95 unique phosphopeptides have 
showed a fold change of ≥ 1.5 between the two infections (Appendix Table IV). In 
total, 57 out of 95 phosphopeptides have higher expressions in T. gondii infection 
and the remaining 38 have higher expressions in N. caninum (Figure 4.8c, appendix 
Table IV). Phosphoproteins with high fold changes were observed in T. gondii 
infection that play critical role in cellular process involved in protein 
productions/translation such as eukaryotic translation initiation factor 4B (EIF4B) 
and 60S acidic ribosomal protein P1. The EIF4B was increased 26 times in infected 
cells with T. gondii than N. caninum. In addition, phosphoproteins with high fold 
change involved in glycolysis were found in infection with both parasites; 
triosephosphate isomerase was found in infection with T. gondii while 
glyceraldehyde-3-phosphate dehydrogenase with N. caninum infection. 
 
 
Figure 4.8: Peptides and phosphopeptides enriched from HFF cells infected with T. gondii and N. 
caninum at 20 hr p.i. a: total number of quantified peptides and phosphopeptides, b: Total number of 
significant phosphopeptides with p value < 0.05 and c: Phosphopeptides with fold change (FC) ≥ 1.5.  
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4.3.10. Upstream regulator analysis of quantified phosphopeptides from host 
cell infected with T. gondii and N. caninum 
 The quantified phosphopeptides were found regulated by different molecules 
that play vital role in normal cellular physiology. The upstream regulator analyses 
showed that kinases were distributed similarly between both infections. In addition, 
transcriptional regulator and enzymes were among the most regulated molecules 
enriched from infection with T. gondii and N. caninum as shown in Figure 4.9 and 
Appendix Table V and VI.  
 
 
Figure 4.9: Upstream analysis of quantified phosphoproteins. Types of upstream regulator of 
phosphoproteins quantified from host cell infected by A: T. gondii and B: N. caninum.  
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4.4. DISCUSSION 
To date there are no large scale host cell phosphoproteome studies in 
response to infection with T. gondii and N. caninum. In the present study, the 
differences in host cell phosphoproteome indicate that these parasites interact with 
the host cells variably at the phosphoprotein and signal transduction level. Thus, 
diverse host cell responses of the signalling pathways are potentially responsible for 
the differences in the biology of these parasites. Enriched phosphoproteomes from 
host cell infected by T. gondii and N. caninum showed similarity of 61.30 % and 
67.54 %, respectively (Figure 4.2a), where only about one-third of the 
phosphoproteome was different. In addition, phosphorylation sites and motif analysis 
from significantly enriched phosphopeptides showed high similarity as well. 
However, four different motifs were found differentially enriched between infection 
with T. gondii and with N. caninum, which is equal to 21.05 %. Furthermore, 
pathway analysis showed that a few pathways were differentially enriched between 
infections with these parasites such as glycolysis/gluconeogenesis and mTOR 
signalling pathway in infection with T. gondii but not N. caninum. Moreover, similar 
profiles were also found in subcellular location and types of phosphoproteins 
identified. The general similarity in host response to these parasites could be related 
to the fact that the genomes and gene expression of the two parasites are remarkably 
preserved (Reid et al., 2012). However, small differences could result in great 
differences in host-parasites interaction, e.g. pseudogenisation of NcROP18 in N. 
caninum failed to phosphorylate immunity-related GTPases (IRGs) of the host cell 
that is necessary for protection of PVM from destruction in IFNγ-induced cells (Lei 
et al., 2014; Reid et al., 2012).  
4.4.1. HFF cell intensively responds to infection with T. gondii and N. 
caninum through protein phosphorylation 
The number of phosphoproteins and phosphorylation sites identified were 
approximately two times higher in infected HFF cells compared to uninfected cells in 
the mock infections (Figure 4.2b and c, Table 4.3). These results suggested that 
infection with T. gondii and N. caninum actively transduce signals to induce protein 
phosphorylation of the host cells which modulates host response and adaptation to 
intracellular environment during infection. In addition, the enrichment of 
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phosphopeptides from infected HFF cell and mock infections showed similar 
enrichment fold which indicated an unbiased sampling. The results from this study 
corroborates the results of a previous study on host response to T. gondii infection at 
different time point; this indicated that protein phosphorylation was actively involved 
in the modulation of host response (Nelson et al., 2008). In addition, the distribution 
of types and subcellular localisation (Figure 4.4, 4.5) of identified phosphoproteins 
from infected host cells showed similar response to infection with these parasites. 
Furthermore, protein phosphomotifs analysis revealed that these motifs were 
phosphorylated by similar groups of kinases and potentially involved in the same 
cellular signalling pathways. Also, upstream analysis regulator of the quantified 
phosphoproteins showed that they are regulated mostly by kinases, transcriptional 
regulator and enzymes. However, transcriptional regulator and enzymes were highly 
processes in N. caninum infection than T. gondii (Figure 4.9), suggesting that they 
play different roles in response to infection with these parasites. These results 
suggest that T. gondii and N. caninum intensively phosphorylate and modulate host 
cells and that host cell protein phosphorylations in response to infection with these 
parasites are generally conserved. However, by using pathway enrichment analysis 
coupled with quantitative data, it was possible to decipher some interesting 
differences in host responses following infection with both parasites. 
4.4.2. Pathway analysis of HFF cells infected with  T. gondii and N. caninum  
Pathway analyses showed that ten and 12 pathways were enriched for HFF 
cells infected with T. gondii and N. caninum, respectively. 
4.4.2.1. mTOR signalling pathway is a key regulatory metabolic pathway of 
host cell regulated differently in T. gondii and N. caninum infections 
Mammalian target of rapamycin (mTOR) is a Ser/Thr kinase playing axial 
contribution in integrating the responses arising from certain conditions such as 
growth factor signalling, energy stress, nutritional prestige, oxygen tension and 
regulation of cellular physiology and metabolic processes (Hay and Sonenberg, 
2004; Tsalikis et al., 2013; Wullschleger et al., 2006).  
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4.4.2.1.1. Phosphorylation of downstream substrate of mTOR signalling 
pathway in T. gondii and N. caninum infection 
Differential phosphorylation of substrates in mTOR signalling pathway 
indicated that host cells infected by T. gondii and N. caninum exploit mTOR pathway 
for selective translation of certain mRNA that are important in translational 
machinery such as ribosomal protein and elongation factors (Bahrami et al., 2014). 
Activation of mTOR could ensure continuous synthesis of proteins and enzymes 
required by rapidly growing and dividing tachyzoites. The result of this study is in 
agreement with Wang et al. (2009), which reported the activation of mTOR 
signalling pathway in different cell types such as HFF cells, HeLa cells and murine 
peritoneal exudate macrophages in response to infection with T. gondii. In this study, 
E4-BP1 and S6K substrates (S6 and eIF4B) but not S6K1 were also found in HFF 
cells infected with N. caninum showing similarity in signalling transduction using 
mTOR pathway. However, quantitative data showed that eIF4B was enriched 26 
times more in infection with T. gondii than N. caninum. In the present study S6K1 
was not identified to be phosphorylated in infection with both parasites at 20 hr p.i. 
which is comparable to the results of Wang et al. (2009) that found S6K1 
phosphorylated for short time following infection at 2-4 hr p.i. Phosphorylation of 
eIF4B and S6 but not S6K1 from HFF cells infected with T. gondii and N. caninum 
imply that these parasites may have the capability to selectively regulate downstream 
substrates regardless of the canonical activation of mTOR signalling pathway.  
4.4.2.1.2. Phosphorylation of upstream substrate of mTOR signalling 
pathway in T. gondii infection 
The PI3K/AKT pathway is an upstream regulator and activator of mTOR 
signalling pathway, which is activated  in response to growth factors and hormones 
(Laplante and Sabatini, 2012; Petroulakis et al., 2006). The growth factors and 
hormones activates class I phosphatidylinositol 3-kinase (PI3K) which further leads 
to phosphorylation (and activation) of PDK1 and AKT with subsequent 
phosphorylation and inactivation of tuberin (TSC2). Inactivation of TSC2 leads to 
the activation of Rheb which in turn activates the mTOR signalling pathway (Bai et 
al., 2007; Li et al., 2004; Shahbazian et al., 2010). In the present study, PDK1, TSC2 
and AMPK) were all shown to be phosphorylated during T. gondii infection but not 
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in N. caninum, suggesting that PDK1 and TSC2 were selectively activated in the host 
cell infected by T. gondii.  The PDK1 and TSC2 were, however, found to be 
phosphorylated in T. gondii infected host cells, but not in uninfected cells, indicating 
that mTOR signalling pathway was activated upon infection. The results presented 
here are comparable with that of Wang et al. (2009) as the latter authors have not 
observed AKT phosphorylation in response to T. gondii infection as shown in our 
study. Also, they found that AKT were not associated with Toxoplasma-induced 
activation of mTOR and did not find it to be activated in HFF, 3T3 and HeLa cells. 
They suggested that AKT activity is not related to the stimulation of mTOR activity 
in response to infection with T. gondii (Wang et al., 2009). Results of the present 
study suggest that PDK1 activation may lead to phosphorylation of TSC2 
independent of AKT activation possibly through other mediators or through kinase-
like proteins of parasite origin.  
In the present study, AMPK was also found phosphorylated during infection 
with T. gondii. AMPK activation is related to the inhibition of mTOR signalling 
pathway (Inoki et al., 2003; Zoncu et al., 2011), as well as the regulation of  
metabolic processes and cellular maintenance (Sanli et al., 2014), stress resistance, 
apoptosis and glucose metabolism (Greer et al., 2007). In the present study, AMPK 
activation could be related to the regulation of transcription factors associated with 
stress but not with inhibition of mTOR due to the fact that pathways associated with 
energy and protein productions were activated. This finding indicates that HFF cells 
exhibited more stressful response of T. gondii infection than that of N. caninum.  
Together, results associated with mTOR signalling pathway suggested that T. 
gondii and N. caninum potentially phosphorylate host mTOR substrates in a parasite-
dependent manner. However, T. gondii seems to interact and manipulate more host 
cells substrates than N. caninum infection and induces more host cell response at this 
time point. 
4.4.2.2. Glycolysis/gluconeogenesis is highly regulated in HFF cells infected 
with T. gondii   
Once infection is established, growing and dividing parasites must obtain 
necessary nutrients from the infected host cells. T. gondii controls the permeability of 
Chapter Four 
136 
 
PVM that selectively allows small molecules to diffuse freely from host cytoplasm to 
PV such as amino acids, sugar, nucleobases and cofactors (Schwab et al., 1994). 
Cholesterol is also transferred from host to PV exploiting host endo-lysosomal 
system (Coppens et al., 2006; Coppens et al., 2000). 
 In this study, pathway analysis showed that phosphoproteins of HFF cells 
infected with T. gondii involved in more metabolic processes than N. caninum (Table 
4.6). In addition, quantified phosphopeptides were also highly up-regulated in host 
cell infected with T. gondii than with N. caninum (Table 4.9, appendix Table IV). 
Previous study showed that host cell molecules involved in metabolism were highly 
modulated in response to T. gondii infection (Nelson et al., 2008). In this study, 
seven phosphoproteins identified were assigned to glycolysis/gluconeogenesis 
pathway in T. gondii infection, while only three of them were identified in N. 
caninum infection. The enzymes identified in this study catalyse most of the 
reactions involved in glycolysis/gluconeogenesis. In addition, acetyl-coA synthase 
was also phosphorylated which catalyses the formation of acetyl-coA (the citric acid 
cycle substrate). This result may indicate that host cell intensively responded to high 
energy demand of T. gondii through glycolysis and potentially activation of oxidative 
phosphorylation to generate more energy.  
High energy production is required to fulfil the demand of fast growing and 
multiplying tachyzoites; these processes are critically involved in the expenditure of 
cellular energy (Sanli et al., 2014). This is supported by the study of Weilhammer et 
al. (2012), which demonstrated that induction of glycolysis by adding glucose or 
inducing expression of AKT gene was found responsible for converting permissive 
cell (cell that allow conversion of tachyzoites to bradyzoites stage) to resistance 
phenotypes and continuous multiplication of tachyzoites. In addition they showed 
that glycolytic metabolite such as lactate to play important roles in inhibition of 
conversion of tachyzoites to bradyzoites in permissive cells (Weilhammer et al., 
2012). This study showed that the activation of the glycolysis pathway and energy 
productions under aerobic condition, which provided complementary evidence to the 
results of microarray study from Blader et al. (2001), which reported that 
Toxoplasma-stimulated transcripts of host cell were up-regulated in anaerobic 
glycolysis. In addition, modification of the seven enzymes involved in the glycolysis 
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indicates up-regulation of this pathway during infection with T. gondii, a result that is 
in agreement with previous proteomic and transcriptomics studies of HFF cells 
infected with T. gondii (Blader et al., 2001; Nelson et al., 2008). The modulation of 
phosphoproteins involved in glycolysis/gluconeogenesis suggests global regulation 
of host cell metabolism during infection with T. gondii more than that induced by N. 
caninum at 20 hr p.i.  
4.4.2.3. Host cells expend high energy during infection with T. gondii than N. 
caninum could be related to virulence differences and transmission 
route 
In this study, the enrichment of phosphoproteins involved in mTOR pathway, 
glycolysis pathway and insulin pathway together (Table 4.6) indicated that high 
energy and proteins production are required for biogenesis and rapidly dividing 
tachyzoites in T. gondii infection comparing to N. caninum. This may reflect the 
urgent needs for T. gondii to rapidly multiply enough before the egress. High energy 
expenditure in cell infected with T. gondii potentially determines virulence through 
modulation of host cells metabolic processes to support tachyzoites replication and 
early egression. These processes consequently lead to cell death and re-invasion of 
new neighbouring cells (Hoff and Carruthers, 2002). In addition, high production of 
energy by the parasite might also determine the virulence of T. gondii in host cells 
compared to N. caninum. Song et al. (2013) showed that type I strain (RH) up 
regulate some metabolic pathways involved in ATP production such as pyrimidine 
biosynthesis, the TCA cycle and pentose phosphate shunt more than the type II strain 
(Me49) which could be account for the virulence differences between both stains. 
The higher energy productivity of host cell during infection with T. gondii than N. 
caninum potentially related to the virulence and transmission strategy of these 
parasites. 
4.4.2.4. ErbB signalling pathway enriched in N. caninum infection may be 
associated with transmission route of N. caninum 
ErbB signalling pathway plays important roles in normal physiology of cells 
and in cancer (Hynes and MacDonald, 2009). This pathway is activated through four 
members of ErbB family of receptor tyrosine kinases (RTKs) including epidermal 
growth factor receptor (EGFR or ErbB1), ErbB2, ErbB3, and ErbB4 in response to 
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different  members of the epidermal growth factor family (EGF-family) of peptides 
(Hynes and MacDonald, 2009). In this study, the downstream substrate of the ErbB2, 
3, 4 and EGFR receptor were found phosphorylated. These substrates link RTKs to 
different intracellular signalling pathways necessary for maintenance of cellular 
physiology such as proliferation, cell migration, metabolism and survival (Citri and 
Yarden, 2006; Hynes and Lane, 2005). In addition, ErbB2 and EGFR have been 
implicated in the development of many types of human cancer (Graus-Porta et al., 
1997) through activation of mitogen-activated protein kinase (MAPK), 
phosphoinositide kinase (PI3K)/AKT, mTOR pathways, proto-oncogene tyrosine-
protein kinase (Src kinase) and STAT transcription factors (Egan and Weinberg, 
1993; Ming et al., 1994; Sharma and Settleman, 2009; Wieduwilt and Moasser, 
2008; Yarden and Sliwkowski, 2001). The greater activation of these pathways in 
host cell infected by N. caninum than T. gondii may not be directly related to cancer 
as there is no evidence that relates N. caninum to the cause of cancer in animals. 
However, these pathways could indicate intimate host-parasite interaction to assure 
that host cell growth is maintained long enough during infection with minimum 
exposure to the immune system of the host and apoptosis. Upstream analysis of the 
quantified phosphoproteins indicates that different kinases such as MAPKs are 
involved in the phosphorylation of the proteins important for cell survival or death 
(appendix Table V and VI). Many pathogens modulate the PI3K/AKT survival 
pathway of the host cell which is primarily associated with activation of 
antiapoptotic pathways that assure safe place for the pathogens within the host cells 
(Carter, 2009). Maintenance of the infected host cell by N. caninum could be also 
related to the transmission route through converting tachyzoites to bradyzoites; this 
process is necessary to maintain the vertical transmission route and allows 
transmission from infected pregnant mother to subsequent generation. 
4.4.3. Conclusion 
To summarise, comparative host-parasite interaction has been studied on the 
host protein phosphorylation in response to infection with T. gondii and N. caninum. 
Despite the general similarities that have been identified, a few interesting 
differences were discovered from phosphorylation sites/ phosphomotifs distribution 
and quantitative analysis of differential regulations of signalling pathways. The 
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differences in host protein phosphorylation and modification of signalling pathways, 
e.g. glycolysis/gluconeogenesis and mTOR signalling pathway potentially associate 
with the differences in the biology of T. gondii and N. caninum. High modulation of 
glycolysis/gluconeogenesis and mTOR signalling pathway during T. gondii infection 
is potentially more associated with the differences in virulence and transmission 
routes compared to infection with N. caninum. 
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Chapter FIVE: Comparative host cell response to infection with 
T. gondii and N. caninum using transcriptome, proteome and 
phosphoproteome 
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5.1. INTRODUCTION  
Genome, proteome and genome-wide post-translational modification analyses 
allow for the understanding of functional relationships between genes, mRNAs, 
proteins and their functional state in both physiological and pathological conditions 
such as in response to different pathogens. Genomic and transcriptomic analyses 
provide a global view of how a cell functions as a system in the regulation of gene 
expression (Komili and Silver, 2008). In addition, the study of genome-wide 
proteomics is essential for understanding the phenotype and system biology of 
cellular processes (Cox and Mann, 2011). Conventionally, analyses and attempts to 
understand different steps elaborated in the regulation of gene expression, RNA 
transcription-maturation, mRNA processing, nuclear export, translation and 
degradation were analysed separately; these analyses were based on using 
biochemical techniques which gave the impression that they function independently 
(Komili and Silver, 2008).  
Protein synthesis is the end product of gene expression; therefore, this 
suggests that there is a positive correlation between mRNA expression and high 
protein synthesis. Despite that fact, a number of studies have shown poor correlations 
between mRNA expression and high protein synthesis. A correlation of 
approximately 40 % between mRNA expression and protein abundance was reported 
(De Sousa Abreu et al., 2009; Maier et al., 2009). Furthermore, Shankavaram et al. 
(2007) performed a comparative study of cancer cell transcripts and proteins 
expression profiling and reported that 65 % of the transcripts and proteins were 
significantly correlated. Likewise, Lu et al. (2007) demonstrated that the correlation 
between protein abundance and mRNA expression in yeast cells was approximately 
73 %. These data suggest that protein abundance cannot be predicted based on 
mRNA expression alone and that post-transcriptional, translational and PTMs of 
protein should be considered (Jüschke et al., 2013; Nelson et al., 2008). A poor 
correlation between mRNA expression and protein level is attributed to three 
reasons; firstly the regulatory processes involved in the course of gene expression 
such as microRNAs (miRNAs) interactions, miRNAs is another large family of small 
RNA of 21-25 nucleotides), secondly due to PTMs of protein resulting in altered 
half-life of involved proteins, and thirdly the detection method used (Perco et al., 
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2010). Therefore, it is important to use quantitative systems biology approaches to 
understand all the processes contributing to gene expression (Jüschke et al., 2013).  
5.1.1. Gene regulation of host cell in a host-pathogen interaction system 
Gene expression is regulated by several different methods in a signalling-
dependent manner from internal or external stimuli. Genes are transcribed to 
different types of RNAs that are modified post-transcriptionally to produce different 
functional RNAs by alternative splicing. Genes expression in eukaryotes are 
controlled both at the gene transcription level and post-translational stages (Figure 
5.1) including pre-mRNA splicing and mRNA transport, mRNA translation, mRNA 
decay (Arraiano and Maquat, 2003) and protein degradation (Jovanovic et al., 2015). 
Messenger RNA is the most abundant RNA that translates to proteins while miRNAs 
play a role as negative regulator of gene expression through translational repression 
and mRNA cleavage, cancer development and probably involved in regulation of 
different part of cellular processes, as reviewed in (He and Hannon, 2004; Su et al., 
2014; Tie and Fan, 2011). Post-transcriptional regulation of gene expression by small 
RNAs may be partly responsible for the low correlation reported between transcripts 
and protein abundance (Ghazalpour et al., 2011; Vogel and Marcotte, 2012) and 
reducing the predictive efficiency of protein expression based on transcripts (Jüschke 
et al., 2013).  
Quantitative analysis of posttranscriptional and translational data are crucial 
for better understanding of genetic information (Vogel and Marcotte, 2012). Post 
translational regulation of genes is determined by several factors such as protein 
modifications and degradation. These modifications determine the status of protein; 
protein turnover is one of the consequences of these modification (Mann and Jensen, 
2003). Degradation of protein is another way that allows proteome of a cell to 
remodel continuously and especially in response to pathogens (Jovanovic et al., 
2015). Pathogens play role as external stimuli through secretion of an array of 
molecules on/into the cells leading to host cell perturbation and re-programming of 
host cell genes necessary for evading host immunity, nutritional acquisition and 
proliferation (Bougdour et al., 2013; Braun et al., 2013; Butcher et al., 2011). 
Studying host response to infection is critical for understanding the molecular 
mechanism involved in host-parasite interaction. Studies of integrated systems 
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biology such as transcriptomics, proteomics and phosphoproteomics of host cell in 
response to infection with pathogens could be very important to highlight 
mechanisms underlying infections. 
 
 
Figure 5.1: Schematic representation of gene regulation in eukaryotes.  
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5.1.2. Analysis of transcriptome and proteome of host cells in response to 
pathogens 
 Transcriptional profiling has been studied in host cells in response to 
infection with different pathogens. Different pathogens release different arrays of 
molecules that are associated with host-pathogen interactions. Microarray profiling 
of host cell in response to T. gondii infection has revealed several unknown 
modulation such as up-regulation of the abundance of transcripts related to immune 
response and modulation of genes involved in important cellular processes such as 
metabolism and apoptosis (Blader et al., 2001). In addition, microarray analysis of 
host immune cells such as macrophages and dendritic cells reveals distinct 
differences in the regulation of genes in response to different pathogens such as 
intracellular T. gondii, Leishmania and Mycobacterium and extracellular nematode 
Brugia malayi (Chaussabel et al., 2003). RNA sequencing of mice forebrains in 
response to infection with T. gondii revealed that the majority of the overexpressed 
transcripts in acute and chronic infections were associated with transcription and 
translation processes (Pittman et al., 2014). Furthermore, they found that in response 
to chronic infection, host cells up-regulate transcripts associated with immunity twice 
more than acute infection. These studies indicate that host cells are remodelled in 
response to infection leading to modulation of host gene regulation, suggesting that 
RNA analysis is important to study global gene regulation in response to different 
pathogens. 
 Proteomics data analysis is considered a perfect complementary set of 
transcriptomics analysis of any cell at a given time (Walduck et al., 2004). Genome 
wide proteome study of host cell in response to infection revealed that host cell 
proteome is extensively remodelled by pathogens. In response to T. gondii, 
quantitative 2D SDS-PAGE of infected host cell proteome showed that it was 
consistently changed and the proteins involved in important biological processes 
were significantly modulated such as glucose, lipid and cholesterol metabolism, 
mitosis and apoptosis (Nelson et al., 2008). In response to bacterial infection such as 
Salmonella enterica Typhimurium, quantitative proteomic analysis of infected 
macrophages using mass spectrometry found that the quantified proteins played roles 
in diverse biological processes implying that they cause global responses (Shi et al., 
2009). In addition, in response to intracellular bacteria such as Mycobacterium 
Chapter Five 
145 
 
tuberculosis lipids, quantitative proteomics showed that host proteins involved in 
innate immune system and lipids metabolic processes were highly up regulated (Shui 
et al., 2009). However, it is found that protein expression cannot be predicted based 
on transcripts alone because PTMs of protein and Post-transcriptional regulation of 
mRNA should also be considered (Jüschke et al., 2013; Nelson et al., 2008; Yang et 
al., 2015). Recent study of host response to pathogens showed that there is direct 
relationship between mRNA abundance and protein expression following infection 
and that the fate of the pre-exited proteins is controlled by protein production and 
proteolysis (Jovanovic et al., 2015). These studies are inferring that individual 
analysis of omics is compromised by the fact that none of the analysis produces 
system wide information about host response to infection. Thus, to understand global 
response of host cell to infection and how different omics respond relative to each 
other in response to pathogens; analyses of transcriptome, proteome and 
phosphoproteome simultaneously provide complementary integrative information at 
the system level.  
5.1.3. Aims and objectives of the study: 
Despite close similarity at the genomic and transcriptomic level between the 
two parasites, there are interesting differences in the host response to infection with 
T. gondii and N. caninum. The mechanism of these differences is not known which 
makes studying the comparative host response on a system biology level a valuable 
approach to decipher the differences. The present study is aimed to compare host cell 
responses to infection with T. gondii and N. caninum at an integrated transcriptomic, 
proteomic and phosphoproteomic level.  
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5.2. MATERIAL AND METHODS 
5.2.1. Host data collection  
Integrated system biology analysis was carried out for HFF cell gene 
regulation in response to infection with T. gondii and N. caninum at 36 hr p.i. 
Transcriptomic and proteomic expression data of host cell were downloaded from 
HostDB version2.2 (http://beta.hostdb.org/hostdb.b23/getDataset.do?display=detail). 
Data were generated by Professor Wastling’s group at the University of Liverpool 
and hosted on HostDB. Only a single (averaged) expression value for each mRNA 
and protein is available on HostDB. To improve statistical power in data analysis, 
triplicate of host cell proteomes data were provided by Dr Dong Xia, University of 
Liverpool. Phosphoproteome data used in this chapter were generated in chapter 4. 
5.2.2. Time point infection and data generation 
According to HostDB, T. gondii and N. caninum were initially cultured in 
Vero cells before being used for infection of HFF cells. Confluent monolayer of HFF 
cells were infected with 1 × 10
7 
tachyzoites of T. gondii and N. caninum and allowed 
to grow for 36 hr p.i. Infected HFF cells were collected using a cell scraper. 
Transcripts and proteins were prepared from infected HFF cells at 36 hr p.i. 
and mRNA data were generated using RNA sequencing and individual value for 
each transcripts was provided in RPKM (Reads Per Kilobase per Million) which is a 
quantitative approximations of the abundance of target transcripts. Protein data were 
generated using LC-MS/MS following trypsin digestion and individual values were 
measured in iBAQ (Intensity Based Absolute Quantification). Generated spectra 
from LC-MS/MS were searched using Mascot version 2.3 against human protein 
reference sequence database (UniProt, May 2013). 
Quantitative phosphoproteome data were generated as described in chapter 4. 
The time point of transcriptome and proteome of host cells in response to 
infection at 36 hr p.i. and phosphoproteome at 20 hr p.i were chosen based on the 
same biological conditions where tachyzoites were just about to egress in the culture. 
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Transcriptomics data were filtered to remove transcripts with zero value. The 
transcripts of host cell infected with T. gondii and N. caninum were matched and to 
avoid ambiguity, only matched transcripts that had unique IDs (one gene expressed 
to one transcript) was selected and used in the analysis.  
Proteome of host cells infected with T. gondii and N. caninum were matched 
and only matched host proteins were selected for analysis.  
5.2.3. Quantitative data analysis of host cell in response to infection with T. 
gondii and N. caninum  
Matched transcripts and proteins of T. gondii and N. caninum were 
normalised separately using online software Normalyzer (Chawade et al., 2014). 
Because of the availability of only one replicate of host transcripts, an artificial 
replicate was generated where individual values of each individual transcripts of 
original replicate were multiplied by 1.2. Artificial replicates were generated because 
of the software requirement of at least two replicates from each condition to be 
processes for normalisation. Following normalisation, the normalisation method with 
low intra group variation was selected. 
Following normalisation, transcripts and proteins were matched based on 
overlapping IDs. Only matched IDs were used for quantitative analysis of transcripts 
and proteins in response to infection with T. gondii and N. caninum. 
Fold change (FC) of transcripts and proteins in host cell infected with T. 
gondii to N. caninum was calculated and a cut-offs of ≥ 2 FC or < 2 FC were applied 
to determine significantly increase or decrease in expression, respectively. The IDs 
that matched the cut-off applied were analysed in DAVID Bioinformatics Resources 
version 6.7 (Huang et al., 2008) for enrichment of biological process in gene 
ontology (GOTERM_BP_FAT) enrichment.  
Quantified protein data were visualised by scatter (volcano) plot using 
Minitab software version 17 (Minitab Inc. 2010) to identify the changes in host cell 
proteins in response to both infection.   
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5.3. RESULTS 
5.3.1. Normalised data from transcriptome and proteome of host cell in 
response to T. gondii and N. caninum infection 
Transcriptome and proteome from host cell infected with T. gondii and N. 
caninum were normalised to reduce biases introduced during sample processing and 
data generation. Figure 5.2 shows normalised data from host proteome in response to 
infection with T. gondii and N. caninum. Normalised VSN-G (Variance stabilising 
normalisation) shows lowest intragroup variation of PMAD (pooled intragroup 
median absolute deviation) which is equal to 49 % compared to Log2 of un-
normalised data which is considered as 100 %. Based on the Normalyzer, lower 
PMAD value compared to Log2 of un-normalised data suggests better normalization. 
Although VSG-R has a lower PMAD value, VSN-G was still selected because this 
method is based on global normalization of the compared groups rather than 
intragroup normalisation methods separately e.g. VSG-R.  
 
 
Figure 5.2: Normalisation of proteome of hot cell in response to infection with T. gondii and N. 
caninum at 36 hr p.i. Log2 of PMAD in un-normalised data is considered as 100 %. PMAD: pooled 
intragroup median absolute deviation. Normalyzer software use several common normalization 
methods such as LOESS (limma package), Robust Linear Regression (RLR), Variance Stabilizing 
Normalization (VSN, vsn package), total intensity (TI), median intensity (MedI), average intensity 
(AI), NormFinder (NF) and quantile (preprocessCore package). The methods used global 
normalization methods (referred to as ‘G’), while those used intragroup normalisation methods 
separately (referred to as ‘R’). 
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5.3.2. Total number of transcripts and proteins identified from analysis of 
host cell infected with T. gondii and N. caninum at 36 hr p.i. 
After excluding zero values, total number of quantified transcripts in T. 
gondii and N. caninum infected host cells was 23635 and 10311, respectively as 
shown in Figure 5.3a. The differences in the number of transcripts of T. gondii and 
N. caninum might have caused by the differences in the cut-off threshold applied for 
separation of expressed RNA sequence from background noise. In total, 10305 host 
transcripts were matched between both infections. However, only the genes that had 
unique transcript were included in this analysis which comprised of 4485 gene IDs. 
On the other hand, total number of protein quantified from both conditions at the 
same time point was 926 and 1318 and out of these, 808 host proteins were matched 
between both infections as shown in Figure 5.3b. There are 403 genes that were 
matched between transcriptomics and proteomics data which is shown in Figure 5.4. 
 
 
Figure 5.3: Total number of identified transcripts and proteins from host cell infected with T. gondii 
and N. caninum at 16 hr p.i. a: total number of transcripts and overlap of one gene to one transcript 
between infection with T. gondii and N. caninum. b: total number of proteins and overlap between 
infection with T. gondii and N. caninum. 
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Figure 5.4: Total number of overlapped transcripts and proteins from host cell infected with T. gondii 
and N. caninum at 16 hr p.i. 
 
5.3.3. Functional analysis of the transcripts and proteins between host cells 
infected with T. gondii and N. caninum 
5.3.3.1. Overlapped transcripts in response to infection with T. gondii and N. 
caninum 
The overlapped 403 gene IDs from transcripts of host cell infected with T. 
gondii and N. caninum were analysed for enriched biological processes (BP) using 
DAVID tool. Based on the fold change (FC) value of the analysed transcripts of T. 
gondii to N. caninum infections, the 403 transcripts were divided into three groups; 
host transcripts with greater than two folds expression in T. gondii infection than in 
N. caninum infection, host transcripts with greater than two folds expression in N. 
caninum infection and transcripts that do not exhibit significant expression changes 
(≥ - 2 and ≤ + 2) between the two infections. 100 (25 %) transcripts were highly 
expressed in T. gondii infection while 22 (5 %) transcripts were found highly 
expressed in N. caninum infection (Figure 5.5). The high similarity of 70 % (281 
transcripts) of the expressed host transcripts indicates a generally similar host 
response upon infection of the two parasites. 
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Figure 5.5: Total number of transcripts of host cell infected with T. gondii and N. caninum. 
Transcripts divided based on the cut-off applied, host transcripts with greater than two folds 
expression in T. gondii infection than in N. caninum infection, host transcripts with greater than two 
folds expression in N. caninum infection and transcripts that do not exhibit significant expression 
changes (≥ - 2 and ≤ + 2) between the two infections. 
 
5.3.3.1.1. Biological processes enriched from host transcripts significantly 
overexpressed in N. caninum infection 
Enriched biological processes were analysed using DAVID tool for host 
transcripts that significantly overexpressed in N. caninum infection. Figure 5.6 shows 
the biological processes with enrichment fold, while Table 5.1 shows the host 
transcripts associated with each BP and Appendix Table VII shows the detailed 
information about each BP enriched. BPs enriched for these transcripts are mostly 
associated with negative regulation of cellular protein metabolic process and protein 
catabolic process. In addition, transcripts associated with positive regulation of 
inflammatory response to pathogen were also enriched in N. caninum infection. T. 
gondii type I and III strains were found to negatively regulate inflammatory response 
of the host cells mediated by cytokine IL-12 (Ong et al., 2010; Saeij et al., 2007; 
Yamamoto et al., 2009).    
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Figure 5.6: Biological processes enriched for host transcripts significantly overexpressed in N. 
caninum infection 
 
Table 5.1: Biological processes enriched from host transcripts significantly 
overexpressed in N. caninum infection.  
Biological processes Gene IDs Protein name  
Negative regulation of 
cellular protein metabolic 
process 
P43686 26S protease regulatory subunit 6B, PSMC4 
P17980 26S protease regulatory subunit 6A, PSMC3 
P38919 Eukaryotic initiation factor 4A-III, EIF4A3 
P01023 Alpha-2-macroglobulin, A2M 
Q16531 DNA damage-binding protein 1, DDB1 
Positive regulation of 
protein metabolic process 
P43686 26S protease regulatory subunit 6B, PSMC4 
P17980 26S protease regulatory subunit 6A, PSMC3 
P60033 CD81 antigen, CD81 
Positive regulation of acute 
inflammatory response and 
immune responses 
P30443 
HLA class I histocompatibility antigen, A-1 alpha chain, 
HLA-A 
Q86WV6 Stimulator of interferon genes protein, TMEM173 
Q01628 Interferon-induced transmembrane protein 3, IFITM3 
P01024 Complement C3, C3 
P02794 Ferritin heavy chain, FTH1 
P01023 Alpha-2-macroglobulin, A2M 
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5.3.3.1.2. Biological processes enriched from host transcripts significantly 
overexpressed in T. gondii infection 
The enriched biological processes from host transcripts significantly 
overexpressed in T. gondii infection were also analysed in DAVID tool. Figure 5.7 
shows the biological processes with enrichment fold, while Table 5.2 shows the host 
transcripts associated with each BP and Appendix Table VIII shows the detailed 
information about each BP enriched. Almost all the biological processes enriched 
associate with protein production which indicates that infected host cell is in high 
demand to build up more protein during infection with T. gondii than in N. caninum. 
The top ten biological processes enriched (Figure 5.7) associates with RNA 
processing, translation, PTM of protein, intracellular protein transport and protein 
targeting. In addition, molecules associated with anti-apoptosis were highly enriched 
in T. gondii infection; suggesting that it reprograms host cell to maintain infection 
long enough before egress. 
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Figure 5.7: Biological processes based on pvalue enriched from DAVID tool for host transcripts 
significantly overexpressed in T. gondii infection 
Chapter Five 
155 
 
Table 5.2: Biological processes enriched from host transcripts significantly 
overexpressed in T. gondii infection. 
Biological processes Gene IDs Protein name  
RNA processes 
Q9Y3F4 
Serine-threonine kinase receptor-associated protein, 
STRAP 
Q9Y2X3 Nucleolar protein 58, NOP58 
O75533 Splicing factor 3B subunit 1, SF3B1 
Q07955 Serine/arginine-rich splicing factor 1, SRSF1 
P11940 Polyadenylate-binding protein 1, PABPC1 
Q08170 Serine/arginine-rich splicing factor 4,  
P62906 60S ribosomal protein L10a, RPL10A 
Q9UQ80 Proliferation-associated protein 2G4, PA2G4 
P62995 Transformer-2 protein homolog beta, TRA2B 
Q6P2Q9 Pre-mRNA-processing-splicing factor 8, PRPF8 
Q00839 Heterogeneous nuclear ribonucleoprotein U, HNRNPU 
P38159 RNA-binding motif protein, X chromosome, RBMX 
Translation elongation 
P36578 60S ribosomal protein L4, RPL4 
P07814 Bifunctional glutamate/proline-tRNA ligase, EPRS 
P05387 60S acidic ribosomal protein P2, RPLP2 
P62750 60S ribosomal protein L23a, RPL23A 
P35268 60S ribosomal protein L22, RPL22 
P84098 60S ribosomal protein L19, RPL19 
P61247 40S ribosomal protein S3a, RPL3A 
P62906 60S ribosomal protein L10a, RPL10A 
Q02878 60S ribosomal protein L6, RPL6 
P62081 40S ribosomal protein S7, RPS7 
P62851 40S ribosomal protein S25, RPS25 
P41091 Eukaryotic translation initiation factor 2 subunit 3, EIF2S3 
Protein folding 
P11142 Heat shock cognate 71 kDa protein, HSPAB 
Q14554 Protein disulfide-isomerase A5, PDIA5 
P08238 Heat shock protein HSP 90-beta, HSP90AB1 
P14625 Endoplasmin, HSP90B1 
P78371 T-complex protein 1 subunit beta, CCT2 
P17987 T-complex protein 1 subunit alpha, TCP1 
P49257 Protein ERGIC-53, LMAN1 
P38646 Stress-70 protein, mitochondrial, HSPA9 
Glycosylation 
Q8TCJ2 
Dolichyl-diphosphooligosaccharide-protein 
glycosyltransferase subunit STT3B, STT3B 
P04843 
Dolichyl-diphosphooligosaccharide-protein 
glycosyltransferase subunit 1, RPN1 
Q9H0U3 Magnesium transporter protein 1, MAGT1 
P46977 
Dolichyl-diphosphooligosaccharide-protein 
glycosyltransferase subunit STT3A, STT3A 
Q16706 Alpha-mannosidase 2, MAN2A1 
Q16706 Alpha-mannosidase 2, MAN2A1 
Protein targeting and 
transporting 
P09936 
Ubiquitin carboxyl-terminal hydrolase isozyme 
L1,UCHL1 
Q01105 Protein SET, SET 
P53007 Tricarboxylate transport protein, mitochondrial, SLC25A1 
Q14974 Importin subunit beta-1, KPNB1 
P49257 Protein ERGIC-53, LMAN1 
Q9Y2X3 Nucleolar protein 58, NOP58 
P43307 Translocon-associated protein subunit alpha, SSR1 
P38646 Stress-70 protein, mitochondrial 
P09038 Fibroblast growth factor 2, FGF2 
P27348 14-3-3 protein theta, YWHAQ 
P11142 Heat shock cognate 71 kDa protein, HSPA8 
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P61106 Ras-related protein Rab-14, RAB14 
P62258 14-3-3 protein epsilon, YWHAE 
P62826 GTP-binding nuclear protein Ran, RAN 
Q00610 Clathrin heavy chain 1, CLTC 
P02452 Collagen alpha-1(I) chain, COL1A1 
Q9NP72 Ras-related protein Rab-18, RAB18 
P13667 Protein disulfide-isomerase A4, PDIA4 
P17301 Integrin alpha-2, ITGA2 
P14625 Endoplasmin, HSP90B1 
Cellular 
macromolecular 
complex assembly 
Q07955 Serine/arginine-rich splicing factor 1, SRSF1 
P0C0S5 Histone H2A.Z, H2AFZ 
P07814 Bifunctional glutamate/proline-tRNA ligase, EPRS 
Q14974 Importin subunit beta-1, KPNB1 
Q01105 Protein SET, SET 
P21980 Protein-glutamine gamma-glutamyltransferase 2, TGM2 
P17987 T-complex protein 1 subunit alpha, TCP1 
P07305 Histone H1.0, H1F0 
Q9NVA2 Septin-11, SEPT11 
Q9BUF5 Tubulin beta-6 chain, TUBB6 
Q5SSJ5 Heterochromatin protein 1-binding protein 3, HP1BP3 
Q16181 Septin-7, SEPT7 
Regulation of cellular 
protein metabolic 
processes 
P09038 Fibroblast growth factor 2, FGF2 
P48556 26S proteasome non-ATPase regulatory subunit 8, PSMD8 
O43242 26S proteasome non-ATPase regulatory subunit 3, PSMD3 
Q13200 26S proteasome non-ATPase regulatory subunit 2, PSMD2 
Q01105 Protein SET, SET 
P08238 Heat shock protein HSP 90-beta, HSP90AB1 
P17301 Integrin alpha-2, ITGA2 
P62258 14-3-3 protein epsilon, YWHAE 
Q9UQ80 Proliferation-associated protein 2G4, PA2G4 
P07996 Thrombospondin-1, THBS1 
P04792 Heat shock protein beta-1, HSPH1 
Anti-apoptosis 
P21980 Protein-glutamine gamma-glutamyltransferase 2, TGM2 
P14625 Endoplasmin, HSP90B1 
P09429 High mobility group protein B1, HMGB1 
P07996 Thrombospondin-1, THBS1 
P04792 Heat shock protein beta-1, HSPB1 
P38646 Stress-70 protein, mitochondrial, HSPA9 
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5.3.3.2. Overlapped proteome in response to infection with T. gondii and N. 
caninum 
The overlapped 403 proteins IDs from host cell infected with T. gondii and N. 
caninum were analysed for enriched biological processes using DAVID tool as 
performed for host transcripts. The 403 proteins were divided into three groups using 
the same criteria as transcriptome data analysis. In total, 116 (29 %) proteins were 
highly expressed in T. gondii infection while 98 (24 %) proteins were found highly 
expressed in N. caninum infection. The lower similarity of 47 % (192 proteins) at 
protein level than transcript level in response to infection with these parasites 
indicates a more divergent protein response upon infection of the two parasites as 
shown in Figure 5.8.  
 
 
Figure 5.8: Total number of proteins of host cell infected with T. gondii and N. caninum. Proteins 
divided based on the cut-off applied, host proteins with greater than two folds expression in T. gondii 
infection than in N. caninum infection, host proteins with greater than two folds expression in N. 
caninum infection and proteins that do not exhibit significant expression changes (≥ - 2 and ≤ + 2) 
between the two infections. 
 
The quantified proteins matched between T. gondii and N. caninum infections 
are presented in the volcano plot below (figure 5.9). Highly expressed host proteins 
upon T. gondii infection (top-right of the plot) include positive regulation of 
translation processes; while the highly expressed host proteins upon N. caninum 
infection (top-left of the plot) includes molecules associated with energy and protein 
production (Figure 5.9). To understand the enriched biological processes of these 
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proteins and to compare with transcriptomics data, same functional analysis was 
performed using DAVID tool. 
 
 
Figure 5.9: Volcano plot of quantified host proteins infected with T. gondii and N. caninum at 36 hr 
p.i. The volcano plot shows p-value versus FC of quantified proteins of host cell infected with the two 
parasites. Red dash line on y-axis at 1.3 is equal to p-value of 0.05. Red dash line at + 1 and - 1 on x-
axis are equivalent to FC of host proteins. Host proteins located at the top-right corner are highly 
expressed in T. gondii infection; while host proteins on the top-left corner are highly expressed in N. 
caninum infection. 
 
5.3.3.2.1. Biological processes enriched from host proteins significantly 
expressed in N. caninum infection 
The biological processes enriched for host proteins significantly 
overexpressed in N. caninum are shown in Figure 5.10, Table 5.3 and Appendix 
Table III. Figure 5.10 shows the BP with enrichment fold, while Table 5.3 shows the 
host transcripts associated with each BP and Appendix Table IX shows the detailed 
information about each BP enriched. The BPs enriched show that the overexpressed 
proteins in N. caninum infection are involved in generation of precursor metabolites 
and energy such as monosaccharide catabolic processes, glycolysis, aerobic 
respiration, coenzyme catabolic process and tricarboxylic acid cycle. In addition, 
proteins associated with protein production and processing are overexpressed in N. 
caninum infection such as translation processes, protein transport and targeting and 
protein folding.  
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Figure 5.10: Biological processes enriched in DAVID tool from host proteins significantly 
overexpressed in N. caninum infection  
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Table 5.3: Table 5.3: Biological processes enriched from host proteins 
significantly overexpressed in N. caninum infection at 36 hr p.i. 
Biological processes Gene 
IDs 
Protein name  
Generation of precursor 
metabolites and energy 
Q5JWF2 
Guanine nucleotide-binding protein G(s) subunit alpha 
isoforms XLas, GNAS 
P31040 
Succinate dehydrogenase [ubiquinone] flavoprotein subunit, 
mitochondrial, SDHA 
P04406 Glyceraldehyde-3-phosphate dehydrogenase, GAPDH 
P60174 Triosephosphate isomerase, TPI1 
P49821 
NADH dehydrogenase [ubiquinone] flavoprotein 1, 
mitochondrial, NDUFV1 
P00558 Phosphoglycerate kinase 1, PGK1 
P06733 Alpha-enolase, ENO1 
P07954 Fumarate hydratase, mitochondrial, FH 
O75390 Citrate synthase, mitochondrial, CS 
P22695 
Cytochrome b-c1 complex subunit 2, mitochondrial, 
UQCRC2 
P17858 ATP-dependent 6-phosphofructokinase, liver type, PFKL 
O00764 Pyridoxal kinase, PDXK 
Translation processes 
P26641 Elongation factor 1-gamma, EEF1G 
P61513 60S ribosomal protein L37a, RPL37A 
P27635 60S ribosomal protein L10, RPL10 
P46778 60S ribosomal protein L21, RPL21 
P35268 60S ribosomal protein L22, RPL22 
P62841 40S ribosomal protein S15, RPS15 
Q9NSE4 Isoleucine--tRNA ligase, mitochondrial, IARS2 
Intracellular protein 
transport and targeting 
Q5JWF2 
Guanine nucleotide-binding protein G(s) subunit alpha 
isoforms XLas, GNAS 
P13667 Protein disulfide-isomerase A4, PDIA4 
P27348 14-3-3 protein theta, YWHAQ 
O75396 Vesicle-trafficking protein SEC22b, SEC22B 
Q01082 Spectrin beta chain, non-erythrocytic 1, SPTBN1 
P62258 14-3-3 protein epsilon, YWHAE 
P46459 Vesicle-fusing ATPase, NSF 
Q9Y5X1 Sorting nexin-9, SNX9 
Q15363 
Transmembrane emp24 domain-containing protein 2, 
TMED2 
P27797 Calreticulin, CALR 
O43707 Alpha-actinin-4, ACTN4 
P61981 14-3-3 protein gamma, YWHAG 
Protein folding 
Q15084 Protein disulfide-isomerase A6, PDIA6 
Q9NYU2 UDP-glucose:glycoprotein glucosyltransferase 1, UGGT1 
P48643 T-complex protein 1 subunit epsilon, CCT5 
P27797 Calreticulin, CALR 
O60884 DnaJ homolog subfamily A member 2, DNAJA2 
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5.3.3.2.2. Biological processes enriched from host proteins significantly 
overexpressed in T. gondii infection 
The biological processes enriched using DAVID tool for the host proteins 
significantly overexpressed in T. gondii infection with enrichment fold are shown in 
Figure 5.11. Table 5.4 shows the host transcripts associated with each BP while 
Appendix Table X shows the detailed information about each BP enriched. Several 
biological processes were highly enriched such as translation processes, RNA 
processes, ribosomal biogenesis, protein transport and targeting, protein folding, 
phagocytosis and responses to inflammation. 
 
 
Figure 5.11: Biological processes enriched in David tool from host proteins significantly 
overexpressed in T. gondii infection 
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Table 5.4: Biological processes enriched from host proteins significantly 
overexpressed in T. gondii infection. 
Biological processes Gene IDs Protein name  
Translation processes 
P18124 60S ribosomal protein L7, RPL7 
P14868 Aspartate-tRNA ligase, cytoplasmic, DARS 
P62750 60S ribosomal protein L23a, RPL23A 
Q07020 60S ribosomal protein L18, RPL18 
P62280 40S ribosomal protein S11, RPS11 
P62249 40S ribosomal protein S16, RPS16 
P62424 60S ribosomal protein L7a, RPL7A 
P84098 60S ribosomal protein L19, RPS19 
P62269 40S ribosomal protein S18, RPS18 
P61247 40S ribosomal protein S3a, RPS3A 
P62241 40S ribosomal protein S8, RPS8 
P62829 60S ribosomal protein L23, RPL23 
P47914 60S ribosomal protein L29, RPL29 
P61313 60S ribosomal protein L15, RPL15 
O00425 
Insulin-like growth factor 2 mRNA-binding protein 3, 
IGF2BP3 
P62854 40S ribosomal protein S26, RPS26 
P62851 40S ribosomal protein S25, RPS25 
P46782 40S ribosomal protein S5, RPS5 
P46781 40S ribosomal protein S9, RPS9 
P15880 40S ribosomal protein S2, RPS2 
Q02543 60S ribosomal protein L18a, RPL18A 
P42766 60S ribosomal protein L35, RPL35 
P62913 60S ribosomal protein L11, RPL11 
P07814 Bifunctional glutamate/proline-tRNA ligase, EPRS 
P61254 60S ribosomal protein L26, RPL26 
Q02878 60S ribosomal protein L6, RPL6 
P18077 60S ribosomal protein L35a, RPL35A 
P40429 60S ribosomal protein L13a, RPL13A 
Ribosomal biogenesis 
P62249 40S ribosomal protein S16, RPS16 
P18124 60S ribosomal protein L7, RPL7 
P62424 60S ribosomal protein L7a, RPL7A 
P61254 60S ribosomal protein L26, RPL26 
P62913 60S ribosomal protein L11, RPL11 
P18077 60S ribosomal protein L35a, RPL35A 
O00567 Nucleolar protein 56, NOP56 
P22087 rRNA 2'-O-methyltransferase fibrillarin, FBL 
RNA processes 
P18124 60S ribosomal protein L7, RPL7 
P62913 60S ribosomal protein L11, RPL11 
P17844 Probable ATP-dependent RNA helicase DDX5, DDX5 
P31943 
Heterogeneous nuclear ribonucleoprotein HFF cells, 
HNRNPH1 
O00567 Nucleolar protein 56, NOP56 
Q92841 Probable ATP-dependent RNA helicase DDX17, DDX17 
P22087 rRNA 2'-O-methyltransferase fibrillarin, FBL 
P62249 40S ribosomal protein S16, RPS16 
P11940 Polyadenylate-binding protein 1, PABPC1 
Q08170 Serine/arginine-rich splicing factor 4, SRSF4 
P61254 60S ribosomal protein L26, RPL26 
O75400 Pre-mRNA-processing factor 40 homolog A, PRPF40A 
P18077 60S ribosomal protein L35a, RPL35A 
Q15365 Poly(rC)-binding protein 1, PCBP1 
Protein transporting 
and targeting 
P61204 ADP-ribosylation factor 3, ARF3 
Q14974 Importin subunit beta-1, KPNB1 
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Q9Y3Q3 
Transmembrane emp24 domain-containing protein 3, 
TMED3 
Q9UL25 Ras-related protein Rab-21, RAB21 
P60033 CD81 antigen, CD81 
P61026 Ras-related protein Rab-10, RAB10 
P02452 Collagen alpha-1(I) chain, COL1A1 
Q9H444 Charged multivesicular body protein 4b, CHMP4B 
P62913 60S ribosomal protein L11, RPL11 
P43307 Translocon-associated protein subunit alpha, SSR1 
P35579 Myosin-9, MYH9 
P38646 Stress-70 protein, mitochondrial, HSPA9 
P61106 Ras-related protein Rab-14, RAB14 
P17301 Integrin alpha-2, ITGA2 
P48444 Coatomer subunit delta, ARCN1 
P62829 60S ribosomal protein L23, RPL23 
P62826 GTP-binding nuclear protein Ran, RAN 
Protein folding 
P23284 Peptidyl-prolyl cis-trans isomerase B, PPIB 
P78371 T-complex protein 1 subunit beta, CCT2 
P17987 T-complex protein 1 subunit alpha, TCP1 
P30533 
Alpha-2-macroglobulin receptor-associated protein, 
LRPAP1 
Q9UBS4 DnaJ homolog subfamily B member 11, DNAJB11 
Q9Y230 RuvB-like 2, RUVBL2 
P38646 Stress-70 protein, mitochondrial, HSPA9 
positive regulation of 
phagocytosis 
P17301 Integrin alpha-2, ITGA2 
P01024 Complement C3, C3 
Q08431 Lactadherin, MFGE8 
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5.3.3.3. Overlapped phosphoproteome of host cell in response to infection 
with T. gondii and N. caninum 
Table 5.5 shows the total number of the quantified host phosphoproteins 
matched with the host transcripts and proteins infected with T. gondii and N. 
caninum. In total, 57 out of 473 of the quantified phosphoproteins were matched with 
the quantified transcripts and proteins. 
 
Table 5.5: Quantified phosphoproteins that match transcriptomic and proteomic 
datasets.   
ID Description Max fold 
change 
Infection with 
higher expression 
Q14697 Neutral alpha-glucosidase AB 196.94 T. gondii infection 
Q9UQ35 Serine/arginine repetitive matrix protein 2 7.63 T. gondii infection 
Q9H3N1 Thioredoxin-related transmembrane protein 1 7.37 T. gondii infection 
P08238 Heat shock protein HSP 90-beta 6.97 T. gondii infection 
P04792 Heat shock protein beta-1 6.92 T. gondii infection 
P29966 Myristoylated alanine-rich C-kinase substrate 6.85 T. gondii infection 
P62081 40S ribosomal protein S7 6.14 T. gondii infection 
Q9P035 
Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier 
protein] dehydratase 3 
4.08 T. gondii infection 
Q15084 Protein disulfide-isomerase A6 3.73 T. gondii infection 
Q9C0C2 182 kDa tankyrase-1-binding protein 3.35 T. gondii infection 
Q14847 LIM and SH3 domain protein 1 3.26 T. gondii infection 
P60174 Triosephosphate isomerase 2.58 T. gondii infection 
P31943 Heterogeneous nuclear ribonucleoprotein H 2.34 T. gondii infection 
P08670 Vimentin 2.27 T. gondii infection 
Q07065 Cytoskeleton-associated protein 4 1.99 T. gondii infection 
P67809 Nuclease-sensitive element-binding protein 1 1.97 T. gondii infection 
Q16555 Dihydropyrimidinase-related protein 2 1.88 T. gondii infection 
P48681 Nestin 1.70 T. gondii infection 
P35221 Catenin alpha-1 1.57 T. gondii infection 
P35606 Coatomer subunit beta' 1.45 T. gondii infection 
Q9UMS6 Synaptopodin-2 1.31 T. gondii infection 
Q9NR30 Nucleolar RNA helicase 2 1.27 T. gondii infection 
P43307 Translocon-associated protein subunit alpha 1.21 T. gondii infection 
Q03135 Caveolin-1 1.19 T. gondii infection 
O00264 
Membrane-associated progesterone receptor 
component 1 
1.17 T. gondii infection 
Q9UKM9 RNA-binding protein Raly 1.11 T. gondii infection 
P23284 Peptidyl-prolyl cis-trans isomerase B 1.09 T. gondii infection 
O94826 Mitochondrial import receptor subunit TOM70 1.09 T. gondii infection 
P23396 40S ribosomal protein S3 1.04 T. gondii infection 
P17858 6-phosphofructokinase, liver type 1.03 T. gondii infection 
Q07666 
KH domain-containing, RNA-binding, signal 
transduction-associated protein 1 
1.02 T. gondii infection 
Q9UBG0 C-type mannose receptor 2 1.02 T. gondii infection 
Q9Y2X3 Nucleolar protein 58 1.01 T. gondii infection 
P08648 Integrin alpha-5 1.00 T. gondii infection 
Q6NZI2 Polymerase I and transcript release factor 11.07 N. caninum infection 
P04406 Glyceraldehyde-3-phosphate dehydrogenase 4.39 N. caninum infection 
Chapter Five 
165 
 
Q14247 Src substrate cortactin 2.93 N. caninum infection 
P08123 Collagen alpha-2(I) chain 1.67 N. caninum infection 
Q969G5 Protein kinase C delta-binding protein 1.63 N. caninum infection 
P50454 Serpin H1 1.62 N. caninum infection 
P02794 Ferritin heavy chain 1.58 N. caninum infection 
P68363 Tubulin alpha-1B chain 1.55 N. caninum infection 
Q14204 Cytoplasmic dynein 1 heavy chain 1 1.49 N. caninum infection 
P39023 60S ribosomal protein L3 1.46 N. caninum infection 
Q00839 Heterogeneous nuclear ribonucleoprotein U 1.40 N. caninum infection 
Q9Y490 Talin-1 1.39 N. caninum infection 
O75396 Vesicle-trafficking protein SEC22b 1.34 N. caninum infection 
Q9NZN4 EH domain-containing protein 2 1.30 N. caninum infection 
Q01082 Spectrin beta chain, non-erythrocytic 1 1.22 N. caninum infection 
P35579 Myosin-9 1.21 N. caninum infection 
Q06210 
Glutamine--fructose-6-phosphate aminotransferase 
[isomerizing] 1 
1.16 N. caninum infection 
P17302 Gap junction alpha-1 protein 1.14 N. caninum infection 
P07814 Bifunctional glutamate/proline--tRNA ligase 1.13 N. caninum infection 
Q13200 26S proteasome non-ATPase regulatory subunit 2 1.09 N. caninum infection 
Q1KMD3 
Heterogeneous nuclear ribonucleoprotein U-like 
protein 2 
1.08 N. caninum infection 
Q13425 Beta-2-syntrophin 1.07 N. caninum infection 
O76021 Ribosomal L1 domain-containing protein 1 1.04 N. caninum infection 
 
5.3.4. Integrated data analysis of 3omics  
The integrated data analysis was performed to study the changes in 3omics 
(transcriptome, proteome and phosphoproteome) in response to infection with T. 
gondii and N. caninum at a system level. The criteria used to determine discrepancies 
between transcript and protein expressions was based on directions of genes with 
over two fold differences between infections e.g. when a transcript increased two 
fold in expression between T. gondii and N. caninum infection, the protein of the 
same transcript decreased two fold in expression. Results show that the majority (94 
%) of transcriptome and proteome are following the same trends in T. gondii and N. 
caninum infections. However, 6 % of the transcriptome and proteome were regulated 
differently from both infections. The biological processes that these different 
molecules are associated are shown in Table 5.6. The majority of these molecules are 
associated with protein production and processing. 
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Table 5.6: differentially regulated transcripts and proteins of host cell infected 
with T. gondii and N. caninum.    
Protein 
IDs  
Description Biological 
processes 
FC in 
transcriptome  
FC in   
proteome  
Q969G5 
Protein kinase C delta-
binding protein, 
PRKCDBP 
Circadian 
regulation of 
gene expression 
2.133 0.375 
P62258 
14-3-3 protein epsilon, 
YWHAE 
Protein targeting 
and transporting 
2.14 0.195 
Q9Y3I0 
tRNA-splicing ligase RtcB 
homolog, RTCB 
Cell-matrix 
adhesion 
2.149 0.48 
P30041 Peroxiredoxin-6, PRPDX6 
Cell redox 
homeostasis,  
2.275 0.294 
P09936 
Ubiquitin carboxyl-
terminal hydrolase isozyme 
L1, UCHL1 
Protein targeting 
and transporting 
2.337 0.181 
Q99536 
Synaptic vesicle membrane 
protein VAT-1 homolog, 
VAT1 
Negative 
regulation of 
mitochondrial 
fusion 
2.343 0.141 
P38159 
RNA-binding motif 
protein, X chromosome, 
RBMX 
RNA processes 2.477 0.397 
P13667 
Protein disulfide-isomerase 
A4, PDIA4 
Intracellular 
protein transport 
and targeting 
2.57 0.15 
Q9NVA2 Septin-11, SEPT11 
Cellular 
macromolecular 
complex 
assembly 
2.661 0.344 
Q16181 Septin-7, SEPT7 
Cellular 
macromolecular 
complex 
assembly 
2.796 0.318 
P27348 
14-3-3 protein theta, 
YWHAQ 
Intracellular 
protein transport 
and targeting 
3.481 0.249 
P09429 
High mobility group 
protein B1, HMGB1 
Anti-apoptosis 3.563 0.301 
Q96A33 
Coiled-coil domain-
containing protein 47, 
CCDC47 
Calcium ion 
homeostasis 
3.667 0.438 
Q14980 
Nuclear mitotic apparatus 
protein 1, NUMA1 
Cell division 3.774 0.328 
Q9UQ80 
Proliferation-associated 
protein 2G4, PA2G4 
Regulation of 
cellular protein 
metabolic 
processes 
3.915 0.106 
O75390 
Citrate synthase, 
mitochondrial, CS 
Generation of 
precursor 
metabolites and 
energy 
4.316 0.411 
P35555 Fibrillin-1, FBN1 
Extracellular 
matrix 
organization 
4.372 0.268 
P05204 
Non-histone chromosomal 
protein HMG-17, HMGN2 
- 5.242 0.204 
O94832 Unconventional myosin-Id, Cellular 5.262 0.39 
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MYO1D localization 
P35268 
60S ribosomal protein L22, 
RPL22 
Translation 
processes 
8.975 0.31 
P01024 Complement C3, C3 
Positive 
regulation of 
phagocytosis 
0.38 2.234 
P01023 
Alpha-2-macroglobulin, 
A2M 
Regulation of 
acute 
inflammatory 
response and 
immune 
responses 
0.391 8.681 
Q15113 
Procollagen C-
endopeptidase enhancer 1, 
PCOLCE 
Proteolysis  0.405 5.126 
Q8N357 
Solute carrier family 35 
member F6, SLC35F6 
Positive 
regulation of cell 
proliferation 
0.454 2.08 
P60033 CD81 antigen, CD81 
Protein 
transporting and 
targeting 
0.482 2.127 
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The quantified host phosphoproteins (473) and proteins (403) were 
compared; total of 57 host phosphoproteins and proteins were matched. The criteria 
used to select different host cell expression were based on two folds expression 
(decreased or increased) in protein and one and a half fold expression in 
phosphoproteins. Lower fold changes applied to phosphoproteins is due to the fact 
these two parasites are closely related and often small proportion of a protein are 
phosphorylated, thus small changes happen in the protein phosphorylation potentially 
indicate great differences in response to these two parasites. Results show that the 
majority 86 % out of the 57 of the matched proteome and phosphoproteome are 
following the same trends in T. gondii and N. caninum infections. However, 14 % of 
the 57 matched phosphoproteome and proteome were regulated differently from both 
infections. The biological processes that these different molecules are associated are 
shown in Table 5.7. The majority of these molecules are associated with energy and 
protein production. 
 
Table 5.7: Host phosphoproteins and proteins were significantly overexpresses 
differently in T. gondii and N. caninum infection.  
Protein 
ID 
Description Biological 
processes 
FC in 
proteome 
FC in 
phosphoproteome 
Q14697 Neutral alpha-glucosidase AB 
post-translational 
protein 
modification 
0.296 196.943 
P29966 
Myristoylated alanine-rich C-
kinase substrate 
Energy reserve 
metabolic process 
0.453 6.854 
Q15084 Protein disulfide-isomerase A6 Protein folding 0.451 3.730 
P60174 Triosephosphate isomerase 
Glycolytic 
process 
0.115 2.581 
P67809 
Nuclease-sensitive element-
binding protein 1 
mRNA splicing 0.204 1.971 
P68363 Tubulin alpha-1B chain Cell division 3.829 0.646 
P50454 Serpin H1 
Collagen 
biosynthesis 
process 
2.810 0.619 
P08123 Collagen alpha-2(I) chain 
Collagen fibril 
organisation 
2.833 0.597 
 
  
Chapter Five 
169 
 
The quantified host transcripts (403) and phosphoproteins (473) were 
compared; total of 57 host phosphoproteins and transcripts were matched. The 
criteria used to select different host cell expression were based on two folds 
expression (decreased or increased) in transcripts and one and a half fold expression 
in phosphoproteins. Results show that the majority 96.5 % out of the 57 of the 
matched transcriptome and phosphoproteome are following the same trends in T. 
gondii and N. caninum infections. However, 3.5 % of the 57 matched transcriptome 
and phosphoproteome were regulated differently from both infections. The biological 
process that these different molecules are associated is circadian regulation of gene 
expression as shown in Table 5.8.  
 
Table 5.8: Host transcriptome and phosphoproteome infected with T. gondii and 
N. caninum. These IDs were significantly overexpresses differently in 
transcriptome and phosphoproteome. 
Protein 
ID 
Description Biological 
processes 
FC in 
transcriptome 
FC in 
phosphoproteome 
Q969G5 
Protein kinase C delta-
binding protein 
Circadian  
regulation of gene 
expression 
2.133 0.615 
Q00839 
Heterogeneous nuclear 
ribonucleoprotein U 
Circadian 
regulation of gene 
expression 
2.353 0.713 
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5.4. DISCUSSION 
The present study aimed to analyse and compare the host cell response to 
infection with T. gondii and N. caninum at system wide level using quantitative 
transcriptome, proteome and phosphoproteome data.  
Total number of quantified host cell transcripts in T. gondii infection was 
twice that found in N. caninum infection (Figure 5.3). These differences could be 
related to the quality of a particular RNASeq experiment that had higher noise level 
than the other. However, this does not greatly influence the overall comparison 
between transcriptome and proteome as only half of the quantified host proteins were 
matched to the transcripts after one gene, one transcript criteria was used for the 
matching (Figure 5.4). 
5.4.1. Host cell is selectively regulated to fulfil the parasites requirement 
T. gondii scavenge essential host nutrition as amino acids, sugar, nucleobases 
and co-factors (Schwab et al., 1994) and cholesterol (Coppens et al., 2006; Coppens 
et al., 2000). In this study, data analysis showed that at expression level of proteins 
associates with protein production (Figure 5.11) was highly up-regulated in host cell 
infected with T. gondii compared to N. caninum at 36 hr p.i. On the other hand, 
proteins associate with energy production (Figure 5.10) where down regulated 
compared to N. caninum at the same time point of infection. These proteins that 
regulate energy and protein production could indicate that parasites selectively direct 
host cell to fulfil their essential requirements. Protein regulation is related to the 
compensation of protein metabolism acquired by replicating parasites and to 
maintain housekeeping protein necessary for maintaining normal cellular functions 
(Jovanovic et al., 2015). These results indicate that these parasites like other 
pathogens e.g. HIV (Wojcechowskyj et al., 2013), not only take advantage of the 
host cell signalling pathway but also manipulate pathways to fulfil their 
requirements. Host cell regulation is potentially associated with the demands of the 
highly replicating tachyzoites during different phases of their development (Francia 
and Striepen, 2014). This is comparable with the studies of Blader et al. (2001) and 
Nelson et al. (2008), in that they found high gene modulation and host cell regulation 
in later time point (24 hr p.i.) than early infection. The results show that following 
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infection of host cell, parasite selectively control and manipulate the host cell and 
intimate host-parasite interaction to co-opt the requirement of the replicating 
tachyzoites.  
5.4.2. T. gondii stimulates higher activity of protein production in host cell  
Based on the biological processes enriched from host cell proteins 
significantly overexpressed in T. gondii infection; translation processes were found 
highly enriched in T. gondii infection (Figure 5. 9 and 5.10). Overexpression of 
proteins involved in translation could be related to the differences at host-parasite 
interaction to produce more proteins require for continuous replication of tachyzoites 
before egress at this time point. In addition, almost all the biological processes 
enriched were related to protein production particularly translation processes as 
shown in Figure 5.7. The dynamic of protein fold changes is directly regulated by 
high abundance of mRNA in infection with T. gondii. The result of the present study 
is comparable to the study of Jovanovic et al. (2015) where they found a relationship 
between relative fold changes of protein expression and abundance of mRNA in 
response to lipopolysaccharide in stimulated mouse dendritic cells. Investigation 
showed that during acute and chronic infection of mouse forebrain with T. gondii, the 
majority of the transcripts of the parasite that highly up-regulated were associated 
with transcription and translation processes (Pittman et al., 2014). In addition, 
microarray analysis showed that host cell responded to infection with T. gondii 
through regulation of large number of genes associated with transcription and protein 
synthesis, targeting and degradation and signalling (Blader et al., 2001). The results 
associated with protein production show the importance of protein regulation both 
transcriptionally and translationally during infection with these parasites. In addition, 
because division in these parasites are synchronised based on the doubling processes; 
high protein production could be related to the stage of the replication of tachyzoites 
e.g. at G1 phase tachyzoites starts to synthesis and build up more proteins before 
start mitosis as reviewed in Francia and Striepen (2014). The high up-regulation of 
protein production during infection with T. gondii potentially is related to the high 
demand of T. gondii replication at this time point than N. caninum. 
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5.4.3. T. gondii inhibits apoptosis and acute inflammatory response of host 
cell  
T. gondii has evolved mechanisms to inhibit host cell apoptosis and evade 
immune system using arrays of effectors that allow its survival and host cell 
maintenance through avoiding tissue destruction by inflammatory responses of host 
(Lüder and Gross, 2005). In the present study, infection with T. gondii results in 
overexpression of anti-apoptosis transcripts (Table 5.2) more than infection with N. 
caninum. IFN-γ-treated murine fibroblasts infected with T. gondii were found to resist 
apoptosis whereas apoptosis was found in cells infected with N. caninum. The 
apoptosis of host cell with N. caninum was found associated with high induction of 
DNA fragmentation and increase in the activity of caspase-3 and -8 (Nishikawa et 
al., 2002). In addition N. caninum was found to induce the ligand (FasL) of death 
receptor (Fas) in the presence or absence of IFN-γ treatment which is important in 
induction of extrinsic apoptotic pathway, suggesting that N. caninum induces 
apoptosis more readily than T. gondii (Nishikawa et al., 2002). T. gondii protects 
infected cell from different apoptotic inducer such as actinomycin-D (Kim et al., 
2006) or cycloheximide in combination with actinomyocine-D or TNF-α through 
inhibition of caspases such as caspase 3, -8 and -9 (Goebel et al., 1998). Thus the 
results of the present study provided supporting evidence that T. gondii inhibited 
apoptosis more than N. caninum infection.  
In addition, host cell infected with T. gondii was found resulted in 
suppression of transcripts associated with acute inflammatory response more than N. 
caninum infection (Table 5.1). HFF cell infection with T. gondii type I and III at 18 
hr p.i. was found associated with high phosphorylation of STAT3/6 more than 
infection with type II strain (Saeij et al., 2007). In types I and III strain of T. gondii, 
ROP16 was found involved in direct and sustained phosphorylation and translocation 
of STAT3/6 into nucleus which consequently leading to inhibition of host cell early 
immune response mediated by cytokines, IL-12. While in Type II strain, 
phosphorylation (and activation) and translocation of STAT3 was found for only a 
short time and followed by induction of high IL-12p40 (Ong et al., 2010; Saeij et al., 
2007; Yamamoto et al., 2009). The results of these studies are comparable with the 
present study in that T. gondii types III strain was used in the experiment and that 
lower immune response was found compared to N. caninum infection. In addition, 
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other ROP proteins in T. gondii such as ROP18 was also found associated with 
virulence of these parasites. TgROP18 phosphorylates host cell IRGs necessary for 
destruction of PVM in infected cells while N. caninum does not due to 
pseudogenisation of NcROP18 (Lei et al., 2014; Reid et al., 2012). The result of the 
present study suggests that differential induction of early immune response is 
associated with the regulation of virulence in T. gondii and N. caninum. 
5.4.4. Integrated data analysis shows consistencies in response to infection 
with T. gondii and N. caninum 
Regulation of eukaryotic gene expression is control by processes at system 
level that maintain balance between transcripts and proteins within cell for normal 
physiological state or in response to external stimuli. These processes associate with 
gene transcription, RNA processing, translation and protein life cycle (Jüschke et al., 
2013). In addition, lower correlation was also reported at 40 % between mRNA 
expression and protein abundance (De Sousa Abreu et al., 2009; Maier et al., 2009); 
suggested that several factors are contributing to the differences in the abundance of 
mRNA and protein that are controlled by post-transcriptional, translational and 
protein degradation (Vogel and Marcotte, 2012). 
Host-pathogen interactions result in high protein expression which 
maintained by mRNA transcription and abundance (Jovanovic et al., 2015). In the 
present study, a general agreement was reported between omics of host cell in 
response to infection with T. gondii and N. caninum. Thus the present study is 
comparable with the study of Jovanovic et al. (2015) in that transcriptome/proteome, 
proteome/phosphoproteome and transcriptome/phosphoproteome for matched 
transcripts and proteins from both T. gondii and N. caninum were very similar. This 
similarity is potentially associated with the fact that these two parasites possess 
remarkably conserved genomes and transcriptomes (Reid et al., 2012).  
Presence of differentially enriched pathway from phosphoproteome analysis 
such as mTOR signalling pathway and glycolysis/gluconeogenesis; biological 
processes such as protein and energy production, host cell response to apoptosis and 
inflammatory responses, suggest that these parasites selectively target and 
manipulate host cell system for their benefit. 
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5.4.5. Limitation of data analysis 
In this data analysis, only one replicate of transcriptome data was available, 
for this purpose artificial replicates were generated. The latter was to meet the 
requirement of the software Normalyzer which does not affect the normalisation 
method performed for the transcripts data. Replicates offer more confidence to 
normally distributed data analysis. The quantified omics data were analysed without 
applying significant threshold as cut-off e.g. p-value <0.05 to individual value of 
transcripts, proteins and phosphoproteins after normalisation. Because of the fact that 
p-value was not possible to be generated from single replicate of the quantified 
transcripts.  
5.4.6. Conclusion 
In conclusion, host cell responses are determined by pathogen effectors; 
infection with T. gondii and N. caninum results in selective energy and protein 
induction of host cell to fulfil the requirement of highly dividing tachyzoites. These 
results indicate that these parasites synchronise their requirement due to continuous 
synchronous endodyogeny. Therefore energy is potentially produced first then 
followed by protein production; and determines the parasites to enter new cycle of 
cell division or to egress when there are not enough resources. In addition, integrated 
data analyses from omics of host cell show that the majority of omics trends of host 
cell in response to infection with these parasites are similar. The similarity in 
transcriptomics, proteomics and phosphoproteomics in response to infection with 
these parasites indicate that the molecular organisations of these parasites are 
preserved.  
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Chapter SIX: Discussion and future perspectives
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6.1. DISCUSSION 
T. gondii and N. caninum are closely related intracellular obligatory 
protozoan parasites. The genome, transcriptome and proteome are similar in both 
parasites; however there exist several biological differences between the two 
parasites including host range, zoonotic potential, transmission and virulence. The 
exact causes and mechanisms leading to these biological differences are yet to be 
fully elucidated. These parasites have to invade successfully and establish an 
infection within the host cell to survive, grow, differentiate and multiply. These 
biological activities require continuous interactions and communications between the 
host cell and the parasites which could potentially be responsible for the biological 
differences between T. gondii and N. caninum.  
While there is more information about protein-protein interactions and 
multiple protein complexes in T. gondii, less is known about these in N. caninum. In 
addition, there are limited comparative host cell transcriptomics and proteomics 
studies in response to infection with the two parasites, and there is no comparative 
host phosphoproteomics study in response to infection with T. gondii and N. 
caninum. The aim of this study was to understand the cause of the biological 
differences between T. gondii and N. caninum through dissecting host-parasite 
interactions. The comparison of host-parasite interactions between the two parasites 
was performed through the implementation of advanced global analysis of 
tachyzoites MPCs and the host cell transcriptome, proteome and phosphoproteome 
during infection with the two parasites. 
The results shown in this thesis support the hypothesis that there are 
differences in the host-parasite interactions in response to infection with N. caninum 
when compared to T. gondii. The main finding of the present study was the 
identification of the host pathways that are differentially expressed in response to 
infection with T. gondii and N. caninum and these are associated with energy and 
protein metabolisms such as glycolysis/gluconeogenesis and mTOR signalling 
pathways. The results of the present study are complementary to the findings from 
previous studies where differences were shown in the host innate immune responses 
and host cell necrosis during infection with the two parasites (Lei et al., 2014; 
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Nishikawa et al., 2002). The differences in host-parasite interactions at the 
qualitative and quantitative level are potentially associated with the differences in the 
virulence and transmission strategy of T. gondii and N. caninum. 
In chapter two, BN-PAGE combined with LC MS/MS analysis was used for 
the comparative investigation of the whole tachyzoites PPIs and MPCs of T. gondii 
and N. caninum in their native state. Although the technique is used for one-step 
isolation and high resolution of separation of MPCs from different biological 
samples, it is laborious and requires optimisation for different biological samples 
from different organisms. The MPCs identified from BN-PAGE prepared from 
tachyzoites of both T. gondii and N. caninum were difficult to compare due to 
differences in protein separation on BN-PAGE. The differences could be due to non-
specific interactions and/or migration of different MPCs to different molecular 
weight locations. Despite this, several different complexes were identified in T. 
gondii and N. caninum tachyzoites. In T. gondii, a complex that plays an important 
part in attachment [MIC6/1 and SAC1 (SRS29B)] was identified. The 
oligomerisation of proteins from different organelles and complex formation 
facilitates invasion of host cell collaboratively (Alexander et al., 2005; Carruthers 
and Tomley, 2008). The interaction/co-localisation of MIC6/1 and SAG1 potentially 
indicates that these proteins function together in tachyzoites and facilitate attachment 
and invasion of host cells. In addition, three subunits (TgMyoA-MLC1-GAP45) of 
the glideosome were identified in N. caninum. This is in agreement with the findings 
of Frenal et al. (2010) on T. gondii and Sanders et al. (2007) from detergent-resistant 
membranes of Plasmodium falciparum schizonts. The similarity in the subunit of the 
glideosome of T. gondii and N. caninum potentially indicates that both parasites use 
the same cytoskeletal elements to power the gliding motility and invasion of host 
cells. However, further studies are needed to confirm the presence of other subunits 
of the glideosome in N. caninum.  
Another important finding was the identification of proteins associated with 
MJ formation, which drive invasion of host cell by N. caninum and these include 
RON1, RON2, RON3, RON5, RON8, a ROP2 family member and ROP40. These 
results are in agreement with previous results from a proteomic analysis of rhoptry 
organelle fractions, showing several proteins from the rhoptry bulb and neck in T. 
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gondii namely TgRON1, 2, 3, and 4 (Bradley et al., 2005) and in N. caninum - 
NcRON2, 3, 4, and 8 (Marugán-Hernández et al., 2011). In addition RON2, 3, 4, 5 
and 8 have been found to be associated with MJ formation in T. gondii and N. 
caninum tachyzoites (Alexander et al., 2005; Sohn et al., 2011; Straub et al., 2009). 
Oligomerisation of these proteins inside the parasite rhoptry and beyond the parasite 
plasma membrane and their role in MJ formation suggests that these proteins are 
secreted as one macromolecule to help accelerate host cells invasion and 
establishment of an infection. 
In chapter three, a pull-down assay has been used to study direct PPIs of T. 
gondii and N. caninum proteins (GRA2 and GRA7) with host cell lysate proteins and 
further analysed using LC-MS/MS. This method is more accurate to study PPIs than 
BN-PAGE because it uses expressed recombinant tagged proteins of interest as bait 
to pull-down prey proteins from targeted cell lysate. However purification of 
recombinant protein was found to be challenging. Recombinant GRA2 and GRA7 
proteins from both parasites were expressed in transformed BL21 (DE3) competent 
cells; however, the expressed recombinant proteins were co-purified with other 
proteins from the expression system using Ni-NTA purification column. Expression 
and purification of GRA proteins was difficult due to the presence of multiple 
hydrophobic or amphipathic alpha helices (Bittame et al., 2015). Therefore, several 
different methods were carried out to purify expressed recombinant GRA proteins 
such as using different growth media (LB, minimal media), different purification 
system (cobalt HisPur Resin kit) and purification under denaturing condition using 8 
M urea. However, none of these methods resulted in the purification of the 
recombinant GRA proteins. In addition, a second step of purification was applied to 
the elution fraction of Ni-NTA HisTrap exploiting the solubility of these proteins 
using HPLC. The HPLC fractionation resulted in the successful purification of the 
recombinant TgGRA2. However, due to limitation of access to HPLC, the 
purification of more recombinant TgGRA2 protein was not possible.  
Another key aim of this thesis was to understand the differences in host 
responses arising during infection with T. gondii and N. caninum through protein 
phosphorylation and signal transduction. 
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In chapter four, the phosphopeptides of host cell in response to infection with 
T. gondii and N. caninum at 20 hr p.i. were enriched and analysed by LC MS/MS. 
The identified phosphopeptides of host cells during infection with T. gondii and N. 
caninum were compared using label free quantitative phosphoproteomics. A previous 
study showed that T. gondii secretes an array of proteins and kinases into the infected 
host cells, suggesting that they play a role in phosphorylation and control of the 
parasite and/or host cell proteins (Treeck et al., 2011). In addition, following T. 
gondii invasion and establishment of infection, PTMs of host proteins have been 
found to increase over time with protein phosphorylation in particular peaking at 24 
hr p.i. (Nelson et al., 2008). In this study, the total number of phosphorylated 
proteins in host cells during infection with T. gondii and N. caninum shows that the 
infected cells induce about twice more protein phosphorylations than non-infected 
cells. Three main differences were reported between the host protein phosphorylation 
during infection with T. gondii and N. caninum. Firstly, almost one third of the 
enriched phosphoproteome differed between cells infected with T. gondii and N. 
caninum. Secondly, approximately 21 % of identified phospho-motifs from 
significantly enriched phosphopeptides differed between cells infected with the two 
parasites. Thirdly, the pathway analysis showed a few pathways that were 
differentially enriched between infections with T. gondii and N. caninum; in 
particular, the mTOR and glycolysis/gluconeogenesis pathways were enriched in 
infection with T. Gondii, but not N. caninum. The differences in the 
phosphoproteome of host cells in response to infection as observed with both 
parasites are greater than the differences reported between the protein-coding genes, 
which is less than 5 % between both parasites (Reid et al., 2012). Small differences 
in the protein phosphorylation of host cells by T. gondii and N. caninum were found 
to be responsible for great differences in the virulence of these parasites (Lei et al., 
2014). The differences found in the present study indicate that these parasites induce 
and/or manipulate the host canonical pathway and signalling cascades, such as the 
mTOR and the glycolysis/gluconeogenesis signalling pathways. The modulation of 
these pathways results in high energy production and protein expression which are 
highly required for tachyzoites division. 
Results of the present study concerning the mTOR signalling pathway 
suggest that T. gondii and N. caninum phosphorylate the host mTOR substrates in a 
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parasite-dependent manner. These results are comparable with the study of Wang et 
al. (2009), which found that T. gondii phosphorylates the mTOR signalling pathway. 
In addition, based on the mTOR and glycolysis/gluconeogenesis signalling pathways, 
T. gondii appears to interact and manipulate more host cell proteins than N. caninum 
and thus, T. gondii induces more host cell response after 20 hr p.i. in vitro. 
Manipulation of these pathways during infection with T. gondii indicates that the 
host cell exerts more energy compared to infection with N. caninum. Thus, our 
results revealed high energy expenditure during T. gondii infection than N. caninum 
and this is probably related to the differences in virulence and transmission routes of 
T. gondii and N. caninum. 
Development of more advanced tools and state of the art techniques for global 
analysis of genomic, transcriptomic and proteomic data allows researchers to study 
cells or organisms as a whole in systems biology. Systems biology allows the 
understanding of all the events arising in response to external or internal stimuli at a 
given time. 
In chapter five, the comparative system-wide host cell responses to infection 
with T. gondii and N. caninum were analysed using quantitative transcriptomic, 
proteomic and phosphoproteomic data. Comparative quantitative analysis of the 
system-wide response of a host cell to infection with these parasites may uncover the 
mechanisms behind some of their biological differences. In this study, data analysis 
showed that significantly overexpressed transcripts and proteins in T. gondii and N. 
caninum infections perform markedly different tasks. The biological processes 
analysis of enriched host cell proteins and transcripts significantly overexpressed 
during infection with T. gondii showed that host cells build up more proteins in 
response to infection with T. gondii compared to N. caninum at 36 hr p.i. The 
proteins that were overexpressed were found to be the same ones involved in protein 
production (synthesis). On the one hand, the increase production of proteins is 
required for continuous replication of tachyzoites in T. gondii infection before egress 
at this time point (36 hr p.i.). On the other hand, proteins associated with energy 
production were down regulated in T. gondii compared to N. caninum at the same 
time point during infection. The selective regulation of proteins involved in energy 
and protein production by these parasites is potentially associated with their 
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multiplication requirements at this time point of infection. These results indicate that 
the parasites not only take advantage of the host cell signalling pathways, but also 
manipulate necessary pathways to fulfil their requirements. In addition, another key 
finding was that T. gondii infection resulted in the down regulation of acute 
inflammatory responses and induced the expression of anti-apoptotic transcripts in 
host cells to a greater degree compared to N. caninum. This is compatible with the 
results of Saeij et al. (2007), which found that infection with T. gondii type I and III 
in HFF cells at 18 hr p.i. resulted in the inhibition of the early immune responses of 
the host cells  and these responses are mediated by the cytokine IL-12. In T. gondii 
type I and III, ROP16 was found to be involved in the direct and sustained 
phosphorylation and translocation of STAT3/6 into the host cell nucleus more than 
type II strain (Ong et al., 2010; Saeij et al., 2007; Yamamoto et al., 2009). In 
addition, ROP18 in T. gondii was also found to phosphorylate the host cell IRGs 
necessary for the destruction of PVM in infected cells; while in  N. caninum, this is 
not dependent on pseudogenisation of NcROP18 (Lei et al., 2014; Reid et al., 2012). 
The result of the present study suggests that induction of early immune responses is 
associated with the regulation of virulence in T. gondii and N. caninum. In addition, 
early immune responses in N. caninum are potentially associated with the convertion 
of  tachyzoites to tissue cysts and avoiding host immune response that would 
guarantee a successful transmission from infected mother to offspring’s through 
vertical transmission. 
6.2. FUTURE PERSPECTIVES 
The comparative host-parasite interactions of T. gondii and N. caninum can 
be further investigated using different approaches. First of all, optimising BN-PAGE 
to study MPCs and PPIs of tachyzoites was not possible because of technical 
limitations. Therefore, we recommend optimising this promising technique to 
investigate the global PPIs and MPCs that are associated with different stages of the 
parasites, in particular tachyzoites and tissue cysts. Analyses of MPCs at different 
stages allow for a better understanding of the differences between different stages of 
the same parasite and between the same stages of the two parasites. In addition, 
dissecting the native MPCs of these parasites during and after invasion of the host 
cell is also critical to understand the proteins responsible for the interaction between 
Chapter Six 
182 
 
the parasite and the host cells. Mapping PPIs of apicomplexan parasites may be 
helpful to understand the biological differences between the two parasites. The PPIs 
database should contain the interactome of apicomplexan parasites based on 
manually curated interactions (reviewed from published papers) and computer-
generated interactions (inferred). In addition, performing further genome-wide 
studies using different methods of analysing PPIs are also important such as Yeast 
two-hybrid, co-immunoprecipitation, protein microarray and also bioinformatics. 
Characterising the host-parasite interactome is one way to develop vaccines and 
identifying drug targets for the subsequent prevention and control of these parasites.  
In order to study direct host-parasite interactions, other secretory proteins 
from the DGs as well as from other organelles such as rhoptries and micronemes 
from both parasites can be used to pull-down binding partners from the host cells. 
Different host cell types for in vitro pull-down should be used to confirm binding 
partners for different secretory proteins. In addition, co-immunoprecipitation can also 
be used besides pull-down assay to study and confirm wild type secretory proteins 
interaction with host cell during infection with the two parasites. 
Further studies of protein phosphorylation patterns in host cells in response to 
infection with T. gondii and N. caninum are recommended. These studies should 
include different cell types such as macrophages, neuronal cells, myocytes and foetal 
cells of both human and animal origin to understand cell type-related differences in 
response to infection with these parasites. Moreover, in vivo models are 
recommended to study the host pathways regulation in response to infection with 
these parasites in the presence and absence of host immunity. In addition, we 
recommend using different strains from both parasites which may result in different 
host cell responses through host protein phosphorylation and signal transduction. It is 
important to enrich phosphopeptides from large amount of host protein extracts in 
response to infection with these parasites using SCX combined with IMAC or 
MOAC before using LC MS/MS. Longer runs of different fractions on LC MS/MS is 
also recommended to identify and quantify all peptides that phosphorylate in 
response to infection.  
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Using functional protein microarrays would be important to screen and 
identify substrates of parasite kinases within the host cell, which is a critical step for 
determining the target and downstream effectors of kinases and the signalling 
pathway involved (Smith et al., 2011). 
Finally, enrichment of different genome modifications such as histone 
acetylation and DNA methylation would be important to understand host genes 
regulation in response to infection. 
6.3. CONCLUSION 
In conclusion, the results of this project have provided new insights into the 
biological differences between T. gondii and N. caninum, especially through the 
analysis of host cell signalling pathways in response to infection at the systems 
biology level. The results indicated that host cell responses to infection with T. 
gondii and N. caninum are not only restricted to immune modulation and inhibition 
of apoptosis, but they also include a system-wide modulation of the host cell 
including transcription regulation, protein metabolism and PTMs. The 
phosphoproteome of host cells largely overlapped between infection with T. gondii 
and N. caninum: such results were expected due to the fact that the genome and 
transcriptome of both parasites are relatively similar (Reid et al., 2012). However, 
differences in the phosphoproteome of host cells in response to infection with T. 
gondii and N. caninum were also observed and include the number of protein 
phosphorylations, phospho-motifs and signalling pathways. In addition, the 
quantified phosphopeptides were higher in T. gondii infection indicating that the host 
cell responds more to T. gondii compared to N. caninum and this could also mean 
that T. gondii manipulates more host cell signalling pathways as do N. caninum 
tachyzoites. These qualitative and quantitative differences in host-parasite 
interactions are potentially associated with the biological differences observed 
between these parasites, especially in terms of their virulence and transmission 
strategy. 
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APPENDIX 
Table I: All proteins identified by MS analyses of in-gel digestion from BN-PAGE and SDS-PAGE of N. caninum. Based on Mascot 
scoring, ions scores > 31 of an individual peptide indicate identity or extensive homology (p<0.05). 
Gel spot 
no.* (no. 
proteins 
identified) 
Protein accession Protein description Protein 
score 
Protein 
mass 
(Da) 
No. of 
significant 
protein 
sequences 
Protein 
coverage 
T. gondii orthologue 
(Protein ID accession)** 
1 (19) 
NCLIV_034460 Hypothetical protein 341 65224 6 11.6 
Cell division cycle 48 protein 
(TGME49_273090) 
NCLIV_001970 Unspecified product 171 67177 5 9.6 TgROP2 family member 
NCLIV_048570 Conserved hypothetical protein 151 28575 3 16.3 
Gliding-associated protein 45 
(GAP45) (TGME49_223940) 
NCLIV_049900 Hypothetical protein 106 93837 2 3.4 Myosin A (TGME49_235470) 
NCLIV_065750 
Alpha 2 subunit of 20S proteasome (ISS), 
related 
99 28771 3 11.6 - 
NCLIV_029420 Putative myosin light chain TgMLC1 98 25052 2 11.1 - 
NCLIV_019110 HSP90-like protein, related 73 97392 3 3.5 - 
NCLIV_048880 Proteasome subunit beta type-7, related 73 25629 2 9.5 - 
NCLIV_061160 Putative acid phosphatase 71 47250 1 3 - 
NCLIV_028230 Proteasome subunit alpha type-7, related 62 27566 1 5.7 - 
NCLIV_017470 Proteasome subunit alpha type, related 59 33463 1 3.7 - 
NCLIV_022220 Hypothetical protein 51 63784 2 3.1 
Mitochondrial-processing peptidase 
beta subunit, putative 
(TGME49_202680) 
NCLIV_033230 SRS domain-containing protein 51 33911 1 4.7 - 
NCLIV_050470 Hypothetical protein 49 60165 2 3.2 
Peptidase M16 family protein, 
putative (TGME49_236210) 
NCLIV_034470 Hypothetical protein 47 21721 1 4.2 No T. gondii orthologue is available 
NCLIV_003050 Putative myosin heavy chain 40 125340 1 1.3 - 
NCLIV_050770 Putative cation-transporting ATPase 34 244077 1 0.4 - 
NCLIV_042410 Putative sortilin 33 105595 1 1.3 - 
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NCLIV_055490 Heat shock protein 70 (Precursor), related 31 73215 1 1.5 - 
2 (12) 
NCLIV_032770 Hypothetical protein 112 102113 3 4 
Vacuolar proton-translocating 
ATPase subunit, putative 
(TGME49_232830) 
NCLIV_019110 HSP90-like protein, related 105 97392 4 6 - 
NCLIV_033230 SRS domain-containing protein 91 33911 2 8.8 - 
NCLIV_001970 Unspecified product 67 67177 3 5.2 TgROP2 family member 
NCLIV_003050 Putative myosin heavy chain 64 125340 1 0.9 - 
NCLIV_048590 Unspecified product 58 220934 1 0.8 
Rhoptry neck protein RON3 
(TGME49_223920) 
NCLIV_003650 Hypothetical protein 49 38097 1 4.2 
Cytochrome c oxidase subunit, 
putative (TGME49_209260) 
NCLIV_029800 Conserved hypothetical protein 41 17170 1 7.1 
Hypothetical protein 
(TGME49_257160) 
NCLIV_049080 Hypothetical protein 40 17718 1 5.3 
Vacuolar ATP synthetase 
(TGME49_212310) 
NCLIV_042690 
Putative vacuolar proton-translocating 
ATPase subunit 
38 121381 1 0.8 - 
NCLIV_045350 Conserved hypothetical protein 36 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
NCLIV_016800 
Putative TCP-1/cpn60 chaperonin family 
protein 
31 63060 1 1.7 - 
3 (15) 
NCLIV_011410 Protein disulfide isomerase 227 53333 6 12.7 - 
NCLIV_024820 14-3-3 protein homolog 97 30961 4 15 - 
NCLIV_010200 Hypothetical protein 96 35538 1 3.8 
Ribosomal protein RPL5 
(TGME49_320050) 
NCLIV_021050 Unspecified product 77 93761 2 2 
Subtilisin SUB1 
(TGME49_204050) 
NCLIV_053840 Unspecified product 72 38965 1 3.1 
Rhoptry protein ROP1 
(TGME49_309590) 
NCLIV_047630 Putative 40S ribosomal protein S18 62 17979 2 12.7 - 
NCLIV_048020 Hypothetical protein 57 36545 1 3 
Ribosomal protein RPSA 
(TGME49_266060) 
NCLIV_003440 Actin, related 53 42277 2 5.6 - 
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NCLIV_020220 Putative elongation factor 2 51 94169 1 1.3 - 
NCLIV_054700 Putative uridine phosphorylase 47 33380 1 4 - 
NCLIV_028540 Conserved hypothetical protein 46 30255 1 2.9 
Hypothetical protein 
(TGME49_255420) 
NCLIV_032290 SSU ribosomal protein S3P, related 41 26415 1 3.4 - 
NCLIV_043110 
Putative interferon gamma-inducible 
protein 30 
34 42952 1 3.1 - 
NCLIV_045350 Conserved hypothetical protein 32 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
NCLIV_008730 Hypothetical protein 31 18124 1 9 
Ribosomal protein RPL12 
(TGME49_254440) 
4 (22) 
NCLIV_011410 Protein disulfide isomerase 274 53333 9 18.2 - 
NCLIV_017370 
Putative CAMP-dependent protein kinase 
regulatory subunit 
92 43204 2 5.2 - 
NCLIV_010200 Hypothetical protein 76 35538 1 3.8 
Ribosomal protein RPL5 
(TGME49_320050) 
NCLIV_024870 Hypothetical protein 74 24203 1 5.2 
Ribosomal protein RPL13 
(TGME49_263050) 
NCLIV_021080 Hypothetical protein 72 28448 2 9.2 
Ribosomal protein RPL8 (RPL8) 
(TGME49_204020) 
NCLIV_053840 Unspecified product 71 38965 1 3.1 
Rhoptry protein ROP1 
(TGME49_309590) 
NCLIV_011270 Hypothetical protein 69 45133 3 6.4 
Phosphoglycerate kinase PGKI 
(TGME49_318230) 
NCLIV_046040 Hypothetical protein 60 18976 1 6.2 
Ribosomal protein RPS11 
(TGME49_226970) 
NCLIV_028540 Conserved hypothetical protein 53 30255 1 2.9 
Hypothetical protein 
(TGME49_255420) 
NCLIV_024820 14-3-3 protein homolog 52 30961 2 7.5 - 
NCLIV_003440 Actin, related 51 42277 1 2.7 - 
NCLIV_021050 Unspecified product 47 93761 1 0.9 
Subtilisin SUB1 
(TGME49_204050) 
NCLIV_008730 Hypothetical protein 40 18124 1 9 
Ribosomal protein RPL12 
(TGME49_254440) 
Appendix 
187 
 
NCLIV_029000 Conserved hypothetical protein 40 178459 1 1 
Tetratricopeptide repeat-containing 
protein (TGME49_256100) 
NCLIV_025240 Putative Gbp1p protein 39 32118 1 3.4 - 
NCLIV_033680 
Solute carrier family 25 (Mitochondrial 
carrier, dicarboxylate transporter), member 
10, related 
38 36863 1 2.4 - 
NCLIV_019970 
Peptidyl-prolyl cis-trans isomerase A, 
related 
38 19256 1 5.2 - 
NCLIV_048020 Hypothetical protein 37 36545 1 2.4 
Ribosomal protein RPSA 
(TGME49_266060) 
NCLIV_046820 
Putative pterin-4a-carbinolamine 
dehydratase 
36 12022 1 12.4 - 
NCLIV_047990 Conserved hypothetical protein 35 932829 1 0.1 
Phosphatidylinositol 3- and 4-
kinase (TGME49_266010) 
NCLIV_000740 Class I chitinase, related 34 75107 1 1.6 - 
NCLIV_011550 Novel protein (Zgc:77155), related 33 24657 1 4.8 - 
5 (2) 
NCLIV_044550 Conserved hypothetical protein 37 205533 1 0.6 
Myb family DNA-binding domain-
containing protein 
(TGME49_306320) 
NCLIV_042860 Conserved hypothetical protein 32 259558 1 0.4 
HEAT repeat-containing protein 
(TGME49_290990) 
6 (4) 
NCLIV_045350 Conserved hypothetical protein 42 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
NCLIV_053840 Unspecified product 40 38965 1 3.1 
Rhoptry protein ROP1 
(TGME49_309590) 
NCLIV_046230 
Putative cgmp-inhibited 3~,5~-cyclic 
phosphodiesterase 
35 317922 1 0.3 - 
NCLIV_040860 Tryptophanyl-trna synthetase, related 34 68374 1 1.3 - 
7 (1) NCLIV_045350 Conserved hypothetical protein 40 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
8 (4) 
NCLIV_070010 Hypothetical protein, conserved 209 329150 7 2.6 
Rhoptry neck protein RON8 
(TGME49_306060) 
NCLIV_042820 
cDNA FLJ58099, highly similar to Homo 
sapiens clathrin, heavy polypeptide-like 1 
99 196066 2 1.2 - 
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(CLTCL1), transcript variant 1, mRNA, 
related 
NCLIV_031970 Hypothetical protein 59 294704 3 1.4 
Pre-mRNA processing splicing 
factor PRP8 (TGME49_231970) 
NCLIV_045350 Conserved hypothetical protein 43 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
9 (6) 
NCLIV_007800 Unspecified product 86 213846 2 1.7 
Hypothetical protein 
(TGME49_253370) 
NCLIV_042820 
cDNA FLJ58099, highly similar to Homo 
sapiens clathrin, heavy polypeptide-like 1 
(CLTCL1), transcript variant 1, mRNA, 
related 
53 196066 3 2 - 
NCLIV_038320 Unspecified product 46 122855 1 1.4 
PAN domain-containing protein 
(TGME49_209920) 
NCLIV_045350 Conserved hypothetical protein 42 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
NCLIV_015430 Hypothetical protein 39 213813 1 0.7 
protein disulfide-isomerase domain-
containing protein 
(TGME49_238040) 
NCLIV_026260 GA26239, related 34 467672 1 0.2 - 
10 (6) 
NCLIV_042820 
cDNA FLJ58099, highly similar to Homo 
sapiens clathrin, heavy polypeptide-like 1 
(CLTCL1), transcript variant 1, mRNA, 
related 
243 196066 9 5 - 
NCLIV_070010 Hypothetical protein, conserved 177 329150 10 3.4 
Rhoptry neck protein RON8 
(TGME49_306060) 
NCLIV_048590 Unspecified product 135 220934 8 4.1 
Rhoptry neck protein RON3 
(TGME49_223920) 
NCLIV_029100 Putative SET domain containing protein 37 140267 1 0.9 - 
NCLIV_045350 Conserved hypothetical protein 33 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
NCLIV_058530 
Tetratricopeptide TPR_2 repeat protein, 
related 
32 62544 1 1.9 - 
11 (1) NCLIV_045350 Conserved hypothetical protein 36 108340 1 0.8 Hypothetical protein 
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(TGME49_228060) 
12 (6) 
NCLIV_064620 Unspecified product 215 165970 6 4.5 
Rhoptry neck protein RON2 
(TGME49_300100) 
NCLIV_025730 Conserved hypothetical protein 52 84225 1 1.3 
Rhoptry neck protein RON10 
(TGME49_261750) 
NCLIV_056900 AGAP005082-PA, related 43 1315974 1 0.1 - 
NCLIV_021870 Unspecified product 39 250434 1 0.4 
AP2 domain transcription factor 
AP2VIIa-6 (TGME49_203050) 
NCLIV_045350 Conserved hypothetical protein 38 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
NCLIV_006290 Conserved hypothetical protein 34 466790 1 0.2 
Hypothetical protein 
(TGME49_297210) 
13 (4) 
NCLIV_064620 Unspecified product 200 165970 6 4.5 
Rhoptry neck protein RON2 
(TGME49_300100) 
NCLIV_045350 Conserved hypothetical protein 48 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
NCLIV_032010 Putative protein phosphatase 2C 34 410004 1 0.2 - 
NCLIV_057960 Unspecified product 33 119961 1 1.1 
Rhoptry protein ROP14 
(TGME49_315220) 
14 (6) 
NCLIV_003050 Putative myosin heavy chain 158 125340 5 4.6 - 
NCLIV_021050 Unspecified product 100 93761 3 4.5 
Subtilisin SUB1 
(TGME49_204050) 
NCLIV_055360 Unspecified product 65 182101 2 2.1 
Rhoptry neck protein RON5 
(TGME49_311470) 
NCLIV_045350 Conserved hypothetical protein 36 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
NCLIV_043150 Conserved hypothetical protein 34 36835 1 3.1 
Hypothetical protein 
(TGME49_291650) 
NCLIV_042410 Putative sortilin 32 105595 1 1.3 - 
15 (5) 
NCLIV_055360 Unspecified product 112 182101 4 2.6 
Rhoptry neck protein RON5 
(TGME49_311470) 
NCLIV_036700 Putative M16 family peptidase 65 158286 1 0.9 - 
NCLIV_019110 HSP90-like protein, related 53 97392 2 2.6 - 
NCLIV_021050 Unspecified product 38 93761 1 0.8 Subtilisin SUB1 
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(TGME49_204050) 
NCLIV_048590 Unspecified product 32 220934 1 0.6 
Rhoptry neck protein RON3 
(TGME49_223920) 
16 (3) 
NCLIV_049900 Hypothetical protein 91 93837 1 1.8 myosin A (TGME49_235470) 
NCLIV_055360 Unspecified product 90 182101 2 2.4 
Rhoptry neck protein RON5 
(TGME49_311470) 
NCLIV_045350 Conserved hypothetical protein 34 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
17 (4) 
NCLIV_066100 Putative microtubule-binding protein 44 92401 1 1.9 - 
NCLIV_021050 Unspecified product 35 93761 1 1 
Subtilisin SUB1 
(TGME49_204050) 
NCLIV_045350 Conserved hypothetical protein 34 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
NCLIV_014060 Putative lysophospholipase 33 106908 1 0.8 - 
18 (3) 
NCLIV_001970 Unspecified product 134 67177 3 5.4 TgROP2 family member 
NCLIV_045350 Conserved hypothetical protein 51 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
NCLIV_060730 Unspecified product 44 61652 1 2.4 
Rhoptry protein ROP5 
(TGME49_308090) 
19 (4) 
NCLIV_054120 Unspecified product 98 121119 2 1.6 RON1 (TGME49_310010) 
NCLIV_028680 Putative apical membrane antigen 1  54 64401 1 1.4 - 
NCLIV_052500 Hypothetical protein 47 33213 1 4 
Flavoprotein subunit of succinate 
dehydrogenase 
NCLIV_045350 Conserved hypothetical protein 40 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
20 (2) 
NCLIV_001970 Unspecified product 165 67177 5 6.9 TgROP2 family member 
NCLIV_045350 Conserved hypothetical protein 34 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
21 (1) NCLIV_045350 Conserved hypothetical protein 34 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
22 (1) NCLIV_048300 Hypothetical protein 40 634244 1 0.2 
PHD-finger domain-containing 
protein (TGME49_224260) 
23 (3) NCLIV_042820 cDNA FLJ58099, highly similar to Homo 328 196066 9 4.9 - 
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sapiens clathrin, heavy polypeptide-like 1 
(CLTCL1), transcript variant 1, mRNA, 
related 
NCLIV_048590 Unspecified product 84 220934 4 2.3 
Rhoptry neck protein RON3 
(TGME49_223920) 
NCLIV_030080 
Putative peroxisomal multifunctional 
enzyme 
35 36206 1 3.7 - 
24 (4) 
NCLIV_064620 Unspecified product 270 165970 10 7.8 TgRON2 (TGME49_300100) 
NCLIV_045350 Conserved hypothetical protein 49 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
NCLIV_061250 Putative acetoacetyl-coA synthetase 36 57747 1 1.4 - 
NCLIV_000760 Conserved hypothetical protein 33 35979 1 2.6 
Hypothetical protein 
(TGME49_293790) 
26 (6) 
NCLIV_055360 Unspecified product 134 182101 8 4.9 
Rhoptry neck protein RON2 
(TGME49_300100) 
NCLIV_003050 Putative myosin heavy chain 82 125340 1 1.3 - 
NCLIV_019110 HSP90-like protein, related 76 97392 1 1.8 - 
NCLIV_042410 Putative sortilin 55 105595 1 1.3 - 
NCLIV_021050 Unspecified product 43 93761 1 1 
Subtilisin SUB1 
(TGME49_204050) 
NCLIV_048300 Hypothetical protein 34 634244 1 0.2 
PHD-finger domain-containing 
protein (TGME49_224260) 
27 (6) 
NCLIV_049900 Hypothetical protein 70 93837 1 1.7 Myosin A (TGME49_235470) 
NCLIV_055360 Unspecified product 47 182101 2 1 TgRON5 (TGME49_311470) 
NCLIV_048300 Hypothetical protein 38 634244 1 0.2 
PHD-finger domain-containing 
protein (TGME49_224260) 
NCLIV_019700 Conserved hypothetical protein 33 142302 1 0.6 
Hypothetical protein 
(TGME49_280450) 
NCLIV_015150 Conserved hypothetical protein 32 30925 1 2.9 
Hypothetical protein 
(TGME49_284570) 
NCLIV_044170 
Putative myosin head motor domain-
containing protein 
31 202943 1 0.8 - 
29 (10) 
NCLIV_055490 Heat shock protein 70 (Precursor), related 67 73215 2 14.8 - 
NCLIV_061920 Putative zinc finger (CCCH type) protein 43 123026 1 2.5 - 
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NCLIV_054120 Unspecified product 37 121119 1 2.6 RON1 (TGME49_310010) 
30 (1) NCLIV_001970 Unspecified product 235 67177 7 12.8 TgROP2 family member 
31 (7) 
NCLIV_001970 Unspecified product 220 67177 5 8.9 TgROP2 family member 
NCLIV_012920 Unspecified product 63 43319 2 4.8 TgROP40 (TGME49_291960) 
NCLIV_020840 Hypothetical protein 55 61971 1 2.1 
ATPase synthase subunit alpha, 
putative 
NCLIV_027600 Conserved hypothetical protein 39 63711 1 2.2 
Hypothetical protein 
(TGME49_258870) 
NCLIV_061250 Putative acetoacetyl-coA synthetase 38 57747 1 1.4 - 
NCLIV_025670 ATP synthase subunit beta, related 34 60327 1 1.8 - 
NCLIV_031670 Conserved hypothetical protein 33 66820 1 1.4 
Hypothetical protein 
(TGME49_231410) 
33 (9) 
NCLIV_053580 50S ribosomal protein L4P, related 170 46046 6 15.8 - 
NCLIV_001970 Unspecified product 130 67177 6 9.9 TgROP2 family member 
NCLIV_047530 Conserved hypothetical protein 85 69818 2 4.6 
Hypothetical protein 
(TGME49_225150) 
NCLIV_006180 Putative duplicated carbonic anhydrase 61 59137 2 3.8 - 
NCLIV_010710 SRS domain-containing protein 53 43258 1 3 - 
NCLIV_018120 Conserved hypothetical protein 45 75282 1 1.2 
Hypothetical protein 
(TGME49_243378) 
NCLIV_061040 Hypothetical protein 43 50946 2 4.2 
Dihydrolipoyllysine-residue 
succinyltransferase component of 
oxoglutarate dehydrogenase 
(TGME49_219550) 
NCLIV_012920 Unspecified product 42 43319 1 2.3 TgROP40 (TGME49_291960) 
NCLIV_061160 Putative acid phosphatase 33 47250 1 3.2 - 
34 (8) 
NCLIV_050470 Hypothetical protein 159 60165 5 8.3 
Peptidase M16 family protein  beta 
subunit, putative 
(TGME49_236210) 
NCLIV_022220 Hypothetical protein 124 63784 4 6.3 
Mitochondrial-processing peptidase 
beta subunit, putative 
(TGME49_202680) 
NCLIV_048570 Conserved hypothetical protein 96 28575 2 11.5 
Gliding-associated protein 45 
(GAP45) (TGME49_223940) 
Appendix 
193 
 
NCLIV_017370 
Putative CAMP-dependent protein kinase 
regulatory subunit 
93 43204 3 9.8 - 
NCLIV_061940 Hypothetical protein 88 52724 1 5.4 - 
NCLIV_011410 Protein disulfide isomerase 74 53333 1 2.5 - 
NCLIV_001970 Unspecified product 72 67177 3 5.4 TgROP2 family member 
NCLIV_046190 
Multidomain chromatinic protein with the 
following architecture: 3x PHD-bromo-
3xphd-SET domain and associated 
cysteine cluster at the C-terminus, related 
35 718468 1 0.1 - 
35 (5) 
NCLIV_010600 Putative microneme protein MIC3 105 40366 3 8.5  
NCLIV_011120 Malate dehydrogenase, related 48 34237 1 3.5 - 
NCLIV_060660 SRS domain-containing protein 38 39552 1 3.4 - 
NCLIV_018350 Conserved hypothetical protein 37 365390 1 0.3 
Hypothetical protein 
(TGME49_243635) 
37 (4) 
NCLIV_019110 HSP90-like protein, related 436 97392 17 20.4 - 
NCLIV_028570 Conserved hypothetical protein 34 30412 1 2.8 
Hypothetical protein 
(TGME49_255380) 
NCLIV_045350 Conserved hypothetical protein 33 108340 1 0.8 
Hypothetical protein 
(TGME49_228060) 
25, 28, 32, 
36 
No proteins identified 
* Gel spots 1-5 are from 1D BN-PAGE (Figure 2.3a) and spots 6-37 are from 2D BN/SDS-PAGE (Figure 2.3b) of N. caninum  
** Orthologue name of T. gondii protein for uncharacterised (hypothetical protein, unspecified product and conserved hypothetical protein) N. caninum proteins. 
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Table II: All proteins identified by MS analyses of in-gel digestion from BN-PAGE and SDS-PAGE of T. gondii. Based on Mascot 
scoring, ions scores > 31 of an individual peptide indicate identity or extensive homology (p<0.05).  
Gel spot no.* 
(no. proteins 
identified) 
Protein accession Protein description Protein score Protein mass Protein sequences 
significance 
Protein 
coverage 
2 (1) TGME49_308090 Rhoptry protein ROP5 (ROP5) 35 61403 1 2.9 
3 (2) 
TGME49_320220 Ubiquinol cytochrome c oxidoreductase, putative 113 55439 2 4.7 
TGME49_308090 Rhoptry protein ROP5 (ROP5) 70 61403 1 2.9 
TGME49_202680 Peptidase M16, alpha subunit, putative 59 62788 1 2.3 
TGME49_219320 Acid phosphatase GAP50 (GAP50) 58 46916 1 3 
TGME49_248160 Hypothetical protein 39 123821 1 0.7 
4 (3) 
TGME49_244560 Heat shock protein 90, putative 171 97159 5 7.8 
TGME49_219320 Acid phosphatase GAP50 (GAP50) 71 46916 1 3 
TGME49_248160 Hypothetical protein 40 123821 1 0.7 
6 (3) 
TGME49_201780 Microneme protein MIC2 (MIC2) 74 85030 2 3.5 
TGME49_248160 Hypothetical protein 47 123821 1 0.7 
TGME49_228250 
Elongation factor Tu GTP binding domain-containing 
protein 
31 123234 1 1.1 
7 (6) 
TGME49_233460 SAG-related sequence SRS29B (SRS29B) 157 35619 5 19.9 
TGME49_218520 Microneme protein MIC6 (MIC6) 66 37897 2 8 
TGME49_269190 
Glyceraldehyde-3-phosphate dehydrogenase GAPDH2 
(GAPDH2) 
45 106249 1 1.4 
TGME49_248810 Nuclear factor NF7 39 54531 1 2.8 
TGME49_232350 Lactate dehydrogenase LDH1 (LDH1) 32 36206 1 3.6 
9 (8) 
TGME49_211680 Protein disulfide isomerase 304 53165 9 22.5 
TGME49_263090 14-3-3 protein 215 37490 8 23.8 
TGME49_266060 Ribosomal protein RPSA (RPSA) 54 31831 2 8 
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TGME49_248390 Ribosomal protein RPL26 (RPL26) 52 16467 1 6.3 
TGME49_227620 Dense granule protein GRA2 (GRA2) 51 19960 1 5.9 
TGME49_262620 RNA recognition motif-containing protein 50 32022 1 3.7 
TGME49_254440 Ribosomal protein RPL12 (RPL12) 46 18092 1 6.6 
TGME49_226430 Reticulon protein 40 22401 1 5.1 
10 (1) TGME49_211680 Protein disulfide isomerase 499 53165 8 19.9 
11 (2) 
TGME49_221210 Cyclophilin 50 19703 1 7.8 
TGME49_215430 Hypothetical protein 32 27705 1 5.3 
12 (2) 
TGME49_290950 Clathrin heavy chain, putative 406 195918 8 5.9 
TGME49_257470 Myosin J 35 276135 1 0.4 
14 (1) TGME49_248160 Hypothetical protein 33 123821 1 0.7 
19 (2) 
TGME49_244560 Heat shock protein 90, putative 219 97159 5 7.9 
TGME49_248160 Hypothetical protein 37 123821 1 0.7 
20 (2) 
TGME49_248160 Hypothetical protein 48 123821 1 0.7 
TGME49_235470 Myosin A 32 93998 1 1.7 
21 (2) 
TGME49_247550 Heat shock protein HSP60 (HSP60) 70 61499 4 8.2 
TGME49_308090 Rhoptry protein ROP5 (ROP5) 46 61403 1 2.9 
24 (2) 
TGME49_221210 Cyclophilin 52 19703 1 7.8 
TGME49_242625 
ATPase family associated with various cellular activities 
(AAA) subfamily protein 
33 985689 1 0.1 
1, 5, 8, 13, 15-
18, 22-23 
No proteins identified 
* Gel spots 1-11 are from 1D BN-PAGE (Figure 2.4a) and spots 12-24 are from 2D BN/SDS-PAGE (Figure 2.4b) of T. gondii   
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Table III: DNA sequences of recombinant GRA gene used for expression of recombinant proteins.  
Gene name Accession 
number 
Gene sequences
1 
TgGRA2 TGME49_227620 
ATGTTCGCCGTAAAACATTGTTTGCTGGTTGTTGCCGTTGGCGCCCTGGTCAACGTCTCGGTGAGGGCTGCCGAGT
TTTCCGGAGTTGTTAACCAGGGACCAGTCGACGTGCCTTTCAGCGGTAAACCTCTTGATGAGAGAGCAGTTGGAGGAAAA
GGTGAACATACACCACCACTCCCAGACGAGAGGCAACAAGAGCCAGAAGAACCGGTTTCCCAACGTGCATCCAGAGTGG
CAGAACAACTGTTTCGCAAGTTCTTGAAGTTCGCTGAAAACGTCGGACAGCACAGTGAGAAGGCCTTCAAAAAAGCAAA
GGTGGTGGCAGAAAAAGGCTTCACCGCGGCAAAAACGCACACGGTTAGGGGTTTCAAGGTGGCCAAAGAAGCAGCTGG
AAGGGGCATGGTGACCGTTGGCAAGAAACTCGCGAATGTGGAGAGTGACAGAAGCACTACGACAACGCAGGCCCCCGA
CAGCCCTAATGGCCTGGCAGAAACCCAGGCTCCAGTGGAGCCCCAACAGCGGGCCGCACACGTGCCCGTCCCAGACTTTT
CGCAGTAA 
TgGRA7 TGME49_203310 
ATGGCCCGACACGCAATTTTTTTCGCGCTTTGTGTTTTAGGCCTGGTGGCGGCGGCTTTGCCCCAGTTCGCTACCG
CGGCCACCGCGTCAGATGACGAACTGATGAGTCGAATCCGAAATTCTGACTTTTTCGATGGTCAAGCACCCGTTGACAGT
CTCAGACCGACGAACGCCGGTGTCGACTCGAAAGGGACCGACGATCACCTCACCACCAGCATGGATAAGGCATCTGTAG
AGAGTCAGCTTCCGAGAAGAGAGCCATTGGAGACGGAGCCAGATGAACAAGAAGAAGTTCATTTCAGGAAGCGAGGCG
TCCGTTCCGACGCTGAAGTGACTGACGACAACATCTACGAGGAGCACACTGATCGTAAAGTGGTTCCGAGGAAGTCGGA
GGGCAAGCGAAGCTTCAAAGACTTGCTGAAGAAGCTCGCGCTGCCGGCTGTTGGTATGGGTGCATCGTATTTTGCCGCTG
ATAGAATTCTGCCGGAACTAACAGAGCAGCAACAGACAGGCGAAGAACCCCTAACCACCGGCCAGAATGTGAGCACTGT
GTTAGGCTTCGCAGCGCTTGCTGCTGCCGCAGCGTTCCTTGGCATGGGTCTCACGAGGACGTACCGACATTTTTCCCCACG
CAAAAACAGATCACGGCAGCCTGCACTCGAGCAAGAGGTGCCTGAATCAGGCAAAGATGGGGAGGATGCCCGCCAGTA
G 
NcGRA2 NCLIV_045650 
ATGTTCACGGGGAAACGTTGGATACTTGTTGTTGCCGTTGGCGCCCTGGTCGGCGCCTCGGTAAAGGCAGCCGATT
TTTCTGGCAGGGGAACCGTCAATGGACAGCCGGTTGGCAGCGGTTATTCCGGATATCCCCGTGGCGATGATGTTAGAGAA
TCAATGGCTGCACCCGAAGATCTGCCAGGCGAGAGGCAACCGGAGACACCCACGGCGGAAGCTGTAAAACAGGCAGCG
GCAAAAGCTTATCGATTACTCAAGCAGTTTACTGCGAAGGTCGGACAGGAAACTGAGAACGCCTACTACCACGTGAAGA
AAGCGACAATGAAAGGCTTTGACGTTGCAAAAGACCAGTCGTATAAGGGCTACTTGGCCGTCAGGAAAGCCACAGCTAA
GGGCCTGCAGAGCGCTGGCAAGAGCCTTGAGCTTAAAGAGTCGGCACCGACAGGCACTACGACTGCGGCGCCGACTGAA
AAAGTGCCCCCCAGTGGCCCGCGATCAGGTGAAGTTCAGCGTACTCGTAAAGAGCAAAATGACGTGCAGCAAACCGCAG
AGATGTTGGCTGAGGAAATTCTTGAGGCTGGGCTTAAGAAGGACGATGGAGAAGGACGGGGAACGCCAGAAGCTGAAG
TCAATTAA 
NcGRA7 NCLIV_021640 
ATGGCCCGACAAGCAACCTTCATCGTGGCTCTGTGCGTTTGTGGACTGGCAATCGCGGGCCTGCCGAGGCTCGCT
AGCGCTGGAGACTTGGCAACCGAACAGCATGAAGGGGACATCGGATATGGGGTTAGGGCATATGCCGGCGTTTCAAACT
ATGACGGCGATGACGATGCTGCAGGAAACCCTGTCGACTCGGATGTGACTGACGATGCCATTACAGATGGTGAGTGGCC
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ACGTGTTGTATCGGGGCAGAAGCCGCACACGACTCAGAAAGGCAGCTTGATCAAGAAGCTGGCAGTACCGGTGGTCGGC
GCTCTTACGTCGTATCTTGTTGCTGACAGGGTGCTGCCCGAGTTGACTTCTGCAGAAGAAGAAGGAACAGAGTCCATCCC
CGGTAAAAAACGTGTCAAGACTGCCGTGGGCATAGCCGCGTTAGTTGCAGCAGCCGCATTTGCTGGATTGGGTCTCGCGA
GAACATTCAGGCATTTCGTGCCAAAAAAGTCAAAGACGGTTGCGAGTGAGGACTCTGCGCTCGGAAACAGTGAAGAGCA
GTATGTGGAAGGAACCGTGAACGGGAGCAGTGATCCGGAACAGGAGCGGGCGGGTGGGCCTCTTATCCCGGAAGGAGA
CGAGCAGGAAGTAGACACCGAATAG 
6 × 
Histidine-
SUMO 
tag 
 
ATGGGTCATCACCATCATCATCACGGGTCCCTGCAGGACTCAGAAGTCAATCAAGAAGCTAAGCCAGAGGTCAAGCCAG
AAGTCAAGCCTGAGACTCACATCAATTTAAAGGTGTCCGATGGATCTTCAGAGATCTTCTTCAAGATCAAAAAGACCACT
CCTTTAAGAAGGCTGATGGAAGCGTTCGCTAAAAGACAGGGTAAGGAAATGGACTCCTTAAGATTCTTGTACGACGGTAT
TAGAATTCAAGCTGATCAGGCCCCTGAAGATTTGGACATGGAGGATAACGATATTATTGAGGCTCACCGCGAACAGATTG
G 
1
The underlined nucleotides are signal peptides coding sequences that are not included in the recombinant genes. 
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Table IV: Quantified phosphopeptides enriched using TiO2 using progenesis software from host cell infected by T. gondii and N. caninum 
at 20 hr p.i. 
Protein Accession Peptid
e score 
Phosphorylated sequence Modifications Protein description Max fold 
change 
Highest mean 
condition 
P value 
Q8NC51|PAIRB_HUMAN 97.88 SKSEEAHAEDSVMDHHFR [3] S+79.97 
Plasminogen activator inhibitor 1 
RNA-binding protein 
Infinity HFF-Tg* 2.81E-05 
P43243|MATR3_HUMAN 0 
RDSFDDRGPSLNPVLDYD
HGSR 
[3] S+79.97 Matrin-3 41.32084 HFF-Tg 4.66E-03 
O43399|TPD54_HUMAN 99.86 VEEEIVTLR [7] T+79.97 Tumor protein D54 29.11005 HFF-Tg 1.67E-04 
P23588|IF4B_HUMAN 0 SQSSDTEQQSPTSGGGK [1] S+79.97 
Eukaryotic translation initiation 
factor 4B 
26.03601 HFF-Tg 1.03E-04 
Q8N6H7|ARFG2_HUMAN 8.05 
HGTDLWIDNMSSAVPNHS
PEKK 
[11] S+79.97 
ADP-ribosylation factor GTPase-
activating protein 2 
20.42531 HFF-Tg 2.13E-02 
Q16643|DREB_HUMAN 97.18 
MAPTPIPTRSPSDSSTASTP
VAEQIER 
[10] S+79.97 Drebrin 16.87304 HFF-Tg 1.38E-03 
P27816|MAP4_HUMAN 80.57 
KKPCSETSQIEDTPSSKPTL
LANGGHGVEGSDTTGSPT
EFLEEK 
[4] 
C+58.01|[36] 
S+79.97 
Microtubule-associated protein 4 14.16188 HFF-Tg 2.50E-04 
P52926|HMGA2_HUMAN 75.61 KPAQEETEETSSQESAEED 
[10] 
T+79.97|[12] 
S+79.97 
High mobility group protein 
HMGI-C 
9.943278 HFF-Tg 1.61E-03 
Q9Y5K6|CD2AP_HUMAN 96.59 
TSSSETEEKKPEKPLILQSL
GPK 
[4] S+79.97 CD2-associated protein 8.733796 HFF-Tg 1.42E-03 
O60524|NEMF_HUMAN 99.94 LASKEESSNSSDSK [3] S+79.97 
Nuclear export mediator factor 
NEMF 
8.114517 HFF-Tg 1.17E-02 
Q9UNL2|SSRG_HUMAN 99.59 KLSEADNR [3] S+79.97 
Translocon-associated protein 
subunit gamma 
7.629456 HFF-Tg 5.93E-04 
Q9UQ35|SRRM2_HUMAN 0 YSHSGSSSPDTK [6] S+79.97 
Serine/arginine repetitive matrix 
protein 2 
7.62512 HFF-Tg 3.05E-04 
Q8IUD2|RB6I2_HUMAN 99.94 
RTNSTGGSSGSSVGGGSG
K 
[4] S+79.97 
ELKS/Rab6-interacting/CAST 
family member 1 
7.058231 HFF-Tg 5.00E-03 
P08238|HS90B_HUMAN 42.88 IEDVGSDEEDDSGKDKK [6] S+79.97 Heat shock protein HSP 90-beta 6.971021 HFF-Tg 4.05E-03 
P04792|HSPB1_HUMAN 99.9 GPSWDPFRDWYPHSR [3] S+79.97 Heat shock protein beta-1 6.915229 HFF-Tg 8.39E-03 
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P29966|MARCS_HUMAN 78.87 VNGDASPAAAESGAK 
[1] 
V+27.99|[12] 
S+79.97 
Myristoylated alanine-rich C-
kinase substrate 
6.854313 HFF-Tg 1.08E-04 
Q13459|MYO9B_HUMAN 99.94 
KKPGDASSLPDAGLSPGSQ
VDSK 
[15] S+79.97 Unconventional myosin-IXb 6.609514 HFF-Tg 4.06E-04 
Q8TD16|BICD2_HUMAN 6.69 TSPGGRTSPEAR 
[1] 
T+79.97|[8] 
S+79.97 
Protein bicaudal D homolog 2 6.548232 HFF-Tg 3.43E-02 
Q9H0D6|XRN2_HUMAN 99.94 KAEDSDSEPEPEDNVR 
[5] 
S+79.97|[7] 
S+79.97 
5'-3' exoribonuclease 2 6.272299 HFF-Tg 1.80E-02 
Q07960|RHG01_HUMAN 99.78 SSSPELVTHLK [3] S+79.97 Rho GTPase-activating protein 1 6.243514 HFF-Tg 5.20E-03 
Q9NWV8|BABA1_HUMAN 99.9 TRSNPEGAEDR [3] S+79.97 
BRISC and BRCA1-A complex 
member 1 
6.217384 HFF-Tg 3.59E-04 
O60256|KPRB_HUMAN 93.55 
LGIAVIHGEAQDAESDLVD
GRHSPPMVR 
[15] S+79.97 
Phosphoribosyl pyrophosphate 
synthase-associated protein 2 
5.859535 HFF-Tg 4.37E-02 
Q9UKV3|ACINU_HUMAN 99.89 SSSISEEKGDSDDEKPR [11] S+79.97 
Apoptotic chromatin 
condensation inducer in the 
nucleus 
5.837208 HFF-Tg 1.91E-03 
O60716|CTND1_HUMAN 97.77 GSLASLDSLR 
[2] 
S+79.97|[5] 
S+79.97 
Catenin delta-1 4.955117 HFF-Tg 2.28E-02 
P52569|CTR2_HUMAN 99.57 NLSSPFIFHEK [3] S+79.97 
Low affinity cationic amino acid 
transporter 2 
4.76651 HFF-Tg 3.13E-03 
Q8TBM8|DJB14_HUMAN 93.07 KPSGSGDQSKPNCTK 
[3] 
S+79.97|[13] 
C+57.02 
DnaJ homolog subfamily B 
member 14 
4.718028 HFF-Tg 2.42E-02 
Q8TF72|SHRM3_HUMAN 59.09 ERSGSMDNTSAR [3] S+79.97 Protein Shroom3 4.060433 HFF-Tg 1.50E-03 
Q12797|ASPH_HUMAN 97.98 
SSGNSSSSGSGSGSTSAGSS
SPGAR 
[20] S+79.97 
Aspartyl/asparaginyl beta-
hydroxylase 
3.967675 HFF-Tg 1.94E-02 
Q9NYF8|BCLF1_HUMAN 54.29 ETQSPEQVKSEK [2] T+79.97 
Bcl-2-associated transcription 
factor 1 
3.860327 HFF-Tg 2.12E-03 
Q15084|PDIA6_HUMAN 99.95 
DGELPVEDDIDLSDVELDD
LGKDEL 
[13] S+79.97 Protein disulfide-isomerase A6 3.729874 HFF-Tg 2.40E-02 
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O75351|VPS4B_HUMAN 99.6 
EGQPSPADEKGNDSDGEG
ESDDPEK 
[14] S+79.97 
Vacuolar protein sorting-
associated protein 4B 
3.714813 HFF-Tg 2.36E-02 
Q9C0C2|TB182_HUMAN 81.14 EHGVGGVSQCPEPGLR 
[8] 
S+79.97|[10] 
C+58.01|[11] 
P+31.99 
182 kDa tankyrase-1-binding 
protein 
3.345621 HFF-Tg 4.90E-03 
P46937|YAP1_HUMAN 97.35 GDSETDLEALFNAVMNPK 
[3] 
S+79.97|[8] 
E+21.98 
Yorkie homolog 3.232932 HFF-Tg 1.73E-02 
Q8NEY8|PPHLN_HUMAN 99.95 DTSPSSGSAVSSSK [3] S+79.97 Periphilin-1 3.197906 HFF-Tg 1.79E-02 
P05386|RLA1_HUMAN 99.83 KEESEESDDDMGFGLFD 
[7] 
S+79.97|[11] 
M+15.99 
60S acidic ribosomal protein P1 3.102044 HFF-Tg 3.37E-03 
Q96Q45|TM237_HUMAN 13.35 RPSEGNEPSTK [10] T+79.97 Transmembrane protein 237 2.865537 HFF-Tg 1.96E-02 
P60174|TPIS_HUMAN 81.96 KQSLGELIGTLNAAK 
[3] 
S+79.97|[15] 
K+21.98 
Triosephosphate isomerase 2.581143 HFF-Tg 9.38E-03 
P40123|CAP2_HUMAN 56.39 SHTPSPTSPK 
[3] 
T+79.97|[5] 
S+79.97 
Adenylyl cyclase-associated 
protein 2 
2.561357 HFF-Tg 2.22E-03 
Q9Y2D5|AKAP2_HUMAN 92.99 TNGHSPSQPR 
[1] 
T+79.97|[2] 
N+0.98 
A-kinase anchor protein 2 2.432455 HFF-Tg 4.26E-03 
O60271|JIP4_HUMAN 99.94 
ERPISLGIFPLPAGDGLLTP
DAQK 
[19] T+79.97 
C-Jun-amino-terminal kinase-
interacting protein 4 
2.355563 HFF-Tg 3.99E-02 
P31943|HNRH1_HUMAN 95.5 HTGPNSPDTANDGFVR [2] T+79.97 
Heterogeneous nuclear 
ribonucleoprotein H 
2.344253 HFF-Tg 3.57E-03 
P61978|HNRPK_HUMAN 99.84 DYDDMSPR [6] S+79.97 
Heterogeneous nuclear 
ribonucleoprotein K 
2.212441 HFF-Tg 1.68E-02 
Q00613|HSF1_HUMAN 98.1 
VEEASPGRPSSVDTLLSPT
ALIDSILR 
[11] S+79.97 Heat shock factor protein 1 2.10717 HFF-Tg 9.50E-03 
Q07065|CKAP4_HUMAN 99.92 GAHPSGGADDVAK [5] S+79.97 Cytoskeleton-associated protein 4 1.988499 HFF-Tg 1.62E-03 
Q86VR2|F134C_HUMAN 93.06 
GQTPLTEGSEDLDGHSDPE
ESFAR 
[21] S+79.97 Protein FAM134C 1.972753 HFF-Tg 1.95E-03 
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Q16555|DPYL2_HUMAN 97.84 TVTPASSAKTSPAK 
[1] 
T+79.97|[7] 
S+79.97|[11] 
S+79.97 
Dihydropyrimidinase-related 
protein 2 
1.883443 HFF-Tg 2.77E-02 
P05412|JUN_HUMAN 97.97 NSDLLTSPDVGLLK [6] T+79.97 Transcription factor AP-1 1.841234 HFF-Tg 7.56E-03 
Q9UPQ0|LIMC1_HUMAN 97.72 CSPTVAFVEFPSSPQLK 
[1] 
C+57.02|[2] 
S+79.97 
LIM and calponin homology 
domains-containing protein 1 
1.754757 HFF-Tg 2.67E-02 
P48681|NEST_HUMAN 97.29 ETLKSLGEEIQESLK [5] S+79.97 Nestin 1.704636 HFF-Tg 7.41E-03 
Q969E4|TCAL3_HUMAN 98 GTDDSPKDSQEDLQER [2] T+79.97 
Transcription elongation factor A 
protein-like 3 
1.6973 HFF-Tg 3.06E-03 
Q15942|ZYX_HUMAN 99.88 
EKVSSIDLEIDSLSSLLDDM
TK 
[4] 
S+79.97|[20] 
M+15.99 
Zyxin 1.670009 HFF-Tg 5.89E-03 
P07355|ANXA2_HUMAN 0 
STVHEILCKLSLEGDHSTP
PSAYGSVK 
[1] 
S+42.01|[8] 
C+57.02|[11] 
S+79.97 
Annexin A2 1.630623 HFF-Tg 4.43E-02 
O75822|EIF3J_HUMAN 97.92 
AAAAAAAGDSDSWDADA
FSVEDPVRK 
[1] 
A+42.01|[10] 
S+79.97 
Eukaryotic translation initiation 
factor 3 subunit J 
1.609533 HFF-Tg 4.94E-02 
P46821|MAP1B_HUMAN 99.93 SDISPLTPR [4] S+79.97 
Microtubule-associated protein 
1B 
1.58957 HFF-Tg 2.13E-03 
Q86VM9|ZCH18_HUMAN 93.41 RPNTSPDRGSR 
[4] 
T+79.97|[10] 
S+79.97 
Zinc finger CCCH domain-
containing protein 18 
1.580815 HFF-Tg 6.61E-03 
P35221|CTNA1_HUMAN 99.93 SRTSVQTEDDQLIAGQSAR 
[1] 
S+79.97|[4] 
S+79.97 
Catenin alpha-1 1.570152 HFF-Tg 4.89E-02 
P04264|K2C1_HUMAN 53.81 SSGGSSSVK [1] S+79.97 Keratin, type II cytoskeletal 1 1.539394 HFF-Tg 2.76E-02 
P22059|OSBP1_HUMAN 81.44 
GVAAAGPAPAPPTGGSGG
SGAGGSGSAR 
[24] S+79.97 Oxysterol-binding protein 1 169.1061 HFF-Nc** 4.28E-03 
O00193|SMAP_HUMAN 97.47 
SASPDDDLGSSNWEAADL
GNEER 
[1] S+79.97 Small acidic protein 22.31701 HFF-Nc 2.50E-02 
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Q9NQC3|RTN4_HUMAN 80.68 SDSPPRPQPAFK [1] S+79.97 Reticulon-4 14.44466 HFF-Nc 7.77E-05 
O15427|MOT4_HUMAN 99.81 LHKPPADSGVDLR [8] S+79.97 Monocarboxylate transporter 4 14.37004 HFF-Nc 2.29E-04 
Q05519|SRS11_HUMAN 0 
TAGPGPSGGPGGGGGGGG
GGGGTEVIQ 
[1] 
T+42.01|[7] 
S+79.97 
Serine/arginine-rich splicing 
factor 11 
12.54036 HFF-Nc 5.32E-04 
Q8NE71|ABCF1_HUMAN 92.59 
GGNVFAALIQDQSEEEEEE
EKHPPKPAKPEK 
[13] S+79.97 
ATP-binding cassette sub-family 
F member 1 
11.62282 HFF-Nc 2.55E-03 
Q92538|GBF1_HUMAN 99.56 GYTSDSEVYTDHGRPGK [4] S+79.97 
Golgi-specific brefeldin A-
resistance guanine nucleotide 
exchange factor 1 
11.16622 HFF-Nc 4.24E-03 
Q6NZI2|PTRF_HUMAN 98.07 RGSSPDVHALLEIT 
[3] 
S+79.97|[4] 
S+79.97 
Polymerase I and transcript 
release factor 
11.07213 HFF-Nc 2.59E-04 
Q15746|MYLK_HUMAN 99.94 KSSTGSPTSPLNAEK 
[3] 
S+79.97|[6] 
S+79.97 
Myosin light chain kinase, smooth 
muscle 
4.604182 HFF-Nc 3.96E-03 
P04406|G3P_HUMAN 0 
VIHDNFGIVEGLMTTVHAI
TATQK 
[20] T+79.97 
Glyceraldehyde-3-phosphate 
dehydrogenase 
4.391173 HFF-Nc 3.12E-03 
Q14247|SRC8_HUMAN 7.34 
TQTPPVSPAPQPTEERLPSS
PVYEDAASFK 
[1] 
T+79.97|[23] 
Y+79.97 
Src substrate cortactin 2.927259 HFF-Nc 2.46E-03 
Q8IWB9|TEX2_HUMAN 99.27 SLSTEVEPK [3] S+79.97 
Testis-expressed sequence 2 
protein 
2.626984 HFF-Nc 3.18E-02 
P29692|EF1D_HUMAN 89.82 ATAPQTQHVSPMR [10] S+79.97 Elongation factor 1-delta 2.260407 HFF-Nc 4.92E-02 
Q9Y6F6|MRVI1_HUMAN 89.4 GLSWDSGPEEPGPR [3] S+79.97 Protein MRVI1 2.144264 HFF-Nc 2.72E-02 
P29590|PML_HUMAN 99.48 AVSPPHLDGPPSPR 
[3] 
S+79.97|[12] 
S+79.97 
Protein PML 2.10862 HFF-Nc 1.03E-03 
Q3KQU3|MA7D1_HUMAN 98.09 
ESAAPASPAPSPAPSPTPAP
PQK 
[2] 
S+79.97|[11] 
S+79.97|[15] 
S+79.97 
MAP7 domain-containing protein 
1 
2.088762 HFF-Nc 1.79E-02 
Q96CV9|OPTN_HUMAN 99.85 KNSAIPSELNEK [3] S+79.97 Optineurin 2.082669 HFF-Nc 4.04E-02 
Q8WWI1|LMO7_HUMAN 99.94 EDSFESLDSLGSR [3] S+79.97 LIM domain only protein 7 1.993567 HFF-Nc 3.07E-03 
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P10644|KAP0_HUMAN 99.94 EDEISPPPPNPVVK [5] S+79.97 
cAMP-dependent protein kinase 
type I-alpha regulatory subunit 
1.893618 HFF-Nc 2.08E-02 
P42167|LAP2B_HUMAN 99.69 SSTPLPTISSSAENTR [1] S+79.97 
Lamina-associated polypeptide 2, 
isoforms beta/gamma 
1.862157 HFF-Nc 3.97E-03 
Q13439|GOGA4_HUMAN 99.94 TSSFTEQLDEGTPNR [1] T+79.97 Golgin subfamily A member 4 1.83503 HFF-Nc 4.55E-03 
O95817|BAG3_HUMAN 98.06 
VPPAPVPCPPPSPGPSAVPS
SPK 
[8] 
C+57.02|[12] 
S+79.97|[20] 
S+79.97 
BAG family molecular chaperone 
regulator 3 
1.830106 HFF-Nc 2.47E-02 
Q9H1E3|NUCKS_HUMAN 99.81 LKATVTPSPVK [6] T+79.97 
Nuclear ubiquitous casein and 
cyclin-dependent kinase substrate 
1 
1.823225 HFF-Nc 3.71E-02 
O43294|TGFI1_HUMAN 99.87 KRPSLPSSPSPGLPK 
[4] 
S+79.97|[10] 
S+79.97 
Transforming growth factor beta-
1-induced transcript 1 protein 
1.81477 HFF-Nc 1.66E-02 
P02545|LMNA_HUMAN 98.05 ASSHSSQTQGGGSVTKK 
[2] 
S+79.97|[6] 
S+79.97 
Prelamin-A/C 1.789225 HFF-Nc 2.22E-02 
P21333|FLNA_HUMAN 96.67 RAPSVANVGSHCDLSLK 
[4] 
S+79.97|[12] 
C+57.02 
Filamin-A 1.739089 HFF-Nc 4.98E-03 
P78559|MAP1A_HUMAN 99.93 VPSAPGQESPIPDPK [9] S+79.97 
Microtubule-associated protein 
1A 
1.688718 HFF-Nc 6.44E-03 
Q96PE2|ARHGH_HUMAN 97.25 SLSDPIPQR [3] S+79.97 
Rho guanine nucleotide exchange 
factor 17 
1.663462 HFF-Nc 2.32E-02 
Q969G5|PRDBP_HUMAN 99.94 IQSGLGALSR [3] S+79.97 
Protein kinase C delta-binding 
protein 
1.62541 HFF-Nc 1.44E-02 
Q68CZ2|TENS3_HUMAN 99.93 
KLSLGQYDNDAGGQLPFS
K 
[3] S+79.97 Tensin-3 1.621837 HFF-Nc 4.04E-02 
O14558|HSPB6_HUMAN 99.93 RASAPLPGLSAPGR [3] S+79.97 Heat shock protein beta-6 1.609559 HFF-Nc 9.53E-03 
Q8IYB3|SRRM1_HUMAN 99.91 SRVSVSPGR 
[4] 
S+79.97|[6] 
S+79.97 
Serine/arginine repetitive matrix 
protein 1 
1.585139 HFF-N 1.19E-03 
P02794|FRIH_HUMAN 88.05 MGAPESGLAEYLFDKHTL [1] Ferritin heavy chain 1.579336 HFF-Nc 3.79E-02 
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GDSDNES M+15.99|[17] 
T+79.97 
Q641Q2|FA21A_HUMAN 93.21 SRPTSFADELAAR 
[1] 
S+79.97|[5] 
S+79.97 
WASH complex subunit 
FAM21A 
1.559013 HFF-Nc 1.07E-02 
Q14195|DPYL3_HUMAN 97.76 GSPTRPNPPVR [2] S+79.97 
Dihydropyrimidinase-related 
protein 3 
1.558031 HFF-Nc 1.20E-02 
P68363|TBA1B_HUMAN 99.83 SIQFVDWCPTGFK 
[1] 
S+79.97|[8] 
C+57.02 
Tubulin alpha-1B chain 1.548237 HFF-Nc 6.77E-03 
Q8N3V7|SYNPO_HUMAN 99.94 AASPAKPSSLDLVPNLPK [3] S+79.97 Synaptopodin 1.516943 HFF-Nc 2.82E-02 
P29536|LMOD1_HUMAN 99.86 NSLSPATQR [4] S+79.97 Leiomodin-1 1.50808 HFF-Nc 9.96E-03 
* Maximum fold change of phosphopeptides quantified from host cell infected by T. gondii at 20 hr p.i. 
** Maximum fold change of phosphopeptides quantified from host cell infected by N. caninum at 20 hr p.i. 
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Table V: Upstream analysis of quantified phosphopeptides from host cell 
infected with T. gondii   
Upstream Regulator Molecule Type p-value of overlap Target molecules 
in dataset 
Integrin Complex 8.36E-03 JUN 
Lh Complex 2.04E-02 
ARHGAP1,CAP2
,CTNND1 
FSH Complex 3.90E-02 
ARHGAP1,CAP2
,CTNND1 
CXCL12 Cytokine 8.29E-03 JUN,MARCKS 
MIF Cytokine 3.03E-02 JUN 
IL22 Cytokine 3.84E-02 KRT1 
RNF187 Enzyme 5.58E-03 JUN 
TRAF7 Enzyme 5.58E-03 JUN 
DDX17 Enzyme 1.66E-02 JUN 
DDX5 Enzyme 2.21E-02 JUN 
UPF1 Enzyme 3.84E-02 HMGA2 
FN1 Enzyme 4.38E-02 NES 
Beta Secretase Group 5.58E-03 NES 
Pkg Group 1.11E-02 JUN 
ERK Group 2.21E-02 DPYSL2,JUN 
CACNA1C Ion channel 8.36E-03 ANXA2 
MAP3K3 Kinase 8.36E-03 JUN 
MAPK12 Kinase 8.36E-03 JUN 
PIK3C2B Kinase 8.36E-03 KRT1 
PINK1 Kinase 8.36E-03 NES 
MAPK7 Kinase 8.36E-03 JUN 
EGFR Kinase 1.51E-02 
HNRNPH1,MAR
CKS 
CSF1R Kinase 1.66E-02 JUN 
ERBB4 Kinase 2.21E-02 JUN 
RARB 
Ligand-dependent 
nuclear receptor 
2.76E-02 KRT1 
ESRRG 
Ligand-dependent 
nuclear receptor 
4.11E-02 TPI1 
miR-142-3p (and other 
miRNAs w/seed GUAGUGU) 
Mature microrna 8.36E-03 BCLAF1 
miR-200b-3p (and other 
miRNAs w/seed AAUACUG) 
Mature microrna 2.49E-02 MARCKS 
let-7a-5p (and other miRNAs 
w/seed GAGGUAG) 
Mature microrna 2.49E-02 HMGA2 
miR-16-5p (and other miRNAs 
w/seed AGCAGCA) 
Mature microrna 3.84E-02 ZYX 
mir-375 Microrna 2.79E-03 YAP1 
mir-33 Microrna 2.79E-03 HMGA2 
mir-1 Microrna 4.11E-02 ANXA2 
mir-8 Microrna 4.11E-02 YAP1 
FILIP1L Other 2.79E-03 HSF1 
CCDC80 Other 2.79E-03 BCLAF1 
SEMA3A Other 5.58E-03 MAP1B 
RPL15 Other 5.58E-03 HMGA2 
PRR7 Other 8.36E-03 JUN 
KLHL2 Other 8.36E-03 JUN 
N4BP1 Other 8.36E-03 JUN 
RPL5 Other 8.36E-03 HMGA2 
RPS11 Other 1.11E-02 HMGA2 
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RPL11 Other 1.11E-02 HMGA2 
RPS18 Other 1.11E-02 HMGA2 
RPL35A Other 1.11E-02 HMGA2 
RPL12 Other 1.11E-02 HMGA2 
RPS15 Other 1.39E-02 HMGA2 
RPS12 Other 1.39E-02 HMGA2 
ALCAM Other 1.39E-02 YAP1 
S100A10 Other 1.66E-02 ANXA2 
THY1 Other 1.94E-02 NES 
BAG1 Other 1.94E-02 JUN 
MEMO1 Other 2.21E-02 JUN 
TINCR Other 2.21E-02 KRT1 
SPARC Other 2.21E-02 NES 
PDCD4 Other 2.21E-02 JUN 
FAT1 Other 2.49E-02 JUN 
CD9 Other 2.76E-02 YAP1 
PNN Other 3.30E-02 JUN 
CUL4B Other 4.38E-02 TPI1 
APP Other 4.91E-02 NES 
PTPRR Phosphatase 1.66E-02 JUN 
MEF2A 
Transcription 
regulator 
5.58E-03 JUN 
MYC 
Transcription 
regulator 
1.25E-02 HSPB1,JUN,TPI1 
TAF6 
Transcription 
regulator 
1.94E-02 JUN 
NANOG 
Transcription 
regulator 
2.21E-02 
HNRNPH1,MAP
1B 
SATB1 
Transcription 
regulator 
2.62E-02 CTNNA1,RPLP1 
HOXA13 
Transcription 
regulator 
3.30E-02 SHROOM3 
CARM1 
Transcription 
regulator 
3.84E-02 KRT1 
SNAI2 
Transcription 
regulator 
4.11E-02 NES 
ATF2 
Transcription 
regulator 
4.38E-02 JUN 
TCF7L2 
Transcription 
regulator 
4.65E-02 YAP1 
ITGA5 
Transmembrane 
receptor 
1.66E-02 JUN 
BCL2 Transporter 2.21E-02 NES 
STAU1 Transporter 2.49E-02 KRT1 
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Table VI: Upstream analysis of quantified phosphopeptides from host cell 
infected with N. caninum   
Upstream 
Regulator 
Molecule Type p-value of overlap Target molecules in 
dataset 
F Actin Complex 1.86E-03 FLNA 
IgG1 Complex 1.11E-02 CTTN 
TNF cytokine 4.74E-02 MYLK,PML,SYNPO 
RALBP1 Enzyme 1.86E-03 GAPDH 
PLCB1 Enzyme 1.86E-03 GAPDH 
FTL Enzyme 3.72E-03 FTH1 
ACO1 Enzyme 7.43E-03 FTH1 
SUZ12 Enzyme 8.60E-03 MAP7D1,TNS3 
NEIL2 Enzyme 1.11E-02 GAPDH 
NDUFA13 Enzyme 1.11E-02 CTTN 
UBE3A Enzyme 1.66E-02 PML 
PIN1 Enzyme 2.39E-02 PML 
PRMT1 Enzyme 2.58E-02 FTH1 
POLR2A Enzyme 4.73E-02 GAPDH 
HCAR1 
G-protein coupled 
receptor 
7.43E-03 SLC16A3 
Lamin b Group 1.86E-03 LMNA 
Actin Group 5.58E-03 FLNA 
VEGFC Growth factor 1.86E-03 CTTN 
MAPK9 Kinase 1.31E-04 GAPDH,LMNA,LMO7 
PRKAR2A Kinase 3.72E-03 PRKAR1A 
PRKAR2B Kinase 9.28E-03 PRKAR1A 
SHC1 Kinase 2.21E-02 FTH1 
ESRRG 
Ligand-dependent 
nuclear receptor 
2.76E-02 GAPDH 
NR3C1 
Ligand-dependent 
nuclear receptor 
3.30E-02 BAG3,PRKAR1A,RTN4 
NUBP1 Other 3.72E-03 FTH1 
STMN1 Other 5.58E-03 TUBA1B 
SMARCA4 
Transcription 
regulator 
3.38E-03 GAPDH,LMNA,MYLK 
PIAS3 
Transcription 
regulator 
5.58E-03 FTH1 
NFYC 
Transcription 
regulator 
7.43E-03 FTH1 
FOSB 
Transcription 
regulator 
7.43E-03 FTH1 
BARX2 
Transcription 
regulator 
1.30E-02 FLNA 
TAF6 
Transcription 
regulator 
1.30E-02 GAPDH 
NFYB 
Transcription 
regulator 
2.03E-02 FTH1 
ATF1 
Transcription 
regulator 
2.58E-02 FTH1 
CARM1 
Transcription 
regulator 
2.58E-02 FTH1 
BACH1 
Transcription 
regulator 
2.58E-02 FTH1 
NFE2L2 
Transcription 
regulator 
2.76E-02 FTH1 
KMT2A 
Transcription 
regulator 
2.76E-02 BAG3 
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SMARCA2 
Transcription 
regulator 
2.94E-02 MYLK 
ATF2 
Transcription 
regulator 
2.94E-02 MYLK 
JUND 
Transcription 
regulator 
3.30E-02 FTH1 
VHL 
Transcription 
regulator 
3.66E-02 FTH1 
NFYA 
Transcription 
regulator 
3.66E-02 FTH1 
GTF2B 
Transcription 
regulator 
3.84E-02 GAPDH 
JUNB 
Transcription 
regulator 
4.02E-02 FTH1 
HIF1A 
Transcription 
regulator 
4.12E-02 GAPDH,NUCKS1 
HDAC6 
Transcription 
regulator 
4.20E-02 TGFB1I1 
DRAP1 
Transcription 
regulator 
4.20E-02 GAPDH 
IREB2 Translation regulator 5.58E-03 FTH1 
CAV1 
Transmembrane 
receptor 
2.39E-02 PTRF 
ABCB7 Transporter 5.58E-03 FTH1 
HNRNPU Transporter 1.11E-02 GAPDH 
S100A6 Transporter 4.91E-02 TMPO 
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Table VII: Biological processes enriched from host transcripts significantly overexpressed in N. caninum infection at 36 hr p.i. 
Biological processes Count % PValue Genes List 
Total 
Pop 
Hits 
Pop 
Total 
Fold 
Enrichment 
Negative regulation of cellular protein metabolic 
process 
4 17.39 0.001919 P43686, P17980, P38919, P01023 20 180 13528 15.031 
Negative regulation of protein metabolic process 4 17.39 0.00214 P43686, P17980, P38919, P01023 20 187 13528 14.468 
Regulation of cellular protein metabolic process 5 21.74 0.003794 P43686, P60033, P17980, P38919, P01023 20 474 13528 7.1350 
Ubiquitin-dependent protein catabolic process 4 17.39 0.004433 Q16531, P43686, P17980 20 242 13528 11.180 
Immune response 5 21.74 0.014087 P30443, Q86WV6, Q01628, P01024, P02794 20 690 13528 4.9014 
Cellular macromolecule catabolic process 5 21.74 0.016644 Q16531, P43686, P17980, P38919 20 725 13528 4.6648 
Macromolecule catabolic process 5 21.74 0.021324 Q16531, P43686, P17980, P38919 20 781 13528 4.3303 
Protein ubiquitination during ubiquitin-dependent 
protein catabolic process 
2 8.696 0.023624 Q16531 20 17 13528 79.576 
Positive regulation of protein modification process 3 13.04 0.027854 P43686, P60033, P17980 20 187 13528 10.851 
Regulation of acute inflammatory response 2 8.696 0.029105 P01024, P01023 20 21 13528 64.419 
Nucleotide-excision repair, DNA damage removal 2 8.696 0.030471 Q16531 20 22 13528 61.490 
Positive regulation of cellular protein metabolic 
process 
3 13.04 0.041669 P43686, P60033, P17980 20 233 13528 8.7090 
Modification-dependent macromolecule catabolic 
process 
4 17.39 0.044396 Q16531, P43686, P17980 20 574 13528 4.7135 
Modification-dependent protein catabolic process 4 17.39 0.044396 Q16531, P43686, P17980 20 574 13528 4.7135 
Positive regulation of protein metabolic process 3 13.04 0.044957 P43686, P60033, P17980 20 243 13528 8.3506 
Proteolysis involved in cellular protein catabolic 
process 
4 17.39 0.049565 Q16531, P43686, P17980 20 600 13528 4.5093 
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Table VIII: Biological processes enriched from host transcripts significantly overexpressed in T. gondii infection at 36 hr p.i. 
Biological processes Count % PValue Genes List 
Total 
Pop 
Hits 
Pop 
Total 
Fold 
Enrichment 
Translational elongation 10 10 2.37E-08 
P36578, P05387, P62750, P35268, P84098, P61247, P62906, 
Q02878, P62081, P62851 
92 101 13528 14.558 
Translation 12 12 1.32E-05 
P36578, P07814, P05387, P62750, P35268, P84098, P61247, 
P62906, Q02878, P62081, P62851, P41091 
92 331 13528 5.3308 
Protein amino acid N-linked 
glycosylation via asparagine 
4 4 3.42E-05 Q8TCJ2, P04843, Q9H0U3, P46977 92 10 13528 58.817 
peptidyl-asparagine modification 4 4 3.42E-05 Q8TCJ2, P04843, Q9H0U3, P46977 92 10 13528 58.817 
RNA processing 14 14 7.11E-05 
Q9Y3F4, Q9Y2X3, O75533, P62081, O00567, Q07955, 
P11940, Q08170, P62906, Q9UQ80, P62995, Q6P2Q9, 
Q00839, P38159 
92 547 13528 3.7634 
Intracellular transport 15 15 1.18E-04 
P09936, Q01105, P53007, Q14974, P49257, Q9Y2X3, 
P43307, P38646, P09038, P27348, P11142, P61106, P62258, 
P62826, Q00610 
92 657 13528 3.3571 
Establishment of protein localization 16 16 1.75E-04 
Q14974, P49257, Q9Y2X3, P02452, Q9NP72, P43307, 
P38646, P13667, P09038, P27348, P61106, P17301, P14625, 
P62258, P62826, Q00610 
92 769 13528 3.0594 
Protein folding 8 8 1.87E-04 
P11142, Q14554, P08238, P14625, P78371, P17987, P49257, 
P38646 
92 177 13528 6.6460 
Protein amino acid N-linked 
glycosylation 
5 5 2.12E-04 Q8TCJ2, Q16706, P04843, Q9H0U3, P46977 92 44 13528 16.709 
Protein transport 15 15 5.38E-04 
Q14974, P49257, Q9Y2X3, P02452, Q9NP72, P43307, 
P38646, P13667, P09038, P27348, P61106, P14625, P62258, 
P62826, Q00610 
92 762 13528 2.8945 
RNA splicing, via transesterification 
reactions 
7 7 5.73E-04 
Q07955, Q08170, O75533, P62995, Q6P2Q9, Q00839, 
P38159 
92 153 13528 6.7274 
nuclear mRNA splicing, via spliceosome 7 7 5.73E-04 
Q07955, Q08170, O75533, P62995, Q6P2Q9, Q00839, 
P38159 
92 153 13528 6.7274 
RNA splicing, via transesterification 
reactions with bulged adenosine as 
nucleophile 
7 7 5.73E-04 
Q07955, Q08170, O75533, P62995, Q6P2Q9, Q00839, 
P38159 
92 153 13528 6.7274 
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Protein targeting 8 8 6.07E-04 
P09038, P27348, Q14974, P62258, Q9Y2X3, P62826, 
P43307, P38646 
92 215 13528 5.4713 
RNA splicing 9 9 6.44E-04 
Q07955, P11940, Q9Y3F4, Q08170, O75533, P62995, 
Q6P2Q9, Q00839, P38159 
92 284 13528 4.6598 
Protein localization 16 16 7.50E-04 
Q14974, P49257, Q9Y2X3, P02452, Q9NP72, P43307, 
P38646, P13667, P09038, P27348, P61106, P17301, P14625, 
P62258, P62826, Q00610 
92 882 13528 2.6674 
Regulation of cellular protein metabolic 
process 
11 11 0.001285 
P09038, P48556, O43242, Q13200, Q01105, P08238, P17301, 
P62258, Q9UQ80, P07996, P04792 
92 474 13528 3.4124 
Negative regulation of cellular protein 
metabolic process 
7 7 0.001336 P48556, O43242, Q13200, Q01105, P08238, P62258, P07996 92 180 13528 5.7183 
mRNA processing 9 9 0.001418 
Q07955, P11940, Q9Y3F4, Q08170, O75533, P62995, 
Q6P2Q9, Q00839, P38159 
92 321 13528 4.1227 
Negative regulation of protein metabolic 
process 
7 7 0.001623 P48556, O43242, Q13200, Q01105, P08238, P62258, P07996 92 187 13528 5.5043 
mRNA metabolic process 9 9 0.003424 
Q07955, P11940, Q9Y3F4, Q08170, O75533, P62995, 
Q6P2Q9, Q00839, P38159 
92 370 13528 3.5767 
Intracellular protein transport 9 9 0.003655 
P09038, P27348, Q14974, P62258, Q9Y2X3, Q00610, 
P62826, P43307, P38646 
92 374 13528 3.5384 
Nucleocytoplasmic transport 6 6 0.004011 P09038, Q14974, Q01105, Q9Y2X3, P62826, P38646 92 156 13528 5.6555 
Nuclear transport 6 6 0.004234 P09038, Q14974, Q01105, Q9Y2X3, P62826, P38646 92 158 13528 5.5839 
Macromolecular complex assembly 12 12 0.004925 
Q07955, P0C0S5, P07814, Q14974, Q01105, P21980, 
P17987, P07305, Q9NVA2, Q9BUF5, Q5SSJ5, Q16181 
92 665 13528 2.6534 
Cellular macromolecular complex 
assembly 
8 8 0.00557 
Q07955, P0C0S5, Q14974, Q01105, P17987, P07305, 
Q9BUF5, Q5SSJ5 
92 318 13528 3.6992 
Response to protein stimulus 5 5 0.005838 P11142, O00299, P08238, P17301, P04792 92 107 13528 6.8711 
Blood vessel development 7 7 0.006143 P09038, P21980, P02452, P15144, P02461, P07996, Q6UVK1 92 245 13528 4.2012 
Cellular protein localization 9 9 0.006402 
P09038, P27348, Q14974, P62258, Q9Y2X3, Q00610, 
P62826, P43307, P38646 
92 411 13528 3.2199 
Cellular macromolecule localization 9 9 0.006679 
P09038, P27348, Q14974, P62258, Q9Y2X3, Q00610, 
P62826, P43307, P38646 
92 414 13528 3.1965 
Vasculature development 7 7 0.00689 P09038, P21980, P02452, P15144, P02461, P07996, Q6UVK1 92 251 13528 4.1008 
Positive regulation of cell adhesion 4 4 0.007642 P21980, P17301, P07996, Q53GQ0 92 60 13528 9.8028 
Macromolecular complex subunit 12 12 0.007945 Q07955, P0C0S5, P07814, Q14974, Q01105, P21980, 92 710 13528 2.4852 
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organization P17987, P07305, Q9NVA2, Q9BUF5, Q5SSJ5, Q16181 
Negative regulation of protein 
modification process 
5 5 0.008453 P48556, O43242, Q13200, Q01105, P62258 92 119 13528 6.1782 
Cell redox homeostasis 4 4 0.008741 P30041, P13667, Q14554, P09622 92 63 13528 9.3360 
Cellular macromolecular complex 
subunit organization 
8 8 0.010225 
Q07955, P0C0S5, Q14974, Q01105, P17987, P07305, 
Q9BUF5, Q5SSJ5 
92 357 13528 3.2950 
Protein amino acid glycosylation 5 5 0.010851 Q8TCJ2, Q16706, P04843, Q9H0U3, P46977 92 128 13528 5.7438 
Biopolymer glycosylation 5 5 0.010851 Q8TCJ2, Q16706, P04843, Q9H0U3, P46977 92 128 13528 5.7438 
Glycosylation 5 5 0.010851 Q8TCJ2, Q16706, P04843, Q9H0U3, P46977 92 128 13528 5.7438 
Response to unfolded protein 4 4 0.012106 P11142, O00299, P08238, P04792 92 71 13528 8.2841 
Anti-apoptosis 6 6 0.01261 P21980, P14625, P09429, P07996, P04792, P38646 92 206 13528 4.2828 
Peptide cross-linking 3 3 0.013097 P21980, P02461, P07996 92 26 13528 16.966 
Regulation of cell adhesion 5 5 0.013651 P21980, P17301, P02452, P07996, Q53GQ0 92 137 13528 5.3665 
Postranscriptional regulation of gene 
expression 
6 6 0.013868 P11940, P17301, Q9UQ80, Q00839, P07996, P04792 92 211 13528 4.1813 
Acetyl-CoA metabolic process 3 3 0.018337 P36957, P09622, O75390 92 31 13528 14.230 
Nucleosome assembly 4 4 0.018964 P0C0S5, Q01105, P07305, Q5SSJ5 92 84 13528 7.0020 
Protein import into nucleus 4 4 0.020175 P09038, Q14974, Q9Y2X3, P62826 92 86 13528 6.8392 
Positive regulation of cellular protein 
metabolic process 
6 6 0.020409 P09038, P48556, O43242, Q13200, P17301, P07996 92 233 13528 3.7865 
Chromatin assembly 4 4 0.020796 P0C0S5, Q01105, P07305, Q5SSJ5 92 87 13528 6.7606 
Nuclear import 4 4 0.021427 P09038, Q14974, Q9Y2X3, P62826 92 88 13528 6.6837 
Dicarboxylic acid metabolic process 3 3 0.021837 P36957, P09622, O75390 92 34 13528 12.974 
Glycoprotein biosynthetic process 5 5 0.021859 Q8TCJ2, Q16706, P04843, Q9H0U3, P46977 92 158 13528 4.6532 
Cell-matrix adhesion 4 4 0.022069 Q14112, P17301, Q9Y3I0, P02461 92 89 13528 6.6086 
Protein-DNA complex assembly 4 4 0.023384 P0C0S5, Q01105, P07305, Q5SSJ5 92 91 13528 6.4634 
Positive regulation of protein metabolic 
process 
6 6 0.023955 P09038, P48556, O43242, Q13200, P17301, P07996 92 243 13528 3.6307 
rRNA processing 4 4 0.024058 Q9Y2X3, P62081, Q9UQ80, O00567 92 92 13528 6.3931 
Nucleosome organization 4 4 0.024741 P0C0S5, Q01105, P07305, Q5SSJ5 92 93 13528 6.3244 
Negative regulation of macromolecule 
metabolic process 
11 11 0.025376 
P09038, P48556, O43242, P27348, Q13200, Q01105, P08238, 
P62258, Q9UQ80, P09429, P07996 
92 734 13528 2.2036 
Protein localization in nucleus 4 4 0.025436 P09038, Q14974, Q9Y2X3, P62826 92 94 13528 6.2571 
rRNA metabolic process 4 4 0.026855 Q9Y2X3, P62081, Q9UQ80, O00567 92 96 13528 6.1268 
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Cell-substrate adhesion 4 4 0.028317 Q14112, P17301, Q9Y3I0, P02461 92 98 13528 6.0017 
Proteasomal ubiquitin-dependent protein 
catabolic process 
4 4 0.031364 P48556, O43242, Q13200, P14625 92 102 13528 5.7664 
Proteasomal protein catabolic process 4 4 0.031364 P48556, O43242, Q13200, P14625 92 102 13528 5.7664 
Ribonucleoprotein complex biogenesis 5 5 0.033135 Q07955, Q9Y2X3, P62081, Q9UQ80, O00567 92 180 13528 4.0845 
Collagen biosynthetic process 2 2 0.033189 P02452, P02461 92 5 13528 58.817 
Regulation of cell-substrate adhesion 3 3 0.038255 P02452, P07996, Q53GQ0 92 46 13528 9.5897 
Acetyl-CoA biosynthetic process 2 2 0.039695 P36957, P09622 92 6 13528 49.014 
Response to nutrient levels 5 5 0.043805 P48681, O00299, P17301, P02786, P02452 92 197 13528 3.7320 
DNA packaging 4 4 0.044256 P0C0S5, Q01105, P07305, Q5SSJ5 92 117 13528 5.0271 
Glycoprotein metabolic process 5 5 0.047271 Q8TCJ2, Q16706, P04843, Q9H0U3, P46977 92 202 13528 3.6396 
Regulation of protein catabolic process 3 3 0.047765 O43242, Q13200, P08238 92 52 13528 8.4832 
Regulation of protein modification 
process 
6 6 0.048688 P09038, P48556, O43242, Q13200, Q01105, P62258 92 295 13528 2.9907 
Ribosome biogenesis 4 4 0.049057 Q9Y2X3, P62081, Q9UQ80, O00567 92 122 13528 4.8210 
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Table IX: Biological processes enriched from host proteins significantly overexpressed in N. caninum infection at 36 hr p.i. 
Biological processes Count % P-value Genes List 
total 
Pop. 
hits 
Pop. 
total 
Fold 
enrichment 
Generation of precursor metabolites 
and energy 
11 11 3.48E-05 
Q5JWF2, P31040, P04406, P60174, P49821, P00558, 
P06733, P07954, O75390, P22695, P17858 
89 313 13528 5.342 
Glycolysis  5 5 2.41E-04 P04406, P60174, P00558, P06733, P17858 89 47 13528 16.17 
Translational elongation 6 6 5.04E-04 P26641, P61513, P46778, P35268, P62841, P27635 89 101 13528 9.03 
Glucose catabolic process 5 5 5.43E-04 P04406, P60174, P00558, P06733, P17858 89 58 13528 13.1 
Hexose catabolic process 5 5 0.001472 P04406, P60174, P00558, P06733, P17858 89 69 13528 11.01 
Monosaccharide catabolic process 5 5 0.0011654 P04406, P60174, P00558, P06733, P17858 89 71 13528 10.7 
Aerobic respiration 4 4 0.0014977 P31040, P07954, O75390, P22695 89 35 13528 17.37 
Alcohol catabolic process 5 5 0.0018996 P04406, P60174, P00558, P06733, P17858 89 81 13528 9.383 
Cellular carbohydrate catabolic 
process 
5 5 0.0022668 P04406, P60174, P00558, P06733, P17858 89 85 13528 8.941 
Energy derivation by oxidation of 
organic compounds 
6 6 0.00246 Q5JWF2, P31040, P49821, P07954, O75390, P22695 89 144 13528 6.333 
Cellular respiration 5 5 0.0036569 P31040, P49821, P07954, O75390, P22695 89 97 13528 7.835 
Carbohydrate catabolic process 5 5 0.0055361 P04406, P60174, P00558, P06733, P17858 89 109 13528 6.972 
Cell redox homeostasis 4 4 0.0079737 P30041, P13667, Q15084, P32119 89 63 13528 9.651 
Tricarboxylic acid cycle 3 3 0.0096858 P31040, P07954, O75390 89 23 13528 19.83 
Acetyl-CoA catabolic process 3 3 0.0096858 P31040, P07954, O75390 89 23 13528 19.83 
Protein transport 12 12 0.0102774 
Q5JWF2, P13667, P27348, O75396, Q01082, P62258, 
P46459, Q9Y5X1, Q15363, P27797, O43707, P61981 
89 762 13528 2.394 
Establishment of protein localization 12 12 0.0109586 
Q5JWF2, P13667, P27348, O75396, Q01082, P62258, 
P46459, Q9Y5X1, Q15363, P27797, O43707, P61981 
89 769 13528 2.372 
Coenzyme catabolic process 3 3 0.0122863 P31040, P07954, O75390 89 26 13528 17.54 
Acetyl-CoA metabolic process 3 3 0.017214 P31040, P07954, O75390 89 31 13528 14.71 
Cofactor catabolic process 3 3 0.017214 P31040, P07954, O75390 89 31 13528 14.71 
Glucose metabolic process 5 5 0.0176227 P04406, P60174, P00558, P06733, P17858 89 153 13528 4.967 
Coenzyme metabolic process 5 5 0.0176227 P31040, P60174, O00764, P07954, O75390 89 153 13528 4.967 
Dicarboxylic acid metabolic process 3 3 0.0205088 P31040, P07954, O75390 89 34 13528 13.41 
Translation 7 7 0.0207888 P26641, P61513, P46778, P35268, Q9NSE4, P62841, 89 331 13528 3.215 
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P27635 
Regulation of neurogenesis 5 5 0.022999 P12956, P27797, P13010, P61158, P61981 89 166 13528 4.578 
Intracellular transport 10 10 0.0267528 
Q5JWF2, P27348, O75396, P09936, Q01082, P62258, 
Q9Y5X1, P27797, P62841, P61981 
89 657 13528 2.314 
Protein localization 12 12 0.0274781 
Q5JWF2, P13667, P27348, O75396, Q01082, P62258, 
P46459, Q9Y5X1, Q15363, P27797, O43707, P61981 
89 882 13528 2.068 
Protein folding 5 5 0.0282516 Q15084, Q9NYU2, P48643, P27797, O60884 89 177 13528 4.294 
Regulation of nervous system 
development 
5 5 0.0364823 P12956, P27797, P13010, P61158, P61981 89 192 13528 3.958 
Hexose metabolic process 5 5 0.0364823 P04406, P60174, P00558, P06733, P17858 89 192 13528 3.958 
Cofactor metabolic process 5 5 0.0382782 P31040, P60174, O00764, P07954, O75390 89 195 13528 3.897 
Regulation of cell development 5 5 0.0446271 P12956, P27797, P13010, P61158, P61981 89 205 13528 3.707 
Posttranscriptional regulation of gene 
expression 
5 5 0.0487042 Q7KZF4, P67809, Q92616, P27797, Q9UQ80 89 211 13528 3.602 
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Table X: Biological processes enriched from host proteins significantly overexpressed in T. gondii infection at 36 hr p.i. 
Biological processes Count % P-value Genes List 
total 
Pop. 
hits 
Pop. 
total 
Fold 
enrichment 
Translational elongation 25 22 1.85E-30 
P18124, P62750, Q07020, P62280, P62249, P62424, P84098, P62269, 
P61247, P62241, P62829, P47914, P61313, P62854, P62851, P46782, 
P46781, P15880, Q02543, P42766, P62913, P61254, Q02878, P18077, 
P40429 
100 101 13528 33.49 
Translation 28 24 2.90E-21 
P18124, P14868, P62750, Q07020, P62280, P62249, P62424, P84098, 
P62269, P61247, P62241, P62829, P47914, P61313, O00425, P62854, 
P62851, P46782, P46781, P15880, Q02543, P42766, P62913, P07814, 
P61254, Q02878, P18077, P40429 
100 331 13528 11.44 
Ribosome biogenesis 8 7 3.06E-05 P62249, P18124, P62424, P61254, P62913, P18077, O00567, P22087 100 122 13528 8.871 
Ribosomal large subunit 
biogenesis 
4 3 4.40E-05 P18124, P61254, P62913, P18077 100 10 13528 54.11 
rRNA processing 7 6 5.66E-05 P62249, P18124, P61254, P62913, P18077, O00567, P22087 100 92 13528 10.29 
rRNA metabolic process 7 6 7.19E-05 P62249, P18124, P61254, P62913, P18077, O00567, P22087 100 96 13528 9.864 
RNA processing 14 12 1.71E-04 
P18124, P62913, P17844, P31943, O00567, Q92841, P22087, P62249, 
P11940, Q08170, P61254, O75400, P18077, Q15365 
100 547 13528 3.462 
ncRNA metabolic 
process 
9 8 2.80E-04 
P62249, P18124, P07814, P14868, P61254, P62913, P18077, O00567, 
P22087 
100 230 13528 5.294 
Ribonucleoprotein 
complex biogenesis 
8 7 3.49E-04 P62249, P18124, P62424, P61254, P62913, P18077, O00567, P22087 100 180 13528 6.012 
Establishment of protein 
localization 
16 14 4.50E-04 
P61204, Q14974, Q9Y3Q3, Q9UL25, P61026, P02452, Q9H444, 
P62913, P43307, P35579, P38646, P61106, P17301, P48444, P62829, 
P62826 
100 769 13528 2.815 
Protein localization 17 15 6.34E-04 
P61204, Q14974, Q9Y3Q3, Q9UL25, P60033, P61026, P02452, 
Q9H444, P62913, P43307, P35579, P38646, P61106, P17301, P48444, 
P62829, P62826 
100 882 13528 2.607 
Positive regulation of 
endocytosis 
4 3 
0.001209
9 
P17301, P01024, P08962, Q08431 100 29 13528 18.66 
Protein transport 15 13 
0.001263
4 
P61204, Q14974, Q9Y3Q3, Q9UL25, P61026, P02452, Q9H444, 
P62913, P43307, P35579, P38646, P61106, P48444, P62829, P62826 
100 762 13528 2.663 
Protein folding 7 6 0.001890 P23284, P78371, P17987, P30533, Q9UBS4, Q9Y230, P38646 100 177 13528 5.35 
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8 
ncRNA processing 7 6 
0.002491
8 
P62249, P18124, P61254, P62913, P18077, O00567, P22087 100 187 13528 5.064 
Positive regulation of 
phagocytosis 
3 3 
0.003335
9 
P17301, P01024, Q08431 100 12 13528 33.82 
Regulation of 
phagocytosis 
3 3 
0.005950
8 
P17301, P01024, Q08431 100 16 13528 25.37 
Intracellular transport 12 10 
0.008467
2 
Q969X5, P61106, Q14974, P12236, P62829, P48444, P02792, 
P62913, P62826, P43307, P35579, P38646 
100 657 13528 2.471 
Positive regulation of cell 
adhesion 
4 3 
0.009623
1 
P21980, P17301, P07996, Q53GQ0 100 60 13528 9.019 
Regulation of 
endocytosis 
4 3 
0.010067
9 
P17301, P01024, P08962, Q08431 100 61 13528 8.871 
Positive regulation of 
response to external 
stimulus 
4 3 
0.011473
4 
P21980, P17301, P01024, P07996 100 64 13528 8.455 
Regulation of cell 
adhesion 
5 4 
0.018081
2 
P21980, P17301, P02452, P07996, Q53GQ0 100 137 13528 4.937 
Regulation of 
inflammatory response 
4 3 
0.018182
6 
P21980, P17301, P01024, P01023 100 76 13528 7.12 
Collagen fibril 
organization 
3 3 
0.018930
4 
P02452, P50454, P08123 100 29 13528 13.99 
Positive regulation of 
inflammatory response 
3 3 
0.020187
1 
P21980, P17301, P01024 100 30 13528 13.53 
Protein targeting 6 5 
0.020765
3 
Q14974, P62829, P62913, P62826, P43307, P38646 100 215 13528 3.775 
Ribosomal protein import 
into nucleus 
2 2 
0.021795
8 
Q14974, P62829 100 3 13528 90.19 
Negative regulation of 
protein maturation by 
peptide bond cleavage 
2 2 0.028956 P07996, P01023 100 4 13528 67.64 
Skin morphogenesis 2 2 0.028956 P02452, P08123 100 4 13528 67.64 
Regulation of response to 
external stimulus 
5 4 
0.029262
7 
P21980, P17301, P01024, P07996, P01023 100 159 13528 4.254 
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Positive regulation of cell 
proliferation 
8 7 
0.032109
7 
P21980, P17301, P60033, P06703, Q13488, P43307, Q08431, P46781 100 414 13528 2.614 
Regulation of vesicle-
mediated transport 
4 3 
0.033306
8 
P17301, P01024, P08962, Q08431 100 96 13528 5.637 
Blood vessel 
development 
6 5 
0.033888
7 
P21980, P02452, P07996, Q6UVK1, P35579, P08123 100 245 13528 3.313 
Collagen biosynthetic 
process 
2 2 
0.036064
4 
P02452, P50454 100 5 13528 54.11 
Vasculature development 6 5 
0.037015
4 
P21980, P02452, P07996, Q6UVK1, P35579, P08123 100 251 13528 3.234 
Extracellular matrix 
organization 
4 3 
0.040730
1 
P02452, P50454, P08123, Q53GQ0 100 104 13528 5.203 
Negative regulation of 
cellular protein metabolic 
process 
5 4 
0.043062
2 
P48556, P62333, O00425, P07996, P01023 100 180 13528 3.758 
Regulation of protein 
maturation by peptide 
bond cleavage 
2 2 
0.043121
2 
P07996, P01023 100 6 13528 45.09 
Regulation of protein 
processing 
2 2 
0.043121
2 
P07996, P01023 100 6 13528 45.09 
Positive regulation of 
cellular component 
organization 
5 4 
0.043796
9 
P17301, P01024, P08962, Q08431, P60981 100 181 13528 3.737 
Regulation of cell-
substrate adhesion 
3 3 
0.044553
8 
P02452, P07996, Q53GQ0 100 46 13528 8.823 
Negative regulation of 
protein metabolic process 
5 4 
0.048353
3 
P48556, P62333, O00425, P07996, P01023 100 187 13528 3.617 
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